1	Available	JJ	O	available	amod	2	SENT_1	[p1l673t81r824b111],
2	online	NN	O	online	_	0	SENT_1	[p1l834t81r938b111],
3	at	IN	O	at	_	0	SENT_1	[p1l949t86r980b111],
4	www.sciencedirect.com	NNP	O	www.sciencedirect.com	prep_at	2	SENT_1	[p1l989t81r1385b111],

1	ScIENcE@DIRECT°	NNP	O	ScIENcE@DIRECT°	nn	4	SENT_2	[p1l804t132r1255b223],
2	Dmmmm	NNP	O	Dmmmm	nn	4	SENT_2	[p1l1696t148r2048b212],
3	Mmcm	NNP	O	Mmcm	nn	4	SENT_2	[p1l1696t148r2048b212],
4	CEHNHCM	NNP	O	CEHNHCM	_	0	SENT_2	[p1l1703t224r1856b251],
5	.	.	O	.	_	0	SENT_2	[p1l1703t224r1856b251],

1	1P	NN	O	1p	dep	7	SENT_3	[p1l1879t223r2040b251],
2	]	CD	NUMBER	]	num	3	SENT_3	[p1l1879t223r2040b251],
3	RA	NN	O	ra	dep	1	SENT_3	[p1l1879t223r2040b251],
4	<	JJR	O	<	amod	5	SENT_3	[p1l1879t223r2040b251],
5	C‘Il	NN	O	c‘il	dep	7	SENT_3	[p1l1879t223r2040b251],
6	‘	CD	NUMBER	‘	num	7	SENT_3	[p1l1879t223r2040b251],
7	1I	NN	O	1us	_	0	SENT_3	[p1l1879t223r2040b251],
8	<	JJR	O	<	amod	9	SENT_3	[p1l1879t223r2040b251],
9	ClB	NN	O	clb	dep	7	SENT_3	[p1l1879t223r2040b251],

1	ELSEVIER	NNP	ORGANIZATION	ELSEVIER	nn	3	SENT_4	[p1l111t296r331b331],
2	Diabetes	NNP	ORGANIZATION	Diabetes	nn	3	SENT_4	[p1l614t307r729b330],
3	Research	NNP	ORGANIZATION	Research	dep	8	SENT_4	[p1l741t307r863b330],
4	and	CC	O	and	_	0	SENT_4	[p1l875t307r922b330],
5	Clinical	JJ	O	clinical	amod	6	SENT_4	[p1l934t307r1038b331],
6	Practice	NN	O	practice	dep	8	SENT_4	[p1l1050t307r1156b330],
7	72	CD	NUMBER	72	dep	8	SENT_4	[p1l1168t307r1200b330],
8	(	CD	NUMBER	(	dep	11	SENT_4	[p1l1213t307r1299b336],
9	2006	CD	DATE	2006	dep	8	SENT_4	[p1l1213t307r1299b336],
10	)	CD	NUMBER	)	num	11	SENT_4	[p1l1213t307r1299b336],
11	148-154	CD	NUMBER	148-154	_	0	SENT_4	[p1l1315t307r1427b331],

1	www.elsevier.com/locate/diabres	NNS	O	www.elsevier.com/locate/diabres	_	0	SENT_5	[p1l1612t346r2049b370],

1	Effect	NN	O	effect	_	0	SENT_6	[p1l245t445r416b494],
2	of	IN	O	of	_	0	SENT_6	[p1l442t445r503b494],
3	C	NN	O	c	nn	4	SENT_6	[p1l527t446r571b495],
4	YP2C9	NN	O	yp2c9	prep_of	1	SENT_6	[p1l575t445r769b495],
5	genetic	JJ	O	genetic	amod	6	SENT_6	[p1l795t445r995b509],
6	polymorphisms	NNS	O	polymorphism	dep	1	SENT_6	[p1l1022t445r1459b509],
7	on	IN	O	on	_	0	SENT_6	[p1l1487t461r1554b494],
8	the	DT	O	the	det	9	SENT_6	[p1l1580t445r1664b494],
9	efﬁcacy	NN	O	efﬁcacy	prep_on	6	SENT_6	[p1l1691t445r1911b509],
10	and	CC	O	and	_	0	SENT_6	[p1l387t528r486b578],
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	6	SENT_6	[p1l510t528r1007b592],
12	of	IN	O	of	_	0	SENT_6	[p1l1035t528r1096b578],
13	glimepiride	NN	O	glimepiride	prep_of	9	SENT_6	[p1l1118t528r1441b592],
14	in	IN	O	in	_	0	SENT_6	[p1l1467t528r1521b577],
15	subjects	NNS	O	subject	prep_in	13	SENT_6	[p1l1548t528r1770b592],
16	with	IN	O	with	_	0	SENT_6	[p1l787t611r910b661],
17	type	NN	O	type	amod	19	SENT_6	[p1l936t618r1055b675],
18	2	CD	NUMBER	2	number	17	SENT_6	[p1l1082t611r1114b660],
19	diabetes	NNS	O	diabetes	prep_with	15	SENT_6	[p1l1141t611r1369b660],

1	Kazuko	NNP	PERSON	Kazuko	nn	2	SENT_7	[p1l410t723r575b761],
2	Suzuki	NNP	PERSON	Suzuki	_	0	SENT_7	[p1l597t723r743b761],
3	a	DT	O	a	det	5	SENT_7	[p1l755t719r811b768],
4	’	JJ	O	’	amod	5	SENT_7	[p1l755t719r811b768],
5	°	NN	O	°	dep	2	SENT_7	[p1l755t719r811b768],
6	,	,	O	,	_	0	SENT_7	[p1l755t719r811b768],
7	Tatsuo	NNP	PERSON	Tatsuo	nn	9	SENT_7	[p1l832t724r974b761],
8	Yanagawa	NNP	PERSON	Yanagawa	nn	9	SENT_7	[p1l994t724r1216b772],
9	b	NN	O	b	appos	5	SENT_7	[p1l1225t711r1255b768],
10	,	,	O	,	_	0	SENT_7	[p1l1225t711r1255b768],
11	Toshiaki	NNP	PERSON	Toshiaki	nn	13	SENT_7	[p1l1277t723r1460b761],
12	Shibasaki	NNP	PERSON	Shibasaki	nn	13	SENT_7	[p1l1482t719r1728b768],
13	°	NNP	O	°	appos	5	SENT_7	[p1l1482t719r1728b768],
14	,	,	O	,	_	0	SENT_7	[p1l1482t719r1728b768],
15	Nahoko	NNP	PERSON	Nahoko	nn	17	SENT_7	[p1l414t786r583b824],
16	Kaniwa	NNP	PERSON	Kaniwa	nn	17	SENT_7	[p1l604t786r771b824],
17	d	NN	O	d	appos	5	SENT_7	[p1l781t774r811b831],
18	,	,	O	,	_	0	SENT_7	[p1l781t774r811b831],
19	Ryuichi	NNP	PERSON	Ryuichi	nn	21	SENT_7	[p1l832t786r1002b835],
20	Hasegawa	NNP	PERSON	Hasegawa	nn	21	SENT_7	[p1l1022t787r1242b835],
21	d	NN	O	d	appos	5	SENT_7	[p1l1252t774r1282b830],
22	,	,	O	,	_	0	SENT_7	[p1l1252t774r1282b830],
23	Masahiro	NNP	PERSON	Masahiro	nn	26	SENT_7	[p1l1303t786r1505b824],
24	Tohkin	NNP	PERSON	Tohkin	nn	26	SENT_7	[p1l1525t786r1677b824],
25	d’	NN	O	d’	nn	26	SENT_7	[p1l1687t774r1740b804],
26	*	NN	O	*	appos	5	SENT_7	[p1l1687t774r1740b804],

1	“	NNP	O	“	nn	2	SENT_8	[p1l471t866r646b898],
2	Department	NNP	ORGANIZATION	Department	_	0	SENT_8	[p1l471t866r646b898],
3	of	IN	ORGANIZATION	of	_	0	SENT_8	[p1l657t868r687b898],
4	Pharmacy	NNP	ORGANIZATION	Pharmacy	prep_of	2	SENT_8	[p1l693t868r832b898],
5	,	,	O	,	_	0	SENT_8	[p1l693t868r832b898],
6	Nerima	NNP	ORGANIZATION	Nerima	nn	8	SENT_8	[p1l846t869r946b892],
7	General	NNP	ORGANIZATION	General	nn	8	SENT_8	[p1l959t868r1066b892],
8	Hospital	NNP	ORGANIZATION	Hospital	appos	4	SENT_8	[p1l1076t868r1196b898],
9	,	,	O	,	_	0	SENT_8	[p1l1076t868r1196b898],
10	Nerima-kn	NN	O	nerima-kn	appos	4	SENT_8	[p1l1209t868r1357b895],
11	,	,	O	,	_	0	SENT_8	[p1l1209t868r1357b895],
12	Tokyo	NNP	LOCATION	Tokyo	appos	4	SENT_8	[p1l1373t868r1449b898],
13	176-8530	CD	NUMBER	176-8530	num	12	SENT_8	[p1l1462t868r1593b895],
14	,	,	O	,	_	0	SENT_8	[p1l1462t868r1593b895],
15	Japan	NNP	LOCATION	Japan	nn	16	SENT_8	[p1l1607t869r1687b898],
16	bDepartment	NNP	O	bDepartment	appos	4	SENT_8	[p1l416t902r593b939],
17	of	IN	O	of	_	0	SENT_8	[p1l604t909r634b939],
18	Internal	NNP	ORGANIZATION	Internal	nn	19	SENT_8	[p1l640t909r747b933],
19	Medicine	NNP	ORGANIZATION	Medicine	prep_of	16	SENT_8	[p1l758t909r887b936],
20	,	,	O	,	_	0	SENT_8	[p1l758t909r887b936],
21	Nerima	NNP	ORGANIZATION	Nerima	nn	23	SENT_8	[p1l901t910r1000b933],
22	General	NNP	ORGANIZATION	General	nn	23	SENT_8	[p1l1013t909r1120b933],
23	Hospital	NNP	ORGANIZATION	Hospital	appos	4	SENT_8	[p1l1131t909r1250b939],
24	,	,	O	,	_	0	SENT_8	[p1l1131t909r1250b939],
25	Nerima-kn	NN	O	nerima-kn	appos	4	SENT_8	[p1l1264t909r1411b936],
26	,	,	O	,	_	0	SENT_8	[p1l1264t909r1411b936],
27	Tokyo	NNP	LOCATION	Tokyo	appos	4	SENT_8	[p1l1428t909r1503b939],
28	176-8530	CD	NUMBER	176-8530	num	27	SENT_8	[p1l1517t909r1647b936],
29	,	,	O	,	_	0	SENT_8	[p1l1517t909r1647b936],
30	Japan	NNP	LOCATION	Japan	appos	4	SENT_8	[p1l1661t910r1741b939],

1	°	NN	O	°	nn	2	SENT_9	[p1l361t947r489b973],
2	Division	NN	O	division	_	0	SENT_9	[p1l361t947r489b973],
3	of	IN	O	of	_	0	SENT_9	[p1l501t949r532b979],
4	Pharmacotherapentics	NNP	O	Pharmacotherapentics	prep_of	2	SENT_9	[p1l538t949r844b979],
5	,	,	O	,	_	0	SENT_9	[p1l538t949r844b979],
6	Kyoritsu	NNP	ORGANIZATION	Kyoritsu	nn	7	SENT_9	[p1l859t950r971b979],
7	University	NNP	ORGANIZATION	University	appos	4	SENT_9	[p1l986t950r1121b979],
8	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l1133t949r1163b979],
9	Pharmacy	NNP	ORGANIZATION	Pharmacy	prep_of	7	SENT_9	[p1l1170t949r1309b979],
10	,	,	O	,	_	0	SENT_9	[p1l1170t949r1309b979],
11	Minato	NNP	O	Minato	nn	13	SENT_9	[p1l1323t949r1467b976],
12	—	CD	NUMBER	—	num	13	SENT_9	[p1l1323t949r1467b976],
13	ku	NN	O	ku	appos	9	SENT_9	[p1l1323t949r1467b976],
14	,	,	O	,	_	0	SENT_9	[p1l1323t949r1467b976],
15	Tokyo	NNP	LOCATION	Tokyo	appos	9	SENT_9	[p1l1483t949r1558b979],
16	105-8512	CD	NUMBER	105-8512	num	15	SENT_9	[p1l1572t950r1702b976],
17	,	,	O	,	_	0	SENT_9	[p1l1572t950r1702b976],
18	Japan	NNP	LOCATION	Japan	nn	19	SENT_9	[p1l1716t950r1796b979],
19	dDivision	NNP	O	dDivision	appos	9	SENT_9	[p1l550t983r680b1014],
20	of	IN	O	of	_	0	SENT_9	[p1l692t991r722b1020],
21	Medicinal	NNP	ORGANIZATION	Medicinal	nn	23	SENT_9	[p1l728t990r863b1014],
22	Safety	NNP	ORGANIZATION	Safety	nn	23	SENT_9	[p1l875t991r955b1020],
23	Science	NNP	ORGANIZATION	Science	prep_of	19	SENT_9	[p1l967t991r1073b1018],
24	,	,	O	,	_	0	SENT_9	[p1l967t991r1073b1018],
25	National	NNP	ORGANIZATION	National	nn	26	SENT_9	[p1l1087t990r1204b1014],
26	Institute	NNP	ORGANIZATION	Institute	appos	9	SENT_9	[p1l1215t991r1323b1014],
27	of	IN	ORGANIZATION	of	_	0	SENT_9	[p1l1336t991r1366b1020],
28	Health	NNP	ORGANIZATION	Health	nn	29	SENT_9	[p1l1372t990r1462b1014],
29	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	26	SENT_9	[p1l1474t991r1593b1018],
30	,	,	O	,	_	0	SENT_9	[p1l1474t991r1593b1018],

1	Setagaya-ku	NN	O	setagaya-ku	nn	3	SENT_10	[p1l830t1031r998b1061],
2	,	,	O	,	_	0	SENT_10	[p1l830t1031r998b1061],
3	Tokyo	NNP	LOCATION	Tokyo	_	0	SENT_10	[p1l1014t1031r1090b1061],
4	158-8501	CD	NUMBER	158-8501	num	3	SENT_10	[p1l1103t1031r1234b1058],
5	,	,	O	,	_	0	SENT_10	[p1l1103t1031r1234b1058],
6	Japan	NNP	LOCATION	Japan	appos	3	SENT_10	[p1l1248t1032r1328b1061],

1	Received	VBN	O	receive	_	0	SENT_11	[p1l413t1072r536b1095],
2	2	CD	DATE	2	dobj	1	SENT_11	[p1l548t1072r563b1095],
3	December	NNP	DATE	December	tmod	1	SENT_11	[p1l575t1072r711b1095],
4	2004	CD	DATE	2004	num	3	SENT_11	[p1l723t1072r796b1099],
5	;	:	O	;	_	0	SENT_11	[p1l723t1072r796b1099],
6	received	VBN	O	receive	parataxis	1	SENT_11	[p1l809t1072r920b1095],
7	in	IN	O	in	_	0	SENT_11	[p1l932t1072r957b1095],
8	revised	JJ	O	revised	amod	9	SENT_11	[p1l969t1072r1064b1095],
9	form	NN	O	form	prep_in	6	SENT_11	[p1l1075t1072r1140b1095],
10	15	CD	DATE	15	num	9	SENT_11	[p1l1154t1072r1182b1095],
11	June	NNP	DATE	June	tmod	9	SENT_11	[p1l1195t1072r1255b1095],
12	2005	CD	DATE	2005	num	11	SENT_11	[p1l1267t1072r1340b1099],
13	;	:	O	;	_	0	SENT_11	[p1l1267t1072r1340b1099],
14	accepted	VBN	O	accept	parataxis	1	SENT_11	[p1l1354t1072r1469b1102],
15	20	CD	DATE	20	dobj	14	SENT_11	[p1l1481t1072r1513b1095],
16	September	NNP	DATE	September	tmod	14	SENT_11	[p1l1526t1072r1667b1102],
17	2005	CD	DATE	2005	num	16	SENT_11	[p1l1679t1072r1742b1095],

1	Available	JJ	O	available	amod	2	SENT_12	[p1l843t1113r968b1137],
2	online	NN	O	online	_	0	SENT_12	[p1l980t1113r1062b1137],
3	1	CD	DATE	1	dep	2	SENT_12	[p1l1077t1114r1087b1137],
4	December	NNP	DATE	December	tmod	3	SENT_12	[p1l1101t1113r1238b1137],
5	2005	CD	DATE	2005	num	4	SENT_12	[p1l1250t1113r1313b1137],

1	Abstract	JJ	O	abstract	_	0	SENT_13	[p1l108t1229r246b1256],

1	Glimepiride	NNP	O	Glimepiride	nsubjpass	9	SENT_14	[p1l158t1300r346b1334],
2	,	,	O	,	_	0	SENT_14	[p1l158t1300r346b1334],
3	a	DT	O	a	det	6	SENT_14	[p1l359t1308r374b1326],
4	sulfonylurea	NN	O	sulfonylurea	nn	6	SENT_14	[p1l386t1300r571b1334],
5	hypoglycemic	JJ	O	hypoglycemic	amod	6	SENT_14	[p1l581t1300r792b1334],
6	agent	NN	O	agent	appos	1	SENT_14	[p1l805t1304r892b1334],
7	,	,	O	,	_	0	SENT_14	[p1l805t1304r892b1334],
8	is	VBZ	O	be	auxpass	9	SENT_14	[p1l904t1300r928b1326],
9	metabolized	VBN	O	metabolize	_	0	SENT_14	[p1l939t1300r1122b1326],
10	by	IN	O	by	_	0	SENT_14	[p1l1132t1300r1169b1334],
11	cytochrome	NN	O	cytochrome	nn	16	SENT_14	[p1l1180t1300r1355b1334],
12	P450	NN	O	p450	nn	16	SENT_14	[p1l1366t1300r1442b1327],
13	2C9	NN	O	2c9	nn	16	SENT_14	[p1l1453t1300r1513b1327],
14	(	CD	NUMBER	(	num	16	SENT_14	[p1l1526t1300r1683b1333],
15	CYPZC9	NN	O	cypzc9	nn	16	SENT_14	[p1l1526t1300r1683b1333],
16	)	NN	O	)	agent	9	SENT_14	[p1l1526t1300r1683b1333],
17	which	WDT	O	which	nsubjpass	19	SENT_14	[p1l1695t1300r1785b1326],
18	is	VBZ	O	be	auxpass	19	SENT_14	[p1l1796t1300r1819b1326],
19	known	VBN	O	know	rcmod	16	SENT_14	[p1l1830t1300r1931b1327],
20	to	TO	O	to	aux	21	SENT_14	[p1l1941t1304r1969b1326],
21	have	VB	O	have	xcomp	19	SENT_14	[p1l1980t1300r2049b1326],
22	genetic	JJ	O	genetic	amod	23	SENT_14	[p1l108t1345r215b1379],
23	polymorphisms	NNS	O	polymorphism	dobj	21	SENT_14	[p1l228t1345r467b1379],
24	.	.	O	.	_	0	SENT_14	[p1l228t1345r467b1379],

1	To	TO	O	to	aux	2	SENT_15	[p1l482t1345r519b1371],
2	examine	VB	O	examine	purpcl	30	SENT_15	[p1l533t1345r658b1371],
3	the	DT	O	the	det	4	SENT_15	[p1l671t1345r716b1371],
4	effects	NNS	O	effect	dobj	2	SENT_15	[p1l729t1345r826b1371],
5	of	IN	O	of	_	0	SENT_15	[p1l840t1345r872b1371],
6	C	NN	O	c	nn	9	SENT_15	[p1l884t1345r908b1372],
7	YPZC9	NN	O	ypzc9	nn	9	SENT_15	[p1l910t1345r1013b1372],
8	genetic	JJ	O	genetic	amod	9	SENT_15	[p1l1025t1345r1132b1379],
9	polymorphisms	NNS	O	polymorphism	prep_of	4	SENT_15	[p1l1145t1345r1376b1379],
10	on	IN	O	on	_	0	SENT_15	[p1l1390t1353r1426b1371],
11	the	DT	O	the	det	12	SENT_15	[p1l1439t1345r1483b1371],
12	safety	NN	O	safety	prep_on	2	SENT_15	[p1l1498t1345r1584b1379],
13	and	CC	O	and	_	0	SENT_15	[p1l1598t1345r1651b1371],
14	efﬁcacy	NN	O	efﬁcacy	conj_and	12	SENT_15	[p1l1664t1345r1780b1379],
15	of	IN	O	of	_	0	SENT_15	[p1l1794t1345r1826b1371],
16	glimepiride	NN	O	glimepiride	prep_of	12	SENT_15	[p1l1837t1345r2008b1379],
17	in	IN	O	in	_	0	SENT_15	[p1l2021t1345r2050b1371],
18	patients	NNS	O	patient	prep_in	2	SENT_15	[p1l107t1390r223b1424],
19	with	IN	O	with	_	0	SENT_15	[p1l233t1390r299b1416],
20	type	NN	O	type	nn	22	SENT_15	[p1l308t1394r371b1424],
21	2	CD	NUMBER	2	num	22	SENT_15	[p1l381t1390r398b1416],
22	diabetes	NN	O	diabetes	prep_with	18	SENT_15	[p1l408t1390r537b1421],
23	,	,	O	,	_	0	SENT_15	[p1l408t1390r537b1421],
24	the	DT	O	the	det	25	SENT_15	[p1l548t1390r593b1416],
25	responses	NNS	O	response	nsubjpass	30	SENT_15	[p1l602t1398r746b1424],
26	to	TO	O	to	_	0	SENT_15	[p1l756t1394r784b1416],
27	the	DT	O	the	det	28	SENT_15	[p1l794t1390r838b1416],
28	glimepiride	NN	O	glimepiride	prep_to	25	SENT_15	[p1l848t1390r1019b1424],
29	were	VBD	O	be	auxpass	30	SENT_15	[p1l1029t1398r1100b1416],
30	measured	VBN	O	measure	_	0	SENT_15	[p1l1109t1390r1252b1416],
31	in	IN	O	in	_	0	SENT_15	[p1l1261t1390r1290b1416],
32	Japanese	JJ	MISC	japanese	amod	36	SENT_15	[p1l1299t1390r1431b1424],
33	type	NN	O	type	nn	36	SENT_15	[p1l1440t1394r1504b1424],
34	2	CD	NUMBER	2	num	36	SENT_15	[p1l1514t1390r1531b1416],
35	diabetic	JJ	O	diabetic	amod	36	SENT_15	[p1l1541t1390r1658b1416],
36	patients	NNS	O	patient	prep_in	30	SENT_15	[p1l1667t1390r1783b1424],
37	with	IN	O	with	_	0	SENT_15	[p1l1793t1390r1859b1416],
38	the	DT	O	the	det	41	SENT_15	[p1l1868t1390r1912b1416],
39	different	JJ	O	different	amod	41	SENT_15	[p1l1922t1390r2050b1416],
40	CYPZC9	NN	O	cypzc9	nn	41	SENT_15	[p1l110t1435r238b1462],
41	genotype	NN	O	genotype	prep_with	30	SENT_15	[p1l248t1439r392b1469],
42	.	.	O	.	_	0	SENT_15	[p1l248t1439r392b1469],

1	The	DT	O	the	det	2	SENT_16	[p1l404t1435r461b1461],
2	reduction	NN	O	reduction	nsubj	33	SENT_16	[p1l471t1435r612b1461],
3	in	IN	O	in	_	0	SENT_16	[p1l623t1435r651b1461],
4	the	DT	O	the	det	5	SENT_16	[p1l661t1435r706b1461],
5	HbA1c	NN	O	hba1c	prep_in	2	SENT_16	[p1l716t1435r814b1468],
6	was	VBD	O	be	cop	33	SENT_16	[p1l825t1443r881b1462],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_16	[p1l893t1435r1076b1469],
8	larger	JJR	O	larger	amod	33	SENT_16	[p1l1087t1435r1174b1469],
9	(	CD	NUMBER	(	num	10	SENT_16	[p1l1184t1435r1218b1468],
10	P	NN	O	p	npadvmod	11	SENT_16	[p1l1184t1435r1218b1468],
11	<	JJR	O	<	amod	33	SENT_16	[p1l1230t1440r1253b1463],
12	0.05	CD	NUMBER	0.05	dep	11	SENT_16	[p1l1266t1435r1342b1468],
13	)	NN	O	)	dep	14	SENT_16	[p1l1266t1435r1342b1468],
14	among	IN	O	among	dep	12	SENT_16	[p1l1354t1443r1454b1469],
15	the	DT	O	the	dep	16	SENT_16	[p1l1464t1435r1509b1461],
16	CYP2C9	NN	O	cyp2c9	dep	18	SENT_16	[p1l1521t1435r1734b1462],
17	*	CD	NUMBER	*	num	16	SENT_16	[p1l1521t1435r1734b1462],
18	I	PRP	O	I	dep	14	SENT_16	[p1l1521t1435r1734b1462],
19	/	:	O	/	punct	18	SENT_16	[p1l1521t1435r1734b1462],
20	*	CD	NUMBER	*	number	21	SENT_16	[p1l1521t1435r1734b1462],
21	3	CD	NUMBER	3	num	22	SENT_16	[p1l1521t1435r1734b1462],
22	subjects	NNS	O	subject	npadvmod	23	SENT_16	[p1l1746t1435r1864b1469],
23	than	IN	O	than	dep	27	SENT_16	[p1l1875t1435r1938b1461],
24	among	IN	O	among	_	0	SENT_16	[p1l1949t1443r2049b1469],
25	the	DT	O	the	det	26	SENT_16	[p1l108t1480r152b1506],
26	C	NN	O	c	prep_among	23	SENT_16	[p1l173t1480r197b1507],
27	YP2C9	NN	O	yp2c9	dep	29	SENT_16	[p1l199t1480r350b1507],
28	*	CD	NUMBER	*	num	27	SENT_16	[p1l199t1480r350b1507],
29	I	PRP	O	I	dep	32	SENT_16	[p1l199t1480r350b1507],
30	/	:	O	/	punct	32	SENT_16	[p1l199t1480r350b1507],
31	*	CD	NUMBER	*	num	32	SENT_16	[p1l354t1480r384b1506],
32	1	CD	NUMBER	1	dep	18	SENT_16	[p1l354t1480r384b1506],
33	subjects	NNS	O	subject	_	0	SENT_16	[p1l406t1480r532b1514],
34	.	.	O	.	_	0	SENT_16	[p1l406t1480r532b1514],

1	The	DT	O	the	det	3	SENT_17	[p1l553t1480r610b1506],
2	long-term	JJ	O	long-term	amod	3	SENT_17	[p1l629t1480r776b1514],
3	observations	NNS	O	observation	dep	11	SENT_17	[p1l794t1480r981b1506],
4	of	IN	O	of	_	0	SENT_17	[p1l1000t1480r1033b1506],
5	2	CD	NUMBER	2	num	6	SENT_17	[p1l1049t1480r1066b1506],
6	patients	NNS	O	patient	prep_of	3	SENT_17	[p1l1085t1480r1200b1514],
7	with	IN	O	with	_	0	SENT_17	[p1l1220t1480r1285b1506],
8	a	DT	O	a	det	9	SENT_17	[p1l1305t1488r1320b1506],
9	C	NN	O	c	prep_with	6	SENT_17	[p1l1340t1480r1364b1507],
10	YP2C9	NN	O	yp2c9	dep	11	SENT_17	[p1l1366t1480r1517b1507],
11	*	CD	NUMBER	*	dep	15	SENT_17	[p1l1366t1480r1517b1507],
12	I	PRP	O	I	dep	11	SENT_17	[p1l1366t1480r1517b1507],
13	/	:	O	/	punct	15	SENT_17	[p1l1366t1480r1517b1507],
14	*	CD	NUMBER	*	num	15	SENT_17	[p1l1521t1480r1553b1506],
15	3	CD	NUMBER	3	_	0	SENT_17	[p1l1521t1480r1553b1506],
16	suggested	VBD	O	suggest	rcmod	15	SENT_17	[p1l1573t1480r1719b1514],
17	that	IN	O	that	complm	28	SENT_17	[p1l1737t1480r1793b1506],
18	subjects	NNS	O	subject	nsubj	28	SENT_17	[p1l1812t1480r1930b1514],
19	with	IN	O	with	prep	18	SENT_17	[p1l1950t1480r2015b1506],
20	a	DT	O	a	det	23	SENT_17	[p1l2035t1488r2050b1506],
21	C	NN	O	c	nn	23	SENT_17	[p1l110t1525r133b1552],
22	YPZC9	NN	O	ypzc9	nn	23	SENT_17	[p1l135t1525r238b1552],
23	*	NN	O	*	dep	19	SENT_17	[p1l243t1525r272b1551],
24	1	CD	NUMBER	1	dep	23	SENT_17	[p1l243t1525r272b1551],
25	/	:	O	/	punct	23	SENT_17	[p1l275t1525r286b1552],
26	*	CD	NUMBER	*	dep	23	SENT_17	[p1l291t1525r322b1551],
27	3	CD	NUMBER	3	dep	26	SENT_17	[p1l291t1525r322b1551],
28	respond	NN	O	respond	ccomp	16	SENT_17	[p1l333t1525r450b1559],
29	well	RB	O	well	advmod	28	SENT_17	[p1l461t1525r524b1551],
30	to	TO	O	to	_	0	SENT_17	[p1l534t1529r562b1551],
31	glimepiride	NN	O	glimepiride	prep_to	29	SENT_17	[p1l573t1525r744b1559],
32	during	IN	O	during	_	0	SENT_17	[p1l755t1525r851b1559],
33	the	DT	O	the	det	35	SENT_17	[p1l862t1525r906b1551],
34	initial	JJ	O	initial	amod	35	SENT_17	[p1l917t1525r1004b1551],
35	phase	NN	O	phase	prep_during	28	SENT_17	[p1l1014t1525r1098b1559],
36	of	IN	O	of	_	0	SENT_17	[p1l1109t1525r1141b1551],
37	treatment	NN	O	treatment	prep_of	35	SENT_17	[p1l1149t1529r1298b1556],
38	,	,	O	,	_	0	SENT_17	[p1l1149t1529r1298b1556],
39	but	CC	O	but	cc	43	SENT_17	[p1l1309t1525r1357b1551],
40	1	CD	NUMBER	1	num	41	SENT_17	[p1l1370t1525r1380b1551],
41	patient	NN	O	patient	nsubj	43	SENT_17	[p1l1393t1525r1496b1559],
42	have	VBP	O	have	aux	43	SENT_17	[p1l1505t1525r1574b1551],
43	shown	VBN	O	show	ccomp	16	SENT_17	[p1l1586t1525r1680b1551],
44	the	DT	O	the	det	46	SENT_17	[p1l1690t1525r1735b1551],
45	weight	NN	O	weight	nn	46	SENT_17	[p1l1745t1525r1846b1559],
46	gain	NN	O	gain	dobj	43	SENT_17	[p1l1856t1525r1920b1559],
47	over	IN	O	over	_	0	SENT_17	[p1l1930t1533r1995b1551],
48	the	DT	O	the	det	50	SENT_17	[p1l2004t1525r2049b1551],
49	long-term	JJ	O	long-term	amod	50	SENT_17	[p1l108t1570r255b1604],
50	treatment	NN	O	treatment	prep_over	43	SENT_17	[p1l267t1574r416b1597],
51	.	.	O	.	_	0	SENT_17	[p1l267t1574r416b1597],

1	The	DT	O	the	det	3	SENT_18	[p1l430t1570r487b1596],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_18	[p1l500t1570r749b1604],
3	study	NN	O	study	nsubj	4	SENT_18	[p1l763t1570r842b1604],
4	showed	VBD	O	show	_	0	SENT_18	[p1l856t1570r967b1597],
5	that	IN	O	that	advmod	4	SENT_18	[p1l980t1570r1036b1596],
6	the	DT	O	the	det	7	SENT_18	[p1l1048t1570r1092b1596],
7	area	NN	O	area	dobj	4	SENT_18	[p1l1106t1578r1167b1596],
8	under	IN	O	under	_	0	SENT_18	[p1l1180t1570r1265b1596],
9	the	DT	O	the	det	11	SENT_18	[p1l1277t1570r1321b1596],
10	concentration-time	JJ	O	concentration-time	amod	11	SENT_18	[p1l1334t1570r1616b1596],
11	curve	NN	O	curve	prep_under	7	SENT_18	[p1l1630t1578r1711b1596],
12	for	IN	O	for	_	0	SENT_18	[p1l1724t1570r1767b1596],
13	glimepiride	NN	O	glimepiride	prep_for	11	SENT_18	[p1l1779t1570r1951b1604],
14	in	IN	O	in	_	0	SENT_18	[p1l1964t1570r1992b1596],
15	the	DT	O	the	det	16	SENT_18	[p1l2004t1570r2049b1596],
16	CYP2C9	NN	O	cyp2c9	prep_in	13	SENT_18	[p1l110t1615r286b1642],
17	*	CD	NUMBER	*	number	18	SENT_18	[p1l110t1615r286b1642],
18	]	CD	NUMBER	]	num	16	SENT_18	[p1l110t1615r286b1642],
19	/	:	O	/	punct	22	SENT_18	[p1l110t1615r286b1642],
20	*	CD	NUMBER	*	number	21	SENT_18	[p1l291t1615r322b1641],
21	3	CD	NUMBER	3	num	22	SENT_18	[p1l291t1615r322b1641],
22	subjects	NNS	O	subject	dep	7	SENT_18	[p1l339t1615r457b1649],
23	was	VBD	O	be	cop	26	SENT_18	[p1l473t1624r530b1641],
24	approximately	RB	O	approximately	advmod	26	SENT_18	[p1l547t1615r761b1649],
25	2.5-fold	RB	O	2.5-fold	advmod	26	SENT_18	[p1l778t1615r896b1642],
26	higher	JJR	O	higher	rcmod	22	SENT_18	[p1l911t1615r1007b1649],
27	than	IN	O	than	_	0	SENT_18	[p1l1021t1615r1085b1641],
28	that	DT	O	that	prep_than	22	SENT_18	[p1l1101t1615r1156b1641],
29	of	IN	O	of	_	0	SENT_18	[p1l1172t1615r1204b1641],
30	the	DT	O	the	det	31	SENT_18	[p1l1217t1615r1262b1641],
31	CYP2C9	NN	O	cyp2c9	prep_of	28	SENT_18	[p1l1279t1615r1456b1642],
32	*	CD	NUMBER	*	num	31	SENT_18	[p1l1279t1615r1456b1642],
33	I	PRP	O	I	dep	31	SENT_18	[p1l1279t1615r1456b1642],
34	/	:	O	/	punct	22	SENT_18	[p1l1279t1615r1456b1642],
35	*	CD	NUMBER	*	number	36	SENT_18	[p1l1460t1616r1490b1641],
36	1	CD	NUMBER	1	num	37	SENT_18	[p1l1460t1616r1490b1641],
37	subjects	NNS	O	subject	dep	7	SENT_18	[p1l1509t1615r1635b1649],
38	.	.	O	.	_	0	SENT_18	[p1l1509t1615r1635b1649],

1	The	DT	O	the	det	3	SENT_19	[p1l1653t1615r1710b1641],
2	intrinsic	JJ	O	intrinsic	amod	3	SENT_19	[p1l1725t1615r1846b1641],
3	clearance	NN	O	clearance	nsubj	13	SENT_19	[p1l1863t1615r2003b1641],
4	of	IN	O	of	_	0	SENT_19	[p1l2020t1615r2052b1641],
5	glimepiride	NN	O	glimepiride	prep_of	3	SENT_19	[p1l108t1660r280b1694],
6	by	IN	O	by	_	0	SENT_19	[p1l293t1660r330b1694],
7	the	DT	O	the	det	11	SENT_19	[p1l344t1660r389b1686],
8	CYP2C9	NN	O	cyp2c9	nn	11	SENT_19	[p1l403t1660r572b1687],
9	*	NN	O	*	nn	11	SENT_19	[p1l403t1660r572b1687],
10	3	CD	NUMBER	3	num	11	SENT_19	[p1l403t1660r572b1687],
11	enzyme	NN	O	enzyme	prep_by	5	SENT_19	[p1l588t1668r703b1694],
12	was	VBD	O	be	cop	13	SENT_19	[p1l717t1668r773b1687],
13	lower	JJR	O	lower	_	0	SENT_19	[p1l788t1660r872b1687],
14	than	IN	O	than	_	0	SENT_19	[p1l885t1660r948b1686],
15	that	DT	O	that	prep_than	13	SENT_19	[p1l962t1660r1018b1686],
16	by	IN	O	by	_	0	SENT_19	[p1l1031t1660r1068b1694],
17	the	DT	O	the	det	21	SENT_19	[p1l1082t1660r1126b1686],
18	CYP2C9	NN	O	cyp2c9	nn	21	SENT_19	[p1l1141t1660r1308b1687],
19	*	NN	O	*	nn	21	SENT_19	[p1l1141t1660r1308b1687],
20	1	CD	NUMBER	1	num	21	SENT_19	[p1l1141t1660r1308b1687],
21	enzyme	NN	O	enzyme	prep_by	13	SENT_19	[p1l1326t1668r1449b1694],
22	.	.	O	.	_	0	SENT_19	[p1l1326t1668r1449b1694],

1	These	DT	O	these	det	2	SENT_20	[p1l1464t1660r1553b1686],
2	results	NNS	O	result	nsubj	3	SENT_20	[p1l1566t1660r1663b1686],
3	suggested	VBD	O	suggest	_	0	SENT_20	[p1l1679t1660r1824b1694],
4	that	IN	O	that	complm	25	SENT_20	[p1l1838t1660r1894b1686],
5	the	DT	O	the	det	8	SENT_20	[p1l1907t1660r1952b1686],
6	lower	JJR	O	lower	amod	8	SENT_20	[p1l1966t1660r2050b1686],
7	hydroxylation	NN	O	hydroxylation	nn	8	SENT_20	[p1l108t1705r317b1739],
8	activity	NN	O	activity	nsubj	25	SENT_20	[p1l327t1705r437b1739],
9	of	IN	O	of	_	0	SENT_20	[p1l447t1705r480b1731],
10	glimepiride	NN	O	glimepiride	prep_of	8	SENT_20	[p1l487t1705r658b1739],
11	in	IN	O	in	prep	10	SENT_20	[p1l668t1705r696b1731],
12	the	DT	O	the	det	13	SENT_20	[p1l706t1705r750b1731],
13	subject	JJ	O	subject	dep	21	SENT_20	[p1l762t1705r866b1739],
14	with	IN	O	with	_	0	SENT_20	[p1l875t1705r941b1731],
15	type	NN	O	type	nn	17	SENT_20	[p1l950t1709r1013b1739],
16	2	CD	NUMBER	2	num	17	SENT_20	[p1l1024t1705r1041b1731],
17	diabetes	NN	O	diabetes	prep_with	13	SENT_20	[p1l1051t1705r1172b1731],
18	and	CC	O	and	_	0	SENT_20	[p1l1183t1705r1235b1731],
19	CYP2C9	NN	O	cyp2c9	prep_with	13	SENT_20	[p1l1246t1705r1409b1731],
20	*	CD	NUMBER	*	num	19	SENT_20	[p1l1246t1705r1409b1731],
21	I	PRP	O	I	dep	24	SENT_20	[p1l1246t1705r1409b1731],
22	/	:	O	/	punct	24	SENT_20	[p1l1412t1705r1423b1731],
23	*	CD	NUMBER	*	num	24	SENT_20	[p1l1427t1705r1459b1731],
24	3	CD	NUMBER	3	dep	11	SENT_20	[p1l1427t1705r1459b1731],
25	led	VBD	O	lead	ccomp	3	SENT_20	[p1l1469t1705r1514b1731],
26	to	TO	O	to	_	0	SENT_20	[p1l1523t1709r1551b1731],
27	a	DT	O	a	det	29	SENT_20	[p1l1562t1713r1577b1731],
28	marked	JJ	O	marked	amod	29	SENT_20	[p1l1586t1705r1698b1731],
29	elevation	NN	O	elevation	prep_to	25	SENT_20	[p1l1708t1705r1843b1731],
30	in	IN	O	in	_	0	SENT_20	[p1l1852t1705r1880b1731],
31	the	DT	O	the	det	33	SENT_20	[p1l1890t1705r1934b1731],
32	plasma	NN	O	plasma	nn	33	SENT_20	[p1l1944t1705r2050b1739],
33	concentrations	NNS	O	concentration	prep_in	25	SENT_20	[p1l108t1750r325b1776],
34	of	IN	O	of	_	0	SENT_20	[p1l339t1750r372b1776],
35	glimepiride	NN	O	glimepiride	prep_of	33	SENT_20	[p1l383t1750r554b1784],
36	and	CC	O	and	_	0	SENT_20	[p1l569t1750r621b1776],
37	a	DT	O	a	det	40	SENT_20	[p1l635t1758r651b1776],
38	stronger	JJR	O	stronger	dep	39	SENT_20	[p1l665t1754r786b1784],
39	pharmacological	JJ	O	pharmacological	amod	40	SENT_20	[p1l798t1750r1048b1784],
40	effect	NN	O	effect	prep_in	25	SENT_20	[p1l1062t1750r1146b1776],
41	of	IN	O	of	_	0	SENT_20	[p1l1159t1750r1191b1776],
42	glimepiride	NN	O	glimepiride	prep_of	40	SENT_20	[p1l1203t1750r1382b1784],
43	.	.	O	.	_	0	SENT_20	[p1l1203t1750r1382b1784],

1	©	RB	O	©	advmod	2	SENT_21	[p1l110t1795r142b1828],
2	2005	CD	DATE	2005	_	0	SENT_21	[p1l158t1795r230b1822],
3	Elsevier	NNP	ORGANIZATION	Elsevier	nn	5	SENT_21	[p1l244t1795r367b1822],
4	Ireland	NNP	ORGANIZATION	Ireland	nn	5	SENT_21	[p1l379t1795r485b1821],
5	Ltd.	NNP	ORGANIZATION	Ltd.	dep	2	SENT_21	[p1l498t1795r557b1821],
6	.	.	O	.	_	0	SENT_21	[p1l498t1795r557b1821],

1	All	DT	O	all	det	2	SENT_22	[p1l572t1795r619b1821],
2	rights	NNS	O	rights	nsubj	3	SENT_22	[p1l632t1795r716b1829],
3	reserved	VBN	O	reserve	_	0	SENT_22	[p1l729t1795r863b1822],
4	.	.	O	.	_	0	SENT_22	[p1l729t1795r863b1822],

1	Keywords	NNS	O	keyword	_	0	SENT_23	[p1l108t1874r246b1904],
2	:	:	O	:	_	0	SENT_23	[p1l108t1874r246b1904],
3	Cytochrome	NN	O	cytochrome	nn	4	SENT_23	[p1l265t1874r428b1905],
4	P450	NN	O	p450	dep	1	SENT_23	[p1l440t1874r515b1902],
5	;	:	O	;	_	0	SENT_23	[p1l440t1874r515b1902],
6	Genetic	JJ	O	genetic	amod	7	SENT_23	[p1l529t1874r631b1898],
7	polymorphism	NN	O	polymorphism	dep	4	SENT_23	[p1l643t1874r844b1905],
8	;	:	O	;	_	0	SENT_23	[p1l643t1874r844b1905],
9	Pharmacokinetics	NNS	O	pharmacokinetic	dep	4	SENT_23	[p1l857t1874r1101b1902],
10	;	:	O	;	_	0	SENT_23	[p1l857t1874r1101b1902],
11	Sulfonylurea	NNP	O	Sulfonylurea	dep	9	SENT_23	[p1l1114t1874r1292b1905],
12	;	:	O	;	_	0	SENT_23	[p1l1114t1874r1292b1905],
13	Type	NN	O	type	dep	4	SENT_23	[p1l1305t1875r1370b1905],
14	2	CD	NUMBER	2	num	15	SENT_23	[p1l1383t1874r1397b1898],
15	diabetes	NNS	O	diabetes	dep	13	SENT_23	[p1l1410t1874r1517b1898],

1	1	LS	NUMBER	1	_	0	SENT_24	[p1l13t2161r72b2225],
2	.	.	O	.	_	0	SENT_24	[p1l13t2161r72b2225],

1	Introduction	NN	O	introduction	_	0	SENT_25	[p1l122t2161r610b2225],

1	The	DT	O	the	det	3	SENT_26	[p1l117t2378r255b2441],
2	ﬁrst	NN	O	ﬁrst	nn	3	SENT_26	[p1l299t2378r462b2441],
3	—	NN	O	—	nsubj	15	SENT_26	[p1l299t2378r462b2441],
4	and	CC	O	and	_	0	SENT_26	[p1l509t2378r636b2441],
5	second	JJ	ORDINAL	second	amod	7	SENT_26	[p1l681t2378r1373b2459],
6	—	NN	O	—	nn	7	SENT_26	[p1l681t2378r1373b2459],
7	generations	NNS	O	generation	conj_and	3	SENT_26	[p1l681t2378r1373b2459],
8	of	IN	O	of	_	0	SENT_26	[p1l1417t2378r1495b2441],
9	oral	JJ	O	oral	amod	14	SENT_26	[p1l1532t2378r1668b2441],
10	sulfony	JJ	O	sulfony	amod	14	SENT_26	[p1l1714t2378r2007b2459],
11	—	NN	O	—	nn	14	SENT_26	[p1l1714t2378r2007b2459],
12	lurea	NN	O	lurea	nn	14	SENT_26	[p1l9t2485r189b2547],
13	antidiabetic	JJ	O	antidiabetic	amod	14	SENT_26	[p1l211t2485r629b2547],
14	agents	NNS	O	agent	prep_of	7	SENT_26	[p1l653t2494r879b2566],
15	(	VBP	O	(	_	0	SENT_26	[p1l904t2485r1127b2562],
16	SUS	NNP	O	SUS	nsubjpass	27	SENT_26	[p1l904t2485r1127b2562],
17	)	CD	NUMBER	)	num	16	SENT_26	[p1l904t2485r1127b2562],
18	,	,	O	,	_	0	SENT_26	[p1l904t2485r1127b2562],
19	such	JJ	O	such	_	0	SENT_26	[p1l1155t2485r1315b2547],
20	as	IN	O	as	_	0	SENT_26	[p1l1338t2504r1407b2547],
21	tolbutamide	NN	O	tolbutamide	prep_such_as	16	SENT_26	[p1l1429t2485r1859b2547],
22	and	CC	O	and	_	0	SENT_26	[p1l1882t2485r2010b2547],
23	glibenclamide	NN	O	glibenclamide	conj_and	21	SENT_26	[p1l10t2592r540b2674],
24	,	,	O	,	_	0	SENT_26	[p1l10t2592r540b2674],
25	have	VBP	O	have	aux	27	SENT_26	[p1l592t2592r759b2655],
26	been	VBN	O	be	auxpass	27	SENT_26	[p1l807t2592r977b2655],
27	used	VBN	O	use	ccomp	15	SENT_26	[p1l1025t2592r1189b2655],
28	for	IN	O	for	_	0	SENT_26	[p1l1238t2591r1342b2655],
29	the	DT	O	the	det	30	SENT_26	[p1l1389t2592r1497b2655],
30	treatment	NN	O	treatment	prep_for	27	SENT_26	[p1l1547t2601r1889b2655],
31	of	IN	O	of	prep	30	SENT_26	[p1l1938t2592r2015b2655],

1	*	NN	O	*	_	0	SENT_27	[p1l53t2875r80b2905],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_27	[p1l117t2875r541b2940],
3	author	NN	O	author	dobj	2	SENT_27	[p1l570t2875r761b2925],
4	.	.	O	.	_	0	SENT_27	[p1l570t2875r761b2925],

1	Tel.	NNP	O	Tel.	_	0	SENT_28	[p1l790t2875r914b2925],
2	:	:	O	:	_	0	SENT_28	[p1l790t2875r914b2925],
3	+81	CD	NUMBER	+81	number	4	SENT_28	[p1l946t2875r1049b2925],
4	3	CD	NUMBER	3	dep	1	SENT_28	[p1l1083t2875r1112b2925],
5	3700	CD	NUMBER	3700	num	6	SENT_28	[p1l1143t2875r1283b2925],
6	1141	CD	DATE	1141	dep	4	SENT_28	[p1l1316t2875r1469b2934],
7	;	:	O	;	_	0	SENT_28	[p1l1316t2875r1469b2934],
8	fax	NN	O	fax	dep	1	SENT_28	[p1l9t2962r115b3013],
9	:	:	O	:	_	0	SENT_28	[p1l9t2962r115b3013],
10	+81	CD	NUMBER	+81	number	11	SENT_28	[p1l146t2963r249b3013],
11	3	CD	NUMBER	3	num	13	SENT_28	[p1l284t2963r312b3013],
12	3700	CD	NUMBER	3700	number	13	SENT_28	[p1l344t2963r483b3013],
13	9788	CD	NUMBER	9788	dep	8	SENT_28	[p1l510t2963r666b3013],
14	.	.	O	.	_	0	SENT_28	[p1l510t2963r666b3013],

1	E	NN	O	e	nn	4	SENT_29	[p1l115t3051r313b3101],
2	—	CD	NUMBER	—	num	4	SENT_29	[p1l115t3051r313b3101],
3	mail	NN	O	mail	nn	4	SENT_29	[p1l115t3051r313b3101],
4	address	NN	O	address	_	0	SENT_29	[p1l337t3050r577b3101],
5	:	:	O	:	_	0	SENT_29	[p1l337t3050r577b3101],
6	tohkin@nihs.go.jp	NN	O	tohkin@nihs.go.jp	dep	4	SENT_29	[p1l607t3050r1138b3116],
7	(	CD	NUMBER	(	num	10	SENT_29	[p1l1167t3051r1265b3112],
8	M.	NNP	NUMBER	M.	nn	10	SENT_29	[p1l1167t3051r1265b3112],
9	Tohkin	NNP	PERSON	Tohkin	nn	10	SENT_29	[p1l1295t3050r1535b3113],
10	)	NN	O	)	dep	6	SENT_29	[p1l1295t3050r1535b3113],
11	.	.	O	.	_	0	SENT_29	[p1l1295t3050r1535b3113],

1	patients	NNS	O	patient	nsubj	7	SENT_30	[p1l82t3456r371b3540],
2	with	IN	O	with	_	0	SENT_30	[p1l447t3456r610b3521],
3	type	NN	O	type	nn	5	SENT_30	[p1l684t3465r841b3540],
4	2	CD	NUMBER	2	num	5	SENT_30	[p1l917t3456r959b3520],
5	diabetes	NN	O	diabetes	prep_with	1	SENT_30	[p1l1035t3456r1359b3532],
6	,	,	O	,	_	0	SENT_30	[p1l1035t3456r1359b3532],
7	enabling	VBG	O	enable	_	0	SENT_30	[p1l1437t3456r1755b3540],
8	effective	JJ	O	effective	amod	10	SENT_30	[p1l1831t3456r2151b3521],
9	glycemic	JJ	O	glycemic	amod	10	SENT_30	[p1l84t3567r423b3651],
10	control	NN	O	control	dobj	7	SENT_30	[p1l465t3567r727b3632],
11	by	IN	O	by	_	0	SENT_30	[p1l765t3567r857b3651],
12	stimulating	VBG	O	stimulate	prepc_by	7	SENT_30	[p1l900t3567r1315b3651],
13	insulin	NN	O	insulin	nn	15	SENT_30	[p1l1355t3567r1608b3632],
14	secretion	NN	O	secretion	nn	15	SENT_30	[p1l1649t3567r1983b3632],
15	[	NN	O	[	dobj	12	SENT_30	[p1l2028t3568r2147b3646],
16	1	CD	NUMBER	1	num	17	SENT_30	[p1l2028t3568r2147b3646],
17	]	NN	O	]	dep	15	SENT_30	[p1l2028t3568r2147b3646],
18	.	.	O	.	_	0	SENT_30	[p1l2028t3568r2147b3646],

1	However	RB	O	however	advmod	5	SENT_31	[p1l83t3680r435b3755],
2	,	,	O	,	_	0	SENT_31	[p1l83t3680r435b3755],
3	their	PRP$	O	they	poss	4	SENT_31	[p1l498t3678r670b3743],
4	use	NN	O	use	nsubj	5	SENT_31	[p1l726t3699r848b3743],
5	tends	VBZ	O	tend	_	0	SENT_31	[p1l908t3678r1101b3743],
6	to	TO	O	to	aux	7	SENT_31	[p1l1163t3688r1232b3743],
7	induce	VB	O	induce	xcomp	5	SENT_31	[p1l1292t3678r1539b3743],
8	hypoglycemia	NN	O	hypoglycemia	dobj	7	SENT_31	[p1l1599t3678r2148b3762],
9	,	,	O	,	_	0	SENT_31	[p1l1599t3678r2148b3762],

1	which	WDT	O	which	nsubj	6	SENT_32	[p2l84t20r310b85],
2	may	MD	O	may	aux	6	SENT_32	[p2l358t40r516b104],
3	be	VB	O	be	cop	6	SENT_32	[p2l564t20r651b85],
4	a	DT	O	a	det	6	SENT_32	[p2l702t40r741b85],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_32	[p2l791t20r1177b104],
6	cause	NN	O	cause	_	0	SENT_32	[p2l1226t40r1429b85],
7	of	IN	O	of	_	0	SENT_32	[p2l1480t20r1561b85],
8	morbidity	NN	O	morbidity	prep_of	6	SENT_32	[p2l1603t20r1969b104],
9	and	CC	O	and	_	0	SENT_32	[p2l2021t20r2152b85],
10	mortality	NN	O	mortality	prep_of	6	SENT_32	[p2l83t131r424b215],
11	and	CC	O	and	_	0	SENT_32	[p2l480t131r611b195],
12	is	VBZ	O	be	cop	15	SENT_32	[p2l663t131r721b195],
13	a	DT	O	a	det	15	SENT_32	[p2l777t151r815b195],
14	limiting	VBG	O	limit	amod	15	SENT_32	[p2l866t131r1160b215],
15	factor	NN	O	factor	conj_and	6	SENT_32	[p2l1214t131r1432b195],
16	in	IN	O	in	_	0	SENT_32	[p2l1482t131r1553b195],
17	the	DT	O	the	det	20	SENT_32	[p2l1605t131r1716b195],
18	successful	JJ	O	successful	amod	19	SENT_32	[p2l1773t131r2151b195],
19	metabolic	JJ	O	metabolic	amod	20	SENT_32	[p2l83t242r450b307],
20	control	NN	O	control	prep_in	15	SENT_32	[p2l489t242r750b307],
21	of	IN	O	of	_	0	SENT_32	[p2l788t242r868b307],
22	diabetes	NN	O	diabetes	prep_of	20	SENT_32	[p2l898t242r1200b307],
23	[	CD	NUMBER	[	number	24	SENT_32	[p2l1245t242r1433b320],
24	2,3	CD	NUMBER	2,3	num	25	SENT_32	[p2l1245t242r1433b320],
25	]	NN	O	]	dobj	6	SENT_32	[p2l1245t242r1433b320],
26	.	.	O	.	_	0	SENT_32	[p2l1245t242r1433b320],

1	These	DT	O	these	det	2	SENT_33	[p2l1474t242r1694b307],
2	agents	NNS	O	agent	nsubj	4	SENT_33	[p2l1733t252r1965b326],
3	also	RB	O	also	advmod	4	SENT_33	[p2l2005t242r2151b307],
4	cause	VBP	O	cause	_	0	SENT_33	[p2l84t374r288b418],
5	pronounced	JJ	O	pronounced	amod	6	SENT_33	[p2l344t353r785b437],
6	hyperinsulinemia	NN	O	hyperinsulinemia	dobj	4	SENT_33	[p2l840t353r1509b437],
7	,	,	O	,	_	0	SENT_33	[p2l840t353r1509b437],
8	which	WDT	O	which	nsubjpass	11	SENT_33	[p2l1569t353r1795b418],
9	may	MD	O	may	aux	11	SENT_33	[p2l1851t374r2009b437],
10	be	VB	O	be	auxpass	11	SENT_33	[p2l2065t353r2151b418],
11	associated	VBN	O	associate	rcmod	6	SENT_33	[p2l85t464r467b529],
12	with	IN	O	with	_	0	SENT_33	[p2l508t464r672b529],
13	further	JJ	O	further	amod	14	SENT_33	[p2l714t464r967b529],
14	increases	NNS	O	increase	prep_with	11	SENT_33	[p2l1007t464r1346b529],
15	in	IN	O	in	_	0	SENT_33	[p2l1390t464r1461b528],
16	body	NN	O	body	nn	18	SENT_33	[p2l1501t464r1686b548],
17	weight	NN	O	weight	nn	18	SENT_33	[p2l1728t464r1981b548],
18	[	NN	O	[	prep_in	14	SENT_33	[p2l2028t465r2147b543],
19	2	CD	NUMBER	2	num	20	SENT_33	[p2l2028t465r2147b543],
20	]	NN	O	]	dep	18	SENT_33	[p2l2028t465r2147b543],
21	.	.	O	.	_	0	SENT_33	[p2l2028t465r2147b543],

1	Both	DT	O	both	nsubj	5	SENT_34	[p2l83t575r263b640],
2	of	IN	O	of	_	0	SENT_34	[p2l291t575r372b640],
3	these	DT	O	these	det	4	SENT_34	[p2l393t575r582b640],
4	effects	NNS	O	effect	prep_of	1	SENT_34	[p2l611t575r853b640],
5	represent	VBP	O	represent	_	0	SENT_34	[p2l882t585r1225b659],
6	signiﬁcant	NN	O	signiﬁcant	nn	7	SENT_34	[p2l1255t575r1641b659],
7	disadvantage	NN	O	disadvantage	dobj	5	SENT_34	[p2l1667t575r2151b659],
8	of	IN	O	of	_	0	SENT_34	[p2l85t686r165b751],
9	older	JJR	O	older	amod	10	SENT_34	[p2l196t686r386b751],
10	SUs	NNS	O	sus	prep_of	7	SENT_34	[p2l423t687r590b751],
11	.	.	O	.	_	0	SENT_34	[p2l423t687r590b751],

1	Glimepiride	NNP	O	Glimepiride	nsubj	7	SENT_35	[p2l633t686r1102b770],
2	,	,	O	,	_	0	SENT_35	[p2l633t686r1102b770],
3	a	DT	O	a	det	5	SENT_35	[p2l1144t707r1182b751],
4	third-generation	JJ	O	third-generation	amod	5	SENT_35	[p2l1216t686r1819b770],
5	SU	NNP	O	SU	appos	1	SENT_35	[p2l1857t687r1990b763],
6	,	,	O	,	_	0	SENT_35	[p2l1857t687r1990b763],
7	has	VBZ	O	have	_	0	SENT_35	[p2l2029t686r2150b751],

1	0168-8227	CD	DURATION	0168-8227	_	0	SENT_36	[p2l528t835r696b863],
2	/	:	O	/	punct	1	SENT_36	[p2l528t835r696b863],
3	$	$	MONEY	$	nsubj	5	SENT_36	[p2l528t835r696b863],
4	—	CD	MONEY	—	num	3	SENT_36	[p2l707t851r725b853],
5	see	VBP	O	see	dep	1	SENT_36	[p2l737t844r777b860],
6	front	JJ	O	front	amod	7	SENT_36	[p2l789t837r854b860],
7	matter	NN	O	matter	dobj	5	SENT_36	[p2l865t840r950b860],
8	©	CD	NUMBER	©	num	12	SENT_36	[p2l963t837r991b866],
9	2005	CD	DATE	2005	num	12	SENT_36	[p2l1006t837r1069b860],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	12	SENT_36	[p2l1082t837r1191b860],
11	Ireland	NNP	ORGANIZATION	Ireland	nn	12	SENT_36	[p2l1202t837r1296b860],
12	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_36	[p2l1307t837r1359b860],
13	.	.	O	.	_	0	SENT_36	[p2l1307t837r1359b860],

1	All	DT	O	all	det	2	SENT_37	[p2l1373t837r1414b860],
2	rights	NNS	O	rights	nsubj	3	SENT_37	[p2l1426t837r1500b867],
3	reserved	VBN	O	reserve	_	0	SENT_37	[p2l1513t837r1631b860],
4	.	.	O	.	_	0	SENT_37	[p2l1513t837r1631b860],

1	doi	FW	O	doi	_	0	SENT_38	[p2l528t878r983b908],
2	:10.1016	CD	NUMBER	:10.1016	dep	1	SENT_38	[p2l528t878r983b908],
3	/	:	O	/	punct	2	SENT_38	[p2l528t878r983b908],
4	j.	NN	O	j.	nsubj	5	SENT_38	[p2l528t878r983b908],
5	diabres	VBZ	O	diabre	dep	2	SENT_38	[p2l528t878r983b908],
6	.2005.09.019	CD	NUMBER	.2005.09.019	dobj	5	SENT_38	[p2l528t878r983b908],

1	K.	NNP	PERSON	K.	nn	2	SENT_39	[p2l331t984r358b1007],
2	Suzuki	NNP	PERSON	Suzuki	_	0	SENT_39	[p2l373t983r459b1009],
3	et	FW	O	et	nn	4	SENT_39	[p2l471t988r495b1007],
4	al.	FW	O	al.	dep	2	SENT_39	[p2l505t983r677b1007],
5	/	:	O	/	punct	2	SENT_39	[p2l505t983r677b1007],
6	Diabetes	NNP	ORGANIZATION	Diabetes	dep	2	SENT_39	[p2l505t983r677b1007],
7	Research	NNP	ORGANIZATION	Research	dep	6	SENT_39	[p2l688t983r810b1007],
8	and	CC	ORGANIZATION	and	_	0	SENT_39	[p2l822t983r873b1007],
9	Clinical	JJ	ORGANIZATION	clinical	amod	10	SENT_39	[p2l885t983r990b1007],
10	Practice	NN	ORGANIZATION	practice	dep	2	SENT_39	[p2l1001t984r1113b1007],
11	72	CD	NUMBER	72	number	12	SENT_39	[p2l1127t983r1157b1007],
12	(	CD	NUMBER	(	num	13	SENT_39	[p2l1170t983r1256b1012],
13	2006	CD	DATE	2006	dep	10	SENT_39	[p2l1170t983r1256b1012],
14	)	CD	NUMBER	)	num	15	SENT_39	[p2l1170t983r1256b1012],
15	148-154 149	CD	NUMBER	148-154 149	dep	10	SENT_39	[p2l1783t983r1828b1007],[p2l1270t983r1384b1007],

1	attracted	VBD	O	attract	csubj	21	SENT_40	[p2l9t1129r341b1196],
2	interest	NN	O	interest	dobj	1	SENT_40	[p2l379t1129r664b1196],
3	because	IN	O	because	mark	5	SENT_40	[p2l700t1129r1005b1196],
4	it	PRP	O	it	nsubj	5	SENT_40	[p2l1045t1129r1098b1196],
5	shows	VBZ	O	show	advcl	1	SENT_40	[p2l1140t1129r1370b1197],
6	distinct	JJ	O	distinct	amod	10	SENT_40	[p2l1412t1129r1696b1196],
7	pharmacological	JJ	O	pharmacological	amod	10	SENT_40	[p2l1733t1129r2143b1216, p2l7t1244r268b1331],
8	and	CC	O	and	_	0	SENT_40	[p2l299t1244r434b1311],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	10	SENT_40	[p2l460t1244r1103b1331],
10	properties	NNS	O	property	dobj	5	SENT_40	[p2l1132t1244r1538b1331],
11	,	,	O	,	_	0	SENT_40	[p2l1132t1244r1538b1331],
12	compared	VBN	O	compare	_	0	SENT_40	[p2l1570t1244r1950b1331],
13	with	IN	O	with	prepc_compared_with	5	SENT_40	[p2l1977t1244r2146b1311],
14	ﬁrst	NN	O	ﬁrst	amod	20	SENT_40	[p2l8t1359r184b1426],
15	-	:	O	-	_	0	SENT_40	[p2l8t1359r184b1426],
16	and	CC	O	and	_	0	SENT_40	[p2l210t1359r346b1426],
17	second	LS	ORDINAL	second	amod	20	SENT_40	[p2l370t1359r662b1426],
18	-	:	O	-	_	0	SENT_40	[p2l370t1359r662b1426],
19	generation	NN	O	generation	nn	20	SENT_40	[p2l668t1359r1075b1446],
20	SUs	NNS	O	sus	pobj	5	SENT_40	[p2l1098t1360r1250b1427],
21	[	VBP	O	[	_	0	SENT_40	[p2l1281t1360r1500b1440],
22	4	CD	NUMBER	4	number	23	SENT_40	[p2l1281t1360r1500b1440],
23	—	CD	NUMBER	—	dobj	21	SENT_40	[p2l1281t1360r1500b1440],
24	8	CD	NUMBER	8	number	25	SENT_40	[p2l1281t1360r1500b1440],
25	]	NN	O	]	amod	23	SENT_40	[p2l1281t1360r1500b1440],
26	.	.	O	.	_	0	SENT_40	[p2l1281t1360r1500b1440],

1	In	IN	O	in	_	0	SENT_41	[p2l1526t1361r1604b1426],
2	clinical	JJ	O	clinical	amod	3	SENT_41	[p2l1625t1359r1908b1426],
3	trials	NNS	O	trial	prep_in	8	SENT_41	[p2l1930t1359r2142b1439],
4	,	,	O	,	_	0	SENT_41	[p2l1930t1359r2142b1439],
5	hypoglycemia	NN	O	hypoglycemia	nsubj	8	SENT_41	[p2l6t1474r555b1561],
6	was	VBD	O	be	cop	8	SENT_41	[p2l636t1496r781b1542],
7	less	RBR	O	less	advmod	8	SENT_41	[p2l865t1474r1006b1541],
8	frequent	JJ	O	frequent	_	0	SENT_41	[p2l1090t1474r1411b1561],
9	among	IN	O	among	_	0	SENT_41	[p2l1495t1496r1752b1561],
10	subjects	NNS	O	subject	prep_among	8	SENT_41	[p2l1839t1474r2144b1561],
11	receiving	VBG	O	receive	partmod	10	SENT_41	[p2l6t1589r363b1676],
12	glimepiride	NN	O	glimepiride	dobj	11	SENT_41	[p2l414t1589r857b1676],
13	than	IN	O	than	advmod	8	SENT_41	[p2l907t1589r1072b1656],
14	among	IN	O	among	_	0	SENT_41	[p2l1123t1610r1380b1676],
15	subjects	NNS	O	subject	prep_among	13	SENT_41	[p2l1434t1589r1738b1676],
16	receiving	VBG	O	receive	partmod	15	SENT_41	[p2l1788t1589r2145b1676],
17	glibenclamide	NN	O	glibenclamide	dobj	16	SENT_41	[p2l8t1704r554b1791],
18	[	CD	NUMBER	[	num	17	SENT_41	[p2l639t1704r906b1785],
19	4,5,8	CD	NUMBER	4,5,8	num	20	SENT_41	[p2l639t1704r906b1785],
20	]	NN	O	]	dep	17	SENT_41	[p2l639t1704r906b1785],
21	.	.	O	.	_	0	SENT_41	[p2l639t1704r906b1785],

1	Glimepiride	NN	O	glimepiride	nsubjpass	5	SENT_42	[p2l990t1704r1453b1791],
2	also	RB	O	also	advmod	5	SENT_42	[p2l1534t1704r1684b1771],
3	has	VBZ	O	have	aux	5	SENT_42	[p2l1761t1704r1886b1771],
4	been	VBN	O	be	auxpass	5	SENT_42	[p2l1964t1704r2146b1771],
5	reported	VBN	O	report	_	0	SENT_42	[p2l6t1819r328b1906],
6	to	TO	O	to	aux	7	SENT_42	[p2l378t1829r449b1886],
7	maintain	VB	O	maintain	xcomp	5	SENT_42	[p2l501t1819r839b1886],
8	lower	JJR	O	lower	amod	10	SENT_42	[p2l889t1819r1106b1887],
9	insulin	NN	O	insulin	nn	10	SENT_42	[p2l1155t1819r1417b1886],
10	levels	NNS	O	level	dobj	7	SENT_42	[p2l1466t1819r1686b1886],
11	under	IN	O	under	_	0	SENT_42	[p2l1737t1819r1957b1886],
12	low	JJ	O	low	amod	15	SENT_42	[p2l2006t1819r2145b1887],
13	blood	NN	O	blood	nn	15	SENT_42	[p2l6t1934r226b2001],
14	glucose	NN	O	glucose	nn	15	SENT_42	[p2l269t1934r560b2021],
15	conditions	NNS	O	condition	prep_under	7	SENT_42	[p2l605t1934r1003b2001],
16	because	IN	O	because	mark	18	SENT_42	[p2l1047t1934r1350b2001],
17	it	PRP	O	it	nsubj	18	SENT_42	[p2l1395t1934r1448b2001],
18	increases	VBZ	O	increase	advcl	7	SENT_42	[p2l1489t1934r1840b2001],
19	insulin	NN	O	insulin	nn	20	SENT_42	[p2l1885t1934r2146b2001],
20	sensitivity	NN	O	sensitivity	nsubj	26	SENT_42	[p2l11t2049r400b2136],
21	and	CC	O	and	_	0	SENT_42	[p2l466t2049r602b2116],
22	responsiveness	NN	O	responsiveness	nsubj	26	SENT_42	[p2l663t2049r1237b2136],
23	in	IN	O	in	_	0	SENT_42	[p2l1301t2049r1375b2115],
24	peripheral	JJ	O	peripheral	amod	25	SENT_42	[p2l1436t2049r1827b2136],
25	tissues	NNS	O	tissue	prep_in	20	SENT_42	[p2l1891t2049r2144b2116],
26	[	VBP	O	[	ccomp	18	SENT_42	[p2l14t2164r402b2245],
27	4,5,9	CD	NUMBER	4,5,9	dobj	26	SENT_42	[p2l14t2164r402b2245],
28	,	,	O	,	_	0	SENT_42	[p2l14t2164r402b2245],
29	lO	NNP	O	lO	appos	27	SENT_42	[p2l14t2164r402b2245],
30	]	CD	NUMBER	]	num	29	SENT_42	[p2l14t2164r402b2245],
31	.	.	O	.	_	0	SENT_42	[p2l14t2164r402b2245],

1	Therefore	RB	O	therefore	advmod	6	SENT_43	[p2l437t2164r836b2243],
2	,	,	O	,	_	0	SENT_43	[p2l437t2164r836b2243],
3	glimepiride	NN	O	glimepiride	nsubjpass	6	SENT_43	[p2l871t2164r1314b2251],
4	is	VBZ	O	be	auxpass	6	SENT_43	[p2l1345t2164r1405b2231],
5	now	RB	DATE	now	advmod	6	SENT_43	[p2l1436t2185r1596b2231],
6	considered	VBN	O	consider	_	0	SENT_43	[p2l1627t2164r2044b2231],
7	to	TO	O	to	aux	14	SENT_43	[p2l2073t2174r2145b2231],
8	be	VB	O	be	cop	14	SENT_43	[p2l6t2279r95b2346],
9	a	DT	O	a	det	14	SENT_43	[p2l120t2301r159b2346],
10	safe	JJ	O	safe	amod	14	SENT_43	[p2l183t2279r332b2346],
11	and	CC	O	and	_	0	SENT_43	[p2l356t2279r492b2346],
12	effective	JJ	O	effective	conj_and	10	SENT_43	[p2l514t2279r846b2347],
13	hypoglycemic	JJ	O	hypoglycemic	amod	14	SENT_43	[p2l866t2279r1411b2366],
14	agent	NN	O	agent	xcomp	6	SENT_43	[p2l1437t2289r1643b2366],
15	that	WDT	O	that	nsubj	18	SENT_43	[p2l1664t2279r1808b2346],
16	does	VBZ	O	do	aux	18	SENT_43	[p2l1830t2279r2001b2346],
17	not	RB	O	not	neg	18	SENT_43	[p2l2025t2290r2147b2346],
18	lead	VB	O	lead	rcmod	14	SENT_43	[p2l7t2394r167b2461],
19	to	TO	O	to	_	0	SENT_43	[p2l201t2404r273b2461],
20	a	DT	O	a	det	21	SENT_43	[p2l311t2416r351b2461],
21	gain	NN	O	gain	prep_to	18	SENT_43	[p2l386t2394r549b2481],
22	in	IN	O	in	_	0	SENT_43	[p2l583t2394r657b2460],
23	body	NN	O	body	nn	24	SENT_43	[p2l690t2394r881b2481],
24	weight	NN	O	weight	prep_in	21	SENT_43	[p2l917t2394r1197b2481],
25	.	.	O	.	_	0	SENT_43	[p2l917t2394r1197b2481],

1	Glimepiride	NN	O	glimepiride	nsubjpass	15	SENT_44	[p2l124t2509r583b2596],
2	is	VBZ	O	be	cop	5	SENT_44	[p2l619t2509r679b2576],
3	almost	RB	O	almost	advmod	5	SENT_44	[p2l718t2509r970b2576],
4	completely	RB	O	completely	advmod	5	SENT_44	[p2l1005t2509r1428b2596],
5	bioavailable	JJ	O	bioavailable	_	0	SENT_44	[p2l1462t2509r1927b2576],
6	from	IN	O	from	_	0	SENT_44	[p2l1962t2509r2147b2576],
7	the	DT	O	the	det	12	SENT_44	[p2l7t2624r121b2691],
8	gastrointestinal	JJ	O	gastrointestinal	amod	12	SENT_44	[p2l174t2624r753b2711],
9	tract	NN	O	tract	nn	12	SENT_44	[p2l806t2634r976b2691],
10	[	NN	O	[	nn	12	SENT_44	[p2l1032t2625r1176b2705],
11	11	CD	NUMBER	11	num	12	SENT_44	[p2l1032t2625r1176b2705],
12	]	NN	O	]	prep_from	5	SENT_44	[p2l1032t2625r1176b2705],
13	and	CC	O	and	_	0	SENT_44	[p2l1236t2624r1370b2691],
14	is	VBZ	O	be	auxpass	15	SENT_44	[p2l1421t2624r1482b2691],
15	metabolized	VBN	O	metabolize	conj_and	5	SENT_44	[p2l1534t2624r2002b2691],
16	by	IN	O	by	_	0	SENT_44	[p2l2051t2624r2145b2711],
17	cytochrome	NN	O	cytochrome	nn	18	SENT_44	[p2l8t2739r455b2826],
18	P450	NN	O	p450	agent	15	SENT_44	[p2l509t2739r702b2807],
19	(	CD	NUMBER	(	num	20	SENT_44	[p2l758t2740r999b2822],
20	CYP	NN	O	cyp	dep	18	SENT_44	[p2l758t2740r999b2822],
21	)	CD	NUMBER	)	num	22	SENT_44	[p2l758t2740r999b2822],
22	2C9	NN	O	2c9	dep	20	SENT_44	[p2l1055t2740r1209b2808],
23	to	TO	O	to	_	0	SENT_44	[p2l1263t2749r1335b2806],
24	hydroxyglimepiride	NN	O	hydroxyglimepiride	nn	27	SENT_44	[p2l1387t2739r2145b2826],
25	(	CD	NUMBER	(	num	27	SENT_44	[p2l10t2854r122b2937],
26	M	NN	O	m	nn	27	SENT_44	[p2l10t2854r122b2937],
27	—	NN	O	—	prep_to	15	SENT_44	[p2l155t2893r213b2898],
28	l	NN	O	l	tmod	15	SENT_44	[p2l256t2854r345b2937],
29	)	NN	O	)	dobj	5	SENT_44	[p2l256t2854r345b2937],
30	,	,	O	,	_	0	SENT_44	[p2l256t2854r345b2937],
31	which	WDT	O	which	nsubj	34	SENT_44	[p2l369t2854r601b2921],
32	is	VBZ	O	be	cop	34	SENT_44	[p2l621t2854r680b2921],
33	the	DT	O	the	det	34	SENT_44	[p2l703t2854r817b2921],
34	rate	NN	O	rate	rcmod	29	SENT_44	[p2l838t2854r1314b2941],
35	—	CD	NUMBER	—	num	34	SENT_44	[p2l838t2854r1314b2941],
36	limiting	VBG	O	limit	xcomp	34	SENT_44	[p2l838t2854r1314b2941],
37	step	NN	O	step	dobj	36	SENT_44	[p2l1340t2864r1487b2941],
38	in	IN	O	in	_	0	SENT_44	[p2l1509t2854r1583b2920],
39	its	PRP$	O	its	poss	41	SENT_44	[p2l1603t2854r1690b2921],
40	elimination	NN	O	elimination	nn	41	SENT_44	[p2l1712t2854r2146b2921],
41	process	NN	O	process	prep_in	36	SENT_44	[p2l6t2990r290b3056],
42	[	CD	NUMBER	[	num	43	SENT_44	[p2l319t2969r631b3050],
43	l2	NN	O	l2	tmod	36	SENT_44	[p2l319t2969r631b3050],
44	—	CD	NUMBER	—	num	46	SENT_44	[p2l319t2969r631b3050],
45	l4	NN	O	l4	nn	46	SENT_44	[p2l319t2969r631b3050],
46	]	NN	O	]	dep	43	SENT_44	[p2l319t2969r631b3050],
47	.	.	O	.	_	0	SENT_44	[p2l319t2969r631b3050],

1	Over	IN	O	over	_	0	SENT_45	[p2l659t2970r847b3036],
2	the	DT	DATE	the	det	5	SENT_45	[p2l867t2969r982b3036],
3	past	JJ	DATE	past	amod	5	SENT_45	[p2l1002t2979r1156b3056],
4	several	JJ	DATE	several	amod	5	SENT_45	[p2l1179t2969r1442b3036],
5	years	NNS	DATE	year	prep_over	21	SENT_45	[p2l1463t2990r1683b3056],
6	,	,	O	,	_	0	SENT_45	[p2l1463t2990r1683b3056],
7	multiple	JJ	O	multiple	amod	8	SENT_45	[p2l1708t2969r2024b3056],
8	(	NN	O	(	nsubjpass	21	SENT_45	[p2l2050t2970r2148b3052],
9	at	IN	O	at	advmod	21	SENT_45	[p2l2050t2970r2148b3052],
10	least	JJS	O	least	pobj	9	SENT_45	[p2l7t3084r183b3151],
11	6	CD	NUMBER	6	number	12	SENT_45	[p2l200t3084r272b3167],
12	)	CD	NUMBER	)	num	18	SENT_45	[p2l200t3084r272b3167],
13	single	JJ	O	single	amod	18	SENT_45	[p2l295t3084r718b3171],
14	—	NN	O	—	nn	18	SENT_45	[p2l295t3084r718b3171],
15	base	NN	O	base	nn	18	SENT_45	[p2l295t3084r718b3171],
16	pair	NN	O	pair	nn	18	SENT_45	[p2l735t3084r884b3171],
17	substitution	NN	O	substitution	nn	18	SENT_45	[p2l903t3084r1343b3151],
18	polymorphisms	NNS	O	polymorphism	nsubjpass	21	SENT_45	[p2l1358t3084r1951b3171],
19	have	VBP	O	have	aux	21	SENT_45	[p2l1968t3084r2145b3151],
20	been	VBN	O	be	auxpass	21	SENT_45	[p2l6t3199r186b3266],
21	identiﬁed	VBN	O	identiﬁed	_	0	SENT_45	[p2l206t3199r566b3267],
22	in	IN	O	in	_	0	SENT_45	[p2l585t3199r658b3266],
23	the	DT	O	the	det	24	SENT_45	[p2l677t3199r793b3266],
24	gene	NN	O	gene	prep_in	21	SENT_45	[p2l813t3221r990b3286],
25	encoding	VBG	O	encode	xcomp	21	SENT_45	[p2l1011t3199r1359b3286],
26	the	DT	O	the	det	28	SENT_45	[p2l1379t3199r1493b3266],
27	CYPZC9	NN	O	cypzc9	nn	28	SENT_45	[p2l1515t3200r1855b3268],
28	protein	NN	O	protein	nsubj	31	SENT_45	[p2l1876t3199r2147b3286],
29	[	CD	NUMBER	[	number	30	SENT_45	[p2l14t3314r301b3395],
30	15,16	CD	NUMBER	15,16	num	31	SENT_45	[p2l14t3314r301b3395],
31	]	NN	O	]	xcomp	25	SENT_45	[p2l14t3314r301b3395],
32	.	.	O	.	_	0	SENT_45	[p2l14t3314r301b3395],

1	Accumulated	VBN	O	accumulate	_	0	SENT_46	[p2l347t3314r857b3381],
2	in	FW	O	in	nn	3	SENT_46	[p2l898t3314r971b3380],
3	vitro	FW	O	vitro	advmod	1	SENT_46	[p2l1009t3314r1185b3381],
4	evidence	NN	O	evidence	dobj	1	SENT_46	[p2l1229t3314r1564b3382],
5	has	VBZ	O	have	aux	6	SENT_46	[p2l1605t3314r1729b3381],
6	suggested	VBN	O	suggest	rcmod	4	SENT_46	[p2l1775t3314r2146b3401],
7	that	IN	O	that	complm	18	SENT_46	[p2l7t3429r150b3496],
8	the	DT	O	the	det	10	SENT_46	[p2l187t3429r302b3496],
9	CYP2C9	NN	O	cyp2c9	nn	10	SENT_46	[p2l346t3429r767b3496],
10	*	NN	O	*	nsubjpass	18	SENT_46	[p2l346t3429r767b3496],
11	2	CD	NUMBER	2	dep	10	SENT_46	[p2l346t3429r767b3496],
12	and	CC	O	and	_	0	SENT_46	[p2l810t3429r945b3496],
13	*	CD	NUMBER	*	number	14	SENT_46	[p2l993t3429r1074b3495],
14	3	CD	NUMBER	3	num	15	SENT_46	[p2l993t3429r1074b3495],
15	alleles	NNS	O	allele	conj_and	10	SENT_46	[p2l1117t3429r1355b3496],
16	are	VBP	O	be	auxpass	18	SENT_46	[p2l1398t3450r1509b3496],
17	both	DT	O	both	advmod	18	SENT_46	[p2l1548t3429r1717b3496],
18	associated	VBN	O	associate	ccomp	6	SENT_46	[p2l1757t3429r2147b3496],
19	with	IN	O	with	_	0	SENT_46	[p2l8t3544r175b3612],
20	signiﬁcant	JJ	O	signiﬁcant	amod	21	SENT_46	[p2l206t3544r600b3631],
21	reductions	NNS	O	reduction	prep_with	18	SENT_46	[p2l625t3544r1020b3611],
22	in	IN	O	in	_	0	SENT_46	[p2l1049t3544r1122b3611],
23	the	DT	O	the	det	24	SENT_46	[p2l1149t3544r1264b3611],
24	metabolism	NN	O	metabolism	prep_in	18	SENT_46	[p2l1291t3544r1737b3611],
25	of	IN	O	of	_	0	SENT_46	[p2l1765t3544r1849b3611],
26	various	JJ	O	various	amod	28	SENT_46	[p2l1869t3544r2144b3612],
27	CYPZC9	NN	O	cypzc9	nn	28	SENT_46	[p2l8t3660r348b3727],
28	substrates	NNS	O	substrate	prep_of	24	SENT_46	[p2l382t3659r772b3739],
29	,	,	O	,	_	0	SENT_46	[p2l382t3659r772b3739],
30	compared	VBN	O	compare	_	0	SENT_46	[p2l805t3659r1181b3746],
31	with	IN	O	with	prepc_compared_with	18	SENT_46	[p2l1209t3659r1377b3726],
32	the	DT	O	the	det	34	SENT_46	[p2l1406t3659r1520b3726],
33	wild-type	JJ	O	wild-type	amod	34	SENT_46	[p2l1548t3659r1912b3746],
34	allele	NN	O	allele	pobj	18	SENT_46	[p2l1942t3659r2145b3726],

1	[	NN	O	[	nn	2	SENT_47	[p3l14t21r326b102],
2	l6	NN	O	l6	_	0	SENT_47	[p3l14t21r326b102],
3	—	CD	NUMBER	—	num	5	SENT_47	[p3l14t21r326b102],
4	l9	NN	O	l9	nn	5	SENT_47	[p3l14t21r326b102],
5	]	NN	O	]	dep	2	SENT_47	[p3l14t21r326b102],
6	.	.	O	.	_	0	SENT_47	[p3l14t21r326b102],

1	In	IN	O	in	_	0	SENT_48	[p3l358t22r435b87],
2	addition	NN	O	addition	prep_in	9	SENT_48	[p3l464t21r794b100],
3	,	,	O	,	_	0	SENT_48	[p3l464t21r794b100],
4	numerous	JJ	O	numerous	nsubj	9	SENT_48	[p3l824t42r1197b88],
5	in	FW	O	in	prep	4	SENT_48	[p3l1226t21r1298b87],
6	vivo	FW	O	vivo	nn	7	SENT_48	[p3l1321t21r1485b88],
7	evaluations	NNS	O	evaluation	pobj	5	SENT_48	[p3l1514t21r1941b88],
8	have	VBP	O	have	aux	9	SENT_48	[p3l1968t21r2145b88],
9	demonstrated	VBN	O	demonstrate	_	0	SENT_48	[p3l8t136r522b203],
10	that	IN	O	that	complm	18	SENT_48	[p3l567t136r710b203],
11	individuals	NNS	O	individual	nsubj	18	SENT_48	[p3l756t136r1175b203],
12	possessing	VBG	O	possess	partmod	11	SENT_48	[p3l1222t136r1627b223],
13	at	IN	O	at	quantmod	15	SENT_48	[p3l1678t146r1744b203],
14	least	JJS	O	least	mwe	13	SENT_48	[p3l1789t136r1964b203],
15	one	CD	NUMBER	one	num	17	SENT_48	[p3l2011t157r2146b203],
16	variant	JJ	O	variant	amod	17	SENT_48	[p3l7t251r271b318],
17	allele	NN	O	allele	dobj	12	SENT_48	[p3l304t251r508b318],
18	exhibit	VBP	O	exhibit	ccomp	9	SENT_48	[p3l543t251r806b318],
19	signiﬁcant	JJ	O	signiﬁcant	amod	20	SENT_48	[p3l841t251r1236b338],
20	reductions	NNS	O	reduction	dobj	18	SENT_48	[p3l1267t251r1662b318],
21	in	IN	O	in	_	0	SENT_48	[p3l1697t251r1770b317],
22	CYPZC9	NN	O	cypzc9	nn	24	SENT_48	[p3l1804t251r2144b319],
23	metabolic	JJ	O	metabolic	amod	24	SENT_48	[p3l7t366r382b433],
24	activity	NN	O	activity	prep_in	20	SENT_48	[p3l406t366r687b453],
25	and	CC	O	and	_	0	SENT_48	[p3l710t366r845b433],
26	the	DT	O	the	det	28	SENT_48	[p3l864t366r978b433],
27	dosing	NN	O	dosing	nn	28	SENT_48	[p3l1000t366r1251b453],
28	requirements	NNS	O	requirement	prep_in	20	SENT_48	[p3l1271t366r1767b453],
29	of	IN	O	of	_	0	SENT_48	[p3l1791t366r1874b433],
30	certain	JJ	O	certain	amod	32	SENT_48	[p3l1888t366r2146b433],
31	CYPZC9	NN	O	cypzc9	nn	32	SENT_48	[p3l8t482r348b549],
32	substrates	NNS	O	substrate	prep_of	28	SENT_48	[p3l382t481r773b560],
33	,	,	O	,	_	0	SENT_48	[p3l382t481r773b560],
34	including	VBG	O	include	_	0	SENT_48	[p3l804t481r1163b568],
35	ﬁrst	SYM	O	ﬁrst	dep	37	SENT_48	[p3l1194t481r1368b548],
36	-	:	O	-	_	0	SENT_48	[p3l1194t481r1368b548],
37	and	CC	O	and	prepc_including	18	SENT_48	[p3l1401t481r1537b548],
38	second	LS	ORDINAL	second	dep	37	SENT_48	[p3l1567t481r1856b548],
39	-	:	O	-	_	0	SENT_48	[p3l1567t481r1856b548],
40	generation	NN	O	generation	nn	41	SENT_48	[p3l1863t503r2144b568, p3l7t596r154b663],
41	SUs	NNS	O	sus	nsubj	42	SENT_48	[p3l207t596r360b663],
42	[	VBP	O	[	parataxis	9	SENT_48	[p3l419t596r731b677],
43	20	CD	NUMBER	20	number	44	SENT_48	[p3l419t596r731b677],
44	—	CD	NUMBER	—	dobj	42	SENT_48	[p3l419t596r731b677],
45	23	CD	NUMBER	23	number	46	SENT_48	[p3l419t596r731b677],
46	]	NN	O	]	amod	44	SENT_48	[p3l419t596r731b677],
47	.	.	O	.	_	0	SENT_48	[p3l419t596r731b677],

1	Therefore	RB	O	therefore	advmod	8	SENT_49	[p3l787t596r1182b675],
2	,	,	O	,	_	0	SENT_49	[p3l787t596r1182b675],
3	CYPZC9	NN	O	cypzc9	nn	5	SENT_49	[p3l1241t596r1570b663],
4	genetic	JJ	O	genetic	amod	5	SENT_49	[p3l1622t596r1893b683],
5	polymorphisms	NNS	O	polymorphism	nsubj	8	SENT_49	[p3l1945t596r2144b683, p3l7t711r428b798],
6	might	MD	O	might	aux	8	SENT_49	[p3l511t711r735b798],
7	also	RB	O	also	advmod	8	SENT_49	[p3l817t711r966b778],
8	affect	VB	O	affect	_	0	SENT_49	[p3l1050t711r1263b778],
9	the	DT	O	the	det	10	SENT_49	[p3l1344t711r1460b778],
10	metabolism	NN	O	metabolism	dobj	8	SENT_49	[p3l1541t711r1987b778],
11	of	IN	O	of	_	0	SENT_49	[p3l2069t711r2153b778],
12	glimepiride	NN	O	glimepiride	prep_of	10	SENT_49	[p3l8t826r466b913],
13	.	.	O	.	_	0	SENT_49	[p3l8t826r466b913],

1	In	IN	O	in	_	0	SENT_50	[p3l123t942r201b1007],
2	this	DT	O	this	det	3	SENT_50	[p3l224t941r359b1008],
3	study	NN	O	study	prep_in	6	SENT_50	[p3l389t941r606b1028],
4	,	,	O	,	_	0	SENT_50	[p3l389t941r606b1028],
5	we	PRP	O	we	nsubj	6	SENT_50	[p3l634t962r743b1008],
6	investigated	VBD	O	investigate	_	0	SENT_50	[p3l768t941r1231b1028],
7	the	DT	O	the	det	8	SENT_50	[p3l1253t941r1368b1008],
8	efﬁcacy	NN	O	efﬁcacy	dobj	6	SENT_50	[p3l1394t941r1711b1028],
9	,	,	O	,	_	0	SENT_50	[p3l1394t941r1711b1028],
10	safety	NN	O	safety	conj_and	8	SENT_50	[p3l1741t941r1981b1028],
11	,	,	O	,	_	0	SENT_50	[p3l1741t941r1981b1028],
12	and	CC	O	and	_	0	SENT_50	[p3l2010t941r2146b1008],
13	pharmacokinetics	NNS	O	pharmacokinetic	dobj	6	SENT_50	[p3l6t1056r686b1143],
14	of	IN	O	of	_	0	SENT_50	[p3l748t1056r831b1123],
15	glimepiride	NN	O	glimepiride	prep_of	13	SENT_50	[p3l883t1056r1327b1143],
16	in	IN	O	in	_	0	SENT_50	[p3l1385t1056r1458b1122],
17	type	NN	O	type	amod	21	SENT_50	[p3l1515t1066r1679b1143],
18	2	CD	NUMBER	2	number	17	SENT_50	[p3l1739t1056r1782b1122],
19	diabetic	JJ	O	diabetic	amod	21	SENT_50	[p3l1842t1056r2143b1123],
20	Japanese	JJ	MISC	japanese	amod	21	SENT_50	[p3l7t1172r348b1258],
21	patients	NNS	O	patient	prep_in	6	SENT_50	[p3l381t1171r680b1258],
22	with	IN	O	with	_	0	SENT_50	[p3l715t1171r884b1238],
23	different	JJ	O	different	amod	25	SENT_50	[p3l919t1171r1248b1238],
24	CYP2C9	NN	O	cyp2c9	nn	25	SENT_50	[p3l1285t1171r1616b1239],
25	genotypes	NNS	O	genotype	prep_with	21	SENT_50	[p3l1651t1181r2037b1258],
26	to	TO	O	to	aux	27	SENT_50	[p3l2073t1181r2145b1238],
27	predict	VB	O	predict	xcomp	6	SENT_50	[p3l6t1286r275b1373],
28	their	PRP$	O	they	poss	29	SENT_50	[p3l309t1286r486b1353],
29	response	NN	O	response	dobj	27	SENT_50	[p3l518t1308r854b1373],
30	to	TO	O	to	_	0	SENT_50	[p3l890t1296r961b1353],
31	glimepiride	NN	O	glimepiride	prep_to	27	SENT_50	[p3l998t1286r1462b1373],
32	.	.	O	.	_	0	SENT_50	[p3l998t1286r1462b1373],

1	2	LS	NUMBER	2	_	0	SENT_51	[p3l7t1547r68b1609],
2	.	.	O	.	_	0	SENT_51	[p3l7t1547r68b1609],

1	Patients	NNS	O	patient	_	0	SENT_52	[p3l116t1547r412b1609],
2	and	CC	O	and	_	0	SENT_52	[p3l445t1548r581b1609],
3	methods	NNS	O	method	conj_and	1	SENT_52	[p3l612t1548r922b1609],

1	2	LS	NUMBER	2	_	0	SENT_53	[p3l7t1761r127b1822],
2	.	.	O	.	_	0	SENT_53	[p3l7t1761r127b1822],
3	]	SYM	O	]	dep	1	SENT_53	[p3l7t1761r127b1822],

1	.	.	O	.	_	0	SENT_54	[p3l7t1761r127b1822],

1	Patient	NN	O	patient	nn	2	SENT_55	[p3l179t1763r427b1822],
2	selection	NN	O	selection	_	0	SENT_55	[p3l456t1761r762b1822],
3	and	CC	O	and	_	0	SENT_55	[p3l795t1761r926b1822],
4	clinical	JJ	O	clinical	amod	6	SENT_55	[p3l955t1761r1215b1822],
5	study	NN	O	study	nn	6	SENT_55	[p3l1245t1761r1426b1838],
6	design	NN	O	design	conj_and	2	SENT_55	[p3l1457t1761r1680b1838],

1	Japanese	JJ	MISC	japanese	amod	2	SENT_56	[p3l122t1974r436b2051],
2	patients	NNS	O	patient	nsubjpass	27	SENT_56	[p3l454t1972r730b2051],
3	with	IN	O	with	_	0	SENT_56	[p3l751t1972r906b2033],
4	type	NN	O	type	nn	6	SENT_56	[p3l924t1982r1075b2051],
5	2	CD	NUMBER	2	num	6	SENT_56	[p3l1096t1973r1134b2032],
6	diabetes	NN	O	diabetes	prep_with	2	SENT_56	[p3l1155t1972r1442b2033],
7	between	IN	O	between	_	0	SENT_56	[p3l1462t1972r1757b2033],
8	the	DT	O	the	det	9	SENT_56	[p3l1775t1973r1881b2033],
9	ages	NNS	O	age	prep_between	6	SENT_56	[p3l1903t1992r2054b2051],
10	of	IN	O	of	_	0	SENT_56	[p3l2077t1972r2152b2033],
11	35	CD	NUMBER	35	nn	14	SENT_56	[p3l9t2077r89b2139],
12	and	CC	O	and	_	0	SENT_56	[p3l130t2078r254b2138],
13	85	CD	DURATION	85	conj_and	11	SENT_56	[p3l292t2077r370b2139],
14	years	NNS	NUMBER	year	prep_of	9	SENT_56	[p3l408t2097r592b2156],
15	who	WP	O	who	nsubj	17	SENT_56	[p3l629t2078r777b2139],
16	had	VBD	O	have	aux	17	SENT_56	[p3l812t2078r939b2138],
17	received	VBN	O	receive	rcmod	14	SENT_56	[p3l971t2078r1271b2139],
18	medical	JJ	O	medical	amod	19	SENT_56	[p3l1305t2078r1585b2138],
19	treatment	NN	O	treatment	dobj	17	SENT_56	[p3l1621t2087r1957b2138],
20	with	IN	O	with	_	0	SENT_56	[p3l1991t2078r2146b2139],
21	glimepiride	NN	O	glimepiride	prep_with	17	SENT_56	[p3l8t2183r416b2261],
22	at	IN	O	at	_	0	SENT_56	[p3l436t2192r496b2244],
23	Nerima	NNP	LOCATION	Nerima	nn	25	SENT_56	[p3l512t2183r777b2244],
24	General	NNP	LOCATION	General	nn	25	SENT_56	[p3l794t2183r1070b2244],
25	Hospital	NNP	LOCATION	Hospital	prep_at	17	SENT_56	[p3l1088t2183r1386b2261],
26	were	VBD	O	be	auxpass	27	SENT_56	[p3l1405t2202r1572b2244],
27	recruited	VBN	O	recruit	_	0	SENT_56	[p3l1589t2183r1907b2244],
28	for	IN	O	for	_	0	SENT_56	[p3l1923t2183r2025b2244],
29	the	DT	O	the	det	30	SENT_56	[p3l2039t2183r2145b2244],
30	study	NN	O	study	prep_for	27	SENT_56	[p3l10t2288r210b2366],
31	.	.	O	.	_	0	SENT_56	[p3l10t2288r210b2366],

1	Patients	NNS	O	patient	dep	14	SENT_57	[p3l246t2287r523b2348],
2	with	IN	O	with	_	0	SENT_57	[p3l558t2287r712b2348],
3	impaired	JJ	O	impaired	amod	8	SENT_57	[p3l744t2287r1060b2366],
4	liver	NN	O	liver	nn	8	SENT_57	[p3l1091t2287r1250b2349],
5	function	NN	O	function	nn	8	SENT_57	[p3l1282t2287r1576b2348],
6	(	CD	NUMBER	(	num	8	SENT_57	[p3l1611t2288r1953b2366],
7	aspartate	NN	O	aspartate	nn	8	SENT_57	[p3l1611t2288r1953b2366],
8	aminotransferase	NN	O	aminotransferase	prep_with	1	SENT_57	[p3l1987t2287r2143b2348, p3l7t2393r479b2454],
9	>	JJR	O	>	amod	8	SENT_57	[p3l510t2392r657b2456],
10	50	CD	NUMBER	50	dep	14	SENT_57	[p3l510t2392r657b2456],
11	IU/l	NN	O	iu/l	nn	14	SENT_57	[p3l682t2393r822b2454],
12	or	CC	O	or	_	0	SENT_57	[p3l848t2412r919b2454],
13	alanine	NN	O	alanine	conj_or	11	SENT_57	[p3l944t2393r1197b2454],
14	aminotransferase	NN	O	aminotransferase	dep	17	SENT_57	[p3l1225t2393r1829b2454],
15	>	JJR	O	>	dep	14	SENT_57	[p3l1859t2392r2006b2456],
16	50	CD	NUMBER	50	num	17	SENT_57	[p3l1859t2392r2006b2456],
17	IU	NN	O	iu	dep	20	SENT_57	[p3l2031t2393r2148b2454],
18	/	:	O	/	punct	20	SENT_57	[p3l2031t2393r2148b2454],
19	1	CD	NUMBER	1	num	20	SENT_57	[p3l7t2498r79b2573],
20	)	NN	O	)	_	0	SENT_57	[p3l7t2498r79b2573],
21	,	,	O	,	_	0	SENT_57	[p3l7t2498r79b2573],
22	and/or	NN	O	and/or	appos	20	SENT_57	[p3l116t2498r341b2559],
23	who	WP	O	who	nsubj	25	SENT_57	[p3l373t2498r520b2559],
24	had	VBD	O	have	aux	25	SENT_57	[p3l553t2498r680b2559],
25	received	VBN	O	receive	rcmod	22	SENT_57	[p3l711t2498r1010b2559],
26	other	JJ	O	other	amod	30	SENT_57	[p3l1043t2498r1225b2559],
27	CYP2C9	NN	O	cyp2c9	nn	30	SENT_57	[p3l1257t2498r1918b2560],
28	—	CD	NUMBER	—	num	30	SENT_57	[p3l1257t2498r1918b2560],
29	substrate	NN	O	substrate	nn	30	SENT_57	[p3l1257t2498r1918b2560],
30	drugs	NNS	O	drug	nsubjpass	32	SENT_57	[p3l1953t2498r2144b2576],
31	were	VBD	O	be	auxpass	32	SENT_57	[p3l7t2622r176b2664],
32	excluded	VBN	O	exclude	ccomp	25	SENT_57	[p3l218t2602r553b2663],
33	.	.	O	.	_	0	SENT_57	[p3l218t2602r553b2663],

1	After	IN	O	after	_	0	SENT_58	[p3l598t2602r785b2663],
2	obtaining	VBG	O	obtain	prepc_after	35	SENT_58	[p3l825t2602r1157b2681],
3	Written	VBN	O	write	dep	2	SENT_58	[p3l1199t2602r1450b2664],
4	informed	VBN	O	inform	amod	5	SENT_58	[p3l1490t2602r1814b2663],
5	consent	NN	O	consent	dobj	3	SENT_58	[p3l1855t2612r2143b2674],
6	,	,	O	,	_	0	SENT_58	[p3l1855t2612r2143b2674],
7	patients	NNS	O	patient	nsubjpass	35	SENT_58	[p3l6t2708r280b2786],
8	whose	WP$	O	whose	dep	15	SENT_58	[p3l306t2708r527b2768],
9	blood	NN	O	blood	nn	11	SENT_58	[p3l549t2708r751b2768],
10	glucose	NN	O	glucose	nn	11	SENT_58	[p3l773t2708r1040b2786],
11	levels	NNS	O	level	nsubjpass	15	SENT_58	[p3l1063t2708r1265b2769],
12	were	VBD	O	be	auxpass	15	SENT_58	[p3l1289t2727r1457b2769],
13	not	RB	O	not	neg	15	SENT_58	[p3l1480t2717r1592b2768],
14	well	RB	O	well	advmod	15	SENT_58	[p3l1614t2708r1764b2769],
15	controlled	VBN	O	control	dep	7	SENT_58	[p3l1787t2708r2147b2768],
16	by	IN	O	by	_	0	SENT_58	[p3l6t2813r92b2891],
17	diet	NN	O	diet	agent	15	SENT_58	[p3l129t2813r261b2874],
18	and	CC	O	and	_	0	SENT_58	[p3l298t2813r422b2874],
19	exercise	NN	O	exercise	agent	15	SENT_58	[p3l458t2813r745b2874],
20	and	CC	O	and	_	0	SENT_58	[p3l783t2813r907b2874],
21	whose	WP$	O	whose	dep	33	SENT_58	[p3l942t2813r1164b2874],
22	glycosylated	VBN	O	glycosylate	csubj	33	SENT_58	[p3l1200t2813r1649b2891],
23	haemoglobin	NN	O	haemoglobin	nn	24	SENT_58	[p3l1683t2813r2146b2891],
24	Ale	NN	O	ale	tmod	22	SENT_58	[p3l7t2918r130b2991],
25	(	CD	NUMBER	(	num	28	SENT_58	[p3l169t2917r456b2991],
26	HbA1C	NN	O	hba1c	nn	28	SENT_58	[p3l169t2917r456b2991],
27	)	NN	O	)	nn	28	SENT_58	[p3l169t2917r456b2991],
28	values	NNS	O	value	dep	24	SENT_58	[p3l494t2917r715b2977],
29	were	VBD	O	be	cop	33	SENT_58	[p3l752t2936r921b2977],
30	more	JJR	O	more	mwe	31	SENT_58	[p3l957t2936r1136b2977],
31	than	IN	O	than	quantmod	32	SENT_58	[p3l1172t2917r1324b2977],
32	7	CD	PERCENT	7	num	33	SENT_58	[p3l1359t2917r1470b2977],
33	%	NN	PERCENT	%	agent	15	SENT_58	[p3l1359t2917r1470b2977],
34	were	VBD	O	be	auxpass	35	SENT_58	[p3l1509t2936r1678b2977],
35	treated	VBN	O	treat	_	0	SENT_58	[p3l1714t2917r1957b2977],
36	with	IN	O	with	_	0	SENT_58	[p3l1991t2917r2146b2977],
37	glimepiride	NN	O	glimepiride	prep_with	35	SENT_58	[p3l8t3022r435b3100],
38	.	.	O	.	_	0	SENT_58	[p3l8t3022r435b3100],

1	HbA1C	NN	O	hba1c	nsubjpass	3	SENT_59	[p3l457t3022r687b3096],
2	Were	VBD	O	be	auxpass	3	SENT_59	[p3l705t3041r874b3083],
3	measured	VBN	O	measure	conj_and	3	SENT_59	[p3l892t3022r1231b3082],
4	before	IN	O	before	_	0	SENT_59	[p3l1247t3022r1471b3082],
5	and	CC	O	and	_	0	SENT_59	[p3l1492t3022r1615b3082],
6	after	IN	O	after	_	0	SENT_59	[p3l1633t3022r1795b3082],
7	treatment	NN	O	treatment	prep_before	3	SENT_59	[p3l1810t3031r2147b3082],
8	with	IN	O	with	_	0	SENT_59	[p3l8t3127r163b3188],
9	glimepiride	NN	O	glimepiride	prep_with	3	SENT_59	[p3l193t3127r600b3205],
10	every	DT	SET	every	det	11	SENT_59	[p3l632t3146r823b3205],
11	month	NN	SET	month	tmod	3	SENT_59	[p3l853t3127r1095b3188],
12	.	.	O	.	_	0	SENT_59	[p3l853t3127r1095b3188],

1	One	CD	NUMBER	one	num	2	SENT_60	[p3l1131t3127r1273b3188],
2	hundred	CD	NUMBER	hundred	nsubj	8	SENT_60	[p3l1303t3127r1592b3188],
3	and	CC	NUMBER	and	_	0	SENT_60	[p3l1623t3127r1748b3188],
4	thirty	CD	NUMBER	thirty	num	7	SENT_60	[p3l1776t3127r2147b3205],
5	—	CD	NUMBER	—	num	7	SENT_60	[p3l1776t3127r2147b3205],
6	four	CD	NUMBER	four	num	7	SENT_60	[p3l1776t3127r2147b3205],
7	patients	NNS	O	patient	conj_and	2	SENT_60	[p3l7t3232r282b3310],
8	participated	VBD	O	participate	_	0	SENT_60	[p3l309t3232r731b3310],
9	in	IN	O	in	_	0	SENT_60	[p3l756t3232r822b3292],
10	a	DT	O	a	det	12	SENT_60	[p3l850t3251r886b3292],
11	C	NN	O	c	nn	12	SENT_60	[p3l915t3233r969b3293],
12	YP2C9	NN	O	yp2c9	prep_in	8	SENT_60	[p3l975t3232r1299b3293],
13	*	CD	NUMBER	*	num	14	SENT_60	[p3l975t3232r1299b3293],
14	]	NN	O	]	dobj	8	SENT_60	[p3l975t3232r1299b3293],
15	,	,	O	,	_	0	SENT_60	[p3l1313t3282r1325b3303],
16	*	NN	O	*	dobj	8	SENT_60	[p3l1364t3232r1459b3303],
17	2	CD	NUMBER	2	num	16	SENT_60	[p3l1364t3232r1459b3303],
18	,	,	O	,	_	0	SENT_60	[p3l1364t3232r1459b3303],
19	and	CC	O	and	_	0	SENT_60	[p3l1490t3232r1614b3292],
20	*	NN	O	*	nn	23	SENT_60	[p3l1649t3232r1723b3292],
21	3	CD	NUMBER	3	num	23	SENT_60	[p3l1649t3232r1723b3292],
22	genotyping	NN	O	genotyping	nn	23	SENT_60	[p3l1751t3232r2146b3310],
23	study	NN	O	study	conj_and	14	SENT_60	[p3l12t3337r210b3415],
24	.	.	O	.	_	0	SENT_60	[p3l12t3337r210b3415],

1	After	IN	O	after	_	0	SENT_61	[p3l254t3337r441b3398],
2	the	DT	O	the	det	5	SENT_61	[p3l479t3337r585b3398],
3	CYPZC9	NN	O	cypzc9	nn	5	SENT_61	[p3l629t3337r933b3398],
4	genotype	NN	O	genotype	nn	5	SENT_61	[p3l972t3346r1293b3415],
5	analysis	NN	O	analysis	prep_after	33	SENT_61	[p3l1336t3337r1638b3415],
6	,	,	O	,	_	0	SENT_61	[p3l1336t3337r1638b3415],
7	6	CD	NUMBER	6	num	8	SENT_61	[p3l1682t3337r1721b3398],
8	patients	NNS	O	patient	nsubjpass	33	SENT_61	[p3l1760t3337r2035b3415],
9	(	CD	NUMBER	(	number	10	SENT_61	[p3l2080t3337r2147b3412],
10	4	CD	NUMBER	4	num	11	SENT_61	[p3l2080t3337r2147b3412],
11	patients	NNS	O	patient	npadvmod	8	SENT_61	[p3l8t3442r282b3521],
12	with	IN	O	with	_	0	SENT_61	[p3l351t3442r506b3503],
13	a	DT	O	a	det	15	SENT_61	[p3l574t3461r609b3503],
14	CYP2C9	NN	O	cyp2c9	nn	15	SENT_61	[p3l678t3442r1176b3503],
15	*	NN	O	*	prep_with	8	SENT_61	[p3l678t3442r1176b3503],
16	1	CD	NUMBER	1	dep	15	SENT_61	[p3l678t3442r1176b3503],
17	/	:	O	/	punct	19	SENT_61	[p3l678t3442r1176b3503],
18	*	CD	NUMBER	*	num	19	SENT_61	[p3l678t3442r1176b3503],
19	1	CD	NUMBER	1	dep	15	SENT_61	[p3l678t3442r1176b3503],
20	and	CC	O	and	_	0	SENT_61	[p3l1251t3442r1376b3503],
21	2	CD	NUMBER	2	num	22	SENT_61	[p3l1442t3443r1481b3502],
22	patients	NNS	O	patient	conj_and	19	SENT_61	[p3l1547t3442r1822b3521],
23	with	IN	O	with	_	0	SENT_61	[p3l1890t3442r2045b3503],
24	a	DT	O	a	det	26	SENT_61	[p3l2113t3461r2149b3503],
25	CYP2C9	NN	O	cyp2c9	nn	26	SENT_61	[p3l13t3547r545b3622],
26	*	NN	O	*	prep_with	19	SENT_61	[p3l13t3547r545b3622],
27	1	CD	NUMBER	1	dep	19	SENT_61	[p3l13t3547r545b3622],
28	/	:	O	/	punct	19	SENT_61	[p3l13t3547r545b3622],
29	*	CD	NUMBER	*	number	30	SENT_61	[p3l13t3547r545b3622],
30	3	CD	NUMBER	3	num	31	SENT_61	[p3l13t3547r545b3622],
31	)	NN	O	)	dep	15	SENT_61	[p3l13t3547r545b3622],
32	were	VBD	O	be	auxpass	33	SENT_61	[p3l587t3566r755b3608],
33	asked	VBN	O	ask	_	0	SENT_61	[p3l797t3547r996b3607],
34	to	TO	O	to	aux	35	SENT_61	[p3l1035t3556r1100b3607],
35	participate	VB	O	participate	xcomp	33	SENT_61	[p3l1139t3547r1516b3625],
36	in	IN	O	in	_	0	SENT_61	[p3l1556t3547r1623b3607],
37	a	DT	O	a	det	40	SENT_61	[p3l1664t3566r1699b3607],
38	glimepiride	NN	O	glimepiride	nn	40	SENT_61	[p3l1739t3547r2146b3625],
39	pharmacokinetic	JJ	O	pharmacokinetic	amod	40	SENT_61	[p3l7t3652r599b3730],
40	study	NN	O	study	prep_in	35	SENT_61	[p3l643t3652r842b3730],
41	.	.	O	.	_	0	SENT_61	[p3l643t3652r842b3730],

1	These	DT	O	these	det	3	SENT_62	[p3l885t3652r1095b3713],
2	6	CD	NUMBER	6	num	3	SENT_62	[p3l1135t3652r1174b3713],
3	patients	NNS	O	patient	nsubj	4	SENT_62	[p3l1213t3652r1488b3730],
4	ingested	VBD	O	ingest	_	0	SENT_62	[p3l1529t3652r1824b3730],
5	1	CD	NUMBER	1	num	6	SENT_62	[p3l1870t3652r1896b3712],
6	mg	NN	O	mg	dobj	4	SENT_62	[p3l1929t3671r2037b3730],
7	of	IN	O	of	_	0	SENT_62	[p3l2078t3652r2153b3713],
8	glimepiride	NN	O	glimepiride	nn	10	SENT_62	[p4l9t20r417b99],
9	(	CD	NUMBER	(	num	10	SENT_62	[p4l437t20r752b99],
10	Amaryl	NN	PERSON	amaryl	prep_of	6	SENT_62	[p4l437t20r752b99],
11	,	,	O	,	_	0	SENT_62	[p4l437t20r752b99],
12	1	CD	NUMBER	1	num	14	SENT_62	[p4l780t21r805b80],
13	mg	NN	O	mg	nn	14	SENT_62	[p4l838t39r947b99],
14	tablet	NN	O	tablet	appos	10	SENT_62	[p4l964t20r1182b92],
15	;	:	O	;	_	0	SENT_62	[p4l964t20r1182b92],
16	Aventis	NNP	ORGANIZATION	Aventis	nsubj	36	SENT_62	[p4l1202t20r1489b92],
17	,	,	O	,	_	0	SENT_62	[p4l1202t20r1489b92],
18	Japan	NNP	LOCATION	Japan	dep	36	SENT_62	[p4l1508t21r1734b99],
19	)	CD	NUMBER	)	num	18	SENT_62	[p4l1508t21r1734b99],
20	after	IN	O	after	_	0	SENT_62	[p4l1756t20r1917b81],
21	eating	VBG	O	eat	prepc_after	36	SENT_62	[p4l1933t20r2146b99],
22	a	DT	O	a	det	23	SENT_62	[p4l10t144r46b185],
23	meal	NN	O	meal	dobj	21	SENT_62	[p4l72t125r242b185],
24	between	IN	O	between	_	0	SENT_62	[p4l268t125r564b186],
25	7	CD	NUMBER	7	prep_between	23	SENT_62	[p4l590t126r628b185],
26	and	CC	O	and	_	0	SENT_62	[p4l660t125r784b185],
27	8	CD	TIME	8	num	31	SENT_62	[p4l814t125r848b186],
28	a.m.	NN	TIME	a.m.	nn	31	SENT_62	[p4l881t144r1025b186],
29	Plasma	NN	O	plasma	nn	31	SENT_62	[p4l1056t125r1311b185],
30	glimepiride	NN	O	glimepiride	nn	31	SENT_62	[p4l1338t125r1746b203],
31	concentrations	NNS	O	concentration	prep_between	23	SENT_62	[p4l1775t134r2145b185, p4l8t230r199b301],
32	,	,	O	,	_	0	SENT_62	[p4l1775t134r2145b185, p4l8t230r199b301],
33	blood	NN	O	blood	nn	35	SENT_62	[p4l222t230r423b291],
34	glucose	NN	O	glucose	nn	35	SENT_62	[p4l445t230r711b308],
35	levels	NNS	O	level	nsubj	36	SENT_62	[p4l734t230r935b291],
36	(	VBP	O	(	parataxis	4	SENT_62	[p4l961t230r1141b305],
37	BS	NN	O	b	nn	38	SENT_62	[p4l961t230r1141b305],
38	)	NN	O	)	dobj	36	SENT_62	[p4l961t230r1141b305],
39	,	,	O	,	_	0	SENT_62	[p4l961t230r1141b305],
40	and	CC	O	and	_	0	SENT_62	[p4l1167t230r1291b291],
41	immunoreactive	JJ	O	immunoreactive	amod	43	SENT_62	[p4l1312t230r1886b291],
42	insulin	NN	O	insulin	nn	43	SENT_62	[p4l1907t230r2148b291],
43	(	NN	O	(	nsubjpass	47	SENT_62	[p4l11t336r181b410],
44	IRI	NNP	O	IRI	dep	43	SENT_62	[p4l11t336r181b410],
45	)	CD	NUMBER	)	num	44	SENT_62	[p4l11t336r181b410],
46	were	VBD	O	be	auxpass	47	SENT_62	[p4l218t354r387b396],
47	measured	VBN	O	measure	conj_and	36	SENT_62	[p4l423t335r779b396],
48	.	.	O	.	_	0	SENT_62	[p4l423t335r779b396],

1	This	DT	O	this	det	2	SENT_63	[p4l818t335r972b396],
2	study	NN	O	study	nsubjpass	4	SENT_63	[p4l1011t335r1197b414],
3	was	VBD	O	be	auxpass	4	SENT_63	[p4l1233t354r1365b396],
4	carried	VBN	O	carry	_	0	SENT_63	[p4l1402t335r1648b396],
5	out	RP	O	out	prt	4	SENT_63	[p4l1683t344r1793b396],
6	in	IN	O	in	_	0	SENT_63	[p4l1827t335r1894b395],
7	accordance	NN	O	accordance	_	0	SENT_63	[p4l1930t354r2146b396, p4l9t440r213b500],
8	With	IN	O	with	_	0	SENT_63	[p4l238t440r394b501],
9	the	DT	O	the	det	10	SENT_63	[p4l420t440r525b500],
10	principals	NNS	O	principal	prep_in_accordance_with	4	SENT_63	[p4l552t440r901b518],
11	of	IN	O	of	_	0	SENT_63	[p4l930t440r1006b500],
12	the	DT	O	the	det	13	SENT_63	[p4l1027t440r1132b500],
13	Declaration	NN	O	declaration	prep_of	10	SENT_63	[p4l1159t440r1573b500],
14	of	IN	O	of	_	0	SENT_63	[p4l1601t440r1677b500],
15	Helsinki	NNP	LOCATION	Helsinki	prep_of	13	SENT_63	[p4l1697t440r1994b500],
16	and	CC	O	and	_	0	SENT_63	[p4l2024t440r2148b500],
17	“	CD	NUMBER	“	conj_and	13	SENT_63	[p4l17t545r196b606],
18	The	DT	O	the	det	20	SENT_63	[p4l17t545r196b606],
19	Ethical	JJ	O	ethical	amod	20	SENT_63	[p4l237t545r488b606],
20	Guidelines	NNS	O	guideline	dep	17	SENT_63	[p4l532t545r912b606],
21	for	IN	O	for	_	0	SENT_63	[p4l955t545r1057b606],
22	Human	JJ	O	human	amod	24	SENT_63	[p4l1097t546r1354b606],
23	Genome	NNP	O	Genome	nn	24	SENT_63	[p4l1395t545r1691b606],
24	Analysis	NN	O	analysis	prep_for	4	SENT_63	[p4l1732t545r2039b623],
25	in	IN	O	in	_	0	SENT_63	[p4l2081t545r2148b605],
26	Japan	NNP	LOCATION	Japan	prep_in	24	SENT_63	[p4l8t650r279b729],
27	”	CD	NUMBER	”	num	26	SENT_63	[p4l8t650r279b729],
28	.	.	O	.	_	0	SENT_63	[p4l8t650r279b729],

1	The	DT	O	the	det	2	SENT_64	[p4l309t650r444b711],
2	study	NN	O	study	nsubjpass	4	SENT_64	[p4l474t650r660b729],
3	was	VBD	O	be	auxpass	4	SENT_64	[p4l687t669r819b711],
4	approved	VBN	O	approve	_	0	SENT_64	[p4l848t650r1174b729],
5	by	IN	O	by	_	0	SENT_64	[p4l1198t650r1284b729],
6	the	DT	O	the	det	8	SENT_64	[p4l1310t650r1415b711],
7	Ethical	JJ	ORGANIZATION	ethical	amod	8	SENT_64	[p4l1442t650r1693b711],
8	Committees	NNS	ORGANIZATION	committee	agent	4	SENT_64	[p4l1721t650r2146b711],
9	of	IN	ORGANIZATION	of	_	0	SENT_64	[p4l9t754r85b815],
10	Nerima	NNP	ORGANIZATION	Nerima	nn	12	SENT_64	[p4l120t754r385b815],
11	General	NNP	ORGANIZATION	General	nn	12	SENT_64	[p4l426t754r703b815],
12	Hospital	NNP	ORGANIZATION	Hospital	prep_of	8	SENT_64	[p4l745t754r1044b833],
13	and	CC	O	and	_	0	SENT_64	[p4l1087t754r1211b815],
14	the	DT	O	the	det	16	SENT_64	[p4l1251t754r1357b815],
15	National	NNP	ORGANIZATION	National	nn	16	SENT_64	[p4l1398t754r1703b815],
16	Institute	NNP	ORGANIZATION	Institute	agent	4	SENT_64	[p4l1745t754r2035b815],
17	of	IN	ORGANIZATION	of	_	0	SENT_64	[p4l2078t754r2153b815],
18	Health	NNP	ORGANIZATION	Health	nn	19	SENT_64	[p4l9t859r244b919],
19	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	16	SENT_64	[p4l275t859r600b919],
20	.	.	O	.	_	0	SENT_64	[p4l275t859r600b919],

1	2.2	CD	NUMBER	2.2	_	0	SENT_65	[p4l8t1071r128b1131],
2	.	.	O	.	_	0	SENT_65	[p4l8t1071r128b1131],

1	Laboratory	NNP	O	Laboratory	nn	2	SENT_66	[p4l180t1070r574b1148],
2	methods	NNS	O	method	_	0	SENT_66	[p4l605t1070r892b1131],

1	The	DT	O	the	det	3	SENT_67	[p4l124t1282r257b1343],
2	CYP2C9	NN	O	cyp2c9	nn	3	SENT_67	[p4l296t1282r594b1343],
3	genotypes	NNS	O	genotype	nsubjpass	8	SENT_67	[p4l628t1291r976b1361],
4	of	IN	O	of	_	0	SENT_67	[p4l1012t1282r1087b1343],
5	the	DT	O	the	det	6	SENT_67	[p4l1115t1282r1219b1343],
6	patients	NNS	O	patient	prep_of	3	SENT_67	[p4l1253t1282r1521b1361],
7	were	VBD	O	be	auxpass	8	SENT_67	[p4l1557t1301r1723b1343],
8	determined	VBN	O	determine	_	0	SENT_67	[p4l1758t1282r2148b1343],
9	using	VBG	O	use	xcomp	8	SENT_67	[p4l8t1386r193b1465],
10	a	DT	O	a	det	12	SENT_67	[p4l228t1406r264b1447],
11	Pre	JJ	O	pre	amod	12	SENT_67	[p4l294t1386r794b1465],
12	—	NN	O	—	nsubj	13	SENT_67	[p4l294t1386r794b1465],
13	developed	VBD	O	develop	ccomp	9	SENT_67	[p4l294t1386r794b1465],
14	TaqMan	NNP	O	TaqMan	nn	16	SENT_67	[p4l824t1388r1110b1465],
15	Assay	NN	O	assay	nn	16	SENT_67	[p4l1142t1387r1350b1465],
16	System	NN	O	system	dobj	13	SENT_67	[p4l1385t1387r1637b1465],
17	for	IN	O	for	_	0	SENT_67	[p4l1669t1386r1769b1447],
18	the	DT	O	the	det	20	SENT_67	[p4l1799t1386r1903b1447],
19	allelic	JJ	O	allelic	amod	20	SENT_67	[p4l1938t1386r2145b1447],
20	discrimination	NN	O	discrimination	prep_for	16	SENT_67	[p4l9t1492r510b1553],
21	of	IN	O	of	_	0	SENT_67	[p4l538t1492r612b1553],
22	CYP2C9	NN	O	cyp2c9	nn	25	SENT_67	[p4l638t1492r936b1553],
23	(	CD	NUMBER	(	num	25	SENT_67	[p4l965t1492r1269b1570],
24	Applied	NNP	O	Applied	nn	25	SENT_67	[p4l965t1492r1269b1570],
25	Biosystems	NNP	O	Biosystems	prep_of	20	SENT_67	[p4l1295t1492r1712b1570],
26	,	,	O	,	_	0	SENT_67	[p4l1295t1492r1712b1570],
27	Foster	NNP	LOCATION	Foster	nn	28	SENT_67	[p4l1743t1493r1958b1553],
28	City	NNP	LOCATION	City	appos	25	SENT_67	[p4l1984t1492r2144b1570],
29	,	,	O	,	_	0	SENT_67	[p4l1984t1492r2144b1570],
30	CA	NNP	LOCATION	CA	nn	31	SENT_67	[p4l9t1597r173b1672],
31	)	NNP	O	)	appos	28	SENT_67	[p4l9t1597r173b1672],
32	,	,	O	,	_	0	SENT_67	[p4l9t1597r173b1672],
33	according	VBG	O	accord	_	0	SENT_67	[p4l223t1597r561b1676],
34	to	TO	O	to	prepc_according_to	13	SENT_67	[p4l606t1606r671b1658],
35	the	DT	O	the	det	36	SENT_67	[p4l716t1597r819b1658],
36	manufacturer	NN	O	manufacturer	poss	38	SENT_67	[p4l865t1597r1383b1658],
37	’s	POS	O	’s	_	0	SENT_67	[p4l865t1597r1383b1658],
38	instructions	NNS	O	instruction	pobj	13	SENT_67	[p4l1429t1597r1850b1658],
39	.	.	O	.	_	0	SENT_67	[p4l1429t1597r1850b1658],

1	Plasma	NN	O	plasma	nn	2	SENT_68	[p4l1898t1597r2148b1658],
2	glimepiride	NN	O	glimepiride	nsubjpass	9	SENT_68	[p4l9t1701r408b1780],
3	and	CC	O	and	_	0	SENT_68	[p4l433t1701r556b1762],
4	M	NN	O	m	nn	5	SENT_68	[p4l578t1703r653b1761],
5	—	NN	O	—	conj_and	2	SENT_68	[p4l683t1737r736b1741],
6	1	CD	NUMBER	1	num	7	SENT_68	[p4l774t1702r799b1761],
7	concentrations	NNS	O	concentration	dep	2	SENT_68	[p4l831t1701r1334b1762],
8	were	VBD	O	be	auxpass	9	SENT_68	[p4l1359t1721r1525b1762],
9	determined	VBN	O	determine	_	0	SENT_68	[p4l1550t1701r1939b1762],
10	using	VBG	O	use	xcomp	9	SENT_68	[p4l1961t1701r2147b1780],
11	a	DT	O	a	det	16	SENT_68	[p4l10t1826r46b1868],
12	liquid	JJ	O	liquid	amod	16	SENT_68	[p4l82t1807r284b1885],
13	chromatography	NN	O	chromatography	nn	16	SENT_68	[p4l321t1807r1103b1885],
14	—	CD	NUMBER	—	num	16	SENT_68	[p4l321t1807r1103b1885],
15	mass	NN	O	mass	nn	16	SENT_68	[p4l321t1807r1103b1885],
16	spectrometry	NN	O	spectrometry	dobj	10	SENT_68	[p4l1144t1816r1593b1885],
17	according	VBG	O	accord	_	0	SENT_68	[p4l1632t1807r1971b1885],
18	to	TO	O	to	prepc_according_to	10	SENT_68	[p4l2009t1816r2073b1868],
19	a	DT	O	a	det	23	SENT_68	[p4l2113t1826r2149b1868],
20	previously	RB	DATE	previously	advmod	23	SENT_68	[p4l8t1912r371b1991],
21	reported	VBN	O	report	amod	23	SENT_68	[p4l403t1912r693b1991],
22	method	NN	O	method	nn	23	SENT_68	[p4l725t1912r985b1973],
23	[	NN	O	[	pobj	10	SENT_68	[p4l1023t1912r1177b1985],
24	24	CD	NUMBER	24	num	25	SENT_68	[p4l1023t1912r1177b1985],
25	]	NN	O	]	dep	23	SENT_68	[p4l1023t1912r1177b1985],
26	.	.	O	.	_	0	SENT_68	[p4l1023t1912r1177b1985],

1	After	IN	O	after	_	0	SENT_69	[p4l1214t1912r1397b1973],
2	the	DT	O	the	det	3	SENT_69	[p4l1428t1912r1532b1973],
3	addition	NN	O	addition	prep_after	14	SENT_69	[p4l1567t1912r1850b1973],
4	of	IN	O	of	_	0	SENT_69	[p4l1883t1912r1958b1973],
5	glibenclamide	NN	O	glibenclamide	prep_of	3	SENT_69	[p4l1986t1912r2145b1991, p4l9t2016r364b2077],
6	as	IN	O	as	_	0	SENT_69	[p4l419t2036r486b2077],
7	an	DT	O	a	det	9	SENT_69	[p4l541t2036r619b2077],
8	internal	JJ	O	internal	amod	9	SENT_69	[p4l671t2016r935b2077],
9	standard	NN	O	standard	prep_as	5	SENT_69	[p4l991t2016r1298b2088],
10	,	,	O	,	_	0	SENT_69	[p4l991t2016r1298b2088],
11	plasma	NN	O	plasma	nn	12	SENT_69	[p4l1353t2016r1599b2095],
12	samples	NNS	O	sample	nsubjpass	14	SENT_69	[p4l1654t2016r1927b2095],
13	were	VBD	O	be	auxpass	14	SENT_69	[p4l1981t2036r2146b2077],
14	extracted	VBN	O	extract	_	0	SENT_69	[p4l9t2122r325b2182],
15	using	VBG	O	use	xcomp	14	SENT_69	[p4l373t2121r559b2200],
16	diethyl	NN	O	diethyl	nn	17	SENT_69	[p4l610t2121r848b2200],
17	ether	NN	O	ether	dobj	15	SENT_69	[p4l898t2122r1082b2182],
18	.	.	O	.	_	0	SENT_69	[p4l898t2122r1082b2182],

1	Chromatographic	JJ	MISC	chromatographic	amod	2	SENT_70	[p4l1137t2121r1741b2200],
2	separation	NN	O	separation	nsubjpass	14	SENT_70	[p4l1795t2121r2147b2200],
3	and	CC	O	and	_	0	SENT_70	[p4l10t2227r133b2288],
4	the	DT	O	the	det	5	SENT_70	[p4l166t2227r270b2288],
5	determination	NN	O	determination	nsubjpass	14	SENT_70	[p4l307t2227r788b2288],
6	of	IN	O	of	_	0	SENT_70	[p4l823t2227r898b2288],
7	glimepiride	NN	O	glimepiride	nn	10	SENT_70	[p4l928t2227r1326b2306],
8	and	CC	O	and	_	0	SENT_70	[p4l1363t2227r1485b2288],
9	M	NN	O	m	nn	10	SENT_70	[p4l1518t2229r1593b2287],
10	—	NN	O	—	prep_of	5	SENT_70	[p4l1624t2263r1677b2267],
11	1	CD	NUMBER	1	num	12	SENT_70	[p4l1715t2228r1740b2287],
12	concentrations	NNS	O	concentration	dep	5	SENT_70	[p4l1783t2236r2145b2288, p4l8t2331r173b2392],
13	were	VBD	O	be	auxpass	14	SENT_70	[p4l201t2351r366b2392],
14	performed	VBN	O	perform	_	0	SENT_70	[p4l390t2331r752b2410],
15	by	IN	O	by	_	0	SENT_70	[p4l775t2331r860b2410],
16	applying	VBG	O	apply	agent	14	SENT_70	[p4l887t2331r1187b2410],
17	the	DT	O	the	det	18	SENT_70	[p4l1213t2331r1316b2392],
18	samples	NNS	O	sample	dobj	16	SENT_70	[p4l1345t2331r1618b2410],
19	to	TO	O	to	_	0	SENT_70	[p4l1644t2340r1709b2392],
20	a	DT	O	a	det	23	SENT_70	[p4l1737t2351r1772b2392],
21	ZORBAX	NNP	O	ZORBAX	nn	23	SENT_70	[p4l1796t2332r2148b2392],
22	Eclipse	NNP	O	Eclipse	nn	23	SENT_70	[p4l8t2436r262b2515],
23	XDB	NNP	O	XDB	prep_to	16	SENT_70	[p4l307t2437r658b2498],
24	.	.	O	.	_	0	SENT_70	[p4l307t2437r658b2498],

1	—	NN	O	—	_	0	SENT_71	[p4l307t2437r658b2498],
2	.	.	O	.	_	0	SENT_71	[p4l307t2437r658b2498],

1	Cl8	NN	O	cl8	nn	3	SENT_72	[p4l307t2437r658b2498],
2	analytical	JJ	O	analytical	amod	3	SENT_72	[p4l707t2436r1042b2515],
3	column	NN	O	column	_	0	SENT_72	[p4l1089t2436r1347b2497],
4	(	CD	NUMBER	(	amod	3	SENT_72	[p4l1393t2436r1679b2515],
5	Agilent	NNP	ORGANIZATION	Agilent	nn	6	SENT_72	[p4l1393t2436r1679b2515],
6	Technology	NNP	ORGANIZATION	Technology	dep	4	SENT_72	[p4l1723t2436r2144b2515],
7	,	,	O	,	_	0	SENT_72	[p4l1723t2436r2144b2515],
8	Palo	NNP	LOCATION	Palo	nn	9	SENT_72	[p4l8t2542r158b2603],
9	Alto	NNP	LOCATION	Alto	appos	6	SENT_72	[p4l181t2542r352b2614],
10	,	,	O	,	_	0	SENT_72	[p4l181t2542r352b2614],
11	CA	NNP	LOCATION	CA	nn	12	SENT_72	[p4l378t2542r521b2617],
12	)	NNP	O	)	appos	6	SENT_72	[p4l378t2542r521b2617],
13	using	VBG	O	use	partmod	12	SENT_72	[p4l545t2542r730b2621],
14	an	DT	O	a	det	19	SENT_72	[p4l755t2561r833b2603],
15	Agilent	NNP	O	Agilent	nn	19	SENT_72	[p4l854t2542r1114b2621],
16	1100	CD	DATE	1100	num	19	SENT_72	[p4l1143t2542r1306b2603],
17	series	NN	O	series	nn	19	SENT_72	[p4l1330t2542r1521b2603],
18	LC/MSD	NN	O	lc/msd	nn	19	SENT_72	[p4l1544t2542r1864b2603],
19	system	NN	O	system	dobj	13	SENT_72	[p4l1890t2551r2143b2621],
20	.	.	O	.	_	0	SENT_72	[p4l1890t2551r2143b2621],

1	The	DT	O	the	det	3	SENT_73	[p4l9t2646r141b2707],
2	mass	NN	O	mass	nn	3	SENT_73	[p4l173t2666r342b2707],
3	spectrometer	NN	O	spectrometer	nsubjpass	5	SENT_73	[p4l378t2655r824b2725],
4	was	VBD	O	be	auxpass	5	SENT_73	[p4l855t2666r985b2707],
5	operated	VBN	O	operate	_	0	SENT_73	[p4l1019t2646r1317b2725],
6	in	IN	O	in	_	0	SENT_73	[p4l1347t2646r1413b2706],
7	the	DT	O	the	det	11	SENT_73	[p4l1443t2646r1547b2707],
8	positive	JJ	O	positive	amod	11	SENT_73	[p4l1577t2646r1849b2725],
9	API-ES	NN	O	api-e	nn	11	SENT_73	[p4l1880t2647r2144b2707],
10	ionization	NN	O	ionization	nn	11	SENT_73	[p4l9t2751r355b2812],
11	mode	NN	O	mode	prep_in	5	SENT_73	[p4l378t2751r586b2812],
12	.	.	O	.	_	0	SENT_73	[p4l378t2751r586b2812],

1	The	DT	O	the	nsubj	47	SENT_74	[p4l612t2752r745b2812],
2	optimized	VBN	O	optimize	dep	1	SENT_74	[p4l769t2751r1115b2830],
3	ionization	NN	O	ionization	nn	4	SENT_74	[p4l1137t2751r1484b2812],
4	conditions	NNS	O	condition	nsubj	5	SENT_74	[p4l1507t2751r1864b2812],
5	were	VBD	O	be	ccomp	2	SENT_74	[p4l1889t2771r2054b2812],
6	as	IN	O	as	mark	7	SENT_74	[p4l2079t2771r2146b2812],
7	follows	VBZ	O	follow	advcl	5	SENT_74	[p4l9t2856r283b2917],
8	:	:	O	:	_	0	SENT_74	[p4l9t2856r283b2917],
9	drying	VBG	O	dry	parataxis	2	SENT_74	[p4l309t2856r532b2935],
10	gas	NN	O	gas	nn	11	SENT_74	[p4l553t2876r664b2935],
11	ﬂow	NN	O	ﬂow	dobj	9	SENT_74	[p4l686t2856r847b2928],
12	,	,	O	,	_	0	SENT_74	[p4l686t2856r847b2928],
13	10	CD	NUMBER	10	num	14	SENT_74	[p4l878t2857r954b2917],
14	1/min	NN	O	1/min	appos	11	SENT_74	[p4l979t2856r1181b2928],
15	;	:	O	;	_	0	SENT_74	[p4l979t2856r1181b2928],
16	nebulizer	NN	O	nebulizer	nn	17	SENT_74	[p4l1204t2856r1527b2917],
17	pressure	NN	O	pressure	dep	11	SENT_74	[p4l1543t2876r1850b2935],
18	,	,	O	,	_	0	SENT_74	[p4l1543t2876r1850b2935],
19	40	CD	NUMBER	40	num	20	SENT_74	[p4l1872t2857r1956b2917],
20	psig	NN	O	psig	appos	17	SENT_74	[p4l1980t2856r2144b2935],
21	;	:	O	;	_	0	SENT_74	[p4l1980t2856r2144b2935],
22	drying	VBG	O	dry	parataxis	2	SENT_74	[p4l9t2961r232b3040],
23	gas	NN	O	gas	nn	24	SENT_74	[p4l275t2981r386b3040],
24	temperature	NN	O	temperature	dobj	22	SENT_74	[p4l429t2971r861b3040],
25	,	,	O	,	_	0	SENT_74	[p4l429t2971r861b3040],
26	350	CD	NUMBER	350	num	27	SENT_74	[p4l909t2961r1034b3022],
27	“	NN	O	“	appos	24	SENT_74	[p4l1062t2960r1168b3033],
28	C	NN	O	c	dep	27	SENT_74	[p4l1062t2960r1168b3033],
29	;	:	O	;	_	0	SENT_74	[p4l1062t2960r1168b3033],
30	capillary	JJ	O	capillary	amod	31	SENT_74	[p4l1213t2961r1515b3040],
31	voltage	NN	O	voltage	dep	27	SENT_74	[p4l1558t2961r1829b3040],
32	,	,	O	,	_	0	SENT_74	[p4l1558t2961r1829b3040],
33	3000	CD	NUMBER	3000	num	34	SENT_74	[p4l1876t2962r2045b3022],
34	V	NN	O	v	appos	31	SENT_74	[p4l2070t2963r2144b3033],
35	;	:	O	;	_	0	SENT_74	[p4l2070t2963r2144b3033],
36	fragmentor	NN	O	fragmentor	dep	27	SENT_74	[p4l9t3066r409b3145],
37	,	,	O	,	_	0	SENT_74	[p4l9t3066r409b3145],
38	120	CD	NUMBER	120	appos	36	SENT_74	[p4l461t3067r581b3128],
39	V.	NNP	O	V.	tmod	22	SENT_74	[p4l605t3068r672b3127],
40	The	DT	O	the	det	43	SENT_74	[p4l717t3066r849b3127],
41	selected	VBN	O	select	amod	43	SENT_74	[p4l895t3066r1171b3127],
42	ion	NN	O	ion	nn	43	SENT_74	[p4l1212t3066r1321b3127],
43	monitoring	NN	O	monitoring	dep	39	SENT_74	[p4l1362t3066r1745b3145],
44	conditions	NNS	O	condition	dep	39	SENT_74	[p4l1788t3066r2146b3127],
45	were	VBD	O	be	cop	47	SENT_74	[p4l9t3191r174b3233],
46	m/z	JJ	O	m/z	amod	47	SENT_74	[p4l197t3172r316b3238],
47	494	CD	NUMBER	494	_	0	SENT_74	[p4l337t3172r464b3233],
48	for	IN	O	for	_	0	SENT_74	[p4l488t3172r588b3232],
49	glimepiride	NN	O	glimepiride	prep_for	47	SENT_74	[p4l609t3172r1026b3250],
50	,	,	O	,	_	0	SENT_74	[p4l609t3172r1026b3250],
51	m/z	NN	O	m/z	conj_and	47	SENT_74	[p4l1051t3172r1170b3239],
52	507	CD	NUMBER	507	num	51	SENT_74	[p4l1193t3171r1317b3233],
53	for	IN	O	for	_	0	SENT_74	[p4l1342t3172r1442b3232],
54	M	NN	O	m	nn	55	SENT_74	[p4l1462t3173r1536b3232],
55	—	NN	O	—	prep_for	51	SENT_74	[p4l1567t3207r1620b3212],
56	l	NN	O	l	tmod	55	SENT_74	[p4l1658t3172r1709b3243],
57	,	,	O	,	_	0	SENT_74	[p4l1658t3172r1709b3243],
58	and	CC	O	and	_	0	SENT_74	[p4l1736t3172r1858b3232],
59	m/z	NN	O	m/z	conj_and	47	SENT_74	[p4l1880t3172r1999b3239],
60	494	CD	NUMBER	494	num	59	SENT_74	[p4l2019t3172r2147b3233],
61	for	IN	O	for	_	0	SENT_74	[p4l9t3276r109b3337],
62	glibenclamide	NN	O	glibenclamide	prep_for	59	SENT_74	[p4l154t3276r662b3355],
63	.	.	O	.	_	0	SENT_74	[p4l154t3276r662b3355],

1	We	PRP	O	we	nsubj	2	SENT_75	[p4l712t3278r825b3337],
2	used	VBD	O	use	_	0	SENT_75	[p4l871t3276r1030b3337],
3	microsome	JJ	O	microsome	amod	4	SENT_75	[p4l1075t3276r1459b3337],
4	preparations	NNS	O	preparation	dobj	2	SENT_75	[p4l1506t3276r1932b3355],
5	from	IN	O	from	_	0	SENT_75	[p4l1981t3276r2148b3337],
6	human	JJ	O	human	amod	8	SENT_75	[p4l8t3381r243b3442],
7	CYP2C9	NN	O	cyp2c9	nn	8	SENT_75	[p4l310t3382r699b3443],
8	*	NN	O	*	prep_from	2	SENT_75	[p4l310t3382r699b3443],
9	1	CD	NUMBER	1	number	10	SENT_75	[p4l310t3382r699b3443],
10	(	CD	NUMBER	(	num	12	SENT_75	[p4l776t3382r1090b3460],
11	Argl44	NN	O	argl44	nn	12	SENT_75	[p4l776t3382r1090b3460],
12	)	NN	O	)	dep	8	SENT_75	[p4l776t3382r1090b3460],
13	+	CC	O	+	_	0	SENT_75	[p4l1118t3397r1162b3441],
14	P450	NN	O	p450	nn	16	SENT_75	[p4l1187t3381r1362b3443],
15	Reductase	NN	O	reductase	nn	16	SENT_75	[p4l1429t3382r1784b3442],
16	SUPERSOMES	NNS	O	supersome	prep_from	2	SENT_75	[p4l1853t3382r2145b3443, p4l11t3486r291b3547],
17	and	CC	O	and	_	0	SENT_75	[p4l326t3486r449b3547],
18	human	JJ	O	human	amod	24	SENT_75	[p4l477t3486r712b3547],
19	CYP2C9	NN	O	cyp2c9	nn	24	SENT_75	[p4l744t3486r1136b3547],
20	*	NN	O	*	nn	24	SENT_75	[p4l744t3486r1136b3547],
21	3	CD	NUMBER	3	num	24	SENT_75	[p4l744t3486r1136b3547],
22	(	NN	O	(	nn	24	SENT_75	[p4l1173t3485r1489b3561],
23	Leu359	NN	O	leu359	nn	24	SENT_75	[p4l1173t3485r1489b3561],
24	)	NN	O	)	conj_and	16	SENT_75	[p4l1173t3485r1489b3561],
25	+	CC	O	+	_	0	SENT_75	[p4l1516t3501r1561b3546],
26	P450	NN	O	p450	nn	28	SENT_75	[p4l1586t3486r1761b3547],
27	Reductase	NN	O	reductase	nn	28	SENT_75	[p4l1792t3486r2147b3547],
28	SUPERSOMES	NN	O	supersome	conj_+	16	SENT_75	[p4l11t3592r560b3653],
29	(	CD	NUMBER	(	num	32	SENT_75	[p4l614t3592r922b3666],
30	Gentest	NNP	O	Gentest	nn	32	SENT_75	[p4l614t3592r922b3666],
31	,	,	O	,	_	0	SENT_75	[p4l614t3592r922b3666],
32	Woburn	NNP	LOCATION	Woburn	dep	28	SENT_75	[p4l971t3591r1266b3663],
33	,	,	O	,	_	0	SENT_75	[p4l971t3591r1266b3663],
34	MA	NNP	LOCATION	MA	nn	35	SENT_75	[p4l1315t3592r1500b3667],
35	)	NNP	O	)	appos	8	SENT_75	[p4l1315t3592r1500b3667],
36	,	,	O	,	_	0	SENT_75	[p4l1315t3592r1500b3667],
37	which	WDT	O	which	nsubj	38	SENT_75	[p4l1551t3591r1761b3652],
38	expressed	VBD	O	express	rcmod	35	SENT_75	[p4l1809t3592r2148b3670],
39	human	JJ	O	human	amod	41	SENT_75	[p4l8t3695r243b3756],
40	CYP2C9	NN	O	cyp2c9	nn	41	SENT_75	[p4l293t3696r681b3757],
41	*	NN	O	*	dobj	38	SENT_75	[p4l293t3696r681b3757],
42	l	NN	O	l	tmod	38	SENT_75	[p4l293t3696r681b3757],
43	or	CC	O	or	_	0	SENT_75	[p4l739t3715r810b3756],
44	CYP2C9	NN	O	cyp2c9	conj_or	42	SENT_75	[p4l857t3696r1249b3757],
45	*	CD	NUMBER	*	number	46	SENT_75	[p4l857t3696r1249b3757],
46	3	CD	NUMBER	3	npadvmod	38	SENT_75	[p4l857t3696r1249b3757],
47	in	IN	O	in	_	0	SENT_75	[p4l1303t3695r1369b3756],
48	baculovirus	NN	O	baculovirus	nn	51	SENT_75	[p4l1416t3695r1819b3757],
49	infected	JJ	O	infected	amod	51	SENT_75	[p4l1869t3695r2148b3756],
50	insect	NN	O	insect	nn	51	SENT_75	[p5l8t29r210b89],
51	cells	NNS	O	cell	prep_in	38	SENT_75	[p5l251t29r406b89],
52	for	IN	O	for	_	0	SENT_75	[p5l448t29r549b89],
53	the	DT	O	the	det	56	SENT_75	[p5l588t29r692b89],
54	enzyme	NN	O	enzyme	nn	56	SENT_75	[p5l734t48r1001b107],
55	kinetic	JJ	O	kinetic	amod	56	SENT_75	[p5l1041t29r1276b89],
56	analysis	NN	O	analysis	prep_for	38	SENT_75	[p5l1320t29r1594b107],
57	of	IN	O	of	_	0	SENT_75	[p5l1638t29r1713b89],
58	glimepiride	NN	O	glimepiride	nn	59	SENT_75	[p5l1749t29r2146b107],
59	hydroxylation	NN	O	hydroxylation	prep_of	56	SENT_75	[p5l8t133r511b212],
60	.	.	O	.	_	0	SENT_75	[p5l8t133r511b212],

1	The	DT	O	the	det	3	SENT_76	[p5l541t134r674b194],
2	reaction	NN	O	reaction	nn	3	SENT_76	[p5l699t133r978b194],
3	mixture	NN	O	mixture	nsubj	4	SENT_76	[p5l1004t133r1271b194],
4	contained	VBD	O	contain	_	0	SENT_76	[p5l1299t133r1635b194],
5	0.5	CD	NUMBER	0.5	number	6	SENT_76	[p5l1660t133r1895b195],
6	—	CD	NUMBER	—	num	8	SENT_76	[p5l1660t133r1895b195],
7	10	CD	TIME	10	num	8	SENT_76	[p5l1660t133r1895b195],
8	p.M	NN	TIME	p.m	dobj	4	SENT_76	[p5l1925t135r2052b211],
9	of	IN	O	of	_	0	SENT_76	[p5l2078t133r2153b194],
10	glimepiride	NN	O	glimepiride	nn	14	SENT_76	[p5l9t238r408b317],
11	and	CC	O	and	_	0	SENT_76	[p5l453t239r575b299],
12	NADPH	NN	O	nadph	nn	14	SENT_76	[p5l616t239r909b299],
13	regenerating	VBG	O	regenerate	amod	14	SENT_76	[p5l950t238r1383b317],
14	system	NN	O	system	prep_of	8	SENT_76	[p5l1429t248r1665b317],
15	in	IN	O	in	_	0	SENT_76	[p5l1708t238r1773b299],
16	2.4	CD	NUMBER	2.4	num	17	SENT_76	[p5l1816t239r1921b299],
17	ml	NN	O	ml	prep_in	14	SENT_76	[p5l1946t239r2035b299],
18	of	IN	O	of	_	0	SENT_76	[p5l2078t238r2153b299],
19	0.1	CD	NUMBER	0.1	num	21	SENT_76	[p5l9t344r107b405],
20	M	NN	O	m	nn	21	SENT_76	[p5l138t345r213b404],
21	Tris	NNP	O	Tris	prep_of	17	SENT_76	[p5l238t344r560b405],
22	.	.	O	.	_	0	SENT_76	[p5l238t344r560b405],

1	—	NN	O	—	_	0	SENT_77	[p5l238t344r560b405],
2	.	.	O	.	_	0	SENT_77	[p5l238t344r560b405],

1	HCl	NN	O	hcl	nn	2	SENT_78	[p5l238t344r560b405],
2	buffer	NN	O	buffer	_	0	SENT_78	[p5l584t344r794b404],
3	(	CD	NUMBER	(	num	4	SENT_78	[p5l820t344r950b422],
4	pH	NN	O	ph	dep	2	SENT_78	[p5l820t344r950b422],
5	7.5	CD	NUMBER	7.5	num	6	SENT_78	[p5l975t343r1127b419],
6	)	NN	O	)	dep	4	SENT_78	[p5l975t343r1127b419],
7	.	.	O	.	_	0	SENT_78	[p5l975t343r1127b419],

1	After	IN	O	after	_	0	SENT_79	[p5l1156t344r1339b404],
2	1	CD	DURATION	1	num	4	SENT_79	[p5l1371t344r1396b404],
3	min	NN	DURATION	min	nn	4	SENT_79	[p5l1427t344r1560b404],
4	preincubation	NN	O	preincubation	prep_after	14	SENT_79	[p5l1584t344r2062b422],
5	at	IN	O	at	_	0	SENT_79	[p5l2089t353r2149b404],
6	37	CD	NUMBER	37	number	7	SENT_79	[p5l11t449r90b510],
7	°	CD	NUMBER	°	num	8	SENT_79	[p5l121t447r224b520],
8	C	NN	O	c	prep_at	4	SENT_79	[p5l121t447r224b520],
9	,	,	O	,	_	0	SENT_79	[p5l121t447r224b520],
10	the	DT	O	the	det	12	SENT_79	[p5l254t449r358b509],
11	hydroxylation	NN	O	hydroxylation	nn	12	SENT_79	[p5l386t448r872b527],
12	reaction	NN	O	reaction	nsubjpass	14	SENT_79	[p5l898t448r1177b509],
13	was	VBD	O	be	auxpass	14	SENT_79	[p5l1205t468r1335b509],
14	started	VBN	O	start	_	0	SENT_79	[p5l1367t449r1595b509],
15	by	IN	O	by	_	0	SENT_79	[p5l1620t449r1705b527],
16	the	DT	O	the	det	17	SENT_79	[p5l1732t449r1836b509],
17	addition	NN	O	addition	agent	14	SENT_79	[p5l1866t448r2147b509],
18	of	IN	O	of	_	0	SENT_79	[p5l10t554r84b614],
19	0.1	CD	NUMBER	0.1	num	20	SENT_79	[p5l105t554r203b615],
20	ml	NN	O	ml	prep_of	17	SENT_79	[p5l235t554r324b614],
21	of	IN	O	of	_	0	SENT_79	[p5l352t554r427b614],
22	200	CD	NUMBER	200	num	23	SENT_79	[p5l448t554r574b615],
23	pmol	NN	O	pmol	prep_of	20	SENT_79	[p5l598t554r775b632],
24	of	IN	O	of	_	0	SENT_79	[p5l803t554r877b614],
25	CYP2C9	NN	O	cyp2c9	prep_of	23	SENT_79	[p5l899t554r1226b615],
26	.	.	O	.	_	0	SENT_79	[p5l899t554r1226b615],

1	The	DT	O	the	det	2	SENT_80	[p5l1257t554r1389b614],
2	reaction	NN	O	reaction	nsubjpass	4	SENT_80	[p5l1415t554r1694b614],
3	was	VBD	O	be	auxpass	4	SENT_80	[p5l1722t573r1852b614],
4	stopped	VBN	O	stop	_	0	SENT_80	[p5l1883t554r2148b632],
5	by	IN	O	by	_	0	SENT_80	[p5l7t659r92b737],
6	the	DT	O	the	det	7	SENT_80	[p5l121t659r224b719],
7	addition	NN	O	addition	agent	4	SENT_80	[p5l254t659r536b719],
8	of	IN	O	of	_	0	SENT_80	[p5l565t659r640b719],
9	1	CD	NUMBER	1	num	10	SENT_80	[p5l669t659r695b719],
10	ml	NN	O	ml	prep_of	7	SENT_80	[p5l726t659r816b719],
11	of	IN	O	of	_	0	SENT_80	[p5l845t659r920b719],
12	0.05	CD	NUMBER	0.05	num	14	SENT_80	[p5l942t659r1087b720],
13	M	NN	O	m	nn	14	SENT_80	[p5l1115t660r1189b719],
14	KCl	NN	O	kcl	prep_of	10	SENT_80	[p5l1220t659r1360b720],
15	(	RB	O	(	advmod	16	SENT_80	[p5l1390t659r1705b737],
16	adjusted	VBN	O	adjust	partmod	14	SENT_80	[p5l1390t659r1705b737],
17	with	IN	O	with	_	0	SENT_80	[p5l1732t659r1885b720],
18	HCl	NN	O	hcl	prep_with	16	SENT_80	[p5l1912t659r2054b720],
19	to	TO	O	to	_	0	SENT_80	[p5l2082t668r2146b719],
20	pH	NN	O	ph	nn	22	SENT_80	[p5l7t765r112b842],
21	1.0	CD	NUMBER	1.0	num	22	SENT_80	[p5l144t764r268b839],
22	)	NN	O	)	prep_to	18	SENT_80	[p5l144t764r268b839],
23	after	IN	O	after	_	0	SENT_80	[p5l297t764r454b825],
24	20	CD	DURATION	20	num	26	SENT_80	[p5l478t764r560b825],
25	min	NN	DURATION	min	nn	26	SENT_80	[p5l585t764r719b824],
26	incubation	NN	O	incubation	prep_after	16	SENT_80	[p5l742t764r1125b825],
27	.	.	O	.	_	0	SENT_80	[p5l742t764r1125b825],

1	Concentration	NN	O	concentration	nsubjpass	7	SENT_81	[p5l1155t764r1645b825],
2	of	IN	O	of	_	0	SENT_81	[p5l1670t764r1745b825],
3	M	NN	O	m	nn	4	SENT_81	[p5l1762t765r1837b824],
4	—	NN	O	—	prep_of	1	SENT_81	[p5l1867t800r1921b804],
5	1	CD	NUMBER	1	num	4	SENT_81	[p5l1959t764r1984b824],
6	was	VBD	O	be	auxpass	7	SENT_81	[p5l2016t783r2146b825],
7	measured	VBN	O	measure	_	0	SENT_81	[p5l8t869r340b929],
8	as	IN	O	as	_	0	SENT_81	[p5l380t888r447b929],
9	the	DT	O	the	det	11	SENT_81	[p5l487t869r590b929],
10	same	JJ	O	same	amod	11	SENT_81	[p5l633t888r806b929],
11	method	NN	O	method	prep_as	7	SENT_81	[p5l846t869r1105b929],
12	described	VBN	O	describe	partmod	11	SENT_81	[p5l1144t869r1475b929],
13	in	IN	O	in	_	0	SENT_81	[p5l1514t869r1579b929],
14	the	DT	O	the	det	15	SENT_81	[p5l1618t869r1721b929],
15	analysis	NN	O	analysis	prep_in	12	SENT_81	[p5l1762t869r2037b947],
16	of	IN	O	of	_	0	SENT_81	[p5l2079t869r2153b929],
17	plasma	NN	O	plasma	nn	18	SENT_81	[p5l7t974r254b1052],
18	glimepiride	NN	O	glimepiride	prep_of	15	SENT_81	[p5l285t974r683b1052],
19	and	CC	O	and	_	0	SENT_81	[p5l717t974r839b1034],
20	M	NN	O	m	nn	21	SENT_81	[p5l870t975r944b1034],
21	—	NN	O	—	prep_in	12	SENT_81	[p5l975t1009r1027b1014],
22	1	CD	NUMBER	1	num	23	SENT_81	[p5l1065t974r1091b1034],
23	concentrations	NNS	O	concentration	dep	21	SENT_81	[p5l1130t974r1652b1034],
24	.	.	O	.	_	0	SENT_81	[p5l1130t974r1652b1034],

1	2.3	CD	NUMBER	2.3	_	0	SENT_82	[p5l8t1226r128b1287],
2	.	.	O	.	_	0	SENT_82	[p5l8t1226r128b1287],

1	Data	NN	O	datum	nn	2	SENT_83	[p5l180t1228r352b1287],
2	analysis	NN	O	analysis	_	0	SENT_83	[p5l385t1226r667b1304],

1	The	DT	O	the	det	3	SENT_84	[p5l124t1438r257b1499],
2	statistical	JJ	O	statistical	amod	3	SENT_84	[p5l304t1438r628b1499],
3	analysis	NN	O	analysis	nsubjpass	5	SENT_84	[p5l675t1438r948b1516],
4	was	VBD	O	be	auxpass	5	SENT_84	[p5l995t1457r1125b1499],
5	performed	VBN	O	perform	_	0	SENT_84	[p5l1169t1438r1531b1516],
6	using	VBG	O	use	xcomp	5	SENT_84	[p5l1573t1438r1759b1516],
7	GraphPad	NNP	O	GraphPad	nn	9	SENT_84	[p5l1805t1438r2149b1516],
8	Prism	NNP	O	Prism	nn	9	SENT_84	[p5l8t1543r209b1604],
9	Version	NNP	O	Version	nsubj	11	SENT_84	[p5l251t1543r514b1604],
10	4.0	CD	NUMBER	4.0	num	11	SENT_84	[p5l555t1543r661b1604],
11	Software	NNP	O	Software	xcomp	6	SENT_84	[p5l706t1543r1014b1604],
12	(	CD	NUMBER	(	num	11	SENT_84	[p5l1060t1543r1431b1622],
13	GraphPad	NNP	ORGANIZATION	GraphPad	nn	17	SENT_84	[p5l1060t1543r1431b1622],
14	Software	NNP	ORGANIZATION	Software	nn	17	SENT_84	[p5l1474t1543r1783b1604],
15	Inc.	NNP	ORGANIZATION	Inc.	nn	17	SENT_84	[p5l1825t1545r1974b1615],
16	,	,	O	,	_	0	SENT_84	[p5l1825t1545r1974b1615],
17	San	NNP	LOCATION	San	dep	11	SENT_84	[p5l2022t1543r2148b1604],

1	150	CD	NUMBER	150	num	3	SENT_85	[p5l333t1697r379b1721],
2	K.	NNP	PERSON	K.	nn	3	SENT_85	[p5l774t1698r801b1721],
3	Suzuki	NNP	PERSON	Suzuki	_	0	SENT_85	[p5l816t1697r902b1723],
4	et	FW	O	et	nn	5	SENT_85	[p5l914t1702r938b1721],
5	al.	FW	O	al.	dep	3	SENT_85	[p5l949t1697r979b1721],
6	/	:	O	/	punct	3	SENT_85	[p5l986t1698r1001b1721],
7	Diabetes	NNP	ORGANIZATION	Diabetes	dep	3	SENT_85	[p5l1003t1697r1121b1721],
8	Research	NNP	ORGANIZATION	Research	dep	7	SENT_85	[p5l1131t1697r1254b1721],
9	and	CC	ORGANIZATION	and	_	0	SENT_85	[p5l1265t1697r1316b1721],
10	Clinical	JJ	ORGANIZATION	clinical	amod	11	SENT_85	[p5l1328t1697r1433b1721],
11	Practice	NN	ORGANIZATION	practice	dep	3	SENT_85	[p5l1444t1698r1556b1721],
12	72	CD	NUMBER	72	number	13	SENT_85	[p5l1570t1697r1599b1721],
13	(	CD	NUMBER	(	num	14	SENT_85	[p5l1613t1697r1699b1726],
14	2006	CD	DATE	2006	dep	11	SENT_85	[p5l1613t1697r1699b1726],
15	)	CD	NUMBER	)	num	16	SENT_85	[p5l1613t1697r1699b1726],
16	148-154	CD	NUMBER	148-154	dep	11	SENT_85	[p5l1713t1697r1827b1721],

1	Diego	NNP	PERSON	Diego	_	0	SENT_86	[p5l7t1841r240b1919],
2	,	,	O	,	_	0	SENT_86	[p5l7t1841r240b1919],
3	CA	NNP	O	CA	nn	4	SENT_86	[p5l296t1841r462b1915],
4	)	NNP	O	)	appos	1	SENT_86	[p5l296t1841r462b1915],
5	.	.	O	.	_	0	SENT_86	[p5l296t1841r462b1915],

1	The	DT	O	the	det	2	SENT_87	[p5l518t1841r652b1901],
2	difference	NN	O	difference	nsubjpass	12	SENT_87	[p5l706t1841r1063b1901],
3	in	IN	O	in	_	0	SENT_87	[p5l1116t1841r1183b1901],
4	parameters	NNS	O	parameter	prep_in	2	SENT_87	[p5l1233t1850r1622b1919],
5	between	IN	O	between	_	0	SENT_87	[p5l1674t1841r1969b1902],
6	two	CD	NUMBER	two	num	7	SENT_87	[p5l2021t1850r2150b1902],
7	groups	NNS	O	group	prep_between	4	SENT_87	[p5l8t1965r244b2024],
8	of	IN	O	of	_	0	SENT_87	[p5l284t1946r360b2007],
9	CYPZC9	NN	O	cypzc9	nn	10	SENT_87	[p5l396t1946r700b2007],
10	genotypes	NNS	O	genotype	prep_of	7	SENT_87	[p5l738t1955r1094b2024],
11	were	VBD	O	be	auxpass	12	SENT_87	[p5l1135t1965r1303b2007],
12	compared	VBN	O	compare	_	0	SENT_87	[p5l1342t1946r1691b2024],
13	using	VBG	O	use	xcomp	12	SENT_87	[p5l1727t1946r1917b2024],
14	the	DT	O	the	det	15	SENT_87	[p5l1955t1946r2061b2007],
15	ttest	NN	O	ttest	dobj	13	SENT_87	[p5l2102t1957r2149b2007, p5l7t2060r130b2112],
16	because	IN	O	because	mark	32	SENT_87	[p5l154t2051r434b2112],
17	neither	CC	O	neither	preconj	19	SENT_87	[p5l460t2051r708b2112],
18	the	DT	O	the	det	19	SENT_87	[p5l733t2051r839b2112],
19	equality	NN	O	equality	nsubjpass	32	SENT_87	[p5l866t2051r1150b2130],
20	of	IN	O	of	_	0	SENT_87	[p5l1178t2051r1254b2112],
21	Variance	NNP	O	Variance	prep_of	19	SENT_87	[p5l1274t2051r1572b2112],
22	nor	CC	O	nor	_	0	SENT_87	[p5l1598t2070r1715b2112],
23	the	DT	O	the	det	24	SENT_87	[p5l1740t2051r1846b2112],
24	normality	NN	O	normality	nsubjpass	32	SENT_87	[p5l1872t2051r2149b2112, p5l7t2156r99b2234],
25	of	IN	O	of	_	0	SENT_87	[p5l142t2156r218b2216],
26	distribution	NN	O	distribution	prep_of	24	SENT_87	[p5l255t2156r665b2216],
27	of	IN	O	of	_	0	SENT_87	[p5l708t2156r784b2216],
28	the	DT	O	the	det	30	SENT_87	[p5l819t2156r925b2216],
29	present	JJ	DATE	present	amod	30	SENT_87	[p5l967t2165r1224b2234],
30	data	NNS	O	datum	prep_of	26	SENT_87	[p5l1266t2156r1413b2216],
31	were	VBD	O	be	auxpass	32	SENT_87	[p5l1453t2175r1622b2217],
32	rejected	VBN	O	reject	advcl	13	SENT_87	[p5l1664t2156r1947b2234],
33	by	IN	O	by	_	0	SENT_87	[p5l1986t2156r2073b2234],
34	a	DT	O	a	det	35	SENT_87	[p5l2117t2175r2153b2216],
35	Shapiro	NNP	O	Shapiro	agent	32	SENT_87	[p5l9t2261r504b2339],
36	.	.	O	.	_	0	SENT_87	[p5l9t2261r504b2339],

1	—	NN	O	—	_	0	SENT_88	[p5l9t2261r504b2339],
2	.	.	O	.	_	0	SENT_88	[p5l9t2261r504b2339],

1	Wilk	NNP	PERSON	Wilk	nn	2	SENT_89	[p5l9t2261r504b2339],
2	W	NNP	O	W	nsubj	4	SENT_89	[p5l542t2263r758b2322],
3	—	CD	NUMBER	—	num	2	SENT_89	[p5l542t2263r758b2322],
4	test	NN	O	test	_	0	SENT_89	[p5l542t2263r758b2322],
5	using	VBG	O	use	xcomp	4	SENT_89	[p5l791t2261r980b2339],
6	JMP	NNP	O	JMP	nn	7	SENT_89	[p5l1016t2262r1175b2322],
7	Version	NNP	O	Version	nsubj	10	SENT_89	[p5l1209t2261r1480b2322],
8	5.01	CD	NUMBER	5.01	num	7	SENT_89	[p5l1516t2261r1707b2322],
9	a	DT	O	a	det	10	SENT_89	[p5l1516t2261r1707b2322],
10	(	NN	O	(	xcomp	5	SENT_89	[p5l1744t2261r1926b2336],
11	SAS	NNP	ORGANIZATION	SAS	nn	17	SENT_89	[p5l1744t2261r1926b2336],
12	Institute	NNP	ORGANIZATION	Institute	nn	17	SENT_89	[p5l1965t2261r2149b2322, p5l7t2375r139b2427],
13	Inc.	NNP	ORGANIZATION	Inc.	nn	17	SENT_89	[p5l211t2368r364b2438],
14	,	,	O	,	_	0	SENT_89	[p5l211t2368r364b2438],
15	Tokyo	NNP	LOCATION	Tokyo	appos	17	SENT_89	[p5l438t2366r679b2445],
16	,	,	O	,	_	0	SENT_89	[p5l438t2366r679b2445],
17	Japan	NNP	LOCATION	Japan	dep	10	SENT_89	[p5l754t2367r1002b2445],
18	)	CD	NUMBER	)	num	17	SENT_89	[p5l754t2367r1002b2445],
19	.	.	O	.	_	0	SENT_89	[p5l754t2367r1002b2445],

1	Data	NNS	O	datum	nsubjpass	3	SENT_90	[p5l1078t2368r1244b2427],
2	are	VBP	O	be	auxpass	3	SENT_90	[p5l1316t2385r1419b2427],
3	presented	VBN	O	present	_	0	SENT_90	[p5l1490t2366r1833b2445],
4	as	IN	O	as	_	0	SENT_90	[p5l1905t2385r1972b2427],
5	the	DT	O	the	det	6	SENT_90	[p5l2045t2366r2151b2427],
6	mean	NN	O	mean	prep_as	3	SENT_90	[p5l7t2490r197b2531],
7	:	:	O	:	_	0	SENT_90	[p5l226t2472r284b2531],
8	I	PRP	O	I	dep	6	SENT_90	[p5l226t2472r284b2531],
9	:	:	O	:	_	0	SENT_90	[p5l226t2472r284b2531],
10	S.D.	NNP	O	S.D.	nn	13	SENT_90	[p5l313t2471r462b2532],
11	Pharmacokinetic	JJ	O	pharmacokinetic	amod	13	SENT_90	[p5l500t2471r1096b2531],
12	model	NN	O	model	nn	13	SENT_90	[p5l1131t2471r1749b2549],
13	—	NN	O	—	dep	8	SENT_90	[p5l1131t2471r1749b2549],
14	dependent	JJ	O	dependent	amod	17	SENT_90	[p5l1131t2471r1749b2549],
15	and	CC	O	and	_	0	SENT_90	[p5l1783t2471r1908b2531],
16	independent	JJ	O	independent	conj_and	14	SENT_90	[p5l1942t2471r2149b2531, p5l6t2576r288b2654],
17	parameters	NNS	O	parameter	nsubjpass	21	SENT_90	[p5l334t2585r724b2654],
18	of	IN	O	of	_	0	SENT_90	[p5l776t2576r851b2637],
19	glimepiride	NN	O	glimepiride	prep_of	17	SENT_90	[p5l896t2576r1304b2654],
20	were	VBD	O	be	auxpass	21	SENT_90	[p5l1354t2595r1522b2637],
21	estimated	VBN	O	estimate	rcmod	13	SENT_90	[p5l1573t2576r1914b2637],
22	using	VBG	O	use	xcomp	21	SENT_90	[p5l1962t2576r2151b2654],
23	WinNonlin	NNP	O	WinNonlin	nn	24	SENT_90	[p5l6t2681r402b2742],
24	Professional	NNP	O	Professional	dobj	22	SENT_90	[p5l438t2681r896b2753],
25	,	,	O	,	_	0	SENT_90	[p5l438t2681r896b2753],
26	Version	NNP	O	Version	nn	30	SENT_90	[p5l935t2681r1206b2742],
27	4.01	CD	NUMBER	4.01	num	30	SENT_90	[p5l1242t2681r1388b2742],
28	(	CD	NUMBER	(	num	30	SENT_90	[p5l1434t2681r1797b2760],
29	Pharsight	NNP	ORGANIZATION	Pharsight	nn	30	SENT_90	[p5l1434t2681r1797b2760],
30	Corporation	NNP	ORGANIZATION	Corporation	appos	24	SENT_90	[p5l1834t2681r2149b2760, p5l7t2786r163b2857],
31	,	,	O	,	_	0	SENT_90	[p5l1834t2681r2149b2760, p5l7t2786r163b2857],
32	Mountain	NNP	O	Mountain	nn	33	SENT_90	[p5l196t2786r540b2846],
33	View	NNP	O	View	appos	24	SENT_90	[p5l569t2786r765b2857],
34	,	,	O	,	_	0	SENT_90	[p5l569t2786r765b2857],
35	CA	NNP	LOCATION	CA	nn	36	SENT_90	[p5l799t2786r966b2861],
36	)	NNP	O	)	appos	24	SENT_90	[p5l799t2786r966b2861],
37	.	.	O	.	_	0	SENT_90	[p5l799t2786r966b2861],

1	A	DT	O	a	det	3	SENT_91	[p5l1000t2786r1060b2846],
2	one-compartment	JJ	O	one-compartment	amod	3	SENT_91	[p5l1090t2794r1719b2864],
3	model	NN	O	model	nsubjpass	10	SENT_91	[p5l1746t2786r1966b2846],
4	with	IN	O	with	_	0	SENT_91	[p5l1997t2786r2152b2847],
5	ﬁrst	JJ	O	ﬁrst	amod	8	SENT_91	[p5l8t2891r363b2952],
6	—	NN	O	—	nn	8	SENT_91	[p5l8t2891r363b2952],
7	order	NN	O	order	nn	8	SENT_91	[p5l8t2891r363b2952],
8	absorption	NN	O	absorption	prep_with	3	SENT_91	[p5l395t2891r768b2969],
9	was	VBD	O	be	auxpass	10	SENT_91	[p5l799t2910r932b2952],
10	ﬁtted	VBN	O	ﬁtted	_	0	SENT_91	[p5l966t2891r1147b2952],
11	when	WRB	O	when	advmod	17	SENT_91	[p5l1178t2891r1367b2952],
12	the	DT	O	the	det	13	SENT_91	[p5l1398t2891r1503b2952],
13	model	NN	O	model	npadvmod	14	SENT_91	[p5l1536t2891r1755b2952],
14	dependent	JJ	O	dependent	amod	15	SENT_91	[p5l1788t2891r2152b2969],
15	parameters	NNS	O	parameter	nsubjpass	17	SENT_91	[p5l6t3005r395b3075],
16	were	VBD	O	be	auxpass	17	SENT_91	[p5l428t3015r597b3057],
17	estimated	VBN	O	estimate	advcl	10	SENT_91	[p5l629t2996r987b3057],
18	.	.	O	.	_	0	SENT_91	[p5l629t2996r987b3057],

1	Michaels	NNP	PERSON	Michaels	_	0	SENT_92	[p5l1022t2996r1664b3057],
2	.	.	O	.	_	0	SENT_92	[p5l1022t2996r1664b3057],

1	—	NN	O	—	_	0	SENT_93	[p5l1022t2996r1664b3057],
2	.	.	O	.	_	0	SENT_93	[p5l1022t2996r1664b3057],

1	Menten	JJ	O	menten	amod	3	SENT_94	[p5l1022t2996r1664b3057],
2	kinetic	JJ	O	kinetic	amod	3	SENT_94	[p5l1693t2996r1934b3057],
3	models	NNS	O	model	nsubjpass	5	SENT_94	[p5l1966t2996r2149b3057, p5l8t3100r102b3161],
4	were	VBD	O	be	auxpass	5	SENT_94	[p5l156t3120r324b3161],
5	ﬁtted	VBN	O	ﬁtted	_	0	SENT_94	[p5l378t3100r559b3161],
6	to	TO	O	to	_	0	SENT_94	[p5l610t3109r676b3161],
7	the	DT	O	the	det	8	SENT_94	[p5l729t3100r834b3161],
8	enzyme	NN	O	enzyme	prep_to	5	SENT_94	[p5l888t3120r1160b3179],
9	kinetic	JJ	O	kinetic	amod	10	SENT_94	[p5l1213t3100r1453b3161],
10	data	NNS	O	datum	dobj	5	SENT_94	[p5l1508t3100r1654b3161],
11	using	VBG	O	use	partmod	10	SENT_94	[p5l1704t3100r1894b3179],
12	Prism	NNP	O	Prism	nn	13	SENT_94	[p5l1947t3100r2152b3161],
13	Version	NNP	O	Version	dobj	11	SENT_94	[p5l7t3206r277b3267],
14	4.0	CD	NUMBER	4.0	num	13	SENT_94	[p5l311t3206r438b3267],
15	.	.	O	.	_	0	SENT_94	[p5l311t3206r438b3267],

1	3	LS	NUMBER	3	_	0	SENT_95	[p5l7t3442r75b3511],
2	.	.	O	.	_	0	SENT_95	[p5l7t3442r75b3511],

1	Results	NNS	O	result	_	0	SENT_96	[p5l129t3443r425b3511],

1	3.1	CD	NUMBER	3.1	_	0	SENT_97	[p5l7t3676r140b3743],
2	.	.	O	.	_	0	SENT_97	[p5l7t3676r140b3743],

1	Changes	NNS	O	change	_	0	SENT_98	[p5l206t3675r536b3761],
2	in	IN	O	in	_	0	SENT_98	[p5l575t3678r644b3743],
3	HbA1c	NN	O	hba1c	nn	4	SENT_98	[p5l678t3675r924b3758],
4	values	NNS	O	value	prep_in	1	SENT_98	[p5l959t3675r1204b3743],
5	after	IN	O	after	_	0	SENT_98	[p5l1239t3676r1424b3761],
6	glimepiride	NN	O	glimepiride	nn	7	SENT_98	[p5l1452t3675r1896b3761],
7	treatment	NN	O	treatment	prep_after	4	SENT_98	[p6l9t34r377b88],
8	in	IN	O	in	_	0	SENT_98	[p6l410t23r478b88],
9	patients	NNS	O	patient	prep_in	7	SENT_98	[p6l505t23r818b107],
10	with	IN	O	with	_	0	SENT_98	[p6l852t21r1016b89],
11	CYP2C9	NN	O	cyp2c9	prep_with	9	SENT_98	[p6l1055t21r1600b89],
12	*	CD	NUMBER	*	number	13	SENT_98	[p6l1055t21r1600b89],
13	]	CD	NUMBER	]	dep	1	SENT_98	[p6l1055t21r1600b89],
14	/	:	O	/	punct	19	SENT_98	[p6l1055t21r1600b89],
15	*	CD	NUMBER	*	number	19	SENT_98	[p6l1055t21r1600b89],
16	1	CD	NUMBER	1	number	19	SENT_98	[p6l1055t21r1600b89],
17	and	CC	O	and	_	0	SENT_98	[p6l1640t21r1787b88],
18	*	CD	NUMBER	*	conj_and	19	SENT_98	[p6l1828t21r2033b89],
19	1	CD	NUMBER	1	dep	13	SENT_98	[p6l1828t21r2033b89],
20	/	:	O	/	punct	19	SENT_98	[p6l1828t21r2033b89],
21	*	CD	NUMBER	*	number	22	SENT_98	[p6l1828t21r2033b89],
22	3	CD	NUMBER	3	num	23	SENT_98	[p6l1828t21r2033b89],
23	genotypes	NNS	O	genotype	dep	13	SENT_98	[p6l6t149r392b222],

1	Of	IN	O	of	_	0	SENT_99	[p6l125t367r228b434],
2	the	DT	O	the	det	4	SENT_99	[p6l258t367r373b434],
3	134	CD	NUMBER	134	num	4	SENT_99	[p6l420t367r552b434],
4	patients	NNS	O	patient	prep_of	15	SENT_99	[p6l588t367r887b454],
5	with	IN	O	with	_	0	SENT_99	[p6l926t367r1095b434],
6	type	NN	O	type	nn	8	SENT_99	[p6l1131t377r1295b454],
7	2	CD	NUMBER	2	num	8	SENT_99	[p6l1334t367r1377b433],
8	diabetes	NN	O	diabetes	prep_with	4	SENT_99	[p6l1415t367r1750b446],
9	,	,	O	,	_	0	SENT_99	[p6l1415t367r1750b446],
10	one	CD	NUMBER	one	num	11	SENT_99	[p6l1792t388r1927b434],
11	male	NN	O	male	prep_with	4	SENT_99	[p6l1964t367r2150b434],
12	and	CC	O	and	_	0	SENT_99	[p6l9t482r145b549],
13	one	CD	NUMBER	one	num	14	SENT_99	[p6l199t504r336b549],
14	female	NN	O	female	prep_with	4	SENT_99	[p6l390t482r652b549],
15	had	VBD	O	have	_	0	SENT_99	[p6l706t482r845b549],
16	a	DT	O	a	det	17	SENT_99	[p6l900t504r940b549],
17	CYP2C9	NN	O	cyp2c9	dobj	15	SENT_99	[p6l997t483r1549b550],
18	*	CD	NUMBER	*	num	17	SENT_99	[p6l997t483r1549b550],
19	I	PRP	O	I	nsubj	15	SENT_99	[p6l997t483r1549b550],
20	/	:	O	/	punct	22	SENT_99	[p6l997t483r1549b550],
21	*	CD	NUMBER	*	num	22	SENT_99	[p6l997t483r1549b550],
22	3	CD	NUMBER	3	dep	19	SENT_99	[p6l997t483r1549b550],
23	genotype	NN	O	genotype	dep	22	SENT_99	[p6l1605t492r1976b569],
24	.	.	O	.	_	0	SENT_99	[p6l1605t492r1976b569],

1	No	DT	O	no	det	2	SENT_100	[p6l2035t484r2150b549],
2	subjects	NNS	O	subject	nsubjpass	14	SENT_100	[p6l10t597r315b684],
3	with	IN	O	with	_	0	SENT_100	[p6l362t597r533b664],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_100	[p6l583t597r1008b664],
5	*	NN	O	*	prep_with	2	SENT_100	[p6l583t597r1008b664],
6	2	CD	NUMBER	2	num	5	SENT_100	[p6l583t597r1008b664],
7	or	CC	O	or	_	0	SENT_100	[p6l1058t618r1136b664],
8	homozygous	JJ	O	homozygous	amod	10	SENT_100	[p6l1179t597r1670b684],
9	CYP2C9	NN	O	cyp2c9	nn	10	SENT_100	[p6l1722t597r2150b664],
10	*	NN	O	*	nsubjpass	14	SENT_100	[p6l1722t597r2150b664],
11	3	CD	NUMBER	3	num	12	SENT_100	[p6l1722t597r2150b664],
12	alleles	NNS	O	allele	dep	10	SENT_100	[p6l9t712r251b779],
13	were	VBD	O	be	auxpass	14	SENT_100	[p6l282t733r466b779],
14	identiﬁed	VBN	O	identiﬁed	_	0	SENT_100	[p6l496t712r879b779],
15	.	.	O	.	_	0	SENT_100	[p6l496t712r879b779],

1	HbA1C	NN	O	hba1c	nn	2	SENT_101	[p6l913t712r1165b795],
2	Values	NNS	O	value	nsubjpass	4	SENT_101	[p6l1195t712r1436b779],
3	were	VBD	O	be	auxpass	4	SENT_101	[p6l1467t733r1651b779],
4	measured	VBN	O	measure	dep	20	SENT_101	[p6l1680t712r2051b779],
5	in	IN	O	in	_	0	SENT_101	[p6l2078t712r2151b779],
6	subjects	NNS	O	subject	prep_in	4	SENT_101	[p6l10t828r315b915],
7	with	IN	O	with	prep	6	SENT_101	[p6l385t828r555b896],
8	CYP2C9	NN	O	cyp2c9	dep	7	SENT_101	[p6l627t829r1173b896],
9	*	CD	NUMBER	*	num	8	SENT_101	[p6l627t829r1173b896],
10	I	PRP	O	I	dep	8	SENT_101	[p6l627t829r1173b896],
11	/	:	O	/	punct	8	SENT_101	[p6l627t829r1173b896],
12	*	CD	NUMBER	*	dep	8	SENT_101	[p6l627t829r1173b896],
13	1	CD	NUMBER	1	dep	12	SENT_101	[p6l627t829r1173b896],
14	and	CC	O	and	_	0	SENT_101	[p6l1250t828r1386b895],
15	CYP2C9	NN	O	cyp2c9	conj_and	12	SENT_101	[p6l1458t829r2009b896],
16	*	CD	NUMBER	*	number	17	SENT_101	[p6l1458t829r2009b896],
17	]	CD	NUMBER	]	dep	15	SENT_101	[p6l1458t829r2009b896],
18	/	:	O	/	punct	20	SENT_101	[p6l1458t829r2009b896],
19	*	CD	NUMBER	*	number	20	SENT_101	[p6l1458t829r2009b896],
20	3	CD	NUMBER	3	_	0	SENT_101	[p6l1458t829r2009b896],
21	to	TO	O	to	aux	22	SENT_101	[p6l2078t838r2150b895],
22	estimate	VB	O	estimate	dep	20	SENT_101	[p6l8t943r328b1010],
23	the	DT	O	the	det	26	SENT_101	[p6l411t943r526b1010],
24	blood	NN	O	blood	nn	26	SENT_101	[p6l607t943r827b1010],
25	glucose-lowering	NN	O	glucose-lowering	nn	26	SENT_101	[p6l910t943r1577b1030],
26	response	NN	O	response	dobj	22	SENT_101	[p6l1659t964r1995b1030],
27	to	TO	O	to	_	0	SENT_101	[p6l2078t953r2150b1010],
28	glimepiride	NN	O	glimepiride	prep_to	22	SENT_101	[p6l8t1058r452b1146],
29	in	IN	O	in	_	0	SENT_101	[p6l501t1058r575b1125],
30	these	DT	O	these	det	31	SENT_101	[p6l622t1058r819b1125],
31	subjects	NNS	O	subject	prep_in	28	SENT_101	[p6l871t1058r1197b1146],
32	.	.	O	.	_	0	SENT_101	[p6l871t1058r1197b1146],

1	Since	IN	O	since	_	0	SENT_102	[p6l1253t1058r1462b1126],
2	these	DT	O	these	det	4	SENT_102	[p6l1512t1058r1708b1125],
3	2	CD	NUMBER	2	num	4	SENT_102	[p6l1759t1058r1802b1125],
4	patients	NNS	O	patient	prep_since	71	SENT_102	[p6l1850t1058r2150b1146],
5	with	IN	O	with	_	0	SENT_102	[p6l7t1174r177b1241],
6	C	NN	O	c	nn	8	SENT_102	[p6l207t1176r268b1242],
7	YP2C9	NN	O	yp2c9	nn	8	SENT_102	[p6l273t1175r539b1242],
8	*	NN	O	*	prep_with	4	SENT_102	[p6l552t1175r628b1240],
9	1	CD	NUMBER	1	dobj	28	SENT_102	[p6l552t1175r628b1240],
10	/	:	O	/	punct	22	SENT_102	[p6l636t1175r665b1242],
11	*	CD	NUMBER	*	num	12	SENT_102	[p6l677t1175r759b1241],
12	3	CD	NUMBER	3	dep	22	SENT_102	[p6l677t1175r759b1241],
13	and	CC	O	and	_	0	SENT_102	[p6l788t1174r924b1241],
14	40	CD	NUMBER	40	num	15	SENT_102	[p6l949t1175r1043b1242],
15	patients	NNS	O	patient	conj_and	12	SENT_102	[p6l1068t1174r1367b1261],
16	among	IN	O	among	_	0	SENT_102	[p6l1397t1196r1655b1261],
17	132	CD	NUMBER	132	num	18	SENT_102	[p6l1692t1175r1825b1242],
18	patients	NNS	O	patient	prep_among	12	SENT_102	[p6l1850t1174r2149b1261],
19	with	IN	O	with	_	0	SENT_102	[p6l7t1289r177b1356],
20	CYP2C9	NN	O	cyp2c9	prep_with	18	SENT_102	[p6l232t1289r778b1357],
21	*	CD	NUMBER	*	num	20	SENT_102	[p6l232t1289r778b1357],
22	I	PRP	O	I	dep	9	SENT_102	[p6l232t1289r778b1357],
23	/	:	O	/	punct	22	SENT_102	[p6l232t1289r778b1357],
24	*	CD	NUMBER	*	number	25	SENT_102	[p6l232t1289r778b1357],
25	1	CD	NUMBER	1	nsubjpass	28	SENT_102	[p6l232t1289r778b1357],
26	had	VBD	O	have	aux	28	SENT_102	[p6l834t1289r974b1356],
27	been	VBN	O	be	auxpass	28	SENT_102	[p6l1022t1289r1205b1356],
28	treated	VBN	O	treat	rcmod	8	SENT_102	[p6l1255t1289r1519b1356],
29	with	IN	O	with	_	0	SENT_102	[p6l1569t1289r1739b1356],
30	lmg/day	JJ	O	lmg/day	amod	31	SENT_102	[p6l1799t1289r2150b1376],
31	glimepiride	NN	O	glimepiride	prep_with	28	SENT_102	[p6l8t1404r452b1491],
32	for	IN	O	for	_	0	SENT_102	[p6l482t1404r594b1471],
33	6	CD	DURATION	6	num	34	SENT_102	[p6l623t1404r666b1472],
34	months	NNS	NUMBER	month	prep_for	31	SENT_102	[p6l695t1404r1000b1484],
35	,	,	O	,	_	0	SENT_102	[p6l695t1404r1000b1484],
36	the	DT	O	the	det	37	SENT_102	[p6l1032t1404r1147b1471],
37	changes	NNS	O	change	nsubjpass	71	SENT_102	[p6l1178t1404r1486b1491],
38	in	IN	O	in	_	0	SENT_102	[p6l1516t1404r1589b1470],
39	HbA1C	NN	O	hba1c	prep_in	37	SENT_102	[p6l1618t1404r1871b1488],
40	after	IN	O	after	mark	69	SENT_102	[p6l1903t1404r2078b1471],
41	6	CD	DURATION	6	num	42	SENT_102	[p6l2107t1404r2150b1472],
42	months	NNS	NUMBER	month	dep	49	SENT_102	[p6l7t1519r288b1586],
43	of	IN	O	of	_	0	SENT_102	[p6l361t1519r444b1586],
44	glimepiride	NN	O	glimepiride	nn	45	SENT_102	[p6l509t1519r953b1606],
45	treatment	NN	O	treatment	prep_of	42	SENT_102	[p6l1025t1529r1391b1586],
46	(	NN	O	(	dep	49	SENT_102	[p6l1464t1519r1530b1602],
47	1	CD	NUMBER	1	num	46	SENT_102	[p6l1464t1519r1530b1602],
48	mg/day	NN	O	mg/day	nn	49	SENT_102	[p6l1566t1519r1883b1606],
49	)	NN	O	)	dep	65	SENT_102	[p6l1566t1519r1883b1606],
50	of	IN	O	of	_	0	SENT_102	[p6l1958t1519r2041b1586],
51	2	CD	NUMBER	2	num	52	SENT_102	[p6l2107t1519r2151b1585],
52	patients	NNS	O	patient	prep_of	49	SENT_102	[p6l6t1634r304b1722],
53	with	IN	O	with	prep	52	SENT_102	[p6l376t1634r547b1702],
54	CYP2C9	NN	O	cyp2c9	dep	53	SENT_102	[p6l620t1634r1171b1702],
55	*	CD	NUMBER	*	num	54	SENT_102	[p6l620t1634r1171b1702],
56	I	PRP	O	I	dep	54	SENT_102	[p6l620t1634r1171b1702],
57	/	:	O	/	punct	54	SENT_102	[p6l620t1634r1171b1702],
58	*	CD	NUMBER	*	num	59	SENT_102	[p6l620t1634r1171b1702],
59	3	CD	NUMBER	3	dep	54	SENT_102	[p6l620t1634r1171b1702],
60	and	CC	O	and	_	0	SENT_102	[p6l1244t1634r1380b1701],
61	40	CD	NUMBER	40	num	62	SENT_102	[p6l1448t1634r1542b1702],
62	patients	NNS	O	patient	conj_and	59	SENT_102	[p6l1611t1634r1910b1722],
63	with	IN	O	with	_	0	SENT_102	[p6l1982t1634r2151b1701],
64	CYP2C9	NN	O	cyp2c9	prep_with	59	SENT_102	[p6l12t1751r557b1818],
65	*	NN	O	*	dep	69	SENT_102	[p6l12t1751r557b1818],
66	1	CD	NUMBER	1	num	65	SENT_102	[p6l12t1751r557b1818],
67	/	:	O	/	punct	69	SENT_102	[p6l12t1751r557b1818],
68	*	CD	NUMBER	*	num	69	SENT_102	[p6l12t1751r557b1818],
69	1	CD	NUMBER	1	dep	39	SENT_102	[p6l12t1751r557b1818],
70	were	VBD	O	be	auxpass	71	SENT_102	[p6l612t1772r796b1818],
71	plotted	VBN	O	plot	_	0	SENT_102	[p6l842t1750r1112b1837],
72	in	IN	O	in	_	0	SENT_102	[p6l1158t1750r1231b1816],
73	Fig	NN	O	fig	prep_in	71	SENT_102	[p6l1277t1750r1423b1837],
74	.	.	O	.	_	0	SENT_102	[p6l1277t1750r1423b1837],

1	l.	NN	O	l.	nn	3	SENT_103	[p6l1484t1751r1540b1817],
2	The	DT	O	the	det	3	SENT_103	[p6l1591t1750r1740b1817],
3	reduction	NN	O	reduction	_	0	SENT_103	[p6l1785t1750r2152b1817],
4	in	IN	O	in	_	0	SENT_103	[p6l7t1865r80b1931],
5	HbA1C	NN	O	hba1c	prep_in	3	SENT_103	[p6l143t1865r396b1948],
6	in	IN	O	in	_	0	SENT_103	[p6l460t1865r533b1931],
7	the	DT	O	the	det	8	SENT_103	[p6l596t1865r712b1932],
8	subjects	NNS	O	subject	prep_in	5	SENT_103	[p6l779t1865r1084b1952],
9	with	IN	O	with	_	0	SENT_103	[p6l1150t1865r1320b1932],
10	CYP2C9	NN	O	cyp2c9	prep_with	8	SENT_103	[p6l1388t1865r1938b1932],
11	*	CD	NUMBER	*	number	12	SENT_103	[p6l1388t1865r1938b1932],
12	]	CD	NUMBER	]	num	10	SENT_103	[p6l1388t1865r1938b1932],
13	/	:	O	/	punct	15	SENT_103	[p6l1388t1865r1938b1932],
14	*	CD	NUMBER	*	num	15	SENT_103	[p6l1388t1865r1938b1932],
15	3	CD	NUMBER	3	dep	3	SENT_103	[p6l1388t1865r1938b1932],
16	was	VBD	O	be	cop	18	SENT_103	[p6l2004t1886r2149b1932],
17	signiﬁcantly	RB	O	signiﬁcantly	advmod	18	SENT_103	[p6l10t1980r483b2068],
18	larger	JJR	O	larger	rcmod	15	SENT_103	[p6l516t1980r741b2068],
19	(	CD	NUMBER	(	num	20	SENT_103	[p6l774t1980r860b2063],
20	P	NN	O	p	npadvmod	21	SENT_103	[p6l774t1980r860b2063],
21	<	JJR	O	<	dep	18	SENT_103	[p6l893t1993r952b2050],
22	0.05	CD	NUMBER	0.05	num	23	SENT_103	[p6l986t1979r1181b2063],
23	)	NN	O	)	npadvmod	18	SENT_103	[p6l986t1979r1181b2063],
24	than	IN	O	than	_	0	SENT_103	[p6l1216t1980r1381b2047],
25	that	DT	O	that	prep_than	18	SENT_103	[p6l1412t1980r1556b2047],
26	in	IN	O	in	_	0	SENT_103	[p6l1587t1980r1660b2047],
27	CYP2C9	NN	O	cyp2c9	prep_in	18	SENT_103	[p6l1695t1980r2153b2048],
28	*	CD	NUMBER	*	num	27	SENT_103	[p6l1695t1980r2153b2048],
29	I	PRP	O	I	dep	18	SENT_103	[p6l1695t1980r2153b2048],
30	/	:	O	/	punct	15	SENT_103	[p6l1695t1980r2153b2048],
31	*	CD	NUMBER	*	number	32	SENT_103	[p6l18t2097r94b2162],
32	1	CD	NUMBER	1	num	33	SENT_103	[p6l18t2097r94b2162],
33	subjects	NNS	O	subject	dep	3	SENT_103	[p6l139t2096r465b2183],
34	.	.	O	.	_	0	SENT_103	[p6l139t2096r465b2183],

1	—	NN	O	—	_	0	SENT_104	[p6l233t2974r254b3022],
2	l	NN	O	l	dep	1	SENT_104	[p6l233t2974r254b3022],
3	O	NN	O	o	dep	1	SENT_104	[p6l269t2974r303b3023],

1	O	NN	O	o	_	0	SENT_105	[p6l269t3123r303b3172],

1	Decrease	NN	O	decrease	_	0	SENT_106	[p6l107t3021r165b3369],
2	in	IN	O	in	_	0	SENT_106	[p6l107t2928r164b2990],
3	HbA1	NN	O	hba1	nn	4	SENT_106	[p6l107t2705r165b2894],
4	c	NN	O	c	prep_in	1	SENT_106	[p6l121t2649r165b2687],
5	(	CD	PERCENT	(	num	6	SENT_106	[p6l106t2500r180b2619],
6	%	NN	PERCENT	%	dep	1	SENT_106	[p6l106t2500r180b2619],
7	)	CD	NUMBER	)	number	8	SENT_106	[p6l106t2500r180b2619],
8	3	CD	NUMBER	3	num	6	SENT_106	[p6l233t3264r303b3313],
9	8	CD	NUMBER	8	dep	6	SENT_106	[p6l229t2819r303b2868],

1	:5	NN	O	:5	nn	2	SENT_107	[p6l206t3421r263b3469],
2	o	NN	O	o	_	0	SENT_107	[p6l269t3421r303b3471],

1	CYP2C9	NN	O	cyp2c9	nn	4	SENT_108	[p6l528t3509r795b3560],
2	*	CD	NUMBER	*	num	4	SENT_108	[p6l820t3509r960b3560],
3	1l	NN	O	1l	nn	4	SENT_108	[p6l820t3509r960b3560],
4	*	NN	O	*	_	0	SENT_108	[p6l820t3509r960b3560],
5	1	CD	NUMBER	1	num	6	SENT_108	[p6l820t3509r960b3560],
6	CYP2C9	NN	O	cyp2c9	dep	4	SENT_108	[p6l1409t3509r1677b3560],
7	*	CD	NUMBER	*	num	8	SENT_108	[p6l1702t3508r1849b3560],
8	1l	NN	O	1l	dep	4	SENT_108	[p6l1702t3508r1849b3560],
9	*	CD	NUMBER	*	number	10	SENT_108	[p6l1702t3508r1849b3560],
10	3	CD	NUMBER	3	dep	8	SENT_108	[p6l1702t3508r1849b3560],

1	Fig	NN	O	fig	_	0	SENT_109	[p6l6t3653r123b3723],
2	.	.	O	.	_	0	SENT_109	[p6l6t3653r123b3723],

1	l.	NN	O	l.	nn	3	SENT_110	[p6l177t3653r222b3707],
2	HbA1C	NN	O	hba1c	nn	3	SENT_110	[p6l266t3652r468b3719],
3	response	NN	O	response	_	0	SENT_110	[p6l511t3669r779b3723],
4	to	TO	O	to	_	0	SENT_110	[p6l822t3661r880b3707],
5	lmg	NN	O	lmg	prep_to	3	SENT_110	[p6l931t3653r1078b3723],
6	of	IN	O	of	_	0	SENT_110	[p6l1122t3652r1189b3707],
7	glimepiride	NN	O	glimepiride	prep_of	3	SENT_110	[p6l1227t3652r1582b3723],
8	in	IN	O	in	dep	3	SENT_110	[p6l1625t3653r1684b3706],
9	subjects	NNS	O	subject	pobj	8	SENT_110	[p6l1729t3652r1972b3723],
10	with	IN	O	with	dep	3	SENT_110	[p6l2017t3653r2152b3707],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_111	[p7l11t20r445b74],
2	*	CD	NUMBER	*	number	3	SENT_111	[p7l11t20r445b74],
3	]	CD	NUMBER	]	dep	1	SENT_111	[p7l11t20r445b74],
4	/	:	O	/	punct	15	SENT_111	[p7l11t20r445b74],
5	*	CD	NUMBER	*	number	6	SENT_111	[p7l11t20r445b74],
6	1	CD	NUMBER	1	num	11	SENT_111	[p7l11t20r445b74],
7	(	NN	O	(	nn	11	SENT_111	[p7l494t20r737b87],
8	n	NN	O	n	nn	11	SENT_111	[p7l494t20r737b87],
9	=	JJ	O	=	amod	11	SENT_111	[p7l494t20r737b87],
10	40	CD	NUMBER	40	num	11	SENT_111	[p7l494t20r737b87],
11	)	NN	O	)	dep	15	SENT_111	[p7l494t20r737b87],
12	and	CC	O	and	_	0	SENT_111	[p7l780t20r889b74],
13	CYP2C9	NN	O	cyp2c9	conj_and	11	SENT_111	[p7l932t20r1371b74],
14	*	CD	NUMBER	*	num	13	SENT_111	[p7l932t20r1371b74],
15	I	PRP	O	I	dep	3	SENT_111	[p7l932t20r1371b74],
16	/	:	O	/	punct	15	SENT_111	[p7l932t20r1371b74],
17	*	CD	NUMBER	*	number	18	SENT_111	[p7l932t20r1371b74],
18	3	CD	NUMBER	3	num	24	SENT_111	[p7l932t20r1371b74],
19	(	NN	O	(	nn	24	SENT_111	[p7l1415t20r1620b87],
20	n	NN	O	n	nn	24	SENT_111	[p7l1415t20r1620b87],
21	=	JJ	O	=	amod	24	SENT_111	[p7l1415t20r1620b87],
22	2	CD	NUMBER	2	number	23	SENT_111	[p7l1415t20r1620b87],
23	)	CD	NUMBER	)	num	24	SENT_111	[p7l1415t20r1620b87],
24	genotypes	NNS	O	genotype	dep	3	SENT_111	[p7l1663t28r1989b90],
25	.	.	O	.	_	0	SENT_111	[p7l1663t28r1989b90],

1	The	DT	O	the	det	3	SENT_112	[p7l2033t20r2151b74],
2	HbA1C	NN	O	hba1c	nn	3	SENT_112	[p7l7t114r208b182],
3	Values	NNS	O	value	nsubjpass	5	SENT_112	[p7l236t114r429b169],
4	were	VBD	O	be	auxpass	5	SENT_112	[p7l458t131r605b169],
5	measured	VBN	O	measure	_	0	SENT_112	[p7l633t114r928b169],
6	before	IN	O	before	_	0	SENT_112	[p7l953t114r1149b169],
7	and	CC	O	and	cc	8	SENT_112	[p7l1178t114r1288b169],
8	6	CD	DURATION	6	num	9	SENT_112	[p7l1315t114r1349b169],
9	months	NNS	NUMBER	month	prep_before	5	SENT_112	[p7l1377t114r1602b169],
10	after	IN	O	after	_	0	SENT_112	[p7l1631t114r1771b169],
11	glimepiride	NN	O	glimepiride	nn	12	SENT_112	[p7l1797t114r2152b184],
12	treatment	NN	O	treatment	prep_after	5	SENT_112	[p7l7t220r313b266],
13	.	.	O	.	_	0	SENT_112	[p7l7t220r313b266],

1	Data	NNS	O	datum	nsubjpass	3	SENT_113	[p7l345t213r490b266],
2	are	VBP	O	be	auxpass	3	SENT_113	[p7l518t228r609b266],
3	expressed	VBN	O	express	_	0	SENT_113	[p7l638t212r940b282],
4	as	IN	O	as	_	0	SENT_113	[p7l969t228r1028b266],
5	the	DT	O	the	det	6	SENT_113	[p7l1058t212r1150b266],
6	changes	NNS	O	change	prep_as	3	SENT_113	[p7l1179t212r1424b282],
7	in	IN	O	in	_	0	SENT_113	[p7l1453t211r1511b265],
8	HbA1C	NN	O	hba1c	nn	9	SENT_113	[p7l1539t212r1740b278],
9	Values	NNS	O	value	prep_in	6	SENT_113	[p7l1769t212r1979b266],
10	.	.	O	.	_	0	SENT_113	[p7l1769t212r1979b266],

1	_	NN	O	_	_	0	SENT_114	[p7l238t616r260b663],
2	|	NN	O	|	dep	1	SENT_114	[p7l238t616r260b663],
3	.	.	O	.	_	0	SENT_114	[p7l238t616r260b663],

1	O	NN	O	o	_	0	SENT_115	[p7l274t616r308b665],

1	HbA1	NN	O	hba1	nn	2	SENT_116	[p7l156t1032r213b1220],
2	c	NN	O	c	_	0	SENT_116	[p7l170t976r213b1014],
3	(	CD	PERCENT	(	num	4	SENT_116	[p7l154t827r228b947],
4	%	NN	PERCENT	%	dep	2	SENT_116	[p7l154t827r228b947],
5	)	CD	NUMBER	)	dep	2	SENT_116	[p7l154t827r228b947],

1	(	NN	O	(	nn	2	SENT_117	[p7l274t782r308b831],
2	D	NN	O	d	_	0	SENT_117	[p7l274t782r308b831],

1	Time	NNP	O	Time	_	0	SENT_118	[p7l698t1750r882b1807],
2	After	IN	O	after	dep	1	SENT_118	[p7l910t1750r1095b1807],
3	Treatment	NN	O	treatment	pobj	2	SENT_118	[p7l1120t1750r1506b1807],
4	(	CD	NUMBER	(	num	3	SENT_118	[p7l1533t1749r1822b1822],
5	Month	NNP	DURATION	Month	dep	3	SENT_118	[p7l1533t1749r1822b1822],
6	)	CD	NUMBER	)	num	5	SENT_118	[p7l1533t1749r1822b1822],

1	Case	NNP	O	Case	_	0	SENT_119	[p7l59t1847r221b1899],
2	#	#	MONEY	#	number	3	SENT_119	[p7l246t1850r311b1897],
3	1	CD	MONEY	1	amod	4	SENT_119	[p7l246t1850r311b1897],
4	Case	NN	O	case	dep	1	SENT_119	[p7l59t1924r221b1977],
5	#	#	MONEY	#	number	6	SENT_119	[p7l246t1927r319b1976],
6	2	CD	MONEY	2	amod	4	SENT_119	[p7l246t1927r319b1976],

1	Fig	NN	O	fig	_	0	SENT_120	[p7l6t2085r123b2155],
2	.	.	O	.	_	0	SENT_120	[p7l6t2085r123b2155],

1	2	LS	NUMBER	2	_	0	SENT_121	[p7l149t2085r199b2139],
2	.	.	O	.	_	0	SENT_121	[p7l149t2085r199b2139],

1	Time	NNP	O	Time	nn	3	SENT_122	[p7l243t2085r402b2139],
2	course	NN	O	course	nn	3	SENT_122	[p7l423t2101r622b2139],
3	changes	NNS	O	change	_	0	SENT_122	[p7l643t2084r888b2155],
4	of	IN	O	of	_	0	SENT_122	[p7l910t2084r976b2139],
5	HbA1C	NN	O	hba1c	prep_of	3	SENT_122	[p7l992t2085r1192b2152],
6	of	IN	O	of	dep	3	SENT_122	[p7l1214t2084r1281b2139],
7	glimepiride-treated	JJ	O	glimepiride-treated	amod	8	SENT_122	[p7l1298t2085r1888b2155],
8	patients	NNS	O	patient	pobj	6	SENT_122	[p7l1907t2084r2145b2155],
9	with	IN	O	with	dep	3	SENT_122	[p7l7t2181r142b2235],
10	CYP2C9	NN	O	cyp2c9	nn	11	SENT_122	[p7l174t2181r613b2235],
11	*	NN	O	*	pobj	9	SENT_122	[p7l174t2181r613b2235],
12	1	CD	NUMBER	1	num	11	SENT_122	[p7l174t2181r613b2235],
13	/	:	O	/	punct	3	SENT_122	[p7l174t2181r613b2235],
14	*	CD	NUMBER	*	num	15	SENT_122	[p7l174t2181r613b2235],
15	3	CD	NUMBER	3	dep	3	SENT_122	[p7l174t2181r613b2235],
16	genotypes	NNS	O	genotype	dep	15	SENT_122	[p7l643t2189r968b2251],
17	.	.	O	.	_	0	SENT_122	[p7l643t2189r968b2251],

1	HbA1C	NN	O	hba1c	nn	2	SENT_123	[p7l1000t2181r1201b2248],
2	Values	NNS	O	value	nsubjpass	4	SENT_123	[p7l1230t2181r1423b2235],
3	were	VBD	O	be	auxpass	4	SENT_123	[p7l1453t2198r1600b2235],
4	measured	VBN	O	measure	_	0	SENT_123	[p7l1629t2181r1923b2235],
5	before	IN	O	before	prep	4	SENT_123	[p7l1950t2181r2145b2235],
6	and	CC	O	and	_	0	SENT_123	[p7l8t2277r117b2331],
7	every	DT	SET	every	det	8	SENT_123	[p7l134t2294r300b2347],
8	month	NN	SET	month	nsubj	25	SENT_123	[p7l318t2277r514b2331],
9	during	IN	O	during	_	0	SENT_123	[p7l531t2277r729b2347],
10	the	DT	O	the	det	11	SENT_123	[p7l747t2277r839b2331],
11	treatment	NN	O	treatment	prep_during	8	SENT_123	[p7l857t2285r1149b2331],
12	of	IN	O	of	_	0	SENT_123	[p7l1166t2277r1232b2331],
13	case	NN	O	case	prep_of	11	SENT_123	[p7l1244t2294r1375b2331],
14	#	#	MONEY	#	number	16	SENT_123	[p7l1391t2277r1460b2330],
15	1	CD	MONEY	1	number	16	SENT_123	[p7l1391t2277r1460b2330],
16	(	CD	MONEY	(	num	19	SENT_123	[p7l1487t2277r1658b2347],
17	open	JJ	O	open	amod	19	SENT_123	[p7l1487t2277r1658b2347],
18	circle	NN	O	circle	nn	19	SENT_123	[p7l1676t2277r1869b2343],
19	)	NN	O	)	dep	13	SENT_123	[p7l1676t2277r1869b2343],
20	and	CC	O	and	_	0	SENT_123	[p7l1890t2277r1999b2331],
21	case	NN	O	case	conj_and	13	SENT_123	[p7l2016t2294r2145b2331],
22	#	#	MONEY	#	number	23	SENT_123	[p7l6t2371r81b2424],
23	2	CD	MONEY	2	amod	24	SENT_123	[p7l6t2371r81b2424],
24	(	NN	O	(	dep	21	SENT_123	[p7l102t2371r322b2437],
25	closed	VBD	O	close	conj_and	4	SENT_123	[p7l102t2371r322b2437],
26	circle	NN	O	circle	nn	27	SENT_123	[p7l340t2371r551b2437],
27	)	NN	O	)	dobj	25	SENT_123	[p7l340t2371r551b2437],
28	.	.	O	.	_	0	SENT_123	[p7l340t2371r551b2437],

1	Arrows	NNS	O	arrow	nsubj	2	SENT_124	[p7l573t2371r798b2425],
2	indicate	VBP	O	indicate	_	0	SENT_124	[p7l817t2371r1060b2425],
3	the	DT	O	the	det	4	SENT_124	[p7l1079t2371r1171b2424],
4	time	NN	O	time	dobj	2	SENT_124	[p7l1190t2371r1326b2424],
5	when	WRB	O	when	advmod	12	SENT_124	[p7l1343t2371r1507b2425],
6	the	DT	O	the	det	7	SENT_124	[p7l1525t2371r1617b2424],
7	Values	NNS	O	value	nsubjpass	12	SENT_124	[p7l1635t2371r1827b2424],
8	in	IN	O	in	_	0	SENT_124	[p7l1846t2371r1905b2424],
9	Table	NNP	O	Table	prep_in	7	SENT_124	[p7l1923t2371r2091b2424],
10	1	CD	NUMBER	1	num	9	SENT_124	[p7l2117t2371r2140b2424],
11	were	VBD	O	be	auxpass	12	SENT_124	[p7l7t2485r154b2522],
12	obtained	VBN	O	obtain	dep	4	SENT_124	[p7l174t2468r453b2522],
13	.	.	O	.	_	0	SENT_124	[p7l174t2468r453b2522],

1	Durations	NNS	O	duration	nsubjpass	14	SENT_125	[p7l474t2468r775b2522],
2	of	IN	O	of	_	0	SENT_125	[p7l796t2468r862b2522],
3	g1imepiride	NN	O	g1imepiride	nn	5	SENT_125	[p7l876t2468r1548b2538],
4	—	NN	O	—	nn	5	SENT_125	[p7l876t2468r1548b2538],
5	treatment	NN	O	treatment	prep_of	1	SENT_125	[p7l876t2468r1548b2538],
6	for	IN	O	for	_	0	SENT_125	[p7l1566t2468r1655b2522],
7	cases	NNS	O	case	prep_for	5	SENT_125	[p7l1672t2485r1830b2522],
8	#	#	MONEY	#	dep	9	SENT_125	[p7l1849t2468r1918b2521],
9	1	CD	MONEY	1	dep	7	SENT_125	[p7l1849t2468r1918b2521],
10	and	CC	O	and	_	0	SENT_125	[p7l1945t2468r2054b2522],
11	#	#	MONEY	#	dep	12	SENT_125	[p7l2070t2468r2146b2521],
12	2	CD	MONEY	2	prep_for	5	SENT_125	[p7l2070t2468r2146b2521],
13	are	VBP	O	be	auxpass	14	SENT_125	[p7l8t2581r99b2618],
14	shown	VBN	O	show	_	0	SENT_125	[p7l130t2564r324b2618],
15	under	IN	O	under	_	0	SENT_125	[p7l352t2564r527b2618],
16	the	DT	O	the	det	17	SENT_125	[p7l553t2564r645b2618],
17	ﬁgure	NN	O	ﬁgure	prep_under	14	SENT_125	[p7l674t2564r866b2634],
18	.	.	O	.	_	0	SENT_125	[p7l674t2564r866b2634],

1	3.2	CD	NUMBER	3.2	_	0	SENT_126	[p7l7t2808r141b2875],
2	.	.	O	.	_	0	SENT_126	[p7l7t2808r141b2875],

1	Long-term	JJ	O	long-term	amod	3	SENT_127	[p7l199t2810r605b2894],
2	clinical	JJ	O	clinical	amod	3	SENT_127	[p7l642t2808r930b2875],
3	courses	NNS	O	course	dep	9	SENT_127	[p7l965t2830r1256b2875],
4	of	IN	O	of	_	0	SENT_127	[p7l1292t2808r1379b2894],
5	two	CD	NUMBER	two	num	6	SENT_127	[p7l1401t2821r1534b2875],
6	cases	NNS	O	case	prep_of	3	SENT_127	[p7l1573t2831r1777b2875],
7	with	IN	O	with	prep	6	SENT_127	[p7l1813t2808r1976b2876],
8	CYP2C9	NN	O	cyp2c9	dep	9	SENT_127	[p7l12t2922r561b2989],
9	*	CD	NUMBER	*	dep	13	SENT_127	[p7l12t2922r561b2989],
10	I	PRP	O	I	dep	9	SENT_127	[p7l12t2922r561b2989],
11	/	:	O	/	punct	13	SENT_127	[p7l12t2922r561b2989],
12	*	CD	NUMBER	*	num	13	SENT_127	[p7l12t2922r561b2989],
13	3	CD	NUMBER	3	_	0	SENT_127	[p7l12t2922r561b2989],

1	The	DT	O	the	det	4	SENT_128	[p7l123t3151r272b3218],
2	time	NN	O	time	nn	4	SENT_128	[p7l331t3151r503b3218],
3	course	NN	O	course	nn	4	SENT_128	[p7l563t3172r816b3218],
4	change	NN	O	change	nsubjpass	36	SENT_128	[p7l875t3151r1151b3238],
5	of	IN	O	of	_	0	SENT_128	[p7l1211t3151r1295b3218],
6	HbA1C	NN	O	hba1c	nn	7	SENT_128	[p7l1346t3151r1602b3234],
7	Values	NNS	O	value	prep_of	4	SENT_128	[p7l1661t3151r1907b3218],
8	after	IN	O	after	_	0	SENT_128	[p7l1968t3151r2147b3218],
9	starting	VBG	O	start	prepc_after	7	SENT_128	[p7l10t3266r301b3353],
10	the	DT	O	the	det	13	SENT_128	[p7l326t3266r443b3333],
11	initial	JJ	O	initial	amod	13	SENT_128	[p7l469t3266r699b3333],
12	glimepiride	NN	O	glimepiride	nn	13	SENT_128	[p7l725t3266r1178b3353],
13	treatment	NN	O	treatment	dobj	9	SENT_128	[p7l1203t3276r1577b3333],
14	for	IN	O	for	_	0	SENT_128	[p7l1601t3266r1714b3333],
15	the	DT	O	the	det	17	SENT_128	[p7l1736t3266r1854b3333],
16	female	JJ	O	female	amod	17	SENT_128	[p7l1880t3266r2145b3333],
17	patient	NN	O	patient	prep_for	13	SENT_128	[p7l6t3381r276b3468],
18	with	IN	O	with	_	0	SENT_128	[p7l326t3381r499b3449],
19	the	DT	O	the	det	20	SENT_128	[p7l550t3381r667b3448],
20	CYP2C9	NN	O	cyp2c9	prep_with	17	SENT_128	[p7l724t3382r1283b3449],
21	*	CD	NUMBER	*	number	22	SENT_128	[p7l724t3382r1283b3449],
22	]	CD	NUMBER	]	num	20	SENT_128	[p7l724t3382r1283b3449],
23	/	:	O	/	punct	31	SENT_128	[p7l724t3382r1283b3449],
24	*	CD	NUMBER	*	number	25	SENT_128	[p7l724t3382r1283b3449],
25	3	CD	NUMBER	3	num	26	SENT_128	[p7l724t3382r1283b3449],
26	who	WP	O	who	nsubj	31	SENT_128	[p7l1336t3381r1499b3449],
27	was	VBD	O	be	cop	31	SENT_128	[p7l1551t3403r1697b3449],
28	not	RB	O	not	neg	31	SENT_128	[p7l1750t3392r1874b3448],
29	obese	JJ	O	obese	amod	31	SENT_128	[p7l1925t3381r2145b3448],
30	(	NN	O	(	nn	31	SENT_128	[p7l10t3497r207b3579],
31	case	NN	O	case	dep	13	SENT_128	[p7l10t3497r207b3579],
32	#	#	MONEY	#	number	33	SENT_128	[p7l236t3497r363b3579],
33	1	CD	MONEY	1	amod	34	SENT_128	[p7l236t3497r363b3579],
34	)	NN	O	)	dep	13	SENT_128	[p7l236t3497r363b3579],
35	was	VBD	O	be	auxpass	36	SENT_128	[p7l396t3518r543b3564],
36	shown	VBN	O	show	_	0	SENT_128	[p7l577t3496r825b3563],
37	in	IN	O	in	_	0	SENT_128	[p7l854t3496r929b3562],
38	Fig	NN	O	fig	prep_in	36	SENT_128	[p7l958t3496r1107b3583],
39	.	.	O	.	_	0	SENT_128	[p7l958t3496r1107b3583],

1	2	LS	NUMBER	2	_	0	SENT_129	[p7l1143t3497r1207b3563],
2	.	.	O	.	_	0	SENT_129	[p7l1143t3497r1207b3563],

1	We	PRP	O	we	nsubj	2	SENT_130	[p7l1241t3498r1367b3563],
2	considered	VBD	O	consider	_	0	SENT_130	[p7l1399t3496r1824b3563],
3	case	NN	O	case	nsubj	6	SENT_130	[p7l1854t3518r2021b3563],
4	#	#	MONEY	#	number	5	SENT_130	[p7l2050t3497r2138b3562],
5	1	CD	MONEY	1	amod	3	SENT_130	[p7l2050t3497r2138b3562],
6	showed	VBD	O	show	ccomp	2	SENT_130	[p7l10t3611r303b3678],
7	good	JJ	O	good	amod	9	SENT_130	[p7l345t3611r538b3698],
8	glycemic	JJ	O	glycemic	amod	9	SENT_130	[p7l581t3611r938b3698],
9	control	NN	O	control	dobj	6	SENT_130	[p7l983t3611r1260b3678],
10	when	WRB	O	when	advmod	12	SENT_130	[p7l1303t3611r1513b3678],
11	she	PRP	O	she	nsubj	12	SENT_130	[p7l1557t3611r1681b3678],
12	started	VBD	O	start	advcl	6	SENT_130	[p7l1727t3611r1987b3678],
13	the	DT	O	the	det	15	SENT_130	[p7l2028t3611r2145b3678],
14	glimepiride	NN	O	glimepiride	nn	15	SENT_130	[p7l8t3726r462b3813],
15	treatment	NN	O	treatment	dobj	12	SENT_130	[p7l557t3736r930b3792],
16	because	IN	O	because	mark	20	SENT_130	[p7l1023t3726r1333b3792],
17	her	PRP$	O	she	poss	18	SENT_130	[p7l1427t3726r1553b3792],
18	HbA1C	NN	O	hba1c	nsubjpass	20	SENT_130	[p7l1646t3726r1901b3808],
19	was	VBD	O	be	auxpass	20	SENT_130	[p7l1997t3747r2144b3793],
20	decreased	VBN	O	decrease	advcl	12	SENT_130	[p8l8t24r395b91],
21	from	IN	O	from	_	0	SENT_130	[p8l455t24r644b91],
22	8.6	CD	PERCENT	8.6	num	23	SENT_130	[p8l707t24r900b91],
23	%	NN	PERCENT	%	prep_from	20	SENT_130	[p8l707t24r900b91],
24	to	TO	O	to	_	0	SENT_130	[p8l964t34r1037b91],
25	less	JJR	O	less	mwe	26	SENT_130	[p8l1098t24r1240b91],
26	than	IN	O	than	quantmod	27	SENT_130	[p8l1302t24r1470b91],
27	6.5	CD	PERCENT	6.5	num	28	SENT_130	[p8l1531t24r1727b91],
28	%	NN	PERCENT	%	prep_to	23	SENT_130	[p8l1531t24r1727b91],
29	within	IN	O	within	_	0	SENT_130	[p8l1791t24r2041b91],
30	4	CD	DURATION	4	num	31	SENT_130	[p8l2100t25r2145b90],
31	months	NNS	NUMBER	month	prep_within	28	SENT_130	[p8l7t139r293b206],
32	after	IN	O	after	_	0	SENT_130	[p8l326t139r505b206],
33	starting	VBG	O	start	prepc_after	20	SENT_130	[p8l536t139r826b226],
34	the	DT	O	the	det	37	SENT_130	[p8l856t139r974b206],
35	initial	JJ	O	initial	amod	37	SENT_130	[p8l1004t139r1234b206],
36	glimepiride	NN	O	glimepiride	nn	37	SENT_130	[p8l1265t139r1718b226],
37	treatment	NN	O	treatment	dobj	33	SENT_130	[p8l1747t149r2140b206],
38	.	.	O	.	_	0	SENT_130	[p8l1747t149r2140b206],

1	Her	PRP$	O	she	poss	3	SENT_131	[p8l7t256r153b321],
2	glimepiride	NN	O	glimepiride	nn	3	SENT_131	[p8l212t254r665b341],
3	treatment	NN	O	treatment	nsubjpass	5	SENT_131	[p8l725t264r1099b321],
4	was	VBD	O	be	auxpass	5	SENT_131	[p8l1159t275r1306b321],
5	interrupted	VBN	O	interrupt	_	0	SENT_131	[p8l1367t254r1801b341],
6	after	IN	O	after	_	0	SENT_131	[p8l1862t254r2042b321],
7	6	CD	DURATION	6	num	8	SENT_131	[p8l2102t254r2144b321],
8	months	NNS	NUMBER	month	prep_after	5	SENT_131	[p8l7t370r292b437],
9	because	IN	O	because	mark	13	SENT_131	[p8l323t370r634b437],
10	her	PRP$	O	she	poss	11	SENT_131	[p8l663t370r789b437],
11	HbA1C	NN	O	hba1c	nsubjpass	13	SENT_131	[p8l817t370r1073b453],
12	was	VBD	O	be	auxpass	13	SENT_131	[p8l1104t391r1251b438],
13	decreased	VBN	O	decrease	advcl	5	SENT_131	[p8l1284t370r1671b437],
14	to	TO	O	to	_	0	SENT_131	[p8l1700t380r1773b437],
15	less	JJR	O	less	mwe	16	SENT_131	[p8l1804t370r1947b437],
16	than	IN	O	than	quantmod	17	SENT_131	[p8l1979t370r2146b437],
17	6	CD	PERCENT	6	num	18	SENT_131	[p8l9t485r154b553],
18	%	NN	PERCENT	%	prep_to	13	SENT_131	[p8l9t485r154b553],
19	.	.	O	.	_	0	SENT_131	[p8l9t485r154b553],

1	After	IN	O	after	_	0	SENT_132	[p8l234t485r442b552],
2	6	CD	DURATION	6	num	4	SENT_132	[p8l517t485r559b553],
3	months	NNS	NUMBER	month	nn	4	SENT_132	[p8l635t485r921b552],
4	discontinuance	NN	O	discontinuance	prep_after	9	SENT_132	[p8l999t485r1612b565],
5	,	,	O	,	_	0	SENT_132	[p8l999t485r1612b565],
6	glimepiride	NN	O	glimepiride	nn	7	SENT_132	[p8l1692t485r2145b572],
7	treatment	NN	O	treatment	nsubjpass	9	SENT_132	[p8l7t609r381b666],
8	was	VBD	O	be	auxpass	9	SENT_132	[p8l430t621r577b666],
9	resumed	VBN	O	resume	_	0	SENT_132	[p8l627t599r960b666],
10	because	IN	O	because	mark	14	SENT_132	[p8l1007t599r1318b666],
11	her	PRP$	O	she	poss	12	SENT_132	[p8l1367t599r1493b666],
12	HbA1C	NN	O	hba1c	nsubj	14	SENT_132	[p8l1541t599r1796b681],
13	became	VBD	O	become	cop	14	SENT_132	[p8l1845t599r2145b666],
14	elevated	JJ	O	elevated	advcl	9	SENT_132	[p8l8t714r333b781],
15	up	IN	O	up	dep	20	SENT_132	[p8l359t735r454b801],
16	to	TO	O	to	_	0	SENT_132	[p8l482t724r555b781],
17	9	CD	PERCENT	9	num	18	SENT_132	[p8l585t714r707b782],
18	%	NN	PERCENT	%	prep_to	20	SENT_132	[p8l585t714r707b782],
19	once	RB	DATE	once	advmod	20	SENT_132	[p8l740t735r922b781],
20	again	RB	O	again	advmod	14	SENT_132	[p8l952t714r1162b801],
21	(	CD	NUMBER	(	num	22	SENT_132	[p8l1192t714r1370b801],
22	Fig	NN	O	fig	dep	20	SENT_132	[p8l1192t714r1370b801],
23	.	.	O	.	_	0	SENT_132	[p8l1192t714r1370b801],

1	2	CD	NUMBER	2	num	2	SENT_133	[p8l1405t714r1502b797],
2	)	CD	NUMBER	)	_	0	SENT_133	[p8l1405t714r1502b797],
3	.	.	O	.	_	0	SENT_133	[p8l1405t714r1502b797],

1	Her	PRP$	O	she	poss	2	SENT_134	[p8l1536t715r1681b781],
2	BS	NN	O	b	nsubjpass	14	SENT_134	[p8l1707t714r1819b781],
3	and	CC	O	and	_	0	SENT_134	[p8l1853t714r1991b781],
4	IRI	NN	ORGANIZATION	irus	nsubjpass	14	SENT_134	[p8l2018t715r2146b780],
5	after	IN	O	after	_	0	SENT_134	[p8l9t828r188b895],
6	a	DT	O	a	det	9	SENT_134	[p8l244t850r284b895],
7	single	JJ	O	single	amod	9	SENT_134	[p8l340t829r571b916],
8	oral	JJ	O	oral	amod	9	SENT_134	[p8l627t829r777b895],
9	dose	NN	O	dose	prep_after	2	SENT_134	[p8l833t829r1009b895],
10	of	IN	O	of	_	0	SENT_134	[p8l1066t828r1150b895],
11	1mg	JJ	O	1mg	amod	12	SENT_134	[p8l1208t829r1393b916],
12	glimepiride	NN	O	glimepiride	prep_of	9	SENT_134	[p8l1451t829r1904b916],
13	were	VBD	O	be	auxpass	14	SENT_134	[p8l1958t850r2145b896],
14	measured	VBN	O	measure	_	0	SENT_134	[p8l7t944r383b1011],
15	2	CD	DATE	2	num	16	SENT_134	[p8l457t945r500b1010],
16	weeks	NNS	DATE	week	tmod	14	SENT_134	[p8l575t944r815b1011],
17	later	RB	DATE	later	advmod	16	SENT_134	[p8l891t944r1067b1011],
18	when	WRB	O	when	advmod	20	SENT_134	[p8l1139t944r1349b1011],
19	she	PRP	O	she	nsubj	20	SENT_134	[p8l1426t944r1549b1011],
20	resumed	VBD	O	resume	advcl	14	SENT_134	[p8l1622t944r1956b1011],
21	the	DT	O	the	det	23	SENT_134	[p8l2028t944r2146b1011],
22	glimepiride	NN	O	glimepiride	nn	23	SENT_134	[p8l8t1059r462b1146],
23	treatment	NN	O	treatment	nsubj	24	SENT_134	[p8l520t1069r893b1126],
24	(	CD	NUMBER	(	xcomp	20	SENT_134	[p8l953t1059r1233b1143],
25	shown	VBN	O	show	partmod	24	SENT_134	[p8l953t1059r1233b1143],
26	by	IN	O	by	_	0	SENT_134	[p8l1289t1059r1385b1146],
27	arrow	NN	O	arrow	agent	25	SENT_134	[p8l1445t1081r1668b1127],
28	in	IN	O	in	_	0	SENT_134	[p8l1725t1059r1800b1126],
29	Fig	NN	O	fig	prep_in	27	SENT_134	[p8l1855t1059r2004b1146],
30	.	.	O	.	_	0	SENT_134	[p8l1855t1059r2004b1146],

1	2	CD	NUMBER	2	num	2	SENT_135	[p8l2068t1060r2143b1142],
2	)	NN	O	)	nsubj	5	SENT_135	[p8l2068t1060r2143b1142],
3	and	CC	O	and	_	0	SENT_135	[p8l9t1174r147b1241],
4	we	PRP	O	we	nsubj	5	SENT_135	[p8l187t1196r297b1241],
5	showed	VBD	O	show	_	0	SENT_135	[p8l341t1174r634b1241],
6	these	DT	O	these	det	7	SENT_135	[p8l673t1174r873b1241],
7	values	NNS	O	value	dobj	5	SENT_135	[p8l913t1174r1158b1241],
8	in	IN	O	in	_	0	SENT_135	[p8l1201t1174r1275b1240],
9	Table	NNP	O	Table	prep_in	5	SENT_135	[p8l1315t1174r1529b1241],
10	1	CD	NUMBER	1	num	9	SENT_135	[p8l1580t1175r1636b1241],
11	.	.	O	.	_	0	SENT_135	[p8l1580t1175r1636b1241],

1	BS	NN	O	b	nn	4	SENT_136	[p8l1681t1175r1793b1241],
2	and	CC	O	and	_	0	SENT_136	[p8l1840t1174r1978b1241],
3	IRI	NN	ORGANIZATION	irus	conj_and	1	SENT_136	[p8l2018t1176r2146b1240],
4	values	NNS	O	value	_	0	SENT_136	[p8l7t1289r253b1356],
5	of	IN	O	of	_	0	SENT_136	[p8l282t1289r366b1356],
6	4	CD	NUMBER	4	num	7	SENT_136	[p8l386t1289r430b1355],
7	patients	NNS	O	patient	prep_of	4	SENT_136	[p8l457t1289r761b1376],
8	with	IN	O	with	_	0	SENT_136	[p8l790t1289r963b1356],
9	CYP2C9	NN	O	cyp2c9	nn	10	SENT_136	[p8l993t1289r1576b1368],
10	*	NN	O	*	prep_with	7	SENT_136	[p8l993t1289r1576b1368],
11	1	CD	NUMBER	1	num	10	SENT_136	[p8l993t1289r1576b1368],
12	/	:	O	/	punct	4	SENT_136	[p8l993t1289r1576b1368],
13	*	CD	NUMBER	*	num	14	SENT_136	[p8l993t1289r1576b1368],
14	1	CD	NUMBER	1	nsubjpass	28	SENT_136	[p8l993t1289r1576b1368],
15	,	,	O	,	_	0	SENT_136	[p8l993t1289r1576b1368],
16	who	WP	O	who	nsubjpass	19	SENT_136	[p8l1606t1289r1770b1356],
17	had	VBD	O	have	aux	19	SENT_136	[p8l1796t1289r1937b1356],
18	been	VBN	O	be	auxpass	19	SENT_136	[p8l1961t1289r2146b1356],
19	treated	VBN	O	treat	rcmod	14	SENT_136	[p8l7t1404r276b1471],
20	with	IN	O	with	_	0	SENT_136	[p8l337t1404r509b1472],
21	glimepiride	NN	O	glimepiride	prep_with	19	SENT_136	[p8l571t1404r1024b1491],
22	for	IN	O	for	_	0	SENT_136	[p8l1086t1404r1199b1471],
23	6	CD	DURATION	6	num	24	SENT_136	[p8l1261t1404r1304b1472],
24	months	NNS	NUMBER	month	prep_for	21	SENT_136	[p8l1366t1404r1675b1484],
25	,	,	O	,	_	0	SENT_136	[p8l1366t1404r1675b1484],
26	were	VBD	O	be	auxpass	28	SENT_136	[p8l1740t1426r1927b1472],
27	also	RB	O	also	advmod	28	SENT_136	[p8l1991t1404r2144b1471],
28	measured	VBN	O	measure	dep	4	SENT_136	[p8l7t1519r383b1586],
29	after	IN	O	after	_	0	SENT_136	[p8l416t1519r595b1586],
30	a	DT	O	a	det	33	SENT_136	[p8l626t1541r666b1586],
31	single	JJ	O	single	amod	33	SENT_136	[p8l700t1519r930b1606],
32	oral	JJ	O	oral	amod	33	SENT_136	[p8l963t1519r1113b1586],
33	dose	NN	O	dose	prep_after	28	SENT_136	[p8l1146t1519r1321b1586],
34	of	IN	O	of	_	0	SENT_136	[p8l1355t1519r1439b1586],
35	1	CD	NUMBER	1	num	36	SENT_136	[p8l1473t1520r1501b1585],
36	mg	NN	O	mg	prep_of	33	SENT_136	[p8l1537t1541r1658b1606],
37	glimepiride	NN	O	glimepiride	nn	39	SENT_136	[p8l1692t1519r2145b1606],
38	(	CD	NUMBER	(	num	39	SENT_136	[p8l10t1633r255b1715],
39	Table	NNP	O	Table	dep	36	SENT_136	[p8l10t1633r255b1715],
40	1	CD	NUMBER	1	number	41	SENT_136	[p8l291t1633r381b1715],
41	)	CD	NUMBER	)	dep	39	SENT_136	[p8l291t1633r381b1715],
42	.	.	O	.	_	0	SENT_136	[p8l291t1633r381b1715],

1	HbA1C	NN	O	hba1c	nsubjpass	7	SENT_137	[p8l412t1633r668b1715],
2	of	IN	O	of	_	0	SENT_137	[p8l696t1633r780b1700],
3	case	NN	O	case	prep_of	1	SENT_137	[p8l802t1654r967b1700],
4	#	#	MONEY	#	number	5	SENT_137	[p8l993t1633r1081b1699],
5	1	CD	MONEY	1	amod	3	SENT_137	[p8l993t1633r1081b1699],
6	was	VBD	O	be	auxpass	7	SENT_137	[p8l1116t1654r1263b1700],
7	decreased	VBN	O	decrease	_	0	SENT_137	[p8l1292t1633r1679b1700],
8	from	IN	O	from	_	0	SENT_137	[p8l1705t1633r1894b1700],
9	9	CD	PERCENT	9	number	13	SENT_137	[p8l1920t1633r2042b1700],
10	%	NN	PERCENT	%	dep	13	SENT_137	[p8l1920t1633r2042b1700],
11	to	TO	O	to	dep	13	SENT_137	[p8l2072t1643r2145b1700],
12	8.4	CD	PERCENT	8.4	number	13	SENT_137	[p8l11t1748r204b1815],
13	%	NN	PERCENT	%	prep_from	7	SENT_137	[p8l11t1748r204b1815],
14	within	IN	O	within	_	0	SENT_137	[p8l265t1747r515b1815],
15	2	CD	DURATION	2	num	16	SENT_137	[p8l572t1748r615b1814],
16	weeks	NNS	NUMBER	week	prep_within	7	SENT_137	[p8l672t1748r912b1815],
17	after	IN	O	after	advmod	19	SENT_137	[p8l972t1747r1152b1814],
18	the	DT	O	the	dep	17	SENT_137	[p8l1206t1748r1323b1814],
19	resuming	VBG	O	resume	partmod	16	SENT_137	[p8l1378t1748r1743b1835],
20	(	CD	NUMBER	(	num	21	SENT_137	[p8l1803t1748r1981b1835],
21	Fig	NN	O	fig	dobj	19	SENT_137	[p8l1803t1748r1981b1835],
22	.	.	O	.	_	0	SENT_137	[p8l1803t1748r1981b1835],

1	2	CD	NUMBER	2	num	2	SENT_138	[p8l2043t1748r2141b1830],
2	)	CD	NUMBER	)	_	0	SENT_138	[p8l2043t1748r2141b1830],
3	.	.	O	.	_	0	SENT_138	[p8l2043t1748r2141b1830],

1	Moreover	RB	O	moreover	advmod	12	SENT_139	[p8l7t1865r409b1942],
2	,	,	O	,	_	0	SENT_139	[p8l7t1865r409b1942],
3	her	PRP$	O	she	poss	4	SENT_139	[p8l496t1863r622b1930],
4	BS	NN	O	b	nsubjpass	12	SENT_139	[p8l704t1864r816b1931],
5	after	IN	O	after	_	0	SENT_139	[p8l906t1863r1086b1930],
6	a	DT	O	a	det	8	SENT_139	[p8l1170t1885r1210b1930],
7	single	JJ	O	single	amod	8	SENT_139	[p8l1296t1863r1526b1950],
8	treatment	NN	O	treatment	prep_after	4	SENT_139	[p8l1610t1873r1985b1930],
9	of	IN	O	of	_	0	SENT_139	[p8l2068t1863r2153b1930],
10	glimepiride	NN	O	glimepiride	prep_of	8	SENT_139	[p8l8t1978r462b2065],
11	was	VBD	O	be	auxpass	12	SENT_139	[p8l505t2000r652b2046],
12	decreased	VBN	O	decrease	_	0	SENT_139	[p8l699t1978r1086b2045],
13	from	IN	O	from	_	0	SENT_139	[p8l1130t1978r1319b2045],
14	168	CD	NUMBER	168	num	15	SENT_139	[p8l1372t1978r1503b2046],
15	mg/dl	NN	O	mg/dl	prep_from	12	SENT_139	[p8l1534t1978r1762b2065],
16	(	CD	NUMBER	(	number	17	SENT_139	[p8l1810t1978r1930b2061],
17	45	CD	DURATION	45	num	18	SENT_139	[p8l1810t1978r1930b2061],
18	min	NN	DURATION	min	dep	15	SENT_139	[p8l1962t1978r2143b2061],
19	)	CD	NUMBER	)	number	21	SENT_139	[p8l1962t1978r2143b2061],
20	to	TO	O	to	dep	21	SENT_139	[p8l7t2103r80b2160],
21	114	CD	NUMBER	114	num	26	SENT_139	[p8l147t2094r282b2159],
22	mg/dl	NN	O	mg/dl	nn	26	SENT_139	[p8l310t2093r537b2180],
23	(	NN	O	(	nn	26	SENT_139	[p8l598t2094r673b2176],
24	2	CD	NUMBER	2	num	26	SENT_139	[p8l598t2094r673b2176],
25	h	NN	O	h	nn	26	SENT_139	[p8l701t2093r802b2176],
26	)	NN	O	)	dep	18	SENT_139	[p8l701t2093r802b2176],
27	,	,	O	,	_	0	SENT_139	[p8l701t2093r802b2176],
28	whereas	IN	O	whereas	mark	36	SENT_139	[p8l863t2093r1181b2160],
29	mean	NN	O	mean	nn	31	SENT_139	[p8l1240t2115r1451b2160],
30	BS	NN	O	b	nn	31	SENT_139	[p8l1508t2094r1620b2161],
31	levels	NNS	O	level	nsubj	36	SENT_139	[p8l1681t2093r1905b2160],
32	of	IN	O	of	_	0	SENT_139	[p8l1966t2093r2050b2160],
33	4	CD	NUMBER	4	num	35	SENT_139	[p8l2100t2094r2145b2159],
34	control	NN	O	control	nn	35	SENT_139	[p8l8t2208r284b2275],
35	patients	NNS	O	patient	prep_of	31	SENT_139	[p8l328t2208r633b2295],
36	(	VBP	O	(	advcl	12	SENT_139	[p8l682t2208r1308b2291],
37	CYP2C9	NN	O	cyp2c9	nn	38	SENT_139	[p8l682t2208r1308b2291],
38	*	NN	O	*	dobj	36	SENT_139	[p8l682t2208r1308b2291],
39	1	CD	NUMBER	1	num	38	SENT_139	[p8l682t2208r1308b2291],
40	/	:	O	/	punct	45	SENT_139	[p8l682t2208r1308b2291],
41	*	CD	NUMBER	*	number	42	SENT_139	[p8l682t2208r1308b2291],
42	1	CD	NUMBER	1	num	43	SENT_139	[p8l682t2208r1308b2291],
43	)	NN	O	)	nsubjpass	45	SENT_139	[p8l682t2208r1308b2291],
44	were	VBD	O	be	auxpass	45	SENT_139	[p8l1356t2229r1542b2275],
45	changed	VBN	O	change	parataxis	36	SENT_139	[p8l1588t2208r1914b2295],
46	from	IN	O	from	_	0	SENT_139	[p8l1958t2208r2146b2275],
47	203.3	CD	NUMBER	203.3	num	48	SENT_139	[p8l8t2324r221b2391],
48	mg/dl	NN	O	mg/dl	prep_from	45	SENT_139	[p8l253t2323r480b2410],
49	(	CD	NUMBER	(	number	50	SENT_139	[p8l511t2323r631b2406],
50	45	CD	DURATION	45	num	51	SENT_139	[p8l511t2323r631b2406],
51	min	NN	DURATION	min	dep	48	SENT_139	[p8l663t2323r845b2406],
52	)	CD	NUMBER	)	number	54	SENT_139	[p8l663t2323r845b2406],
53	to	TO	O	to	dep	54	SENT_139	[p8l874t2333r947b2390],
54	217.8	CD	NUMBER	217.8	num	58	SENT_139	[p8l976t2324r1190b2391],
55	mg/dl	NN	O	mg/dl	nn	58	SENT_139	[p8l1221t2323r1449b2410],
56	(	NN	O	(	nn	58	SENT_139	[p8l1480t2324r1554b2406],
57	2	CD	NUMBER	2	num	58	SENT_139	[p8l1480t2324r1554b2406],
58	h	NN	O	h	dep	51	SENT_139	[p8l1582t2323r1659b2407],
59	)	RB	O	)	advmod	45	SENT_139	[p8l1582t2323r1659b2407],
60	as	IN	O	as	mark	61	SENT_139	[p8l1691t2345r1766b2390],
61	shown	VBN	O	show	advcl	36	SENT_139	[p8l1798t2323r2046b2391],
62	in	IN	O	in	_	0	SENT_139	[p8l2072t2323r2146b2390],
63	Table	NNP	O	Table	prep_in	61	SENT_139	[p8l7t2438r222b2505],
64	1	CD	NUMBER	1	num	63	SENT_139	[p8l271t2439r327b2506],
65	.	.	O	.	_	0	SENT_139	[p8l271t2439r327b2506],

1	Therefore	RB	O	therefore	advmod	4	SENT_140	[p8l370t2438r779b2517],
2	,	,	O	,	_	0	SENT_140	[p8l370t2438r779b2517],
3	we	PRP	O	we	nsubj	4	SENT_140	[p8l821t2460r931b2506],
4	considered	VBD	O	consider	_	0	SENT_140	[p8l970t2438r1397b2505],
5	case	NN	O	case	nsubj	8	SENT_140	[p8l1435t2460r1600b2505],
6	#	#	MONEY	#	number	7	SENT_140	[p8l1638t2439r1726b2504],
7	1	CD	MONEY	1	amod	5	SENT_140	[p8l1638t2439r1726b2504],
8	showed	VBD	O	show	ccomp	4	SENT_140	[p8l1775t2438r2068b2506],
9	a	DT	O	a	dobj	8	SENT_140	[p8l2108t2460r2147b2506],

1	K.	NNP	PERSON	K.	nn	2	SENT_141	[p8l332t2593r359b2616],
2	Suzuki	NNP	PERSON	Suzuki	_	0	SENT_141	[p8l374t2592r460b2618],
3	et	FW	O	et	nn	4	SENT_141	[p8l472t2597r496b2616],
4	al.	FW	O	al.	dep	2	SENT_141	[p8l506t2592r678b2616],
5	/	:	O	/	punct	2	SENT_141	[p8l506t2592r678b2616],
6	Diabetes	NNP	ORGANIZATION	Diabetes	dep	2	SENT_141	[p8l506t2592r678b2616],
7	Research	NNP	ORGANIZATION	Research	dep	6	SENT_141	[p8l689t2592r811b2616],
8	and	CC	ORGANIZATION	and	_	0	SENT_141	[p8l823t2592r874b2616],
9	Clinical	JJ	ORGANIZATION	clinical	amod	10	SENT_141	[p8l886t2592r991b2616],
10	Practice	NN	ORGANIZATION	practice	dep	2	SENT_141	[p8l1002t2593r1114b2616],
11	72	CD	NUMBER	72	number	12	SENT_141	[p8l1128t2592r1158b2616],
12	(	CD	NUMBER	(	num	13	SENT_141	[p8l1171t2592r1257b2621],
13	2006	CD	DATE	2006	dep	10	SENT_141	[p8l1171t2592r1257b2621],
14	)	CD	NUMBER	)	num	15	SENT_141	[p8l1171t2592r1257b2621],
15	148-154 151	CD	NUMBER	148-154 151	dep	10	SENT_141	[p8l1784t2592r1827b2616],[p8l1271t2592r1385b2615],

1	Table	NNP	O	Table	_	0	SENT_142	[p8l7t2732r176b2786],
2	1	CD	NUMBER	1	num	1	SENT_142	[p8l211t2732r234b2786],
3	Body	NN	O	body	nn	5	SENT_142	[p8l7t2828r172b2898],
4	mass	NN	O	mass	nn	5	SENT_142	[p8l191t2845r343b2882],
5	index	NN	O	index	dep	1	SENT_142	[p8l363t2828r549b2892],
6	,	,	O	,	_	0	SENT_142	[p8l363t2828r549b2892],
7	blood	NN	O	blood	nn	8	SENT_142	[p8l570t2828r746b2882],
8	glucose	NN	O	glucose	appos	5	SENT_142	[p8l766t2828r1016b2898],
9	,	,	O	,	_	0	SENT_142	[p8l766t2828r1016b2898],
10	and	CC	O	and	_	0	SENT_142	[p8l1039t2828r1148b2882],
11	plasma	NN	O	plasma	nn	13	SENT_142	[p8l1166t2828r1385b2898],
12	insulin	NN	O	insulin	nn	13	SENT_142	[p8l1404t2828r1612b2882],
13	levels	NNS	O	level	conj_and	1	SENT_142	[p8l1632t2828r1806b2882],
14	in	IN	O	in	_	0	SENT_142	[p8l1827t2828r1885b2882],
15	subjects	NNS	O	subject	prep_in	13	SENT_142	[p8l1908t2828r2151b2898],
16	with	IN	O	with	_	0	SENT_142	[p8l7t2924r143b2978],
17	CYP2C9	NN	O	cyp2c9	nn	18	SENT_142	[p8l175t2924r610b2979],
18	*	NN	O	*	prep_with	15	SENT_142	[p8l175t2924r610b2979],
19	1	CD	NUMBER	1	num	18	SENT_142	[p8l175t2924r610b2979],
20	/	:	O	/	punct	22	SENT_142	[p8l175t2924r610b2979],
21	*	CD	NUMBER	*	num	22	SENT_142	[p8l175t2924r610b2979],
22	1	CD	NUMBER	1	dep	15	SENT_142	[p8l175t2924r610b2979],
23	and	CC	O	and	_	0	SENT_142	[p8l645t2924r754b2978],
24	CYP2C9	CD	NUMBER	cyp2c9	num	25	SENT_142	[p8l784t2924r1224b2979],
25	*	NN	O	*	dep	15	SENT_142	[p8l784t2924r1224b2979],
26	1	CD	NUMBER	1	dep	22	SENT_142	[p8l784t2924r1224b2979],
27	/	:	O	/	punct	22	SENT_142	[p8l784t2924r1224b2979],
28	*	CD	NUMBER	*	number	29	SENT_142	[p8l784t2924r1224b2979],
29	3	CD	NUMBER	3	num	30	SENT_142	[p8l784t2924r1224b2979],
30	genotypes	NNS	O	genotype	dep	1	SENT_142	[p8l1255t2932r1564b2994],
31	after	IN	O	after	_	0	SENT_142	[p8l1595t2924r1735b2978],
32	a	DT	O	a	det	35	SENT_142	[p8l1763t2941r1795b2978],
33	single	JJ	O	single	amod	35	SENT_142	[p8l1825t2924r2005b2994],
34	oral	JJ	O	oral	amod	35	SENT_142	[p8l2034t2924r2152b2978],
35	dose	NN	O	dose	prep_after	30	SENT_142	[p8l8t3020r146b3074],
36	of	IN	O	of	_	0	SENT_142	[p8l175t3020r242b3074],
37	1	CD	NUMBER	1	num	38	SENT_142	[p8l272t3020r294b3074],
38	mg	NN	O	mg	prep_of	35	SENT_142	[p8l322t3037r419b3090],
39	of	IN	O	of	_	0	SENT_142	[p8l447t3020r514b3074],
40	glimepiride	NN	O	glimepiride	prep_of	38	SENT_142	[p8l538t3020r893b3090],

1	Parameters	NNS	O	parameter	nsubj	2	SENT_143	[p8l7t3205r347b3258],
2	CYP2C9	VBP	O	cyp2c9	_	0	SENT_143	[p8l739t3204r1103b3259],
3	*	NN	O	*	dobj	2	SENT_143	[p8l739t3204r1103b3259],
4	1	CD	NUMBER	1	num	3	SENT_143	[p8l739t3204r1103b3259],
5	/	:	O	/	punct	7	SENT_143	[p8l739t3204r1103b3259],
6	*	CD	NUMBER	*	number	7	SENT_143	[p8l1113t3204r1173b3257],
7	1	CD	NUMBER	1	dep	3	SENT_143	[p8l1113t3204r1173b3257],
8	C	NN	O	c	prep	7	SENT_143	[p8l1413t3205r1462b3259],
9	YP2C9	NN	O	yp2c9	nn	10	SENT_143	[p8l1466t3204r1679b3258],
10	*	NN	O	*	dep	8	SENT_143	[p8l1689t3204r1778b3258],
11	1	CD	NUMBER	1	num	10	SENT_143	[p8l1689t3204r1778b3258],
12	/	:	O	/	punct	7	SENT_143	[p8l1689t3204r1778b3258],
13	*	CD	NUMBER	*	num	14	SENT_143	[p8l1787t3204r1853b3258],
14	3	CD	NUMBER	3	dep	3	SENT_143	[p8l1787t3204r1853b3258],

1	(	NN	O	(	nn	2	SENT_144	[p8l737t3302r796b3367],
2	I1	NN	O	i1	_	0	SENT_144	[p8l737t3302r796b3367],
3	=	JJ	O	=	quantmod	5	SENT_144	[p8l819t3324r859b3345],
4	4	CD	NUMBER	4	number	5	SENT_144	[p8l881t3301r941b3367],
5	)	CD	NUMBER	)	num	10	SENT_144	[p8l881t3301r941b3367],
6	T	NN	O	t	nn	10	SENT_144	[p8l1408t3355r2153b3360],
7	Case	NN	O	case	nn	10	SENT_144	[p8l1410t3397r1557b3451],
8	#	#	MONEY	#	number	9	SENT_144	[p8l1584t3397r1654b3450],
9	1	CD	MONEY	1	amod	10	SENT_144	[p8l1584t3397r1654b3450],
10	Case	NN	O	case	dep	2	SENT_144	[p8l1901t3397r2048b3451],
11	#	#	MONEY	#	number	13	SENT_144	[p8l2076t3397r2152b3450],
12	2	CD	MONEY	2	number	13	SENT_144	[p8l2076t3397r2152b3450],
13	(	CD	MONEY	(	num	18	SENT_144	[p8l1412t3493r1668b3559],
14	female	JJ	O	female	amod	18	SENT_144	[p8l1412t3493r1668b3559],
15	)	JJ	O	)	amod	18	SENT_144	[p8l1412t3493r1668b3559],
16	(	NN	O	(	nn	18	SENT_144	[p8l1903t3493r2099b3559],
17	male	JJ	O	male	amod	18	SENT_144	[p8l1903t3493r2099b3559],
18	)	NN	O	)	dep	10	SENT_144	[p8l1903t3493r2099b3559],

1	Age	NNP	O	Age	nn	3	SENT_145	[p8l7t3670r133b3739],
2	(	CD	NUMBER	(	num	3	SENT_145	[p8l163t3670r372b3739],
3	years	NNS	NUMBER	year	nsubj	4	SENT_145	[p8l163t3670r372b3739],
4	)	VBP	O	)	_	0	SENT_145	[p8l163t3670r372b3739],
5	66	CD	NUMBER	66	number	6	SENT_145	[p8l736t3669r809b3724],
6	(	CD	NUMBER	(	dobj	4	SENT_145	[p8l840t3669r1079b3736],
7	56-82	CD	NUMBER	56-82	num	8	SENT_145	[p8l840t3669r1079b3736],
8	)	NN	O	)	dep	6	SENT_145	[p8l840t3669r1079b3736],
9	56	CD	NUMBER	56	number	10	SENT_145	[p8l1449t3669r1522b3724],
10	66	CD	NUMBER	66	amod	6	SENT_145	[p8l1941t3669r2013b3724],

1	HbA1C	NN	O	hba1c	dep	15	SENT_146	[p9l7t20r209b86],
2	(	CD	PERCENT	(	num	3	SENT_146	[p9l239t21r349b86],
3	%	NN	PERCENT	%	dep	1	SENT_146	[p9l239t21r349b86],
4	)	CD	NUMBER	)	number	5	SENT_146	[p9l239t21r349b86],
5	7.1	CD	NUMBER	7.1	num	3	SENT_146	[p9l813t21r900b74],
6	i	FW	O	i	dep	3	SENT_146	[p9l931t22r983b73],
7	0.8	CD	NUMBER	0.8	number	8	SENT_146	[p9l1007t21r1098b74],
8	8.4	CD	NUMBER	8.4	amod	11	SENT_146	[p9l1490t21r1580b74],
9	6	CD	NUMBER	6	number	10	SENT_146	[p9l1979t20r2013b74],
10	6	CD	NUMBER	6	amod	11	SENT_146	[p9l2037t20r2072b74],
11	BMI	NN	O	bmus	dep	6	SENT_146	[p9l7t117r151b169],
12	(	CD	NUMBER	(	num	13	SENT_146	[p9l181t99r414b186],
13	kg/m2	NN	O	kg/m2	dep	15	SENT_146	[p9l181t99r414b186],
14	)	CD	NUMBER	)	num	15	SENT_146	[p9l181t99r414b186],
15	22.6	CD	NUMBER	22.6	dep	20	SENT_146	[p9l775t115r906b170],
16	i	FW	O	i	dep	15	SENT_146	[p9l931t117r982b169],
17	4.4	CD	NUMBER	4.4	number	18	SENT_146	[p9l1006t116r1100b170],
18	23.1	CD	NUMBER	23.1	dep	16	SENT_146	[p9l1449t116r1574b170],
19	25.7	CD	NUMBER	25.7	num	20	SENT_146	[p9l1941t115r2070b170],
20	BS	NN	O	b	_	0	SENT_146	[p9l7t220r96b274],
21	(	CD	NUMBER	(	num	23	SENT_146	[p9l129t220r356b290],
22	mg/dl	NN	O	mg/dl	nn	23	SENT_146	[p9l129t220r356b290],
23	)	NN	O	)	dep	20	SENT_146	[p9l129t220r356b290],

1	Pre-treatment	NN	O	pre-treatment	_	0	SENT_147	[p9l84t317r505b370],
2	141.0	CD	NUMBER	141.0	number	3	SENT_147	[p9l742t316r907b370],
3	:1	CD	NUMBER	:1	dep	1	SENT_147	[p9l931t317r983b370],
4	:	:	O	:	_	0	SENT_147	[p9l931t317r983b370],
5	22.5	CD	NUMBER	22.5	number	6	SENT_147	[p9l1008t316r1136b370],
6	126	CD	NUMBER	126	num	8	SENT_147	[p9l1417t316r1522b370],
7	272	CD	NUMBER	272	number	8	SENT_147	[p9l1902t316r2014b370],
8	0.75	CD	NUMBER	0.75	dep	3	SENT_147	[p9l85t412r215b467],
9	h	NN	O	h	dep	8	SENT_147	[p9l238t412r275b466],
10	203.3	CD	NUMBER	203.3	num	9	SENT_147	[p9l736t413r903b467],
11	:	:	O	:	_	0	SENT_147	[p9l931t413r983b466],
12	|	CD	NUMBER	|	dep	8	SENT_147	[p9l931t413r983b466],
13	:	:	O	:	_	0	SENT_147	[p9l931t413r983b466],
14	47.8	CD	NUMBER	47.8	number	15	SENT_147	[p9l1006t412r1137b467],
15	168	CD	NUMBER	168	dep	12	SENT_147	[p9l1417t412r1521b467],
16	286	CD	NUMBER	286	dep	20	SENT_147	[p9l1902t412r2013b467],
17	2	CD	NUMBER	2	dep	16	SENT_147	[p9l85t508r120b561],
18	h	NN	O	h	dep	20	SENT_147	[p9l142t508r180b561],
19	217.8	CD	NUMBER	217.8	num	18	SENT_147	[p9l736t508r904b562],
20	i	FW	O	i	dep	12	SENT_147	[p9l931t509r982b561],
21	35.3	CD	NUMBER	35.3	number	22	SENT_147	[p9l1009t508r1136b562],
22	114	CD	NUMBER	114	num	24	SENT_147	[p9l1417t508r1523b561],
23	226	CD	NUMBER	226	number	24	SENT_147	[p9l1902t508r2013b562],
24	8	CD	NUMBER	8	dep	20	SENT_147	[p9l87t604r118b658],
25	h	NN	O	h	dep	24	SENT_147	[p9l142t604r179b658],
26	198.8	CD	NUMBER	198.8	num	28	SENT_147	[p9l742t604r904b659],
27	:	:	O	:	_	0	SENT_147	[p9l931t605r983b658],
28	|	CD	NUMBER	|	dep	12	SENT_147	[p9l931t605r983b658],
29	:	:	O	:	_	0	SENT_147	[p9l931t605r983b658],
30	93.8	CD	NUMBER	93.8	number	31	SENT_147	[p9l1008t604r1137b659],
31	117	CD	NUMBER	117	dep	8	SENT_147	[p9l1417t604r1521b658],
32	210	CD	NUMBER	210	dep	31	SENT_147	[p9l1902t604r2014b658],

1	IRI	NNP	O	IRI	_	0	SENT_148	[p9l7t750r108b801],
2	(	CD	NUMBER	(	num	4	SENT_148	[p9l138t749r403b815],
3	mU/ml	NN	O	mu/ml	nn	4	SENT_148	[p9l138t749r403b815],
4	)	NN	O	)	dep	1	SENT_148	[p9l138t749r403b815],

1	Pre-treatment	NN	O	pre-treatment	_	0	SENT_149	[p9l84t845r506b898],
2	9.2	CD	NUMBER	9.2	num	1	SENT_149	[p9l813t844r906b898],
3	:	:	O	:	_	0	SENT_149	[p9l931t845r983b897],
4	I	CD	NUMBER	i	dep	1	SENT_149	[p9l931t845r983b897],
5	:	:	O	:	_	0	SENT_149	[p9l931t845r983b897],
6	4.9	CD	NUMBER	4.9	number	7	SENT_149	[p9l1006t844r1099b898],
7	3.2	CD	NUMBER	3.2	dep	4	SENT_149	[p9l1489t844r1580b898],
8	65.7	CD	NUMBER	65.7	dep	12	SENT_149	[p9l1941t843r2070b898],
9	0.75	CD	NUMBER	0.75	dep	8	SENT_149	[p9l85t939r214b994],
10	h	NN	O	h	dep	12	SENT_149	[p9l238t940r275b993],
11	12.5	CD	NUMBER	12.5	num	10	SENT_149	[p9l781t939r903b994],
12	i	FW	O	i	dep	4	SENT_149	[p9l931t941r982b993],
13	4.5	CD	NUMBER	4.5	number	14	SENT_149	[p9l1006t939r1098b994],
14	6.1	CD	NUMBER	6.1	num	16	SENT_149	[p9l1488t939r1574b994],
15	76.9	CD	NUMBER	76.9	number	16	SENT_149	[p9l1940t939r2071b995],
16	2	CD	NUMBER	2	dep	12	SENT_149	[p9l86t1037r120b1090],
17	h	NN	O	h	dep	16	SENT_149	[p9l142t1037r179b1090],
18	19.1	CD	NUMBER	19.1	num	17	SENT_149	[p9l781t1037r900b1092],
19	:	:	O	:	_	0	SENT_149	[p9l931t1038r982b1090],
20	|	CD	NUMBER	|	num	22	SENT_149	[p9l931t1038r982b1090],
21	:	:	O	:	_	0	SENT_149	[p9l931t1038r982b1090],
22	9.0	CD	NUMBER	9.0	dep	16	SENT_149	[p9l1008t1037r1101b1092],
23	3.7	CD	NUMBER	3.7	number	24	SENT_149	[p9l1489t1037r1579b1091],
24	42.9	CD	NUMBER	42.9	dep	22	SENT_149	[p9l1939t1037r2071b1092],
25	8h	NN	O	8h	dep	24	SENT_149	[p9l87t1132r180b1186],
26	14.8	CD	NUMBER	14.8	num	25	SENT_149	[p9l781t1132r982b1186],
27	:	:	O	:	_	0	SENT_149	[p9l781t1132r982b1186],
28	t	NN	O	t	dep	16	SENT_149	[p9l781t1132r982b1186],
29	11.0	CD	NUMBER	11.0	num	28	SENT_149	[p9l1014t1132r1140b1186],
30	1.8	CD	NUMBER	1.8	number	31	SENT_149	[p9l1494t1132r1578b1186],
31	31.7	CD	NUMBER	31.7	dep	28	SENT_149	[p9l1942t1132r2070b1186],

1	Data	NNS	O	datum	nsubjpass	3	SENT_150	[p9l7t1315r153b1368],
2	are	VBP	O	be	auxpass	3	SENT_150	[p9l175t1331r266b1368],
3	represented	VBN	O	represent	_	0	SENT_150	[p9l288t1314r645b1384],
4	as	IN	O	as	_	0	SENT_150	[p9l667t1331r726b1368],
5	the	DT	O	the	det	6	SENT_150	[p9l750t1314r843b1368],
6	mean	NN	O	mean	prep_as	3	SENT_150	[p9l866t1331r1032b1368],
7	:	:	O	:	_	0	SENT_150	[p9l1056t1315r1108b1368],
8	I	PRP	O	I	dep	6	SENT_150	[p9l1056t1315r1108b1368],
9	:	:	O	:	_	0	SENT_150	[p9l1056t1315r1108b1368],
10	S.D.	NNP	LOCATION	S.D.	nn	11	SENT_150	[p9l1134t1314r1262b1369],
11	BMI	NNP	O	BMI	dep	6	SENT_150	[p9l1289t1315r1448b1368],
12	:	:	O	:	_	0	SENT_150	[p9l1289t1315r1448b1368],
13	body	NN	O	body	nn	15	SENT_150	[p9l1475t1314r1628b1384],
14	mass	NN	O	mass	nn	15	SENT_150	[p9l1650t1331r1801b1368],
15	index	NN	O	index	dep	6	SENT_150	[p9l1826t1314r2013b1378],
16	;	:	O	;	_	0	SENT_150	[p9l1826t1314r2013b1378],
17	BS	NNP	O	BS	dep	6	SENT_150	[p9l2039t1315r2147b1369],
18	:	:	O	:	_	0	SENT_150	[p9l2039t1315r2147b1369],
19	blood	NN	O	blood	nn	21	SENT_150	[p9l6t1410r182b1464],
20	glucose	NN	O	glucose	nn	21	SENT_150	[p9l210t1410r443b1480],
21	level	NN	O	level	dep	6	SENT_150	[p9l471t1410r636b1474],
22	;	:	O	;	_	0	SENT_150	[p9l471t1410r636b1474],
23	IRI	NNP	O	IRI	dep	6	SENT_150	[p9l667t1411r784b1464],
24	:	:	O	:	_	0	SENT_150	[p9l667t1411r784b1464],
25	immunoreactive	JJ	O	immunoreactive	amod	26	SENT_150	[p9l817t1410r1317b1464],
26	insulin	NN	O	insulin	dep	6	SENT_150	[p9l1345t1410r1569b1464],
27	.	.	O	.	_	0	SENT_150	[p9l1345t1410r1569b1464],

1	very	RB	O	very	advmod	2	SENT_151	[p9l7t1677r175b1742],
2	rapid	JJ	O	rapid	amod	3	SENT_151	[p9l215t1655r413b1742],
3	improvement	NN	O	improvement	nsubj	12	SENT_151	[p9l453t1655r964b1742],
4	in	IN	O	in	_	0	SENT_151	[p9l1003t1655r1077b1722],
5	glycemic	JJ	O	glycemic	amod	6	SENT_151	[p9l1118t1655r1467b1742],
6	control	NN	O	control	prep_in	3	SENT_151	[p9l1511t1655r1779b1722],
7	within	IN	O	within	_	0	SENT_151	[p9l1822t1655r2065b1723],
8	2	CD	DURATION	2	num	9	SENT_151	[p9l2107t1656r2151b1722],
9	weeks	NNS	NUMBER	week	prep_within	6	SENT_151	[p9l8t1770r244b1837],
10	after	IN	O	after	_	0	SENT_151	[p9l285t1770r458b1837],
11	she	PRP	O	she	prep_after	9	SENT_151	[p9l500t1770r620b1837],
12	resumed	VBD	O	resume	_	0	SENT_151	[p9l659t1770r984b1837],
13	glimepiride	NN	O	glimepiride	nn	14	SENT_151	[p9l1023t1770r1462b1857],
14	treatment	NN	O	treatment	dobj	12	SENT_151	[p9l1501t1780r1881b1837],
15	.	.	O	.	_	0	SENT_151	[p9l1501t1780r1881b1837],

1	These	DT	O	these	det	2	SENT_152	[p9l1925t1770r2151b1837],
2	results	NNS	O	result	nsubj	3	SENT_152	[p9l6t1885r253b1952],
3	suggested	VBD	O	suggest	_	0	SENT_152	[p9l299t1885r673b1972],
4	that	IN	O	that	complm	16	SENT_152	[p9l712t1885r855b1952],
5	the	DT	O	the	det	6	SENT_152	[p9l895t1885r1010b1952],
6	case	NN	O	case	nsubj	16	SENT_152	[p9l1052t1906r1214b1952],
7	#	#	MONEY	#	number	8	SENT_152	[p9l1255t1885r1341b1951],
8	1	CD	MONEY	1	num	6	SENT_152	[p9l1255t1885r1341b1951],
9	with	IN	O	with	prep	6	SENT_152	[p9l1391t1885r1559b1952],
10	CYP2C9	NN	O	cyp2c9	dep	9	SENT_152	[p9l1605t1885r2150b1952],
11	*	CD	NUMBER	*	num	10	SENT_152	[p9l1605t1885r2150b1952],
12	I	PRP	O	I	dep	10	SENT_152	[p9l1605t1885r2150b1952],
13	/	:	O	/	punct	10	SENT_152	[p9l1605t1885r2150b1952],
14	*	CD	NUMBER	*	dep	10	SENT_152	[p9l1605t1885r2150b1952],
15	3	CD	NUMBER	3	dep	14	SENT_152	[p9l1605t1885r2150b1952],
16	showed	VBD	O	show	ccomp	3	SENT_152	[p9l11t2000r296b2068],
17	stronger	JJR	O	stronger	amod	19	SENT_152	[p9l329t2010r639b2087],
18	pharmacological	JJ	O	pharmacological	amod	19	SENT_152	[p9l665t2000r1304b2087],
19	effect	NN	O	effect	dobj	16	SENT_152	[p9l1336t2000r1551b2067],
20	of	IN	O	of	_	0	SENT_152	[p9l1581t2000r1664b2067],
21	glimepiride	NN	O	glimepiride	prep_of	19	SENT_152	[p9l1689t2000r2147b2087],
22	.	.	O	.	_	0	SENT_152	[p9l1689t2000r2147b2087],

1	The	DT	O	the	det	4	SENT_153	[p9l123t2115r271b2182],
2	time	NN	O	time	nn	4	SENT_153	[p9l320t2115r490b2182],
3	course	NN	O	course	nn	4	SENT_153	[p9l540t2137r788b2182],
4	change	NN	O	change	nsubjpass	28	SENT_153	[p9l838t2115r1108b2202],
5	of	IN	O	of	_	0	SENT_153	[p9l1159t2115r1242b2182],
6	HbA1C	NN	O	hba1c	nn	7	SENT_153	[p9l1284t2115r1537b2198],
7	values	NNS	O	value	prep_of	4	SENT_153	[p9l1586t2115r1827b2183],
8	for	IN	O	for	_	0	SENT_153	[p9l1877t2115r1989b2182],
9	the	DT	O	the	det	12	SENT_153	[p9l2035t2115r2151b2182],
10	obese	JJ	O	obese	amod	12	SENT_153	[p9l8t2230r224b2297],
11	male	JJ	O	male	amod	12	SENT_153	[p9l270t2230r456b2297],
12	patient	NN	O	patient	prep_for	7	SENT_153	[p9l500t2230r764b2317],
13	with	IN	O	with	_	0	SENT_153	[p9l808t2230r978b2297],
14	the	DT	O	the	det	16	SENT_153	[p9l1022t2230r1137b2297],
15	CYP2C9	NN	O	cyp2c9	nn	16	SENT_153	[p9l1187t2230r1645b2297],
16	*	NN	O	*	prep_with	12	SENT_153	[p9l1187t2230r1645b2297],
17	1	CD	NUMBER	1	dep	16	SENT_153	[p9l1187t2230r1645b2297],
18	/	:	O	/	punct	25	SENT_153	[p9l1187t2230r1645b2297],
19	*	CD	NUMBER	*	number	20	SENT_153	[p9l1657t2230r1738b2296],
20	3	CD	NUMBER	3	num	22	SENT_153	[p9l1657t2230r1738b2296],
21	(	NN	O	(	nn	22	SENT_153	[p9l1787t2231r1980b2313],
22	case	NN	O	case	dep	25	SENT_153	[p9l1787t2231r1980b2313],
23	#	#	MONEY	#	number	24	SENT_153	[p9l2024t2230r2148b2313],
24	2	CD	MONEY	2	amod	22	SENT_153	[p9l2024t2230r2148b2313],
25	)	NN	O	)	dep	4	SENT_153	[p9l2024t2230r2148b2313],
26	was	VBD	O	be	auxpass	28	SENT_153	[p9l8t2366r153b2413],
27	also	RB	O	also	advmod	28	SENT_153	[p9l198t2345r348b2412],
28	plotted	VBN	O	plot	_	0	SENT_153	[p9l389t2345r659b2433],
29	in	IN	O	in	_	0	SENT_153	[p9l699t2345r772b2412],
30	Fig	NN	O	fig	prep_in	28	SENT_153	[p9l812t2345r959b2433],
31	.	.	O	.	_	0	SENT_153	[p9l812t2345r959b2433],

1	2	LS	NUMBER	2	_	0	SENT_154	[p9l1006t2345r1070b2412],
2	.	.	O	.	_	0	SENT_154	[p9l1006t2345r1070b2412],

1	His	PRP$	O	he	poss	2	SENT_155	[p9l1115t2345r1245b2412],
2	HbA1C	NN	O	hba1c	nsubjpass	4	SENT_155	[p9l1287t2345r1540b2428],
3	was	VBD	O	be	auxpass	4	SENT_155	[p9l1583t2366r1728b2413],
4	decreased	VBN	O	decrease	_	0	SENT_155	[p9l1772t2345r2152b2412],
5	from	IN	O	from	_	0	SENT_155	[p9l7t2461r194b2529],
6	10.7	CD	PERCENT	10.7	num	7	SENT_155	[p9l245t2462r479b2529],
7	%	NN	PERCENT	%	prep_from	4	SENT_155	[p9l245t2462r479b2529],
8	to	TO	O	to	_	0	SENT_155	[p9l525t2472r598b2529],
9	less	JJR	O	less	mwe	10	SENT_155	[p9l641t2461r781b2529],
10	than	IN	O	than	quantmod	11	SENT_155	[p9l826t2461r991b2529],
11	6.5	CD	PERCENT	6.5	num	12	SENT_155	[p9l1035t2461r1228b2529],
12	%	NN	PERCENT	%	prep_to	7	SENT_155	[p9l1035t2461r1228b2529],
13	within	IN	O	within	_	0	SENT_155	[p9l1275t2461r1521b2529],
14	3	CD	DURATION	3	num	15	SENT_155	[p9l1565t2462r1603b2529],
15	months	NNS	NUMBER	month	prep_within	12	SENT_155	[p9l1651t2461r1931b2529],
16	after	IN	O	after	_	0	SENT_155	[p9l1978t2461r2153b2529],
17	starting	VBG	O	start	prepc_after	4	SENT_155	[p9l11t2577r294b2664],
18	the	DT	O	the	det	20	SENT_155	[p9l320t2577r435b2644],
19	glimepiride	NN	O	glimepiride	nn	20	SENT_155	[p9l460t2577r904b2664],
20	treatment	NN	O	treatment	dobj	17	SENT_155	[p9l929t2587r1313b2644],
21	.	.	O	.	_	0	SENT_155	[p9l929t2587r1313b2644],

1	This	DT	O	this	det	2	SENT_156	[p9l1342t2577r1509b2644],
2	result	NN	O	result	nsubj	3	SENT_156	[p9l1534t2577r1749b2644],
3	suggested	VBD	O	suggest	_	0	SENT_156	[p9l1775t2577r2152b2664],
4	case	NN	O	case	nsubj	7	SENT_156	[p9l7t2713r170b2759],
5	#	#	MONEY	#	number	6	SENT_156	[p9l197t2692r291b2758],
6	2	CD	MONEY	2	amod	4	SENT_156	[p9l197t2692r291b2758],
7	showed	VBD	O	show	ccomp	3	SENT_156	[p9l322t2692r610b2759],
8	good	JJ	O	good	amod	10	SENT_156	[p9l638t2692r829b2779],
9	glycemic	JJ	O	glycemic	amod	10	SENT_156	[p9l856t2692r1207b2779],
10	control	NN	O	control	dobj	7	SENT_156	[p9l1237t2692r1507b2759],
11	during	IN	O	during	_	0	SENT_156	[p9l1537t2692r1784b2779],
12	the	DT	O	the	det	14	SENT_156	[p9l1813t2692r1928b2759],
13	early	JJ	O	early	amod	14	SENT_156	[p9l1957t2692r2147b2779],
14	term	NN	O	term	prep_during	7	SENT_156	[p9l6t2818r183b2875],
15	of	IN	O	of	_	0	SENT_156	[p9l255t2808r338b2875],
16	the	DT	O	the	det	17	SENT_156	[p9l404t2808r519b2875],
17	treatment	NN	O	treatment	prep_of	14	SENT_156	[p9l592t2818r976b2875],
18	.	.	O	.	_	0	SENT_156	[p9l592t2818r976b2875],

1	However	RB	O	however	advmod	6	SENT_157	[p9l1053t2809r1418b2888],
2	,	,	O	,	_	0	SENT_157	[p9l1053t2809r1418b2888],
3	his	PRP$	O	he	poss	4	SENT_157	[p9l1493t2808r1602b2875],
4	HbA1C	NN	O	hba1c	nsubjpass	6	SENT_157	[p9l1676t2808r1928b2891],
5	was	VBD	O	be	auxpass	6	SENT_157	[p9l2001t2829r2146b2876],
6	increased	VBN	O	increase	_	0	SENT_157	[p9l6t2923r372b2990],
7	gradually	RB	O	gradually	advmod	6	SENT_157	[p9l424t2923r786b3010],
8	up	IN	O	up	quantmod	10	SENT_157	[p9l839t2945r932b3010],
9	to	TO	O	to	dep	10	SENT_157	[p9l986t2934r1057b2990],
10	7.7	CD	PERCENT	7.7	num	11	SENT_157	[p9l1111t2924r1305b2991],
11	%	NN	PERCENT	%	pobj	7	SENT_157	[p9l1111t2924r1305b2991],
12	after	IN	O	after	_	0	SENT_157	[p9l1364t2923r1539b2990],
13	18	CD	DURATION	18	num	14	SENT_157	[p9l1599t2924r1680b2991],
14	months	NNS	NUMBER	month	prep_after	6	SENT_157	[p9l1735t2923r2017b2990],
15	as	IN	O	as	mark	16	SENT_157	[p9l2072t2945r2146b2990],
16	shown	VBN	O	show	advcl	6	SENT_157	[p9l10t3038r254b3106],
17	in	IN	O	in	_	0	SENT_157	[p9l303t3038r376b3104],
18	Fig	NN	O	fig	prep_in	16	SENT_157	[p9l424t3038r569b3125],
19	.	.	O	.	_	0	SENT_157	[p9l424t3038r569b3125],

1	2	LS	NUMBER	2	_	0	SENT_158	[p9l625t3039r688b3105],
2	.	.	O	.	_	0	SENT_158	[p9l625t3039r688b3105],

1	After	IN	O	after	_	0	SENT_159	[p9l742t3038r946b3105],
2	17	CD	DURATION	17	num	3	SENT_159	[p9l1002t3039r1084b3105],
3	months	NNS	NUMBER	month	prep_after	17	SENT_159	[p9l1136t3038r1416b3105],
4	of	IN	O	of	_	0	SENT_159	[p9l1468t3038r1551b3105],
5	treatment	NN	O	treatment	prep_of	3	SENT_159	[p9l1593t3048r1979b3118],
6	,	,	O	,	_	0	SENT_159	[p9l1593t3048r1979b3118],
7	the	DT	O	the	det	8	SENT_159	[p9l2032t3038r2147b3105],
8	patient	NN	O	patient	poss	10	SENT_159	[p9l6t3153r332b3240],
9	’s	POS	O	’s	_	0	SENT_159	[p9l6t3153r332b3240],
10	BMI	NN	O	bmus	nsubjpass	17	SENT_159	[p9l356t3154r556b3232],
11	,	,	O	,	_	0	SENT_159	[p9l356t3154r556b3232],
12	BS	NN	O	b	appos	10	SENT_159	[p9l583t3153r718b3232],
13	,	,	O	,	_	0	SENT_159	[p9l583t3153r718b3232],
14	and	CC	O	and	_	0	SENT_159	[p9l748t3153r884b3220],
15	IRI	NNP	ORGANIZATION	IRI	conj_and	10	SENT_159	[p9l906t3154r1032b3219],
16	were	VBD	O	be	auxpass	17	SENT_159	[p9l1056t3174r1241b3220],
17	measured	VBN	O	measure	_	0	SENT_159	[p9l1264t3153r1634b3220],
18	after	IN	O	after	_	0	SENT_159	[p9l1659t3153r1834b3220],
19	a	DT	O	a	det	22	SENT_159	[p9l1858t3174r1897b3220],
20	single	JJ	O	single	amod	22	SENT_159	[p9l1922t3153r2147b3240],
21	oral	JJ	O	oral	amod	22	SENT_159	[p9l8t3268r154b3335],
22	dose	NN	O	dose	prep_after	17	SENT_159	[p9l196t3268r368b3335],
23	of	IN	O	of	_	0	SENT_159	[p9l410t3268r493b3335],
24	1	CD	NUMBER	1	num	25	SENT_159	[p9l535t3269r563b3335],
25	mg	NN	O	mg	prep_of	22	SENT_159	[p9l598t3290r718b3355],
26	of	IN	O	of	_	0	SENT_159	[p9l761t3268r844b3335],
27	glimepiride	NN	O	glimepiride	prep_of	25	SENT_159	[p9l878t3268r1322b3355],
28	(	CD	NUMBER	(	num	27	SENT_159	[p9l1365t3268r1642b3351],
29	shown	VBN	O	show	partmod	27	SENT_159	[p9l1365t3268r1642b3351],
30	by	IN	O	by	_	0	SENT_159	[p9l1680t3268r1775b3355],
31	arrow	NN	O	arrow	agent	29	SENT_159	[p9l1817t3290r2035b3336],
32	in	IN	O	in	_	0	SENT_159	[p9l2076t3268r2149b3335],
33	Fig	NN	O	fig	prep_in	31	SENT_159	[p9l6t3383r152b3470],
34	.	.	O	.	_	0	SENT_159	[p9l6t3383r152b3470],

1	2	CD	NUMBER	2	num	2	SENT_160	[p9l181t3384r277b3466],
2	)	CD	NUMBER	)	_	0	SENT_160	[p9l181t3384r277b3466],
3	.	.	O	.	_	0	SENT_160	[p9l181t3384r277b3466],

1	The	DT	O	the	det	2	SENT_161	[p9l305t3383r452b3450],
2	result	NN	O	result	nsubj	6	SENT_161	[p9l474t3383r690b3450],
3	of	IN	O	of	_	0	SENT_161	[p9l712t3383r796b3450],
4	these	DT	O	these	det	5	SENT_161	[p9l812t3383r1008b3450],
5	measurements	NNS	O	measurement	prep_of	2	SENT_161	[p9l1031t3393r1583b3450],
6	indicated	VBD	O	indicate	_	0	SENT_161	[p9l1607t3383r1962b3450],
7	case	NN	O	case	nsubj	10	SENT_161	[p9l1985t3405r2147b3450],
8	#	#	MONEY	#	number	9	SENT_161	[p9l6t3498r99b3564],
9	2	CD	MONEY	2	amod	7	SENT_161	[p9l6t3498r99b3564],
10	kept	VBD	O	keep	ccomp	6	SENT_161	[p9l126t3498r292b3585],
11	high	JJ	O	high	amod	13	SENT_161	[p9l316t3498r487b3585],
12	plasma	NN	O	plasma	nn	13	SENT_161	[p9l512t3498r786b3585],
13	glucose	NN	O	glucose	dobj	10	SENT_161	[p9l812t3498r1104b3585],
14	and	CC	O	and	_	0	SENT_161	[p9l1132t3498r1269b3565],
15	insulin	NN	O	insulin	nn	16	SENT_161	[p9l1294t3498r1556b3565],
16	levels	NNS	O	level	conj_and	13	SENT_161	[p9l1582t3498r1800b3565],
17	until	IN	O	until	_	0	SENT_161	[p9l1828t3498r2003b3565],
18	8	CD	NUMBER	8	num	19	SENT_161	[p9l2034t3498r2072b3565],
19	h	NN	O	h	prep_until	10	SENT_161	[p9l2102t3498r2149b3564],
20	after	IN	O	after	_	0	SENT_161	[p9l8t3614r184b3682],
21	the	DT	O	the	det	22	SENT_161	[p9l240t3614r355b3682],
22	administration	NN	O	administration	prep_after	10	SENT_161	[p9l416t3614r972b3682],
23	(	CD	NUMBER	(	num	24	SENT_161	[p9l1033t3614r1273b3697],
24	Table	NNP	O	Table	dep	22	SENT_161	[p9l1033t3614r1273b3697],
25	1	CD	NUMBER	1	number	26	SENT_161	[p9l1342t3615r1431b3697],
26	)	CD	NUMBER	)	dep	24	SENT_161	[p9l1342t3615r1431b3697],
27	,	,	O	,	_	0	SENT_161	[p9l1342t3615r1431b3697],
28	which	WDT	O	which	nsubj	29	SENT_161	[p9l1493t3614r1727b3682],
29	increased	VBD	O	increase	rcmod	22	SENT_161	[p9l1784t3614r2148b3682],

1	HbA1C	NN	O	hba1c	nn	2	SENT_162	[p10l7t23r259b106],
2	values	NNS	O	value	_	0	SENT_162	[p10l299t23r539b90],
3	up	IN	O	up	quantmod	5	SENT_162	[p10l578t44r672b110],
4	to	TO	O	to	dep	5	SENT_162	[p10l712t33r783b90],
5	7.7	CD	PERCENT	7.7	num	6	SENT_162	[p10l824t23r1017b90],
6	%	NN	PERCENT	%	dep	2	SENT_162	[p10l824t23r1017b90],
7	1	CD	DURATION	1	num	8	SENT_162	[p10l1069t23r1097b89],
8	month	NN	NUMBER	month	tmod	6	SENT_162	[p10l1144t23r1389b90],
9	after	IN	O	after	_	0	SENT_162	[p10l1429t23r1604b90],
10	the	DT	O	the	det	11	SENT_162	[p10l1641t23r1756b90],
11	measurement	NN	O	measurement	prep_after	2	SENT_162	[p10l1795t44r2145b90, p10l6t149r199b205],
12	(	RB	O	(	advmod	11	SENT_162	[p10l234t139r332b221],
13	at	IN	O	at	_	0	SENT_162	[p10l234t139r332b221],
14	the	DT	O	the	det	16	SENT_162	[p10l364t138r480b205],
15	18th	JJ	DATE	18th	amod	16	SENT_162	[p10l523t138r683b206],
16	month	NN	DATE	month	prep_at	11	SENT_162	[p10l716t138r961b205],
17	of	IN	O	of	_	0	SENT_162	[p10l995t138r1078b205],
18	glimepiride	NN	O	glimepiride	nn	20	SENT_162	[p10l1106t138r1550b225],
19	treatment	NN	O	treatment	nn	20	SENT_162	[p10l1584t139r2000b222],
20	)	NN	O	)	prep_of	16	SENT_162	[p10l1584t139r2000b222],
21	.	.	O	.	_	0	SENT_162	[p10l1584t139r2000b222],

1	He	PRP	O	he	nsubj	3	SENT_163	[p10l2039t140r2147b205],
2	also	RB	O	also	advmod	3	SENT_163	[p10l8t253r159b320],
3	gained	VBD	O	gain	_	0	SENT_163	[p10l198t253r453b340],
4	5.6	CD	NUMBER	5.6	num	5	SENT_163	[p10l491t253r606b321],
5	kg	NN	O	kg	dobj	3	SENT_163	[p10l634t253r728b340],
6	of	IN	O	of	_	0	SENT_163	[p10l767t253r850b320],
7	body	NN	O	body	nn	8	SENT_163	[p10l879t253r1070b340],
8	weight	NN	O	weight	prep_of	5	SENT_163	[p10l1108t253r1369b340],
9	over	IN	O	over	_	0	SENT_163	[p10l1406t275r1575b320],
10	an	DT	O	a	det	12	SENT_163	[p10l1612t275r1699b320],
11	17	CD	DURATION	17	num	12	SENT_163	[p10l1744t254r1826b320],
12	months	NNS	NUMBER	month	prep_over	8	SENT_163	[p10l1865t253r2146b320],
13	period	NN	O	period	tmod	3	SENT_163	[p10l6t368r252b455],
14	although	IN	O	although	mark	25	SENT_163	[p10l303t368r638b455],
15	the	DT	O	the	det	18	SENT_163	[p10l687t368r802b435],
16	body	NN	O	body	nn	18	SENT_163	[p10l850t368r1041b455],
17	weight	NN	O	weight	nn	18	SENT_163	[p10l1091t368r1353b455],
18	gains	NNS	O	gain	nsubj	25	SENT_163	[p10l1403t368r1601b455],
19	of	IN	O	of	_	0	SENT_163	[p10l1654t368r1737b435],
20	wild	JJ	O	wild	amod	24	SENT_163	[p10l1779t368r2147b455],
21	—	NN	O	—	nn	24	SENT_163	[p10l1779t368r2147b455],
22	type	NN	O	type	nn	24	SENT_163	[p10l1779t368r2147b455],
23	control	NN	O	control	nn	24	SENT_163	[p10l7t483r278b550],
24	patients	NNS	O	patient	prep_of	18	SENT_163	[p10l326t483r624b570],
25	(	VBP	O	(	advcl	3	SENT_163	[p10l678t484r1293b567],
26	CYP2C9	NN	O	cyp2c9	nn	27	SENT_163	[p10l678t484r1293b567],
27	*	NN	O	*	dep	48	SENT_163	[p10l678t484r1293b567],
28	1	CD	NUMBER	1	dep	27	SENT_163	[p10l678t484r1293b567],
29	/	:	O	/	punct	27	SENT_163	[p10l678t484r1293b567],
30	*	CD	NUMBER	*	number	31	SENT_163	[p10l678t484r1293b567],
31	1	CD	NUMBER	1	num	32	SENT_163	[p10l678t484r1293b567],
32	)	NN	O	)	dep	40	SENT_163	[p10l678t484r1293b567],
33	and	CC	O	and	_	0	SENT_163	[p10l1347t483r1483b550],
34	case	NN	O	case	dep	40	SENT_163	[p10l1532t505r1694b550],
35	#	#	MONEY	#	number	36	SENT_163	[p10l1742t484r1829b550],
36	1	CD	MONEY	1	amod	34	SENT_163	[p10l1742t484r1829b550],
37	patient	NN	O	patient	dep	40	SENT_163	[p10l1885t483r2149b570],
38	(	CD	NUMBER	(	num	37	SENT_163	[p10l9t599r625b681],
39	CYP2C9	NN	O	cyp2c9	nn	40	SENT_163	[p10l9t599r625b681],
40	*	NN	O	*	dep	44	SENT_163	[p10l9t599r625b681],
41	1	CD	NUMBER	1	dep	40	SENT_163	[p10l9t599r625b681],
42	/	:	O	/	punct	44	SENT_163	[p10l9t599r625b681],
43	*	CD	NUMBER	*	num	44	SENT_163	[p10l9t599r625b681],
44	3	CD	NUMBER	3	dep	27	SENT_163	[p10l9t599r625b681],
45	)	NN	O	)	nsubj	48	SENT_163	[p10l9t599r625b681],
46	were	VBD	O	be	cop	48	SENT_163	[p10l698t620r882b665],
47	-0.6	CD	NUMBER	-0.6	num	48	SENT_163	[p10l960t598r1145b666],
48	j	NN	O	j	dep	25	SENT_163	[p10l1178t600r1242b664],
49	:	:	O	:	_	0	SENT_163	[p10l1178t600r1242b664],
50	1.9	CD	NUMBER	1.9	num	51	SENT_163	[p10l1281t599r1388b667],
51	kg	NN	O	kg	nsubj	53	SENT_163	[p10l1416t598r1510b685],
52	(	FW	O	(	dep	51	SENT_163	[p10l1585t599r1821b681],
53	mean	VB	O	mean	parataxis	48	SENT_163	[p10l1585t599r1821b681],
54	i	FW	O	i	nn	56	SENT_163	[p10l1852t600r1917b664],
55	S.D.	FW	O	s.d.	nn	56	SENT_163	[p10l1949t599r2145b681],
56	)	NN	O	)	dobj	53	SENT_163	[p10l1949t599r2145b681],
57	and	CC	O	and	_	0	SENT_163	[p10l8t713r145b780],
58	-0.6	CD	NUMBER	-0.6	num	59	SENT_163	[p10l185t713r370b780],
59	kg	NN	O	kg	dobj	53	SENT_163	[p10l398t713r513b800],
60	,	,	O	,	_	0	SENT_163	[p10l398t713r513b800],
61	respectively	RB	O	respectively	advmod	25	SENT_163	[p10l551t713r1029b800],
62	.	.	O	.	_	0	SENT_163	[p10l551t713r1029b800],

1	These	DT	O	these	det	2	SENT_164	[p10l122t828r350b895],
2	observations	NNS	O	observation	nsubj	3	SENT_164	[p10l384t828r865b895],
3	suggest	VBP	O	suggest	_	0	SENT_164	[p10l903t838r1187b915],
4	that	IN	O	that	complm	29	SENT_164	[p10l1217t828r1362b895],
5	two	CD	NUMBER	two	num	6	SENT_164	[p10l1392t838r1533b895],
6	subjects	NNS	O	subject	nsubj	29	SENT_164	[p10l1570t828r1874b915],
7	with	IN	O	with	_	0	SENT_164	[p10l1907t828r2076b895],
8	a	DT	O	a	det	10	SENT_164	[p10l2110t849r2149b895],
9	CYP2C9	NN	O	cyp2c9	nn	10	SENT_164	[p10l12t943r561b1010],
10	*	NN	O	*	prep_with	6	SENT_164	[p10l12t943r561b1010],
11	1	CD	NUMBER	1	dep	10	SENT_164	[p10l12t943r561b1010],
12	/	:	O	/	punct	10	SENT_164	[p10l12t943r561b1010],
13	*	CD	NUMBER	*	num	14	SENT_164	[p10l12t943r561b1010],
14	3	CD	NUMBER	3	dep	10	SENT_164	[p10l12t943r561b1010],
15	respond	NN	O	respond	rcmod	14	SENT_164	[p10l601t943r907b1030],
16	well	RB	O	well	advmod	15	SENT_164	[p10l945t943r1108b1010],
17	to	TO	O	to	_	0	SENT_164	[p10l1147t953r1219b1010],
18	glimepiride	NN	O	glimepiride	prep_to	16	SENT_164	[p10l1260t943r1704b1030],
19	during	IN	O	during	_	0	SENT_164	[p10l1744t943r1992b1030],
20	the	DT	O	the	det	22	SENT_164	[p10l2032t943r2147b1010],
21	initial	JJ	O	initial	amod	22	SENT_164	[p10l6t1058r231b1125],
22	phase	NN	O	phase	prep_during	15	SENT_164	[p10l265t1058r484b1145],
23	of	IN	O	of	_	0	SENT_164	[p10l521t1058r604b1125],
24	treatment	NN	O	treatment	prep_of	14	SENT_164	[p10l633t1068r1000b1125],
25	and	CC	O	and	_	0	SENT_164	[p10l1036t1058r1172b1125],
26	one	CD	NUMBER	one	num	27	SENT_164	[p10l1208t1080r1343b1125],
27	subject	NN	O	subject	prep_with	6	SENT_164	[p10l1382t1058r1653b1145],
28	have	VBP	O	have	aux	29	SENT_164	[p10l1686t1058r1865b1126],
29	shown	VBN	O	show	ccomp	3	SENT_164	[p10l1904t1058r2149b1126],
30	the	DT	O	the	det	32	SENT_164	[p10l6t1173r122b1240],
31	weight	NN	O	weight	nn	32	SENT_164	[p10l156t1173r418b1260],
32	gain	NN	O	gain	dobj	29	SENT_164	[p10l453t1173r617b1260],
33	over	IN	O	over	_	0	SENT_164	[p10l653t1195r821b1241],
34	the	DT	O	the	det	36	SENT_164	[p10l854t1173r970b1240],
35	long-term	JJ	O	long-term	amod	36	SENT_164	[p10l1005t1173r1387b1260],
36	treatment	NN	O	treatment	prep_over	29	SENT_164	[p10l1420t1183r1805b1240],
37	.	.	O	.	_	0	SENT_164	[p10l1420t1183r1805b1240],

1	3.3	CD	NUMBER	3.3	_	0	SENT_165	[p10l6t1411r140b1478],
2	.	.	O	.	_	0	SENT_165	[p10l6t1411r140b1478],

1	Glimepiride	NNP	O	Glimepiride	_	0	SENT_166	[p10l204t1411r664b1497],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_166	[p10l692t1411r1350b1497],
3	Study	NN	O	study	dep	1	SENT_166	[p10l1386t1411r1587b1497],

1	Two	CD	NUMBER	two	num	2	SENT_167	[p10l122t1644r289b1709],
2	subjects	NNS	O	subject	nsubj	20	SENT_167	[p10l318t1642r623b1729],
3	with	IN	O	with	_	0	SENT_167	[p10l651t1642r820b1709],
4	a	DT	O	a	det	6	SENT_167	[p10l847t1663r887b1709],
5	CYP2C9	NN	O	cyp2c9	nn	6	SENT_167	[p10l915t1642r1248b1710],
6	*	NN	O	*	prep_with	2	SENT_167	[p10l1260t1642r1372b1709],
7	1	CD	NUMBER	1	dep	6	SENT_167	[p10l1260t1642r1372b1709],
8	/	:	O	/	punct	6	SENT_167	[p10l1260t1642r1372b1709],
9	*	CD	NUMBER	*	num	10	SENT_167	[p10l1384t1642r1465b1709],
10	3	CD	NUMBER	3	dep	6	SENT_167	[p10l1384t1642r1465b1709],
11	and	CC	O	and	_	0	SENT_167	[p10l1494t1642r1630b1709],
12	four	CD	NUMBER	four	num	13	SENT_167	[p10l1656t1642r1815b1709],
13	subjects	NNS	O	subject	conj_and	10	SENT_167	[p10l1842t1642r2146b1729],
14	(	JJ	O	(	amod	16	SENT_167	[p10l9t1758r83b1841],
15	2	CD	NUMBER	2	tmod	14	SENT_167	[p10l9t1758r83b1841],
16	females	NNS	O	female	dep	10	SENT_167	[p10l165t1757r461b1825],
17	and	CC	O	and	_	0	SENT_167	[p10l546t1757r682b1825],
18	2	CD	NUMBER	2	num	19	SENT_167	[p10l762t1758r805b1824],
19	males	NNS	O	male	conj_and	6	SENT_167	[p10l886t1757r1139b1840],
20	)	VBP	O	)	dep	28	SENT_167	[p10l886t1757r1139b1840],
21	with	IN	O	with	_	0	SENT_167	[p10l1222t1757r1392b1825],
22	a	DT	O	a	det	24	SENT_167	[p10l1473t1779r1513b1825],
23	CYP2C9	NN	O	cyp2c9	nn	24	SENT_167	[p10l1596t1758r2141b1826],
24	*	NN	O	*	prep_with	20	SENT_167	[p10l1596t1758r2141b1826],
25	1	CD	NUMBER	1	dobj	20	SENT_167	[p10l1596t1758r2141b1826],
26	/	:	O	/	punct	28	SENT_167	[p10l1596t1758r2141b1826],
27	*	CD	NUMBER	*	num	28	SENT_167	[p10l1596t1758r2141b1826],
28	1	CD	NUMBER	1	_	0	SENT_167	[p10l1596t1758r2141b1826],
29	participated	VBD	O	participate	dep	28	SENT_167	[p10l6t1872r464b1959],
30	in	IN	O	in	_	0	SENT_167	[p10l499t1872r573b1938],
31	the	DT	O	the	det	34	SENT_167	[p10l608t1872r723b1939],
32	glimepiride	NN	O	glimepiride	nn	34	SENT_167	[p10l761t1872r1205b1959],
33	pharmacokinetic	JJ	O	pharmacokinetic	amod	34	SENT_167	[p10l1240t1872r1884b1959],
34	study	NN	O	study	prep_in	29	SENT_167	[p10l1927t1872r2143b1959],
35	.	.	O	.	_	0	SENT_167	[p10l1927t1872r2143b1959],

1	The	DT	O	the	det	2	SENT_168	[p10l7t1987r154b2053],
2	CYP2C9	NN	O	cyp2c9	_	0	SENT_168	[p10l223t1987r774b2054],
3	*	NN	O	*	dep	2	SENT_168	[p10l223t1987r774b2054],
4	1	CD	NUMBER	1	num	3	SENT_168	[p10l223t1987r774b2054],
5	/	:	O	/	punct	9	SENT_168	[p10l223t1987r774b2054],
6	*	CD	NUMBER	*	number	7	SENT_168	[p10l223t1987r774b2054],
7	3	CD	NUMBER	3	num	8	SENT_168	[p10l223t1987r774b2054],
8	subjects	NNS	O	subject	nsubj	9	SENT_168	[p10l843t1987r1146b2074],
9	showed	VBD	O	show	dep	2	SENT_168	[p10l1216t1987r1504b2054],
10	higher	JJR	O	higher	amod	12	SENT_168	[p10l1566t1987r1814b2074],
11	plasma	NN	O	plasma	nn	12	SENT_168	[p10l1875t1987r2149b2074],
12	concentration	NN	O	concentration	iobj	9	SENT_168	[p10l7t2102r754b2169],
13	—	CD	NUMBER	—	num	15	SENT_168	[p10l7t2102r754b2169],
14	time	NN	O	time	nn	15	SENT_168	[p10l7t2102r754b2169],
15	curves	NNS	O	curve	dobj	9	SENT_168	[p10l778t2124r1025b2170],
16	for	IN	O	for	_	0	SENT_168	[p10l1049t2102r1160b2169],
17	glimepiride	NN	O	glimepiride	prep_for	9	SENT_168	[p10l1181t2102r1646b2189],
18	,	,	O	,	_	0	SENT_168	[p10l1181t2102r1646b2189],
19	compared	VBN	O	compare	_	0	SENT_168	[p10l1673t2102r2054b2189],
20	to	TO	O	to	prepc_compared_to	9	SENT_168	[p10l2076t2113r2147b2169],
21	the	DT	O	the	det	23	SENT_168	[p10l6t2217r121b2284],
22	CYP2C9	NN	O	cyp2c9	nn	23	SENT_168	[p10l163t2217r708b2285],
23	*	NN	O	*	pobj	9	SENT_168	[p10l163t2217r708b2285],
24	1	CD	NUMBER	1	dep	23	SENT_168	[p10l163t2217r708b2285],
25	/	:	O	/	punct	9	SENT_168	[p10l163t2217r708b2285],
26	*	CD	NUMBER	*	number	27	SENT_168	[p10l163t2217r708b2285],
27	1	CD	NUMBER	1	num	28	SENT_168	[p10l163t2217r708b2285],
28	subjects	NNS	O	subject	dep	2	SENT_168	[p10l755t2217r1081b2304],
29	,	,	O	,	_	0	SENT_168	[p10l755t2217r1081b2304],
30	after	IN	O	after	_	0	SENT_168	[p10l1123t2217r1299b2284],
31	a	DT	O	a	det	34	SENT_168	[p10l1336t2238r1375b2284],
32	single	JJ	O	single	amod	34	SENT_168	[p10l1413t2217r1638b2304],
33	oral	JJ	O	oral	amod	34	SENT_168	[p10l1676t2217r1822b2284],
34	dose	NN	O	dose	prep_after	28	SENT_168	[p10l1861t2217r2033b2284],
35	of	IN	O	of	_	0	SENT_168	[p10l2071t2217r2154b2284],
36	1	CD	NUMBER	1	num	37	SENT_168	[p10l16t2332r44b2398],
37	mg	NN	O	mg	prep_of	34	SENT_168	[p10l79t2353r199b2419],
38	of	IN	O	of	_	0	SENT_168	[p10l277t2332r360b2398],
39	glimepiride	NN	O	glimepiride	nn	41	SENT_168	[p10l430t2332r874b2419],
40	(	CD	NUMBER	(	num	41	SENT_168	[p10l953t2332r1128b2419],
41	Fig	NN	O	fig	prep_of	37	SENT_168	[p10l953t2332r1128b2419],
42	.	.	O	.	_	0	SENT_168	[p10l953t2332r1128b2419],

1	3	CD	NUMBER	3	_	0	SENT_169	[p10l1211t2332r1305b2414],
2	)	NN	O	)	dep	1	SENT_169	[p10l1211t2332r1305b2414],
3	.	.	O	.	_	0	SENT_169	[p10l1211t2332r1305b2414],

1	We	PRP	O	we	nsubj	2	SENT_170	[p10l1385t2333r1510b2399],
2	estimated	VBD	O	estimate	_	0	SENT_170	[p10l1587t2332r1957b2398],
3	the	DT	O	the	dep	5	SENT_170	[p10l2032t2332r2147b2398],
4	pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_170	[p10l6t2447r649b2534],
5	model-independent	JJ	O	model-independent	dobj	2	SENT_170	[p10l713t2447r1462b2534],
6	and	CC	O	and	_	0	SENT_170	[p10l1523t2447r1659b2514],
7	—	NN	O	—	nn	13	SENT_170	[p10l1721t2447r2149b2534],
8	dependent	JJ	O	dependent	amod	13	SENT_170	[p10l1721t2447r2149b2534],
9	(	CD	NUMBER	(	num	13	SENT_170	[p10l9t2563r722b2649],
10	one	CD	NUMBER	one	num	13	SENT_170	[p10l9t2563r722b2649],
11	—	NN	O	—	nn	13	SENT_170	[p10l9t2563r722b2649],
12	compartment	NN	O	compartment	nn	13	SENT_170	[p10l9t2563r722b2649],
13	model	NN	O	model	conj_and	5	SENT_170	[p10l763t2562r1032b2645],
14	)	CD	NUMBER	)	num	15	SENT_170	[p10l763t2562r1032b2645],
15	parameters	NNS	O	parameter	dep	2	SENT_170	[p10l1075t2572r1519b2649],
16	.	.	O	.	_	0	SENT_170	[p10l1075t2572r1519b2649],

1	No	DT	O	no	det	2	SENT_171	[p10l1565t2564r1679b2629],
2	differences	NNS	O	difference	_	0	SENT_171	[p10l1723t2562r2146b2629],

1	OCYP2C9	CD	NUMBER	ocyp2c9	num	2	SENT_172	[p10l864t2791r1092b2823],
2	*	NN	O	*	_	0	SENT_172	[p10l864t2791r1092b2823],
3	1	CD	NUMBER	1	dep	2	SENT_172	[p10l864t2791r1092b2823],
4	/	:	O	/	punct	2	SENT_172	[p10l864t2791r1092b2823],
5	*	CD	NUMBER	*	num	6	SENT_172	[p10l864t2791r1092b2823],
6	3	CD	NUMBER	3	dep	2	SENT_172	[p10l864t2791r1092b2823],
7	.	.	O	.	_	0	SENT_172	[p10l862t2839r1091b2871],

1	CYP2C9	NN	O	cyp2c9	nn	2	SENT_173	[p10l862t2839r1091b2871],
2	*	NN	O	*	nsubj	3	SENT_173	[p10l862t2839r1091b2871],
3	1	CD	NUMBER	1	_	0	SENT_173	[p10l862t2839r1091b2871],
4	/	:	O	/	punct	5	SENT_173	[p10l862t2839r1091b2871],
5	*	CD	NUMBER	*	dep	3	SENT_173	[p10l862t2839r1091b2871],
6	3	CD	NUMBER	3	dep	5	SENT_173	[p10l862t2839r1091b2871],
7	I	PRP	O	I	nsubj	8	SENT_173	[p10l867t2891r892b2919],
8	CYP2C9	VBP	O	cyp2c9	rcmod	3	SENT_173	[p10l900t2893r1087b2917],
9	*	CD	NUMBER	*	number	10	SENT_173	[p10l900t2893r1087b2917],
10	1	CD	NUMBER	1	dobj	8	SENT_173	[p10l900t2893r1087b2917],
11	/	:	O	/	punct	18	SENT_173	[p10l900t2893r1087b2917],
12	*	CD	NUMBER	*	dep	18	SENT_173	[p10l900t2893r1087b2917],
13	1	CD	NUMBER	1	num	14	SENT_173	[p10l900t2893r1087b2917],
14	(	CD	NUMBER	(	dep	12	SENT_173	[p10l914t2924r986b2954],
15	"	``	O	"	punct	18	SENT_173	[p10l914t2924r986b2954],
16	=	JJ	O	=	amod	18	SENT_173	[p10l914t2924r986b2954],
17	4	CD	NUMBER	4	num	18	SENT_173	[p10l914t2924r986b2954],
18	)	NN	O	)	parataxis	3	SENT_173	[p10l914t2924r986b2954],

1	—	NN	O	—	nn	2	SENT_174	[p10l502t2884r512b2905],
2	l	NN	O	l	_	0	SENT_174	[p10l502t2884r512b2905],
3	—	CD	NUMBER	—	num	4	SENT_174	[p10l502t2817r512b2838],
4	|	NN	O	|	dep	2	SENT_174	[p10l502t2817r512b2838],
5	4	CD	NUMBER	4	dep	4	SENT_174	[p10l518t2884r533b2905],
6	:	:	O	:	_	0	SENT_174	[p10l518t2884r533b2905],
7	cn	NN	O	cn	nn	8	SENT_174	[p10l518t2817r533b2839],
8	o	NN	O	o	dep	4	SENT_174	[p10l535t2884r550b2906],
9	o	NN	O	o	nn	13	SENT_174	[p10l535t2817r550b2839],
10	ntration	NN	O	ntration	nn	13	SENT_174	[p10l1183t2794r1202b2888],
11	(	NN	O	(	nn	13	SENT_174	[p10l1183t2699r1207b2784],
12	nglml	NN	O	nglml	nn	13	SENT_174	[p10l1183t2699r1207b2784],
13	)	NN	O	)	dep	8	SENT_174	[p10l1183t2699r1207b2784],

1	—	NN	O	—	nn	4	SENT_175	[p10l502t2955r512b2976],
2	|	CD	NUMBER	|	num	4	SENT_175	[p10l502t2955r512b2976],
3	N	NN	O	n	nn	4	SENT_175	[p10l518t2955r532b2976],
4	O	NN	O	o	_	0	SENT_175	[p10l535t2955r550b2976],
5	100	CD	NUMBER	100	dep	4	SENT_175	[p10l502t3022r550b3044],

1	limepiride	NN	O	limepiride	nn	2	SENT_176	[p10l1183t2976r1207b3097],
2	Conce	NN	O	conce	_	0	SENT_176	[p10l1183t2890r1202b2967],

1	30	CD	NUMBER	30	num	2	SENT_177	[p10l518t3091r550b3113],
2	5	CD	NUMBER	5	_	0	SENT_177	[p10l1183t3100r1202b3117],
3	o	NN	O	o	dep	2	SENT_177	[p10l1268t3107r1279b3122],
4	2	CD	NUMBER	2	num	5	SENT_177	[p10l1348t3107r1359b3122],
5	4	CD	NUMBER	4	dep	3	SENT_177	[p10l1428t3107r1439b3122],
6	e	SYM	O	e	prep	5	SENT_177	[p10l1509t3107r1520b3122],
7	a	DT	O	a	det	11	SENT_177	[p10l1589t3107r1600b3122],
8	1o	NN	O	1o	amod	11	SENT_177	[p10l1670t3107r1692b3122],
9	so	RB	O	so	advmod	8	SENT_177	[p10l518t3162r550b3183],
10	'	''	O	'	_	0	SENT_177	[p10l619t3153r623b3163],
11	4o	NN	O	4o	dep	6	SENT_177	[p10l518t3227r550b3248],
12	,	,	O	,	_	0	SENT_177	[p10l600t3225r608b3253],
13	'	''	O	'	_	0	SENT_177	[p10l600t3225r608b3253],
14	I	PRP	O	I	dep	11	SENT_177	[p10l597t3260r601b3270],
15	20	CD	NUMBER	20	number	16	SENT_177	[p10l518t3292r550b3314],
16	1	CD	NUMBER	1	dep	14	SENT_177	[p10l589t3278r597b3306],
17	'	''	O	'	_	0	SENT_177	[p10l589t3278r597b3306],

1	:2	CD	NUMBER	:2	num	2	SENT_178	[p10l443t3526r461b3549],
2	Plasma	NN	O	plasma	_	0	SENT_178	[p10l437t3342r462b3459],
3	Glimepiride	NNP	O	Glimepiride	nn	6	SENT_178	[p10l436t3141r468b3330],
4	Concentration	NN	O	concentration	nn	6	SENT_178	[p10l436t2898r462b3129],
5	(	NN	O	(	nn	6	SENT_178	[p10l436t2772r469b2885],
6	nglml	NN	O	nglml	dep	2	SENT_178	[p10l436t2772r469b2885],
7	)	NN	O	)	dep	2	SENT_178	[p10l436t2772r469b2885],

1	Fig	NN	O	fig	_	0	SENT_179	[p10l109t3526r159b3556],
2	.	.	O	.	_	0	SENT_179	[p10l109t3526r159b3556],

1	3	LS	NUMBER	3	_	0	SENT_180	[p10l170t3526r191b3549],
2	.	.	O	.	_	0	SENT_180	[p10l170t3526r191b3549],

1	Plasma	NN	O	plasma	nn	3	SENT_181	[p10l210t3526r306b3549],
2	concentra	NN	O	concentra	nn	3	SENT_181	[p10l314t3529r443b3549],
3	ons	NNS	O	on	nsubj	36	SENT_181	[p10l462t3533r506b3549],
4	vs.	CC	O	vs.	prep	3	SENT_181	[p10l515t3533r550b3549],
5	time	NN	O	time	nn	6	SENT_181	[p10l560t3526r618b3549],
6	curves	NNS	O	curve	dep	4	SENT_181	[p10l627t3533r711b3549],
7	for	IN	O	for	_	0	SENT_181	[p10l720t3526r759b3549],
8	glimepiride	NN	O	glimepiride	prep_for	6	SENT_181	[p10l767t3526r919b3556],
9	in	IN	O	in	_	0	SENT_181	[p10l927t3526r952b3549],
10	the	DT	O	the	det	13	SENT_181	[p10l960t3526r1000b3549],
11	CYP2	NN	O	cyp2	nn	13	SENT_181	[p10l1010t3526r1084b3549],
12	C9	NN	O	c9	nn	13	SENT_181	[p10l1088t3526r1124b3549],
13	*	NN	O	*	prep_in	8	SENT_181	[p10l1128t3526r1155b3549],
14	1	CD	NUMBER	1	dep	13	SENT_181	[p10l1128t3526r1155b3549],
15	/	:	O	/	punct	19	SENT_181	[p10l1157t3526r1167b3549],
16	*	CD	NUMBER	*	number	17	SENT_181	[p10l1171t3526r1197b3549],
17	1	CD	NUMBER	1	num	19	SENT_181	[p10l1171t3526r1197b3549],
18	genotype	NN	O	genotype	nn	19	SENT_181	[p10l1208t3529r1329b3556],
19	group	NN	O	group	dep	13	SENT_181	[p10l1337t3533r1413b3556],
20	(	CD	NUMBER	(	num	21	SENT_181	[p10l1422t3526r1541b3556],
21	squares	NNS	O	square	dep	19	SENT_181	[p10l1422t3526r1541b3556],
22	)	CD	NUMBER	)	dep	19	SENT_181	[p10l1422t3526r1541b3556],
23	and	CC	O	and	_	0	SENT_181	[p10l1551t3526r1597b3549],
24	two	CD	NUMBER	two	num	27	SENT_181	[p10l1606t3530r1654b3549],
25	CYP2	NN	O	cyp2	nn	27	SENT_181	[p10l1664t3526r1738b3549],
26	C9	NN	O	c9	nn	27	SENT_181	[p10l1742t3526r1778b3549],
27	*	NN	O	*	dep	13	SENT_181	[p10l1783t3526r1809b3549],
28	1	CD	NUMBER	1	dep	27	SENT_181	[p10l1783t3526r1809b3549],
29	/	:	O	/	punct	19	SENT_181	[p10l1811t3526r1821b3549],
30	*	CD	NUMBER	*	number	31	SENT_181	[p10l1825t3526r1853b3549],
31	3	CD	NUMBER	3	num	32	SENT_181	[p10l1825t3526r1853b3549],
32	subjects	NNS	O	subject	dep	13	SENT_181	[p10l1863t3526r1967b3556],
33	(	RB	O	(	advmod	34	SENT_181	[p10l1977t3526r2051b3556],
34	open	JJ	O	open	_	0	SENT_181	[p10l1977t3526r2051b3556],
35	and	CC	O	and	_	0	SENT_181	[p10l110t3567r156b3590],
36	closed	VBD	O	close	conj_and	34	SENT_181	[p10l164t3567r248b3590],
37	circles	NNS	O	circle	dobj	36	SENT_181	[p10l256t3567r352b3595],
38	)	RB	O	)	advmod	36	SENT_181	[p10l256t3567r352b3595],
39	after	IN	O	after	_	0	SENT_181	[p10l362t3567r422b3590],
40	a	DT	O	a	det	43	SENT_181	[p10l430t3574r444b3590],
41	single	JJ	O	single	amod	43	SENT_181	[p10l453t3567r530b3597],
42	oral	JJ	O	oral	amod	43	SENT_181	[p10l538t3567r589b3590],
43	dose	NN	O	dose	prep_after	36	SENT_181	[p10l597t3567r657b3590],
44	of	IN	O	of	_	0	SENT_181	[p10l665t3567r694b3590],
45	1	CD	NUMBER	1	num	46	SENT_181	[p10l703t3567r713b3590],
46	mg	NN	O	mg	prep_of	43	SENT_181	[p10l725t3574r766b3597],
47	of	IN	O	of	_	0	SENT_181	[p10l775t3567r803b3590],
48	glimepiride	NN	O	glimepiride	prep_of	46	SENT_181	[p10l809t3567r969b3597],
49	.	.	O	.	_	0	SENT_181	[p10l809t3567r969b3597],

1	The	DT	O	the	det	2	SENT_182	[p10l978t3567r1029b3590],
2	inset	NN	O	inset	nsubj	3	SENT_182	[p10l1037t3567r1099b3590],
3	shows	VBZ	O	show	_	0	SENT_182	[p10l1108t3567r1187b3590],
4	a	DT	O	a	det	6	SENT_182	[p10l1197t3574r1210b3590],
5	logarithm	NN	O	logarithm	nn	6	SENT_182	[p10l1218t3567r1347b3597],
6	scale	NN	O	scale	dobj	3	SENT_182	[p10l1355t3567r1427b3590],
7	.	.	O	.	_	0	SENT_182	[p10l1355t3567r1427b3590],

1	Data	NNS	O	datum	_	0	SENT_183	[p10l1436t3567r1499b3590],
2	for	IN	O	for	_	0	SENT_183	[p10l1507t3567r1545b3590],
3	the	DT	O	the	det	5	SENT_183	[p10l1552t3567r1592b3590],
4	CYP2C9	NN	O	cyp2c9	nn	5	SENT_183	[p10l1602t3567r1758b3590],
5	*	NN	O	*	prep_for	1	SENT_183	[p10l1602t3567r1758b3590],
6	1	CD	NUMBER	1	dep	5	SENT_183	[p10l1602t3567r1758b3590],
7	/	:	O	/	punct	10	SENT_183	[p10l1602t3567r1758b3590],
8	*	CD	NUMBER	*	number	9	SENT_183	[p10l1762t3567r1789b3590],
9	1	CD	NUMBER	1	num	10	SENT_183	[p10l1762t3567r1789b3590],
10	group	NN	O	group	dep	5	SENT_183	[p10l1799t3574r1875b3597],
11	are	VBP	O	be	auxpass	12	SENT_183	[p10l1884t3574r1923b3590],
12	shown	VBN	O	show	rcmod	10	SENT_183	[p10l1932t3567r2016b3590],
13	as	IN	O	as	_	0	SENT_183	[p10l2025t3574r2050b3590],
14	the	DT	O	the	det	15	SENT_183	[p10l109t3608r148b3632],
15	mean	NN	O	mean	prep_as	10	SENT_183	[p10l161t3615r232b3632],
16	:	:	O	:	_	0	SENT_183	[p10l242t3619r265b3631],
17	:	:	O	:	_	0	SENT_183	[p10l242t3619r265b3631],
18	S.D.	NNP	O	S.D.	nn	20	SENT_183	[p10l276t3608r331b3632],
19	(	CD	NUMBER	(	num	20	SENT_183	[p10l346t3608r371b3637],
20	n	NN	O	n	dep	1	SENT_183	[p10l346t3608r371b3637],
21	=	JJ	O	=	amod	23	SENT_183	[p10l381t3618r398b3627],
22	4	CD	NUMBER	4	tmod	21	SENT_183	[p10l407t3608r441b3637],
23	)	NN	O	)	dep	20	SENT_183	[p10l407t3608r441b3637],
24	.	.	O	.	_	0	SENT_183	[p10l407t3608r441b3637],

1	152	CD	NUMBER	152	num	3	SENT_184	[p10l333t3712r379b3736],
2	K.	NNP	PERSON	K.	nn	3	SENT_184	[p10l774t3713r801b3736],
3	Suzuki	NNP	PERSON	Suzuki	_	0	SENT_184	[p10l816t3712r902b3738],
4	et	FW	O	et	nn	5	SENT_184	[p10l914t3717r938b3736],
5	al.	FW	O	al.	dep	3	SENT_184	[p10l949t3712r979b3736],
6	/	:	O	/	punct	3	SENT_184	[p10l986t3713r1001b3736],
7	Diabetes	NNP	ORGANIZATION	Diabetes	dep	3	SENT_184	[p10l1003t3712r1121b3736],
8	Research	NNP	ORGANIZATION	Research	dep	7	SENT_184	[p10l1131t3712r1254b3736],
9	and	CC	ORGANIZATION	and	_	0	SENT_184	[p10l1265t3712r1316b3736],
10	Clinical	JJ	ORGANIZATION	clinical	amod	11	SENT_184	[p10l1328t3712r1433b3736],
11	Practice	NN	ORGANIZATION	practice	dep	3	SENT_184	[p10l1444t3713r1556b3736],
12	72	CD	NUMBER	72	number	13	SENT_184	[p10l1570t3712r1599b3736],
13	(	CD	NUMBER	(	num	14	SENT_184	[p10l1613t3712r1699b3741],
14	2006	CD	DATE	2006	dep	11	SENT_184	[p10l1613t3712r1699b3741],
15	)	CD	NUMBER	)	num	16	SENT_184	[p10l1613t3712r1699b3741],
16	148-154	CD	NUMBER	148-154	dep	11	SENT_184	[p10l1713t3712r1827b3736],

1	Table	NNP	O	Table	_	0	SENT_185	[p11l8t71r176b124],
2	2	CD	NUMBER	2	num	1	SENT_185	[p11l205t71r240b124],
3	Pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_185	[p11l8t166r524b220],
4	analysis	NN	O	analysis	dep	1	SENT_185	[p11l548t166r793b236],
5	of	IN	O	of	_	0	SENT_185	[p11l816t166r883b220],
6	glimepiride	NN	O	glimepiride	prep_of	4	SENT_185	[p11l900t166r1254b236],
7	in	IN	O	in	_	0	SENT_185	[p11l1276t166r1334b220],
8	subjects	NNS	O	subject	prep_in	6	SENT_185	[p11l1359t166r1601b236],
9	with	IN	O	with	_	0	SENT_185	[p11l1625t166r1760b220],
10	C	NN	O	c	nn	12	SENT_185	[p11l1785t167r1833b221],
11	YP2C9	NN	O	yp2c9	nn	12	SENT_185	[p11l1837t166r2050b221],
12	*	NN	O	*	prep_with	8	SENT_185	[p11l2060t166r2120b220],
13	1	CD	NUMBER	1	dep	24	SENT_185	[p11l2060t166r2120b220],
14	/	:	O	/	punct	20	SENT_185	[p11l2126t166r2148b220],
15	*	CD	NUMBER	*	num	16	SENT_185	[p11l16t263r77b316],
16	1	CD	NUMBER	1	dep	20	SENT_185	[p11l16t263r77b316],
17	or	CC	O	or	_	0	SENT_185	[p11l116t279r179b316],
18	CYP2C9	CD	NUMBER	cyp2c9	num	19	SENT_185	[p11l214t262r578b317],
19	*	CD	NUMBER	*	dep	20	SENT_185	[p11l214t262r578b317],
20	I	PRP	O	I	dep	13	SENT_185	[p11l214t262r578b317],
21	/	:	O	/	punct	20	SENT_185	[p11l214t262r578b317],
22	*	CD	NUMBER	*	number	23	SENT_185	[p11l586t263r652b316],
23	3	CD	NUMBER	3	num	24	SENT_185	[p11l586t263r652b316],
24	genotypes	NNS	O	genotype	rcmod	8	SENT_185	[p11l686t270r995b332],
25	after	IN	O	after	dep	24	SENT_185	[p11l1030t262r1170b316],
26	a	DT	O	a	det	29	SENT_185	[p11l1202t279r1234b316],
27	single	JJ	O	single	amod	29	SENT_185	[p11l1269t262r1448b332],
28	oral	JJ	O	oral	amod	29	SENT_185	[p11l1481t262r1598b316],
29	dose	NN	O	dose	pobj	25	SENT_185	[p11l1632t262r1771b316],
30	of	IN	O	of	_	0	SENT_185	[p11l1804t262r1871b316],
31	1	CD	NUMBER	1	num	32	SENT_185	[p11l1905t263r1927b316],
32	mg	NN	O	mg	prep_of	29	SENT_185	[p11l1956t279r2052b332],
33	of	IN	O	of	_	0	SENT_185	[p11l2086t262r2152b316],
34	glimepiride	NN	O	glimepiride	prep_of	32	SENT_185	[p11l9t358r362b428],

1	Parameters	NNS	O	parameter	dep	6	SENT_186	[p11l8t510r346b563],
2	C	NN	O	c	nn	3	SENT_186	[p11l961t510r1010b563],
3	YP2	NN	O	yp2	dep	1	SENT_186	[p11l1014t509r1133b562],
4	C9	NN	O	c9	nn	5	SENT_186	[p11l1141t509r1226b563],
5	*	NN	O	*	dep	6	SENT_186	[p11l1236t509r1297b562],
6	1	CD	NUMBER	1	dep	17	SENT_186	[p11l1236t509r1297b562],
7	/	:	O	/	punct	9	SENT_186	[p11l1302t509r1325b563],
8	*	CD	NUMBER	*	num	9	SENT_186	[p11l1334t509r1395b562],
9	1	CD	NUMBER	1	dep	6	SENT_186	[p11l1334t509r1395b562],
10	C	NN	O	c	nn	13	SENT_186	[p11l1537t510r1586b563],
11	YP2	NN	O	yp2	nn	13	SENT_186	[p11l1590t509r1709b562],
12	C9	NN	O	c9	nn	13	SENT_186	[p11l1717t509r1802b563],
13	*	NN	O	*	dep	9	SENT_186	[p11l1811t509r1872b562],
14	1	CD	NUMBER	1	dep	6	SENT_186	[p11l1811t509r1872b562],
15	/	:	O	/	punct	17	SENT_186	[p11l1878t509r1901b563],
16	*	CD	NUMBER	*	num	17	SENT_186	[p11l1910t509r1975b563],
17	3	CD	NUMBER	3	_	0	SENT_186	[p11l1910t509r1975b563],

1	(	NN	O	(	nn	2	SENT_187	[p11l960t607r1019b672],
2	n	NN	O	n	_	0	SENT_187	[p11l960t607r1019b672],
3	=	JJ	O	=	amod	7	SENT_187	[p11l1042t629r1082b650],
4	4	CD	NUMBER	4	amod	7	SENT_187	[p11l1103t606r1163b672],
5	)	NN	O	)	nn	7	SENT_187	[p11l1103t606r1163b672],
6	m	NN	O	m	nn	7	SENT_187	[p11l1532t660r2149b665],
7	Case	NN	O	case	dep	2	SENT_187	[p11l1535t702r1681b755],
8	#	#	MONEY	#	number	9	SENT_187	[p11l1708t702r1778b754],
9	1	CD	MONEY	1	amod	10	SENT_187	[p11l1708t702r1778b754],
10	Case	NN	O	case	npadvmod	14	SENT_187	[p11l1897t702r2044b755],
11	#	#	MONEY	#	number	13	SENT_187	[p11l2071t702r2146b754],
12	2	CD	MONEY	2	number	13	SENT_187	[p11l2071t702r2146b754],
13	(	CD	MONEY	(	num	10	SENT_187	[p11l1536t797r1791b863],
14	female	JJ	O	female	amod	7	SENT_187	[p11l1536t797r1791b863],
15	)	JJ	O	)	amod	18	SENT_187	[p11l1536t797r1791b863],
16	(	NN	O	(	nn	18	SENT_187	[p11l1899t797r2095b863],
17	male	JJ	O	male	amod	18	SENT_187	[p11l1899t797r2095b863],
18	)	NN	O	)	dep	2	SENT_187	[p11l1899t797r2095b863],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_188	[p11l8t946r524b1001],
2	model-independent	JJ	O	model-independent	amod	3	SENT_188	[p11l553t946r1149b1016],
3	analysis	NN	O	analysis	_	0	SENT_188	[p11l1176t946r1420b1016],

1	AUC	NN	O	auc	nn	4	SENT_189	[p11l85t1042r240b1096],
2	(	CD	NUMBER	(	num	4	SENT_189	[p11l271t1042r369b1111],
3	ng	NN	O	ng	nn	4	SENT_189	[p11l271t1042r369b1111],
4	h/ml	NN	O	h/ml	_	0	SENT_189	[p11l390t1041r554b1108],
5	)	CD	NUMBER	)	num	6	SENT_189	[p11l390t1041r554b1108],
6	292.0	CD	NUMBER	292.0	dep	14	SENT_189	[p11l959t1042r1128b1096],
7	i	FW	O	i	dep	6	SENT_189	[p11l1153t1043r1205b1095],
8	1018	CD	DATE	1018	number	9	SENT_189	[p11l1236t1025r1428b1096],
9	*	CD	NUMBER	*	num	11	SENT_189	[p11l1236t1025r1428b1096],
10	654.6	CD	NUMBER	654.6	number	11	SENT_189	[p11l1535t1041r1705b1096],
11	870.9	CD	NUMBER	870.9	dep	7	SENT_189	[p11l1900t1042r2066b1096],
12	Cmax	NN	O	cmax	dep	14	SENT_189	[p11l88t1140r234b1205],
13	(	CD	NUMBER	(	num	12	SENT_189	[p11l264t1139r489b1209],
14	ng/ml	NN	O	ng/ml	dep	25	SENT_189	[p11l264t1139r489b1209],
15	)	CD	NUMBER	)	number	16	SENT_189	[p11l264t1139r489b1209],
16	89.5	CD	NUMBER	89.5	dep	14	SENT_189	[p11l999t1138r1125b1193],
17	i	FW	O	i	dep	16	SENT_189	[p11l1153t1140r1205b1192],
18	37.8	CD	NUMBER	37.8	number	19	SENT_189	[p11l1231t1139r1359b1193],
19	123.8	CD	NUMBER	123.8	dep	16	SENT_189	[p11l1541t1139r1702b1193],
20	159.2	CD	NUMBER	159.2	num	23	SENT_189	[p11l1904t1138r2067b1193],
21	Mean	NN	O	mean	nn	23	SENT_189	[p11l85t1234r258b1287],
22	residence	NN	O	residence	nn	23	SENT_189	[p11l286t1233r575b1287],
23	time	NN	O	time	dep	19	SENT_189	[p11l603t1233r739b1287],
24	(	CD	NUMBER	(	num	25	SENT_189	[p11l769t1233r853b1299],
25	h	NN	O	h	dep	38	SENT_189	[p11l769t1233r853b1299],
26	)	CD	NUMBER	)	number	27	SENT_189	[p11l769t1233r853b1299],
27	3.03	CD	NUMBER	3.03	dep	25	SENT_189	[p11l998t1234r1125b1287],
28	:	:	O	:	_	0	SENT_189	[p11l1153t1234r1205b1286],
29	|	CD	NUMBER	|	dep	27	SENT_189	[p11l1153t1234r1205b1286],
30	:	:	O	:	_	0	SENT_189	[p11l1153t1234r1205b1286],
31	0.11	CD	NUMBER	0.11	num	32	SENT_189	[p11l1229t1217r1390b1287],
32	*	CD	NUMBER	*	dep	29	SENT_189	[p11l1229t1217r1390b1287],
33	4.92	CD	NUMBER	4.92	number	34	SENT_189	[p11l1610t1234r1743b1288],
34	5.23	CD	NUMBER	5.23	num	36	SENT_189	[p11l1975t1233r2103b1287],
35	Total	JJ	O	total	amod	36	SENT_189	[p11l85t1328r240b1382],
36	clearance	NN	O	clearance	dep	32	SENT_189	[p11l269t1328r559b1382],
37	(	CD	NUMBER	(	num	38	SENT_189	[p11l589t1328r715b1394],
38	1/h	NN	O	1/h	dep	40	SENT_189	[p11l589t1328r715b1394],
39	)	CD	NUMBER	)	num	40	SENT_189	[p11l589t1328r715b1394],
40	3.78	CD	NUMBER	3.78	dep	48	SENT_189	[p11l998t1329r1126b1383],
41	i	FW	O	i	dep	40	SENT_189	[p11l1153t1330r1205b1381],
42	144	CD	NUMBER	144	number	43	SENT_189	[p11l1236t1313r1390b1382],
43	*	CD	NUMBER	*	num	45	SENT_189	[p11l1236t1313r1390b1382],
44	1.52	CD	NUMBER	1.52	number	45	SENT_189	[p11l1618t1328r1743b1383],
45	1.18	CD	NUMBER	1.18	dep	41	SENT_189	[p11l1981t1329r2104b1383],
46	Distribution	NN	O	distribution	nn	48	SENT_189	[p11l85t1423r456b1477],
47	volume	NN	O	volume	nn	48	SENT_189	[p11l480t1424r708b1477],
48	(	NN	O	(	dep	4	SENT_189	[p11l739t1423r805b1490],
49	1	CD	NUMBER	1	number	50	SENT_189	[p11l739t1423r805b1490],
50	)	CD	NUMBER	)	dep	48	SENT_189	[p11l739t1423r805b1490],
51	9.23	CD	NUMBER	9.23	num	52	SENT_189	[p11l997t1424r1125b1478],
52	d	NN	O	d	dep	50	SENT_189	[p11l1153t1425r1205b1476],
53	:	:	O	:	_	0	SENT_189	[p11l1153t1425r1205b1476],
54	3.43	CD	NUMBER	3.43	dep	4	SENT_189	[p11l1231t1424r1357b1477],
55	6.89	CD	NUMBER	6.89	number	56	SENT_189	[p11l1612t1423r1742b1478],
56	5.95	CD	NUMBER	5.95	dep	54	SENT_189	[p11l1975t1423r2103b1478],

1	Pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_190	[p11l8t1520r524b1574],
2	model-dependent	JJ	O	model-dependent	amod	3	SENT_190	[p11l553t1520r1088b1590],
3	analysisa	NN	O	analysisa	_	0	SENT_190	[p11l1116t1514r1390b1590],

1	AUC	NN	O	auc	nn	4	SENT_191	[p11l85t1613r240b1667],
2	(	CD	NUMBER	(	num	4	SENT_191	[p11l271t1614r369b1683],
3	ng	NN	O	ng	nn	4	SENT_191	[p11l271t1614r369b1683],
4	h/ml	NN	O	h/ml	dep	16	SENT_191	[p11l390t1613r554b1680],
5	)	CD	NUMBER	)	number	6	SENT_191	[p11l390t1613r554b1680],
6	298.1	CD	NUMBER	298.1	dep	4	SENT_191	[p11l959t1613r1122b1668],
7	:	:	O	:	_	0	SENT_191	[p11l1153t1614r1205b1667],
8	|	CD	NUMBER	|	num	10	SENT_191	[p11l1153t1614r1205b1667],
9	:	:	O	:	_	0	SENT_191	[p11l1153t1614r1205b1667],
10	944	CD	NUMBER	944	dep	6	SENT_191	[p11l1229t1597r1390b1668],
11	*	CD	NUMBER	*	number	12	SENT_191	[p11l1229t1597r1390b1668],
12	601.6	CD	NUMBER	601.6	dep	10	SENT_191	[p11l1535t1613r1705b1667],
13	830.4	CD	NUMBER	830.4	num	14	SENT_191	[p11l1900t1613r2067b1667],
14	Cmax	NN	O	cmax	dep	16	SENT_191	[p11l88t1710r234b1776],
15	(	CD	NUMBER	(	num	16	SENT_191	[p11l264t1709r489b1779],
16	ng/ml	NN	O	ng/ml	dep	19	SENT_191	[p11l264t1709r489b1779],
17	)	CD	NUMBER	)	num	18	SENT_191	[p11l264t1709r489b1779],
18	89.0	CD	NUMBER	89.0	dep	16	SENT_191	[p11l999t1710r1128b1764],
19	i	FW	O	i	dep	26	SENT_191	[p11l1153t1710r1205b1763],
20	36.2	CD	NUMBER	36.2	number	21	SENT_191	[p11l1231t1709r1361b1764],
21	116.5	CD	NUMBER	116.5	dep	19	SENT_191	[p11l1541t1709r1702b1764],
22	147.1	CD	NUMBER	147.1	num	24	SENT_191	[p11l1904t1709r2061b1763],
23	Total	JJ	O	total	amod	24	SENT_191	[p11l85t1805r240b1859],
24	clearance	NN	O	clearance	dep	21	SENT_191	[p11l269t1805r559b1859],
25	(	CD	NUMBER	(	num	26	SENT_191	[p11l589t1805r715b1871],
26	l/h	NN	O	l/h	dep	28	SENT_191	[p11l589t1805r715b1871],
27	)	CD	NUMBER	)	num	28	SENT_191	[p11l589t1805r715b1871],
28	3.65	CD	NUMBER	3.65	_	0	SENT_191	[p11l998t1805r1125b1859],
29	:	:	O	:	_	0	SENT_191	[p11l1153t1806r1205b1858],
30	|	CD	NUMBER	|	num	32	SENT_191	[p11l1153t1806r1205b1858],
31	:	:	O	:	_	0	SENT_191	[p11l1153t1806r1205b1858],
32	1.28	CD	NUMBER	1.28	dep	40	SENT_191	[p11l1236t1789r1390b1859],
33	*	CD	NUMBER	*	number	34	SENT_191	[p11l1236t1789r1390b1859],
34	1.66	CD	NUMBER	1.66	dep	32	SENT_191	[p11l1618t1805r1743b1859],
35	1.2	CD	NUMBER	1.2	num	37	SENT_191	[p11l1981t1806r2067b1859],
36	Distribution	NN	O	distribution	nn	37	SENT_191	[p11l85t1900r456b1953],
37	Volume	NN	O	volume	dep	34	SENT_191	[p11l480t1900r708b1953],
38	(	NN	O	(	dep	40	SENT_191	[p11l739t1900r805b1966],
39	1	CD	NUMBER	1	num	38	SENT_191	[p11l739t1900r805b1966],
40	)	CD	NUMBER	)	dep	43	SENT_191	[p11l739t1900r805b1966],
41	4.68	CD	NUMBER	4.68	dep	40	SENT_191	[p11l996t1900r1126b1954],
42	:	:	O	:	_	0	SENT_191	[p11l1153t1901r1205b1953],
43	|	CD	NUMBER	|	dep	28	SENT_191	[p11l1153t1901r1205b1953],
44	:	:	O	:	_	0	SENT_191	[p11l1153t1901r1205b1953],
45	1.86	CD	NUMBER	1.86	dep	43	SENT_191	[p11l1236t1900r1361b1954],
46	3.14	CD	NUMBER	3.14	num	47	SENT_191	[p11l1613t1900r1743b1954],
47	3.65	CD	NUMBER	3.65	dep	45	SENT_191	[p11l1975t1900r2103b1954],

1	Data	NNS	O	datum	nsubjpass	3	SENT_192	[p11l8t2052r153b2105],
2	are	VBP	O	be	auxpass	3	SENT_192	[p11l182t2067r272b2105],
3	represented	VBN	O	represent	_	0	SENT_192	[p11l301t2050r657b2120],
4	as	IN	O	as	_	0	SENT_192	[p11l686t2067r745b2105],
5	the	DT	O	the	det	7	SENT_192	[p11l775t2050r868b2105],
6	mean	JJ	O	mean	amod	7	SENT_192	[p11l897t2067r1063b2105],
7	:1	NN	O	:1	prep_as	3	SENT_192	[p11l1087t2051r1139b2104],
8	:	:	O	:	_	0	SENT_192	[p11l1087t2051r1139b2104],
9	S.D.	NNP	LOCATION	S.D.	nn	10	SENT_192	[p11l1165t2051r1293b2105],
10	AUC	NN	O	auc	dep	7	SENT_192	[p11l1326t2051r1498b2105],
11	:	:	O	:	_	0	SENT_192	[p11l1326t2051r1498b2105],
12	area	NN	O	area	dep	7	SENT_192	[p11l1534t2067r1661b2105],
13	under	IN	O	under	_	0	SENT_192	[p11l1687t2050r1864b2105],
14	the	DT	O	the	det	15	SENT_192	[p11l1890t2050r1983b2105],
15	concentration	NN	O	concentration	prep_under	12	SENT_192	[p11l2012t2067r2145b2105, p11l8t2147r478b2202],
16	—	CD	NUMBER	—	num	18	SENT_192	[p11l2012t2067r2145b2105, p11l8t2147r478b2202],
17	time	NN	O	time	nn	18	SENT_192	[p11l2012t2067r2145b2105, p11l8t2147r478b2202],
18	curve	NN	O	curve	dep	12	SENT_192	[p11l507t2164r693b2211],
19	;	:	O	;	_	0	SENT_192	[p11l507t2164r693b2211],
20	Cmaxz	NNP	O	Cmaxz	nn	23	SENT_192	[p11l728t2149r890b2214],
21	peak	NN	O	peak	nn	23	SENT_192	[p11l922t2147r1069b2218],
22	plasma	NN	O	plasma	nn	23	SENT_192	[p11l1094t2148r1313b2218],
23	concentration	NN	O	concentration	dep	7	SENT_192	[p11l1340t2148r1773b2202],
24	.	.	O	.	_	0	SENT_192	[p11l1340t2148r1773b2202],

1	3	CD	NUMBER	3	num	3	SENT_193	[p11l61t2238r85b2263],
2	One-compartment	NN	O	one-compartment	nn	3	SENT_193	[p11l123t2244r682b2314],
3	model	NN	O	model	_	0	SENT_193	[p11l709t2243r900b2298],
4	with	IN	O	with	_	0	SENT_193	[p11l928t2243r1063b2298],
5	ﬁrst	NN	O	ﬁrst	nn	7	SENT_193	[p11l1092t2243r1210b2298],
6	order	NN	O	order	nn	7	SENT_193	[p11l1237t2244r1398b2298],
7	absorption	NN	O	absorption	prep_with	3	SENT_193	[p11l1426t2243r1763b2314],
8	.	.	O	.	_	0	SENT_193	[p11l1426t2243r1763b2314],

1	*	NN	O	*	_	0	SENT_194	[p11l59t2321r81b2343],
2	Signiﬁcantly	RB	O	signiﬁcantly	advmod	1	SENT_194	[p11l123t2337r514b2407],
3	different	JJ	O	different	dep	1	SENT_194	[p11l541t2337r804b2392],
4	from	IN	O	from	_	0	SENT_194	[p11l831t2337r979b2392],
5	the	DT	O	the	det	8	SENT_194	[p11l1005t2338r1097b2392],
6	C	NN	O	c	nn	8	SENT_194	[p11l1128t2339r1177b2392],
7	YPZC9	NN	O	ypzc9	nn	8	SENT_194	[p11l1180t2338r1393b2392],
8	*	NN	O	*	prep_from	3	SENT_194	[p11l1403t2338r1464b2391],
9	1	CD	NUMBER	1	dep	8	SENT_194	[p11l1403t2338r1464b2391],
10	/	:	O	/	punct	1	SENT_194	[p11l1469t2338r1492b2392],
11	*	CD	NUMBER	*	dep	15	SENT_194	[p11l1501t2338r1566b2391],
12	3	CD	NUMBER	3	dep	11	SENT_194	[p11l1501t2338r1566b2391],
13	group	NN	O	group	dep	15	SENT_194	[p11l1595t2355r1771b2407],
14	(	CD	NUMBER	(	num	13	SENT_194	[p11l1801t2338r1870b2404],
15	P	NN	O	p	dep	18	SENT_194	[p11l1801t2338r1870b2404],
16	<	JJR	O	<	dep	15	SENT_194	[p11l1896t2349r1943b2393],
17	0.05	CD	NUMBER	0.05	num	18	SENT_194	[p11l1970t2337r2144b2404],
18	)	NN	O	)	dep	1	SENT_194	[p11l1970t2337r2144b2404],
19	.	.	O	.	_	0	SENT_194	[p11l1970t2337r2144b2404],

1	in	IN	O	in	_	0	SENT_195	[p11l8t2581r81b2648],
2	the	DT	O	the	det	4	SENT_195	[p11l139t2581r254b2648],
3	estimated	VBN	O	estimate	amod	4	SENT_195	[p11l314t2581r682b2648],
4	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	7	SENT_195	[p11l739t2581r1420b2668],
5	parameters	NNS	O	parameter	nsubjpass	7	SENT_195	[p11l1479t2591r1901b2668],
6	were	VBD	O	be	auxpass	7	SENT_195	[p11l1961t2603r2145b2649],
7	observed	VBN	O	observe	_	0	SENT_195	[p11l9t2696r355b2763],
8	between	IN	O	between	_	0	SENT_195	[p11l389t2696r711b2763],
9	these	DT	O	these	det	12	SENT_195	[p11l748t2696r945b2763],
10	two	CD	NUMBER	two	num	12	SENT_195	[p11l983t2706r1124b2763],
11	analysis	NN	O	analysis	nn	12	SENT_195	[p11l1164t2696r1470b2783],
12	methods	NNS	O	method	prep_between	7	SENT_195	[p11l1509t2696r1856b2775],
13	,	,	O	,	_	0	SENT_195	[p11l1509t2696r1856b2775],
14	except	IN	O	except	_	0	SENT_195	[p11l1897t2706r2148b2783],
15	for	IN	O	for	_	0	SENT_195	[p11l8t2811r120b2878],
16	the	DT	O	the	det	17	SENT_195	[p11l158t2811r273b2878],
17	distribution	NN	O	distribution	prep_except_for	7	SENT_195	[p11l315t2811r758b2878],
18	Volume	NN	O	volume	nn	20	SENT_195	[p11l794t2811r1081b2878],
19	(	CD	NUMBER	(	num	20	SENT_195	[p11l1124t2811r1363b2894],
20	Table	NNP	O	Table	dep	17	SENT_195	[p11l1124t2811r1363b2894],
21	2	CD	NUMBER	2	number	22	SENT_195	[p11l1406t2811r1501b2894],
22	)	CD	NUMBER	)	dep	20	SENT_195	[p11l1406t2811r1501b2894],
23	.	.	O	.	_	0	SENT_195	[p11l1406t2811r1501b2894],

1	The	DT	O	the	det	3	SENT_196	[p11l1546t2811r1694b2878],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_196	[p11l1733t2811r2144b2898, p11l7t2926r267b2993],
3	parameters	NNS	O	parameter	nsubj	7	SENT_196	[p11l352t2936r774b3013],
4	of	IN	O	of	_	0	SENT_196	[p11l861t2926r944b2993],
5	glimepiride	NN	O	glimepiride	prep_of	3	SENT_196	[p11l1022t2926r1466b3013],
6	were	VBD	O	be	cop	7	SENT_196	[p11l1548t2948r1732b2994],
7	different	JJ	O	different	_	0	SENT_196	[p11l1818t2926r2147b2993],
8	between	IN	O	between	_	0	SENT_196	[p11l7t3041r328b3109],
9	subjects	NNS	O	subject	prep_between	7	SENT_196	[p11l366t3041r670b3128],
10	with	IN	O	with	prep	9	SENT_196	[p11l705t3041r875b3108],
11	a	DT	O	a	det	13	SENT_196	[p11l910t3063r950b3108],
12	CYP2C9	NN	O	cyp2c9	nn	13	SENT_196	[p11l988t3042r1444b3109],
13	*	NN	O	*	dep	10	SENT_196	[p11l988t3042r1444b3109],
14	1	CD	NUMBER	1	dep	13	SENT_196	[p11l988t3042r1444b3109],
15	/	:	O	/	punct	13	SENT_196	[p11l988t3042r1444b3109],
16	*	CD	NUMBER	*	num	17	SENT_196	[p11l1456t3042r1532b3107],
17	1	CD	NUMBER	1	dep	13	SENT_196	[p11l1456t3042r1532b3107],
18	and	CC	O	and	_	0	SENT_196	[p11l1574t3041r1710b3108],
19	those	DT	O	those	dep	13	SENT_196	[p11l1744t3041r1944b3108],
20	with	IN	O	with	_	0	SENT_196	[p11l1977t3041r2147b3108],
21	a	DT	O	a	det	23	SENT_196	[p11l10t3177r50b3223],
22	CYP2C9	NN	O	cyp2c9	nn	23	SENT_196	[p11l99t3156r555b3223],
23	*	NN	O	*	prep_with	17	SENT_196	[p11l99t3156r555b3223],
24	1	CD	NUMBER	1	dep	23	SENT_196	[p11l99t3156r555b3223],
25	/	:	O	/	punct	13	SENT_196	[p11l99t3156r555b3223],
26	*	CD	NUMBER	*	num	27	SENT_196	[p11l567t3156r671b3235],
27	3	CD	NUMBER	3	dep	13	SENT_196	[p11l567t3156r671b3235],
28	,	,	O	,	_	0	SENT_196	[p11l567t3156r671b3235],
29	regardless	RB	O	regardless	dep	27	SENT_196	[p11l718t3156r1106b3243],
30	of	IN	O	of	_	0	SENT_196	[p11l1155t3156r1237b3223],
31	the	DT	O	the	det	33	SENT_196	[p11l1276t3156r1391b3223],
32	analytical	JJ	O	analytical	amod	33	SENT_196	[p11l1439t3156r1813b3243],
33	method	NN	O	method	prep_of	9	SENT_196	[p11l1859t3156r2147b3223],
34	that	WDT	O	that	nsubjpass	36	SENT_196	[p11l8t3271r152b3338],
35	was	VBD	O	be	auxpass	36	SENT_196	[p11l194t3292r338b3338],
36	used	VBN	O	use	rcmod	33	SENT_196	[p11l382t3271r558b3338],
37	(	RB	O	(	dep	38	SENT_196	[p11l603t3271r842b3354],
38	Table	NNP	O	Table	dep	33	SENT_196	[p11l603t3271r842b3354],
39	2	CD	NUMBER	2	number	40	SENT_196	[p11l887t3271r983b3354],
40	)	CD	NUMBER	)	num	38	SENT_196	[p11l887t3271r983b3354],
41	.	.	O	.	_	0	SENT_196	[p11l887t3271r983b3354],

1	The	DT	O	the	det	6	SENT_197	[p11l1030t3271r1178b3338],
2	total	JJ	O	total	amod	6	SENT_197	[p11l1221t3271r1391b3338],
3	clearance	NN	O	clearance	nn	6	SENT_197	[p11l1435t3271r1797b3338],
4	(	CD	NUMBER	(	num	6	SENT_197	[p11l1844t3271r2023b3354],
5	CL	NN	MISC	cl	nn	6	SENT_197	[p11l1844t3271r2023b3354],
6	)	NN	O	)	nsubj	11	SENT_197	[p11l1844t3271r2023b3354],
7	of	IN	O	of	_	0	SENT_197	[p11l2070t3271r2153b3338],
8	glimepiride	NN	O	glimepiride	prep_of	6	SENT_197	[p11l9t3387r452b3474],
9	was	VBD	O	be	cop	11	SENT_197	[p11l480t3409r624b3455],
10	signiﬁcantly	RB	O	signiﬁcantly	advmod	11	SENT_197	[p11l658t3387r1131b3474],
11	smaller	JJR	O	smaller	_	0	SENT_197	[p11l1163t3387r1443b3454],
12	in	IN	O	in	_	0	SENT_197	[p11l1470t3387r1543b3453],
13	subjects	NNS	O	subject	prep_in	11	SENT_197	[p11l1574t3387r1878b3474],
14	with	IN	O	with	prep	11	SENT_197	[p11l1909t3387r2078b3454],
15	a	DT	O	a	det	17	SENT_197	[p11l2108t3409r2148b3454],
16	CYP2C9	NN	O	cyp2c9	nn	17	SENT_197	[p11l13t3503r562b3570],
17	*	NN	O	*	dep	14	SENT_197	[p11l13t3503r562b3570],
18	1	CD	NUMBER	1	dep	17	SENT_197	[p11l13t3503r562b3570],
19	/	:	O	/	punct	17	SENT_197	[p11l13t3503r562b3570],
20	*	CD	NUMBER	*	num	21	SENT_197	[p11l13t3503r562b3570],
21	3	CD	NUMBER	3	npadvmod	22	SENT_197	[p11l13t3503r562b3570],
22	than	IN	O	than	dep	29	SENT_197	[p11l605t3502r769b3569],
23	in	IN	O	in	_	0	SENT_197	[p11l810t3502r883b3569],
24	subjects	NNS	O	subject	prep_in	22	SENT_197	[p11l928t3502r1231b3589],
25	with	IN	O	with	_	0	SENT_197	[p11l1275t3502r1444b3570],
26	a	DT	O	a	det	28	SENT_197	[p11l1487t3524r1527b3569],
27	C	NN	O	c	nn	28	SENT_197	[p11l1571t3504r1632b3570],
28	YPZC9	NN	O	ypzc9	prep_with	24	SENT_197	[p11l1637t3503r1902b3570],
29	*	NN	O	*	dep	33	SENT_197	[p11l1915t3503r1992b3569],
30	1	CD	NUMBER	1	num	29	SENT_197	[p11l1915t3503r1992b3569],
31	/	:	O	/	punct	33	SENT_197	[p11l1999t3503r2028b3570],
32	*	CD	NUMBER	*	num	33	SENT_197	[p11l2040t3503r2115b3569],
33	1	CD	NUMBER	1	dep	17	SENT_197	[p11l2040t3503r2115b3569],
34	.	.	O	.	_	0	SENT_197	[p11l2131t3559r2142b3569],

1	The	DT	O	the	det	2	SENT_198	[p11l8t3616r155b3683],
2	area	NN	O	area	nsubj	8	SENT_198	[p11l179t3637r337b3683],
3	under	IN	O	under	_	0	SENT_198	[p11l357t3616r577b3683],
4	the	DT	O	the	det	7	SENT_198	[p11l596t3616r711b3683],
5	concentration	NN	O	concentration	nn	7	SENT_198	[p11l734t3616r1463b3683],
6	—	CD	NUMBER	—	num	7	SENT_198	[p11l734t3616r1463b3683],
7	time	NN	O	time	prep_under	2	SENT_198	[p11l734t3616r1463b3683],
8	curve	NN	O	curve	_	0	SENT_198	[p11l1487t3637r1696b3683],
9	(	CD	NUMBER	(	num	11	SENT_198	[p11l1721t3616r1975b3698],
10	AUC	NN	O	auc	nn	11	SENT_198	[p11l1721t3616r1975b3698],
11	)	NN	O	)	nsubj	12	SENT_198	[p11l1721t3616r1975b3698],
12	was	VBD	O	be	ccomp	8	SENT_198	[p11l1999t3637r2144b3683],
13	twice	RB	O	twice	advmod	12	SENT_198	[p12l8t23r214b90],
14	as	RB	O	as	prep	12	SENT_198	[p12l287t44r361b90],
15	large	JJ	O	large	dep	19	SENT_198	[p12l433t23r623b110],
16	in	IN	O	in	_	0	SENT_198	[p12l692t23r766b89],
17	CYP2C9	NN	O	cyp2c9	prep_in	15	SENT_198	[p12l840t23r1389b90],
18	*	CD	NUMBER	*	num	17	SENT_198	[p12l840t23r1389b90],
19	I	PRP	O	I	dep	14	SENT_198	[p12l840t23r1389b90],
20	/	:	O	/	punct	19	SENT_198	[p12l840t23r1389b90],
21	*	CD	NUMBER	*	num	23	SENT_198	[p12l840t23r1389b90],
22	3	CD	NUMBER	3	num	23	SENT_198	[p12l840t23r1389b90],
23	subjects	NNS	O	subject	npadvmod	24	SENT_198	[p12l1464t23r1768b110],
24	than	IN	O	than	advmod	25	SENT_198	[p12l1840t23r2004b90],
25	in	IN	O	in	dep	28	SENT_198	[p12l2074t23r2146b89],
26	CYP2C9	NN	O	cyp2c9	nn	27	SENT_198	[p12l13t139r470b206],
27	*	NN	O	*	pobj	25	SENT_198	[p12l13t139r470b206],
28	1	CD	NUMBER	1	dep	19	SENT_198	[p12l13t139r470b206],
29	/	:	O	/	punct	28	SENT_198	[p12l13t139r470b206],
30	*	CD	NUMBER	*	number	31	SENT_198	[p12l481t139r557b205],
31	1	CD	NUMBER	1	num	32	SENT_198	[p12l481t139r557b205],
32	subjects	NNS	O	subject	dobj	12	SENT_198	[p12l614t138r939b225],
33	.	.	O	.	_	0	SENT_198	[p12l614t138r939b225],

1	The	DT	O	the	det	4	SENT_199	[p12l991t138r1139b205],
2	mean	NN	O	mean	nn	4	SENT_199	[p12l1186t160r1395b205],
3	residence	NN	O	residence	nn	4	SENT_199	[p12l1439t138r1804b205],
4	time	NN	O	time	_	0	SENT_199	[p12l1852t138r2021b205],
5	of	IN	O	of	_	0	SENT_199	[p12l2070t138r2153b205],
6	glimepiride	NN	O	glimepiride	prep_of	4	SENT_199	[p12l9t253r452b340],
7	in	IN	O	in	_	0	SENT_199	[p12l511t253r585b319],
8	the	DT	O	the	det	9	SENT_199	[p12l642t253r758b320],
9	CYP2C9	NN	O	cyp2c9	prep_in	6	SENT_199	[p12l821t254r1371b321],
10	*	CD	NUMBER	*	num	9	SENT_199	[p12l821t254r1371b321],
11	I	PRP	O	I	dep	9	SENT_199	[p12l821t254r1371b321],
12	/	:	O	/	punct	15	SENT_199	[p12l821t254r1371b321],
13	*	CD	NUMBER	*	number	14	SENT_199	[p12l821t254r1371b321],
14	3	CD	NUMBER	3	num	15	SENT_199	[p12l821t254r1371b321],
15	subjects	NNS	O	subject	dep	4	SENT_199	[p12l1434t253r1738b340],
16	was	VBD	O	be	cop	18	SENT_199	[p12l1799t275r1944b321],
17	signiﬁcantly	RB	O	signiﬁcantly	advmod	18	SENT_199	[p12l2008t253r2144b340, p12l8t368r370b455],
18	longer	JJR	O	longer	rcmod	15	SENT_199	[p12l393t368r639b455],
19	than	IN	O	than	_	0	SENT_199	[p12l657t368r822b435],
20	that	DT	O	that	prep_than	15	SENT_199	[p12l842t368r987b435],
21	in	IN	O	in	_	0	SENT_199	[p12l1006t368r1080b434],
22	the	DT	O	the	det	26	SENT_199	[p12l1100t368r1215b435],
23	C	NN	O	c	nn	26	SENT_199	[p12l1241t369r1302b435],
24	YP2	NN	O	yp2	nn	26	SENT_199	[p12l1307t368r1456b434],
25	C9	NN	O	c9	nn	26	SENT_199	[p12l1466t368r1572b435],
26	*	NN	O	*	prep_in	20	SENT_199	[p12l1585t368r1662b434],
27	1	CD	NUMBER	1	dep	26	SENT_199	[p12l1585t368r1662b434],
28	/	:	O	/	punct	15	SENT_199	[p12l1669t368r1698b435],
29	*	CD	NUMBER	*	number	30	SENT_199	[p12l1709t368r1785b434],
30	1	CD	NUMBER	1	num	31	SENT_199	[p12l1709t368r1785b434],
31	subjects	NNS	O	subject	dep	4	SENT_199	[p12l1816t368r2141b455],
32	.	.	O	.	_	0	SENT_199	[p12l1816t368r2141b455],

1	These	DT	O	these	det	2	SENT_200	[p12l8t483r236b549],
2	results	NNS	O	result	nsubj	3	SENT_200	[p12l272t483r521b549],
3	indicated	VBD	O	indicate	_	0	SENT_200	[p12l560t483r913b549],
4	that	IN	O	that	complm	22	SENT_200	[p12l949t483r1094b549],
5	the	DT	O	the	det	7	SENT_200	[p12l1129t483r1245b549],
6	hydroxylation	NN	O	hydroxylation	nn	7	SENT_200	[p12l1281t483r1823b570],
7	activity	NN	O	activity	nsubjpass	22	SENT_200	[p12l1861t483r2146b570],
8	of	IN	O	of	_	0	SENT_200	[p12l9t598r92b665],
9	glimepiride	NN	O	glimepiride	prep_of	7	SENT_200	[p12l113t598r556b685],
10	in	IN	O	in	prep	9	SENT_200	[p12l582t598r655b664],
11	the	DT	O	the	dep	12	SENT_200	[p12l680t598r795b665],
12	subjects	NNS	O	subject	dep	16	SENT_200	[p12l825t598r1129b685],
13	with	IN	O	with	_	0	SENT_200	[p12l1157t598r1327b666],
14	a	DT	O	a	det	15	SENT_200	[p12l1354t620r1393b665],
15	CYP2C9	NN	O	cyp2c9	prep_with	12	SENT_200	[p12l1422t599r1753b666],
16	*	NN	O	*	dep	20	SENT_200	[p12l1766t599r1972b666],
17	1	CD	NUMBER	1	num	16	SENT_200	[p12l1766t599r1972b666],
18	/	:	O	/	punct	20	SENT_200	[p12l1766t599r1972b666],
19	*	CD	NUMBER	*	num	20	SENT_200	[p12l1766t599r1972b666],
20	3	CD	NUMBER	3	dep	10	SENT_200	[p12l1766t599r1972b666],
21	was	VBD	O	be	auxpass	22	SENT_200	[p12l1999t620r2144b666],
22	reduced	VBN	O	reduce	ccomp	3	SENT_200	[p12l7t713r332b793],
23	,	,	O	,	_	0	SENT_200	[p12l7t713r332b793],
24	compared	VBN	O	compare	_	0	SENT_200	[p12l388t713r768b800],
25	with	IN	O	with	prepc_compared_with	22	SENT_200	[p12l819t713r988b781],
26	that	DT	O	that	pobj	22	SENT_200	[p12l1039t713r1183b780],
27	in	IN	O	in	prep	26	SENT_200	[p12l1234t713r1307b780],
28	the	DT	O	the	dep	29	SENT_200	[p12l1357t713r1472b780],
29	subjects	NNS	O	subject	dep	33	SENT_200	[p12l1528t713r1832b800],
30	with	IN	O	with	_	0	SENT_200	[p12l1886t713r2055b781],
31	a	DT	O	a	det	32	SENT_200	[p12l2108t735r2148b780],
32	CYP2C9	NN	O	cyp2c9	prep_with	29	SENT_200	[p12l13t828r344b895],
33	*	NN	O	*	dep	37	SENT_200	[p12l356t828r469b895],
34	1	CD	NUMBER	1	num	33	SENT_200	[p12l356t828r469b895],
35	/	:	O	/	punct	37	SENT_200	[p12l356t828r469b895],
36	*	CD	NUMBER	*	num	37	SENT_200	[p12l481t829r583b895],
37	1	CD	NUMBER	1	dep	27	SENT_200	[p12l481t829r583b895],
38	.	.	O	.	_	0	SENT_200	[p12l481t829r583b895],

1	3.4	CD	NUMBER	3.4	_	0	SENT_201	[p12l8t1059r141b1126],
2	.	.	O	.	_	0	SENT_201	[p12l8t1059r141b1126],

1	Enzyme	NN	O	enzyme	_	0	SENT_202	[p12l200t1061r497b1144],
2	kinetic	JJ	O	kinetic	amod	3	SENT_202	[p12l534t1058r790b1126],
3	parameters	NNS	O	parameter	dep	1	SENT_202	[p12l817t1072r1262b1144],
4	for	IN	O	for	_	0	SENT_202	[p12l1282t1059r1412b1144],
5	glimepiride	NN	O	glimepiride	nn	6	SENT_202	[p12l1438t1058r1881b1144],
6	hydroxylation	NN	O	hydroxylation	prep_for	3	SENT_202	[p12l8t1173r538b1259],
7	in	FW	O	in	nn	8	SENT_202	[p12l577t1176r646b1241],
8	vitro	FW	O	vitro	dep	6	SENT_202	[p12l680t1176r854b1241],

1	The	DT	O	the	det	4	SENT_203	[p12l123t1405r271b1471],
2	enzyme	NN	O	enzyme	nn	4	SENT_203	[p12l346t1426r644b1492],
3	kinetic	JJ	O	kinetic	amod	4	SENT_203	[p12l717t1405r978b1471],
4	parameters	NNS	O	parameter	nsubjpass	21	SENT_203	[p12l1052t1415r1474b1492],
5	of	IN	O	of	_	0	SENT_203	[p12l1551t1404r1634b1471],
6	glimepiride	NN	O	glimepiride	nn	7	SENT_203	[p12l1702t1405r2145b1492],
7	hydroxylation	NN	O	hydroxylation	prep_of	4	SENT_203	[p12l7t1520r549b1607],
8	for	IN	O	for	_	0	SENT_203	[p12l575t1520r686b1587],
9	CYP2C9	NN	O	cyp2c9	prep_for	7	SENT_203	[p12l712t1521r1144b1589],
10	*	CD	NUMBER	*	num	11	SENT_203	[p12l712t1521r1144b1589],
11	l	NN	O	l	tmod	7	SENT_203	[p12l712t1521r1144b1589],
12	and	CC	O	and	_	0	SENT_203	[p12l1181t1520r1317b1587],
13	CYP2C9	NN	O	cyp2c9	nsubjpass	21	SENT_203	[p12l1343t1521r1778b1588],
14	*	CD	NUMBER	*	number	15	SENT_203	[p12l1343t1521r1778b1588],
15	3	CD	NUMBER	3	num	16	SENT_203	[p12l1343t1521r1778b1588],
16	enzymes	NNS	O	enzyme	dep	13	SENT_203	[p12l1811t1542r2144b1607],
17	have	VBP	O	have	aux	21	SENT_203	[p12l7t1635r186b1702],
18	not	RB	O	not	neg	21	SENT_203	[p12l217t1645r339b1702],
19	been	VBN	O	be	auxpass	21	SENT_203	[p12l368t1635r550b1702],
20	previously	RB	DATE	previously	advmod	21	SENT_203	[p12l580t1635r984b1722],
21	reported	VBN	O	report	_	0	SENT_203	[p12l1015t1635r1355b1722],
22	.	.	O	.	_	0	SENT_203	[p12l1015t1635r1355b1722],

1	Human	JJ	O	human	amod	3	SENT_204	[p12l1392t1636r1673b1702],
2	CYP2C9	NN	O	cyp2c9	nn	3	SENT_204	[p12l1705t1635r2138b1703],
3	*	NN	O	*	nsubjpass	22	SENT_204	[p12l1705t1635r2138b1703],
4	l	NN	O	l	tmod	3	SENT_204	[p12l1705t1635r2138b1703],
5	or	CC	O	or	_	0	SENT_204	[p12l9t1771r87b1817],
6	CYP2C9	NN	O	cyp2c9	conj_or	3	SENT_204	[p12l138t1750r573b1818],
7	*	CD	NUMBER	*	number	8	SENT_204	[p12l138t1750r573b1818],
8	3	CD	NUMBER	3	dep	6	SENT_204	[p12l138t1750r573b1818],
9	enzyme	NN	O	enzyme	dep	8	SENT_204	[p12l631t1750r1374b1837],
10	—	CD	NUMBER	—	num	9	SENT_204	[p12l631t1750r1374b1837],
11	eXpressing	VBG	O	express	partmod	3	SENT_204	[p12l631t1750r1374b1837],
12	insect	JJ	O	insect	amod	14	SENT_204	[p12l1426t1750r1650b1817],
13	cell	NN	O	cell	nn	14	SENT_204	[p12l1702t1750r1838b1817],
14	microsomes	NNS	O	microsome	dobj	11	SENT_204	[p12l1890t1750r2144b1817, p12l11t1886r244b1932],
15	containing	VBG	O	contain	xcomp	11	SENT_204	[p12l273t1865r677b1952],
16	identical	JJ	O	identical	amod	17	SENT_204	[p12l704t1865r1034b1932],
17	concentrations	NNS	O	concentration	dobj	15	SENT_204	[p12l1062t1865r1621b1932],
18	of	IN	O	of	_	0	SENT_204	[p12l1650t1865r1733b1932],
19	CYP	NN	O	cyp	prep_of	17	SENT_204	[p12l1752t1865r1936b1932],
20	were	VBD	O	be	auxpass	22	SENT_204	[p12l1961t1886r2145b1932],
21	therefore	RB	O	therefore	advmod	22	SENT_204	[p12l8t1980r354b2047],
22	utilized	VBN	O	utilize	_	0	SENT_204	[p12l379t1980r669b2047],
23	in	IN	O	in	_	0	SENT_204	[p12l692t1980r766b2047],
24	an	DT	O	a	det	28	SENT_204	[p12l792t2002r879b2047],
25	enzyme	NN	O	enzyme	nn	28	SENT_204	[p12l903t2002r1201b2067],
26	kinetic	JJ	O	kinetic	amod	28	SENT_204	[p12l1224t1980r1486b2047],
27	parameter	NN	O	parameter	nn	28	SENT_204	[p12l1510t1991r1899b2067],
28	study	NN	O	study	prep_in	22	SENT_204	[p12l1925t1980r2142b2067],
29	.	.	O	.	_	0	SENT_204	[p12l1925t1980r2142b2067],

1	M	NN	O	m	nn	2	SENT_205	[p12l8t2097r91b2161],
2	—	NN	O	—	_	0	SENT_205	[p12l124t2134r183b2139],
3	1	CD	NUMBER	1	num	4	SENT_205	[p12l225t2096r254b2161],
4	production	NN	O	production	nsubj	15	SENT_205	[p12l305t2095r724b2182],
5	by	IN	O	by	_	0	SENT_205	[p12l768t2095r862b2182],
6	CYP2C9	NN	O	cyp2c9	nn	7	SENT_205	[p12l910t2096r1342b2164],
7	*	NN	O	*	prep_by	4	SENT_205	[p12l910t2096r1342b2164],
8	1	CD	NUMBER	1	num	7	SENT_205	[p12l910t2096r1342b2164],
9	was	VBD	O	be	cop	15	SENT_205	[p12l1396t2117r1541b2163],
10	approximately	RB	O	approximately	advmod	15	SENT_205	[p12l1590t2095r2146b2182],
11	Table	NNP	O	Table	pobj	10	SENT_205	[p12l8t2203r176b2256],
12	3	CD	NUMBER	3	dep	11	SENT_205	[p12l207t2203r237b2256],
13	Enzyme	NN	O	enzyme	nn	15	SENT_205	[p12l7t2299r259b2368],
14	kinetic	JJ	O	kinetic	amod	15	SENT_205	[p12l275t2298r483b2352],
15	analysis	NN	O	analysis	rcmod	2	SENT_205	[p12l503t2298r746b2368],
16	of	IN	O	of	_	0	SENT_205	[p12l765t2298r832b2352],
17	glimepiride	NN	O	glimepiride	nn	18	SENT_205	[p12l843t2298r1198b2368],
18	hydroxylation	NN	O	hydroxylation	prep_of	15	SENT_205	[p12l1213t2298r1645b2368],
19	using	VBG	O	use	partmod	18	SENT_205	[p12l1661t2298r1825b2368],
20	insect	JJ	O	insect	amod	22	SENT_205	[p12l1843t2298r2022b2352],
21	cell	NN	O	cell	nn	22	SENT_205	[p12l2038t2298r2146b2352],
22	microsomes	NNS	O	microsome	dobj	19	SENT_205	[p12l8t2394r378b2448],
23	containing	VBG	O	contain	xcomp	19	SENT_205	[p12l439t2394r762b2464],
24	human	JJ	O	human	amod	27	SENT_205	[p12l821t2394r1030b2448],
25	CDNA-expressed	JJ	O	cdna-expressed	amod	27	SENT_205	[p12l1090t2394r1615b2464],
26	CYP2C9	NN	O	cyp2c9	nn	27	SENT_205	[p12l1674t2394r2020b2449],
27	*	NN	O	*	dobj	23	SENT_205	[p12l1674t2394r2020b2449],
28	l	NN	O	l	tmod	27	SENT_205	[p12l1674t2394r2020b2449],
29	or	CC	O	or	_	0	SENT_205	[p12l2087t2411r2149b2448],
30	CYP2C9	NN	O	cyp2c9	dobj	23	SENT_205	[p12l9t2490r357b2545],
31	*	CD	NUMBER	*	number	32	SENT_205	[p12l9t2490r357b2545],
32	3	CD	NUMBER	3	dep	30	SENT_205	[p12l9t2490r357b2545],

1	CYPZC9	NN	O	cypzc9	nn	2	SENT_206	[p12l9t2640r282b2694],
2	Variants	NNS	O	variant	_	0	SENT_206	[p12l311t2640r551b2693],
3	Vmax	NN	O	vmax	nn	4	SENT_206	[p12l679t2642r820b2706],
4	Km	NN	O	km	dep	2	SENT_206	[p12l1162t2642r1258b2705],
5	Intrinsic	JJ	O	intrinsic	amod	6	SENT_206	[p12l1574t2640r1828b2693],
6	clearance	NN	O	clearance	dep	2	SENT_206	[p12l1858t2640r2147b2693],

1	(	NN	O	(	nn	2	SENT_207	[p12l677t2734r1022b2801],
2	nmol/min	NN	O	nmol/min	_	0	SENT_207	[p12l677t2734r1022b2801],
3	/	:	O	/	punct	6	SENT_207	[p12l677t2734r1022b2801],
4	(	CD	NUMBER	(	num	6	SENT_207	[p12l1165t2735r1329b2803],
5	MM	NN	O	mm	nn	6	SENT_207	[p12l1165t2735r1329b2803],
6	)	NN	O	)	dep	2	SENT_207	[p12l1165t2735r1329b2803],
7	(	CD	NUMBER	(	num	8	SENT_207	[p12l1576t2734r1845b2801],
8	m1/min	NN	O	m1/min	dep	6	SENT_207	[p12l1576t2734r1845b2801],
9	/	:	O	/	punct	6	SENT_207	[p12l1576t2734r1845b2801],
10	nmol	NN	O	nmol	nn	11	SENT_207	[p12l675t2830r831b2883],
11	P450	NN	O	p450	dep	2	SENT_207	[p12l852t2830r1032b2896],
12	)	CD	NUMBER	)	num	14	SENT_207	[p12l852t2830r1032b2896],
13	nmol	NN	O	nmol	nn	14	SENT_207	[p12l1574t2830r1730b2883],
14	P450	NN	O	p450	dep	2	SENT_207	[p12l1752t2830r1931b2896],
15	)	CD	NUMBER	)	dep	14	SENT_207	[p12l1752t2830r1931b2896],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_208	[p12l9t2980r354b3034],
2	*	CD	NUMBER	*	num	3	SENT_208	[p12l9t2980r354b3034],
3	l	NN	O	l	dep	1	SENT_208	[p12l9t2980r354b3034],
4	184.7	CD	NUMBER	184.7	dep	3	SENT_208	[p12l682t2979r844b3034],
5	:	:	O	:	_	0	SENT_208	[p12l870t2980r922b3033],
6	|	CD	NUMBER	|	dep	3	SENT_208	[p12l870t2980r922b3033],
7	:	:	O	:	_	0	SENT_208	[p12l870t2980r922b3033],
8	8.8	CD	NUMBER	8.8	number	9	SENT_208	[p12l949t2980r1038b3034],
9	4.1	CD	NUMBER	4.1	dep	6	SENT_208	[p12l1162t2979r1250b3033],
10	i	FW	O	i	dep	13	SENT_208	[p12l1281t2980r1333b3033],
11	0.4	CD	NUMBER	0.4	dep	10	SENT_208	[p12l1357t2979r1450b3034],
12	45.1	CD	NUMBER	45.1	dep	13	SENT_208	[p12l1573t2979r1700b3034],
13	CYP2C9	NN	O	cyp2c9	dep	6	SENT_208	[p12l9t3076r357b3130],
14	*	CD	NUMBER	*	dep	13	SENT_208	[p12l9t3076r357b3130],
15	3	CD	NUMBER	3	number	16	SENT_208	[p12l9t3076r357b3130],
16	55.6	CD	NUMBER	55.6	amod	6	SENT_208	[p12l714t3075r845b3130],
17	:	:	O	:	_	0	SENT_208	[p12l870t3076r922b3129],
18	|	CD	NUMBER	|	dep	3	SENT_208	[p12l870t3076r922b3129],
19	:	:	O	:	_	0	SENT_208	[p12l870t3076r922b3129],
20	0.5	CD	NUMBER	0.5	number	21	SENT_208	[p12l947t3075r1037b3130],
21	5.4	CD	NUMBER	5.4	dep	18	SENT_208	[p12l1164t3075r1256b3130],
22	:	:	O	:	_	0	SENT_208	[p12l1281t3076r1333b3129],
23	l	NN	O	l	dep	3	SENT_208	[p12l1281t3076r1333b3129],
24	:	:	O	:	_	0	SENT_208	[p12l1281t3076r1333b3129],
25	0.5	CD	NUMBER	0.5	number	26	SENT_208	[p12l1357t3075r1448b3130],
26	10.3	CD	NUMBER	10.3	dep	23	SENT_208	[p12l1581t3076r1703b3130],

1	Data	NNS	O	datum	nsubjpass	3	SENT_209	[p12l8t3229r153b3282],
2	are	VBP	O	be	auxpass	3	SENT_209	[p12l181t3245r271b3282],
3	represented	VBN	O	represent	_	0	SENT_209	[p12l299t3228r655b3298],
4	as	IN	O	as	_	0	SENT_209	[p12l683t3245r742b3282],
5	the	DT	O	the	det	6	SENT_209	[p12l771t3228r863b3282],
6	mean	NN	O	mean	prep_as	3	SENT_209	[p12l891t3245r1057b3282],
7	:	:	O	:	_	0	SENT_209	[p12l1082t3229r1133b3281],
8	I	PRP	O	I	dep	6	SENT_209	[p12l1082t3229r1133b3281],
9	:	:	O	:	_	0	SENT_209	[p12l1082t3229r1133b3281],
10	S.D.	NNP	O	S.D.	dep	6	SENT_209	[p12l1159t3228r1288b3282],

1	linear	JJ	O	linear	nsubj	23	SENT_210	[p12l8t3472r229b3539],
2	for	IN	O	for	_	0	SENT_210	[p12l259t3472r370b3539],
3	40	CD	DURATION	40	num	4	SENT_210	[p12l399t3472r493b3539],
4	min	NN	DURATION	min	prep_for	1	SENT_210	[p12l520t3472r668b3538],
5	when	WRB	O	when	advmod	15	SENT_210	[p12l699t3472r906b3539],
6	200	CD	NUMBER	200	num	8	SENT_210	[p12l939t3472r1079b3539],
7	pmol	NN	O	pmol	nn	8	SENT_210	[p12l1105t3472r1302b3559],
8	CYPZC9	NN	O	cypzc9	nsubjpass	15	SENT_210	[p12l1335t3472r1677b3540],
9	and	CC	O	and	_	0	SENT_210	[p12l1713t3472r1849b3539],
10	10	CD	TIME	10	num	11	SENT_210	[p12l1888t3472r1972b3539],
11	p.M	NN	TIME	p.m	conj_and	8	SENT_210	[p12l2006t3473r2146b3558],
12	of	IN	O	of	_	0	SENT_210	[p12l9t3587r92b3654],
13	glimepiride	NN	O	glimepiride	prep_of	11	SENT_210	[p12l114t3587r557b3674],
14	were	VBD	O	be	auxpass	15	SENT_210	[p12l583t3609r767b3655],
15	added	VBN	O	add	dep	4	SENT_210	[p12l797t3587r1024b3654],
16	to	TO	O	to	_	0	SENT_210	[p12l1050t3598r1122b3654],
17	the	DT	O	the	det	20	SENT_210	[p12l1150t3587r1265b3654],
18	reaction	NN	O	reaction	nn	20	SENT_210	[p12l1291t3587r1602b3654],
19	mixture	NN	O	mixture	nn	20	SENT_210	[p12l1629t3587r1928b3654],
20	(	NN	O	(	prep_to	15	SENT_210	[p12l1959t3587r2148b3670],
21	data	NNS	O	datum	npadvmod	22	SENT_210	[p12l1959t3587r2148b3670],
22	not	RB	O	not	neg	23	SENT_210	[p12l8t3712r131b3769],
23	shown	VBN	O	show	_	0	SENT_210	[p12l212t3702r507b3785],
24	)	NN	O	)	dobj	23	SENT_210	[p12l212t3702r507b3785],
25	.	.	O	.	_	0	SENT_210	[p12l212t3702r507b3785],

1	Therefore	RB	O	therefore	advmod	4	SENT_211	[p12l592t3702r992b3782],
2	,	,	O	,	_	0	SENT_211	[p12l592t3702r992b3782],
3	we	PRP	O	we	nsubj	4	SENT_211	[p12l1076t3724r1184b3769],
4	incubated	VBD	O	incubate	_	0	SENT_211	[p12l1265t3702r1640b3769],
5	subsequent	JJ	O	subsequent	amod	7	SENT_211	[p12l1723t3702r2148b3789],
6	reaction	NN	O	reaction	nn	7	SENT_211	[p13l7t21r319b88],
7	mixtures	NNS	O	mixture	dobj	4	SENT_211	[p13l345t21r680b88],
8	for	IN	O	for	_	0	SENT_211	[p13l708t21r819b88],
9	20	CD	DURATION	20	num	10	SENT_211	[p13l845t22r937b88],
10	min	NN	DURATION	min	prep_for	4	SENT_211	[p13l964t21r1132b88],
11	.	.	O	.	_	0	SENT_211	[p13l964t21r1132b88],

1	For	IN	O	for	_	0	SENT_212	[p13l1163t23r1296b88],
2	all	PDT	O	all	predet	4	SENT_212	[p13l1322t21r1414b88],
3	the	DT	O	the	det	4	SENT_212	[p13l1442t21r1557b88],
4	concentrations	NNS	O	concentration	prep_for	21	SENT_212	[p13l1585t21r2144b88],
5	of	IN	O	of	_	0	SENT_212	[p13l9t136r92b203],
6	glimepiride	NN	O	glimepiride	prep_of	4	SENT_212	[p13l184t136r626b223],
7	that	WDT	O	that	nsubjpass	9	SENT_212	[p13l725t136r869b203],
8	were	VBD	O	be	auxpass	9	SENT_212	[p13l965t157r1149b203],
9	studied	VBN	O	study	rcmod	4	SENT_212	[p13l1251t136r1525b203],
10	(	RB	O	(	advmod	9	SENT_212	[p13l1624t136r1916b219],
11	0.5	CD	NUMBER	0.5	number	12	SENT_212	[p13l1624t136r1916b219],
12	—	CD	NUMBER	—	num	16	SENT_212	[p13l1624t136r1916b219],
13	l0	NN	O	l0	nn	16	SENT_212	[p13l1624t136r1916b219],
14	p.	NN	O	p.	nn	16	SENT_212	[p13l1950t137r2143b222],
15	M	NN	O	m	nn	16	SENT_212	[p13l1950t137r2143b222],
16	)	NN	O	)	nsubj	21	SENT_212	[p13l1950t137r2143b222],
17	,	,	O	,	_	0	SENT_212	[p13l1950t137r2143b222],
18	CYP2C9	NN	O	cyp2c9	nn	19	SENT_212	[p13l9t251r445b319],
19	*	NN	O	*	appos	16	SENT_212	[p13l9t251r445b319],
20	3	CD	NUMBER	3	dep	19	SENT_212	[p13l9t251r445b319],
21	showed	VBD	O	show	_	0	SENT_212	[p13l489t251r776b318],
22	an	DT	O	a	det	24	SENT_212	[p13l813t272r901b318],
23	appreciable	JJ	O	appreciable	amod	24	SENT_212	[p13l938t251r1380b338],
24	decrease	NN	O	decrease	dobj	21	SENT_212	[p13l1417t251r1747b318],
25	in	IN	O	in	_	0	SENT_212	[p13l1784t251r1857b317],
26	hydroxylase	NN	O	hydroxylase	nn	27	SENT_212	[p13l1891t251r2144b338, p13l8t366r252b453],
27	activity	NN	O	activity	prep_in	21	SENT_212	[p13l276t366r576b453],
28	,	,	O	,	_	0	SENT_212	[p13l276t366r576b453],
29	compared	VBN	O	compare	_	0	SENT_212	[p13l601t366r981b453],
30	with	IN	O	with	prepc_compared_with	21	SENT_212	[p13l1001t366r1170b434],
31	CYP2C9	NN	O	cyp2c9	nn	33	SENT_212	[p13l1193t367r1579b435],
32	*	CD	NUMBER	*	num	33	SENT_212	[p13l1193t367r1579b435],
33	l.	NN	O	l.	pobj	21	SENT_212	[p13l1596t367r1652b433],
34	The	DT	O	the	det	37	SENT_212	[p13l1679t366r1826b433],
35	enzyme	NN	O	enzyme	nn	37	SENT_212	[p13l1848t388r2146b453],
36	kinetic	JJ	O	kinetic	amod	37	SENT_212	[p13l7t481r268b548],
37	parameters	NNS	O	parameter	nsubjpass	50	SENT_212	[p13l325t491r747b568],
38	of	IN	O	of	_	0	SENT_212	[p13l806t481r889b548],
39	glimepiride	NN	O	glimepiride	nn	40	SENT_212	[p13l940t481r1383b568],
40	hydroxylation	NN	O	hydroxylation	prep_of	37	SENT_212	[p13l1439t481r1981b568],
41	for	IN	O	for	_	0	SENT_212	[p13l2037t481r2148b548],
42	CYP2C9	NN	O	cyp2c9	prep_for	40	SENT_212	[p13l9t597r442b665],
43	*	CD	NUMBER	*	num	44	SENT_212	[p13l9t597r442b665],
44	l	NN	O	l	tmod	40	SENT_212	[p13l9t597r442b665],
45	and	CC	O	and	_	0	SENT_212	[p13l510t597r645b664],
46	CYP2C9	NN	O	cyp2c9	nsubjpass	50	SENT_212	[p13l703t597r1139b665],
47	*	CD	NUMBER	*	number	48	SENT_212	[p13l703t597r1139b665],
48	3	CD	NUMBER	3	dep	46	SENT_212	[p13l703t597r1139b665],
49	are	VBP	O	be	auxpass	50	SENT_212	[p13l1203t618r1316b664],
50	shown	VBN	O	show	rcmod	33	SENT_212	[p13l1378t597r1621b665],
51	in	IN	O	in	_	0	SENT_212	[p13l1679t597r1751b664],
52	Table	NNP	O	Table	prep_in	50	SENT_212	[p13l1809t597r2018b664],
53	3	CD	NUMBER	3	num	52	SENT_212	[p13l2080t597r2142b665],
54	.	.	O	.	_	0	SENT_212	[p13l2080t597r2142b665],

1	Although	IN	O	although	mark	12	SENT_213	[p13l8t711r371b798],
2	the	DT	O	the	det	4	SENT_213	[p13l402t711r517b778],
3	apparent	JJ	O	apparent	amod	4	SENT_213	[p13l551t721r881b798],
4	Km	NN	O	km	nsubj	12	SENT_213	[p13l910t714r1030b794],
5	of	IN	O	of	_	0	SENT_213	[p13l1061t711r1144b779],
6	CYP2C9	NN	O	cyp2c9	prep_of	4	SENT_213	[p13l1170t712r1606b780],
7	*	CD	NUMBER	*	number	8	SENT_213	[p13l1170t712r1606b780],
8	3	CD	NUMBER	3	num	6	SENT_213	[p13l1170t712r1606b780],
9	remained	VBD	O	remain	cop	12	SENT_213	[p13l1640t712r2000b779],
10	the	DT	O	the	det	12	SENT_213	[p13l2031t712r2146b779],
11	same	JJ	O	same	amod	12	SENT_213	[p13l11t849r204b894],
12	value	NN	O	value	advcl	23	SENT_213	[p13l225t827r430b894],
13	as	IN	O	as	_	0	SENT_213	[p13l456t849r530b894],
14	that	DT	O	that	prep_as	12	SENT_213	[p13l554t827r698b894],
15	of	IN	O	of	_	0	SENT_213	[p13l721t827r804b894],
16	CYP2C9	NN	O	cyp2c9	prep_of	14	SENT_213	[p13l821t828r1283b907],
17	*	CD	NUMBER	*	num	18	SENT_213	[p13l821t828r1283b907],
18	l	NN	O	l	tmod	14	SENT_213	[p13l821t828r1283b907],
19	,	,	O	,	_	0	SENT_213	[p13l821t828r1283b907],
20	CYP2C9	NN	O	cyp2c9	nn	21	SENT_213	[p13l1310t828r1743b896],
21	*	NN	O	*	nsubj	23	SENT_213	[p13l1310t828r1743b896],
22	l	NN	O	l	tmod	23	SENT_213	[p13l1310t828r1743b896],
23	had	VBD	O	have	_	0	SENT_213	[p13l1773t827r1911b894],
24	a	DT	O	a	det	29	SENT_213	[p13l1936t849r1975b894],
25	3.3	CD	NUMBER	3.3	num	26	SENT_213	[p13l1999t828r2144b894, p13l8t942r163b1009],
26	fold	NN	O	fold	npadvmod	27	SENT_213	[p13l1999t828r2144b894, p13l8t942r163b1009],
27	higher	JJR	O	higher	amod	29	SENT_213	[p13l198t942r445b1029],
28	Vmax	NN	MISC	vmax	nn	29	SENT_213	[p13l486t945r662b1026],
29	value	NN	O	value	dobj	23	SENT_213	[p13l699t942r903b1010],
30	than	IN	O	than	_	0	SENT_213	[p13l942t942r1106b1009],
31	CYP2C9	NN	O	cyp2c9	prep_than	29	SENT_213	[p13l1144t943r1604b1011],
32	*	CD	NUMBER	*	number	33	SENT_213	[p13l1144t943r1604b1011],
33	3	CD	NUMBER	3	num	31	SENT_213	[p13l1144t943r1604b1011],
34	.	.	O	.	_	0	SENT_213	[p13l1144t943r1604b1011],

1	The	DT	O	the	det	6	SENT_214	[p13l1646t942r1794b1009],
2	intrinsic	JJ	O	intrinsic	amod	6	SENT_214	[p13l1831t942r2145b1009],
3	clearance	NN	O	clearance	nn	6	SENT_214	[p13l9t1058r372b1126],
4	(	NN	O	(	nn	6	SENT_214	[p13l423t1058r811b1142],
5	Vmax/Km	NN	O	vmax/km	nn	6	SENT_214	[p13l423t1058r811b1142],
6	)	NN	O	)	nsubjpass	12	SENT_214	[p13l423t1058r811b1142],
7	of	IN	O	of	_	0	SENT_214	[p13l862t1058r945b1126],
8	CYP2C9	NN	O	cyp2c9	prep_of	6	SENT_214	[p13l987t1058r1423b1127],
9	*	CD	NUMBER	*	number	10	SENT_214	[p13l987t1058r1423b1127],
10	3	CD	NUMBER	3	num	8	SENT_214	[p13l987t1058r1423b1127],
11	was	VBD	O	be	auxpass	12	SENT_214	[p13l1475t1079r1620b1126],
12	found	VBN	O	find	_	0	SENT_214	[p13l1669t1058r1893b1126],
13	to	TO	O	to	aux	17	SENT_214	[p13l1938t1068r2010b1126],
14	be	VB	O	be	cop	17	SENT_214	[p13l2057t1058r2146b1126],
15	about	RB	O	about	quantmod	16	SENT_214	[p13l10t1172r222b1239],
16	20	CD	PERCENT	20	num	17	SENT_214	[p13l258t1172r426b1239],
17	%	NN	PERCENT	%	xcomp	12	SENT_214	[p13l258t1172r426b1239],
18	of	IN	O	of	_	0	SENT_214	[p13l467t1172r550b1239],
19	that	DT	O	that	prep_of	17	SENT_214	[p13l577t1172r722b1239],
20	for	IN	O	for	_	0	SENT_214	[p13l757t1172r868b1239],
21	CYP2C9	NN	O	cyp2c9	nn	22	SENT_214	[p13l902t1172r1334b1240],
22	*	NN	O	*	prep_for	19	SENT_214	[p13l902t1172r1334b1240],
23	1	CD	NUMBER	1	number	24	SENT_214	[p13l902t1172r1334b1240],
24	(	CD	NUMBER	(	num	27	SENT_214	[p13l1381t1172r1621b1254],
25	Table	NNP	O	Table	nn	27	SENT_214	[p13l1381t1172r1621b1254],
26	3	CD	NUMBER	3	num	27	SENT_214	[p13l1660t1172r1754b1254],
27	)	NN	O	)	dep	22	SENT_214	[p13l1660t1172r1754b1254],
28	.	.	O	.	_	0	SENT_214	[p13l1660t1172r1754b1254],

1	4	LS	NUMBER	4	_	0	SENT_215	[p13l8t1402r76b1470],
2	.	.	O	.	_	0	SENT_215	[p13l8t1402r76b1470],

1	Discussion	NN	O	discussion	_	0	SENT_216	[p13l129t1401r561b1470],

1	The	DT	O	the	det	2	SENT_217	[p13l124t1634r272b1700],
2	purpose	NN	O	purpose	nsubj	7	SENT_217	[p13l305t1655r609b1721],
3	of	IN	O	of	_	0	SENT_217	[p13l645t1633r728b1700],
4	the	DT	O	the	det	6	SENT_217	[p13l755t1634r871b1700],
5	present	JJ	DATE	present	amod	6	SENT_217	[p13l904t1644r1184b1721],
6	study	NN	O	study	prep_of	2	SENT_217	[p13l1220t1634r1423b1721],
7	was	VBD	O	be	_	0	SENT_217	[p13l1458t1655r1603b1701],
8	to	TO	O	to	aux	9	SENT_217	[p13l1639t1643r1710b1700],
9	clarify	VB	O	clarify	xcomp	7	SENT_217	[p13l1747t1633r1995b1721],
10	the	DT	O	the	dobj	9	SENT_217	[p13l2031t1634r2146b1700],
11	effects	NNS	O	effect	dep	20	SENT_217	[p13l9t1749r259b1816],
12	of	IN	O	of	_	0	SENT_217	[p13l287t1749r370b1816],
13	the	DT	O	the	det	16	SENT_217	[p13l387t1749r502b1816],
14	C	NN	O	c	nn	16	SENT_217	[p13l531t1751r592b1817],
15	YP2	NN	O	yp2	nn	16	SENT_217	[p13l597t1750r746b1815],
16	C	NN	O	c	prep_of	11	SENT_217	[p13l756t1751r817b1817],
17	9	CD	NUMBER	9	num	18	SENT_217	[p13l818t1750r864b1817],
18	*	NN	O	*	dep	20	SENT_217	[p13l876t1750r958b1816],
19	3	CD	NUMBER	3	num	20	SENT_217	[p13l876t1750r958b1816],
20	polymorphism	NN	O	polymorphism	dep	10	SENT_217	[p13l982t1749r1546b1836],
21	on	IN	O	on	_	0	SENT_217	[p13l1570t1771r1663b1816],
22	the	DT	O	the	det	23	SENT_217	[p13l1686t1749r1801b1816],
23	efﬁcacy	NN	O	efﬁcacy	prep_on	20	SENT_217	[p13l1826t1749r2144b1836],
24	,	,	O	,	_	0	SENT_217	[p13l1826t1749r2144b1836],
25	safety	NN	O	safety	appos	23	SENT_217	[p13l11t1864r251b1951],
26	,	,	O	,	_	0	SENT_217	[p13l11t1864r251b1951],
27	and	CC	O	and	_	0	SENT_217	[p13l295t1864r430b1931],
28	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	20	SENT_217	[p13l465t1864r1146b1951],
29	of	IN	O	of	_	0	SENT_217	[p13l1187t1864r1270b1931],
30	glimepiride	NN	O	glimepiride	nn	31	SENT_217	[p13l1301t1864r1744b1951],
31	treatment	NN	O	treatment	prep_of	28	SENT_217	[p13l1782t1874r2148b1931],
32	in	IN	O	in	_	0	SENT_217	[p13l8t1979r81b2045],
33	Japanese	JJ	MISC	japanese	amod	34	SENT_217	[p13l151t1981r492b2066],
34	patients	NNS	O	patient	prep_in	9	SENT_217	[p13l562t1979r860b2066],
35	with	IN	O	with	_	0	SENT_217	[p13l934t1979r1103b2046],
36	type	NN	O	type	nn	38	SENT_217	[p13l1173t1989r1336b2066],
37	2	CD	NUMBER	2	num	38	SENT_217	[p13l1409t1979r1453b2045],
38	diabetes	NN	O	diabetes	prep_with	9	SENT_217	[p13l1525t1979r1858b2046],
39	.	.	O	.	_	0	SENT_217	[p13l1525t1979r1858b2046],

1	Since	IN	O	since	_	0	SENT_218	[p13l1937t1979r2146b2046],
2	C	NN	O	c	nn	3	SENT_218	[p13l13t2095r73b2162],
3	YP2C9	NN	O	yp2c9	prep_since	12	SENT_218	[p13l78t2094r441b2162],
4	*	CD	NUMBER	*	number	8	SENT_218	[p13l78t2094r441b2162],
5	5	CD	NUMBER	5	number	8	SENT_218	[p13l78t2094r441b2162],
6	and	CC	O	and	_	0	SENT_218	[p13l503t2094r639b2161],
7	*	CD	NUMBER	*	nsubjpass	12	SENT_218	[p13l710t2093r796b2160],
8	6	CD	NUMBER	6	nsubjpass	12	SENT_218	[p13l710t2093r796b2160],
9	have	VBP	O	have	aux	12	SENT_218	[p13l853t2094r1032b2161],
10	not	RB	O	not	neg	12	SENT_218	[p13l1093t2104r1215b2161],
11	been	VBN	O	be	auxpass	12	SENT_218	[p13l1273t2094r1455b2161],
12	reported	VBN	O	report	ccomp	47	SENT_218	[p13l1515t2094r1837b2181],
13	in	IN	O	in	_	0	SENT_218	[p13l1897t2094r1970b2160],
14	the	DT	O	the	det	16	SENT_218	[p13l2031t2094r2146b2161],
15	Japanese	JJ	MISC	japanese	amod	16	SENT_218	[p13l7t2211r349b2296],
16	population	NN	O	population	prep_in	12	SENT_218	[p13l384t2209r797b2296],
17	and	CC	O	and	_	0	SENT_218	[p13l834t2209r970b2276],
18	only	RB	O	only	advmod	21	SENT_218	[p13l1005t2209r1173b2296],
19	one	CD	NUMBER	one	num	21	SENT_218	[p13l1210t2231r1346b2276],
20	Japanese	JJ	MISC	japanese	amod	21	SENT_218	[p13l1381t2211r1722b2296],
21	individual	NN	O	individual	nsubjpass	28	SENT_218	[p13l1758t2209r2146b2277],
22	with	IN	O	with	_	0	SENT_218	[p13l8t2324r178b2391],
23	CYP2C9	NN	O	cyp2c9	prep_with	21	SENT_218	[p13l257t2325r684b2392],
24	*	CD	NUMBER	*	number	25	SENT_218	[p13l257t2325r684b2392],
25	4	CD	NUMBER	4	num	23	SENT_218	[p13l257t2325r684b2392],
26	has	VBZ	O	have	aux	28	SENT_218	[p13l758t2324r883b2391],
27	been	VBN	O	be	auxpass	28	SENT_218	[p13l958t2324r1140b2391],
28	identiﬁed	VBN	O	identiﬁed	conj_and	12	SENT_218	[p13l1214t2324r1579b2391],
29	[	CD	NUMBER	[	num	30	SENT_218	[p13l1660t2324r1952b2405],
30	l5	NN	O	l5	dobj	28	SENT_218	[p13l1660t2324r1952b2405],
31	,25	CD	NUMBER	,25	num	32	SENT_218	[p13l1660t2324r1952b2405],
32	]	NN	O	]	dep	30	SENT_218	[p13l1660t2324r1952b2405],
33	,	,	O	,	_	0	SENT_218	[p13l1660t2324r1952b2405],
34	the	DT	O	the	det	36	SENT_218	[p13l2031t2324r2146b2391],
35	CYP2C9	NN	O	cyp2c9	nn	36	SENT_218	[p13l13t2439r345b2506],
36	*	NN	O	*	appos	30	SENT_218	[p13l358t2439r461b2518],
37	1	CD	NUMBER	1	dep	36	SENT_218	[p13l358t2439r461b2518],
38	,	,	O	,	_	0	SENT_218	[p13l358t2439r461b2518],
39	*	CD	NUMBER	*	number	40	SENT_218	[p13l504t2439r608b2518],
40	2	CD	NUMBER	2	nsubjpass	47	SENT_218	[p13l504t2439r608b2518],
41	,	,	O	,	_	0	SENT_218	[p13l504t2439r608b2518],
42	and	CC	O	and	_	0	SENT_218	[p13l643t2439r779b2506],
43	*	NN	O	*	conj_and	40	SENT_218	[p13l818t2439r899b2505],
44	3	CD	NUMBER	3	num	45	SENT_218	[p13l818t2439r899b2505],
45	polymorphisms	NNS	O	polymorphism	dep	43	SENT_218	[p13l929t2439r1527b2526],
46	were	VBD	O	be	auxpass	47	SENT_218	[p13l1559t2460r1743b2506],
47	examined	VBN	O	examine	_	0	SENT_218	[p13l1774t2439r2148b2506],
48	in	IN	O	in	_	0	SENT_218	[p13l8t2554r81b2620],
49	the	DT	O	the	det	51	SENT_218	[p13l145t2554r260b2620],
50	present	JJ	DATE	present	amod	51	SENT_218	[p13l324t2564r603b2641],
51	study	NN	O	study	prep_in	47	SENT_218	[p13l670t2554r887b2641],
52	.	.	O	.	_	0	SENT_218	[p13l670t2554r887b2641],

1	The	DT	O	the	det	3	SENT_219	[p13l955t2554r1103b2620],
2	allele	NN	O	allele	nn	3	SENT_219	[p13l1170t2554r1376b2620],
3	frequency	NN	O	frequency	nsubjpass	17	SENT_219	[p13l1441t2554r1824b2641],
4	of	IN	O	of	_	0	SENT_219	[p13l1890t2554r1973b2620],
5	the	DT	O	the	det	10	SENT_219	[p13l2031t2554r2146b2620],
6	C	NN	O	c	nn	10	SENT_219	[p13l13t2671r73b2737],
7	YP2C9	NN	O	yp2c9	nn	10	SENT_219	[p13l78t2670r439b2737],
8	*	CD	NUMBER	*	number	9	SENT_219	[p13l78t2670r439b2737],
9	3	CD	NUMBER	3	num	10	SENT_219	[p13l78t2670r439b2737],
10	polymorphism	NN	O	polymorphism	prep_of	3	SENT_219	[p13l480t2669r1044b2756],
11	in	IN	O	in	_	0	SENT_219	[p13l1083t2669r1156b2735],
12	the	DT	O	the	det	14	SENT_219	[p13l1196t2669r1312b2736],
13	Japanese	JJ	MISC	japanese	amod	14	SENT_219	[p13l1352t2671r1693b2756],
14	population	NN	O	population	prep_in	10	SENT_219	[p13l1733t2669r2147b2756],
15	was	VBD	O	be	auxpass	17	SENT_219	[p13l8t2805r153b2851],
16	previously	RB	DATE	previously	advmod	17	SENT_219	[p13l192t2784r596b2871],
17	observed	VBN	O	observe	_	0	SENT_219	[p13l636t2784r982b2851],
18	to	TO	O	to	aux	25	SENT_219	[p13l1018t2794r1090b2851],
19	be	VB	O	be	cop	25	SENT_219	[p13l1128t2784r1217b2851],
20	around	RB	O	around	advmod	25	SENT_219	[p13l1257t2784r1522b2851],
21	2	CD	PERCENT	2	num	22	SENT_219	[p13l1561t2784r1681b2851],
22	%	NN	PERCENT	%	pobj	20	SENT_219	[p13l1561t2784r1681b2851],
23	[	CD	NUMBER	[	number	24	SENT_219	[p13l1730t2783r2144b2865],
24	15,26,27	CD	NUMBER	15,26,27	num	25	SENT_219	[p13l1730t2783r2144b2865],
25	]	NN	O	]	xcomp	17	SENT_219	[p13l1730t2783r2144b2865],
26	,	,	O	,	_	0	SENT_219	[p13l1730t2783r2144b2865],
27	although	IN	O	although	mark	35	SENT_219	[p13l10t2899r344b2986],
28	the	DT	O	the	det	30	SENT_219	[p13l390t2899r506b2966],
29	allele	NN	O	allele	nn	30	SENT_219	[p13l554t2899r759b2966],
30	frequency	NN	O	frequency	nsubjpass	35	SENT_219	[p13l806t2899r1189b2986],
31	among	IN	O	among	_	0	SENT_219	[p13l1237t2920r1496b2986],
32	Caucasians	NNPS	MISC	Caucasians	prep_among	30	SENT_219	[p13l1543t2899r1973b2966],
33	has	VBZ	O	have	aux	35	SENT_219	[p13l2020t2899r2145b2966],
34	been	VBN	O	be	auxpass	35	SENT_219	[p13l7t3014r188b3081],
35	reported	VBN	O	report	dep	25	SENT_219	[p13l234t3014r556b3101],
36	to	TO	O	to	aux	38	SENT_219	[p13l602t3024r673b3081],
37	be	VB	O	be	cop	38	SENT_219	[p13l719t3014r808b3081],
38	higher	JJR	O	higher	xcomp	35	SENT_219	[p13l854t3014r1102b3101],
39	than	IN	O	than	mark	44	SENT_219	[p13l1146t3014r1310b3081],
40	that	DT	O	that	nsubj	44	SENT_219	[p13l1356t3014r1500b3081],
41	among	IN	O	among	_	0	SENT_219	[p13l1548t3035r1806b3101],
42	oriental	JJ	O	oriental	amod	43	SENT_219	[p13l1854t3014r2146b3081],
43	populations	NNS	O	population	prep_among	40	SENT_219	[p13l7t3129r455b3216],
44	[	VBP	O	[	ccomp	38	SENT_219	[p13l500t3129r912b3210],
45	l5	NN	O	l5	dobj	44	SENT_219	[p13l500t3129r912b3210],
46	,	,	O	,	_	0	SENT_219	[p13l500t3129r912b3210],
47	l6	NN	O	l6	nn	49	SENT_219	[p13l500t3129r912b3210],
48	,28	CD	NUMBER	,28	num	49	SENT_219	[p13l500t3129r912b3210],
49	]	NN	O	]	appos	45	SENT_219	[p13l500t3129r912b3210],
50	.	.	O	.	_	0	SENT_219	[p13l500t3129r912b3210],

1	The	DT	O	the	det	3	SENT_220	[p13l954t3129r1101b3196],
2	allele	NN	O	allele	nn	3	SENT_220	[p13l1139t3129r1346b3196],
3	frequency	NN	O	frequency	nsubj	14	SENT_220	[p13l1382t3129r1765b3216],
4	observed	VBN	O	observe	partmod	3	SENT_220	[p13l1802t3129r2149b3197],
5	in	IN	O	in	_	0	SENT_220	[p13l8t3244r81b3310],
6	the	DT	O	the	det	8	SENT_220	[p13l145t3244r259b3311],
7	present	JJ	DATE	present	amod	8	SENT_220	[p13l324t3254r603b3331],
8	study	NN	O	study	prep_in	4	SENT_220	[p13l669t3244r872b3331],
9	(	CD	PERCENT	(	num	11	SENT_220	[p13l940t3244r1245b3327],
10	0.75	CD	PERCENT	0.75	num	11	SENT_220	[p13l940t3244r1245b3327],
11	%	NN	PERCENT	%	tmod	4	SENT_220	[p13l940t3244r1245b3327],
12	)	CD	NUMBER	)	dep	11	SENT_220	[p13l940t3244r1245b3327],
13	was	VBD	O	be	cop	14	SENT_220	[p13l1312t3266r1457b3311],
14	lower	JJR	O	lower	_	0	SENT_220	[p13l1523t3244r1741b3312],
15	than	IN	O	than	_	0	SENT_220	[p13l1802t3244r1967b3311],
16	the	DT	O	the	det	20	SENT_220	[p13l2031t3244r2146b3311],
17	previously	RB	DATE	previously	advmod	18	SENT_220	[p13l7t3359r411b3446],
18	reported	VBN	O	report	amod	20	SENT_220	[p13l451t3359r773b3446],
19	Japanese	JJ	MISC	japanese	amod	20	SENT_220	[p13l811t3360r1152b3446],
20	frequency	NN	O	frequency	prep_than	14	SENT_220	[p13l1193t3359r1590b3446],
21	.	.	O	.	_	0	SENT_220	[p13l1193t3359r1590b3446],

1	One	CD	NUMBER	one	num	3	SENT_221	[p13l1636t3359r1792b3426],
2	possible	JJ	O	possible	amod	3	SENT_221	[p13l1831t3359r2146b3446],
3	explanation	NN	O	explanation	nsubj	11	SENT_221	[p13l9t3474r458b3561],
4	for	IN	O	for	_	0	SENT_221	[p13l505t3474r617b3540],
5	this	DT	O	this	det	6	SENT_221	[p13l663t3474r799b3540],
6	discrepancy	NN	O	discrepancy	prep_for	3	SENT_221	[p13l850t3474r1308b3561],
7	may	MD	O	may	aux	11	SENT_221	[p13l1356t3495r1520b3561],
8	be	VB	O	be	cop	11	SENT_221	[p13l1567t3474r1657b3540],
9	a	DT	O	a	det	11	SENT_221	[p13l1708t3495r1748b3540],
10	sampling	NN	O	sampling	nn	11	SENT_221	[p13l1797t3474r2146b3561],
11	bias	NN	O	bias	_	0	SENT_221	[p13l7t3589r181b3656],
12	.	.	O	.	_	0	SENT_221	[p13l7t3589r181b3656],

1	Some	DT	O	some	det	2	SENT_222	[p13l222t3590r436b3657],
2	subjects	NNS	O	subject	nsubjpass	12	SENT_222	[p13l474t3589r777b3676],
3	with	IN	O	with	_	0	SENT_222	[p13l814t3589r983b3657],
4	a	DT	O	a	det	6	SENT_222	[p13l1019t3611r1058b3656],
5	C	NN	O	c	nn	6	SENT_222	[p13l1095t3591r1156b3657],
6	YP2C9	NN	O	yp2c9	prep_with	2	SENT_222	[p13l1161t3590r1521b3657],
7	*	CD	NUMBER	*	number	8	SENT_222	[p13l1161t3590r1521b3657],
8	3	CD	DATE	3	num	6	SENT_222	[p13l1161t3590r1521b3657],
9	may	MD	DATE	may	aux	12	SENT_222	[p13l1557t3611r1720b3676],
10	have	VB	O	have	aux	12	SENT_222	[p13l1754t3589r1932b3656],
11	been	VBN	O	be	auxpass	12	SENT_222	[p13l1965t3589r2147b3656],
12	excluded	VBN	O	exclude	_	0	SENT_222	[p13l9t3704r356b3771],
13	from	IN	O	from	_	0	SENT_222	[p13l432t3704r617b3771],
14	the	DT	O	the	det	15	SENT_222	[p13l693t3704r808b3771],
15	study	NN	O	study	prep_from	12	SENT_222	[p13l889t3704r1091b3791],
16	if	IN	O	if	mark	19	SENT_222	[p13l1168t3704r1231b3770],
17	they	PRP	O	they	nsubj	19	SENT_222	[p13l1301t3704r1464b3791],
18	had	VBD	O	have	aux	19	SENT_222	[p13l1540t3704r1678b3771],
19	developed	VBN	O	develop	advcl	12	SENT_222	[p13l1755t3704r2148b3791],
20	hypoglycemia	NN	O	hypoglycemia	dobj	19	SENT_222	[p14l7t21r556b108],
21	or	CC	O	or	_	0	SENT_222	[p14l597t42r675b88],
22	a	DT	O	a	det	25	SENT_222	[p14l717t42r757b88],
23	serious	JJ	O	serious	amod	25	SENT_222	[p14l799t21r1065b88],
24	weight	NN	O	weight	nn	25	SENT_222	[p14l1108t21r1370b108],
25	gain	NN	O	gain	dobj	19	SENT_222	[p14l1411t21r1574b108],
26	as	IN	O	as	_	0	SENT_222	[p14l1617t42r1691b88],
27	a	DT	O	a	det	28	SENT_222	[p14l1737t42r1776b88],
28	result	NN	O	result	prep_as	19	SENT_222	[p14l1815t21r2029b88],
29	of	IN	O	of	_	0	SENT_222	[p14l2070t21r2153b88],
30	glimepiride	NN	O	glimepiride	nn	31	SENT_222	[p14l9t136r452b223],
31	treatment	NN	O	treatment	prep_of	28	SENT_222	[p14l488t146r854b203],
32	at	IN	O	at	_	0	SENT_222	[p14l890t146r957b203],
33	the	DT	O	the	det	34	SENT_222	[p14l990t136r1106b203],
34	time	NN	O	time	prep_at	19	SENT_222	[p14l1141t136r1311b203],
35	of	IN	O	of	_	0	SENT_222	[p14l1348t136r1431b203],
36	recruitment	NN	O	recruitment	prep_of	34	SENT_222	[p14l1458t136r1923b203],
37	.	.	O	.	_	0	SENT_222	[p14l1458t136r1923b203],

1	We	PRP	O	we	nsubj	2	SENT_223	[p14l123t253r248b318],
2	demonstrated	VBD	O	demonstrate	_	0	SENT_223	[p14l299t251r818b319],
3	that	IN	O	that	complm	12	SENT_223	[p14l867t251r1011b318],
4	the	DT	O	the	det	5	SENT_223	[p14l1058t251r1174b318],
5	responses	NNS	O	response	nsubj	12	SENT_223	[p14l1222t273r1594b338],
6	of	IN	O	of	_	0	SENT_223	[p14l1646t251r1730b318],
7	HbA1C	NN	O	hba1c	prep_of	5	SENT_223	[p14l1773t251r2024b334],
8	to	TO	O	to	_	0	SENT_223	[p14l2074t261r2146b318],
9	glimepiride	NN	O	glimepiride	nn	10	SENT_223	[p14l9t366r452b453],
10	treatment	NN	O	treatment	prep_to	7	SENT_223	[p14l495t376r860b433],
11	were	VBD	O	be	cop	12	SENT_223	[p14l900t388r1084b433],
12	greater	JJR	O	greater	ccomp	2	SENT_223	[p14l1126t376r1393b453],
13	in	IN	O	in	_	0	SENT_223	[p14l1432t366r1506b432],
14	subjects	NNS	O	subject	prep_in	12	SENT_223	[p14l1550t366r1853b453],
15	with	IN	O	with	_	0	SENT_223	[p14l1897t366r2066b434],
16	a	DT	O	a	prep_with	14	SENT_223	[p14l2109t388r2148b433],

1	K.	NNP	PERSON	K.	nn	2	SENT_224	[p14l332t529r359b552],
2	Suzuki	NNP	PERSON	Suzuki	_	0	SENT_224	[p14l374t528r460b554],
3	et	FW	O	et	nn	4	SENT_224	[p14l472t533r496b552],
4	al.	FW	O	al.	dep	2	SENT_224	[p14l506t528r678b552],
5	/	:	O	/	punct	2	SENT_224	[p14l506t528r678b552],
6	Diabetes	NNP	ORGANIZATION	Diabetes	dep	2	SENT_224	[p14l506t528r678b552],
7	Research	NNP	ORGANIZATION	Research	dep	6	SENT_224	[p14l689t528r811b552],
8	and	CC	ORGANIZATION	and	_	0	SENT_224	[p14l823t528r874b552],
9	Clinical	JJ	ORGANIZATION	clinical	amod	10	SENT_224	[p14l886t528r991b552],
10	Practice	NN	ORGANIZATION	practice	dep	2	SENT_224	[p14l1002t529r1114b552],
11	72	CD	NUMBER	72	number	12	SENT_224	[p14l1128t528r1158b552],
12	(	CD	NUMBER	(	num	13	SENT_224	[p14l1171t528r1257b557],
13	2006	CD	DATE	2006	dep	10	SENT_224	[p14l1171t528r1257b557],
14	)	CD	NUMBER	)	num	15	SENT_224	[p14l1171t528r1257b557],
15	148-154 153	CD	NUMBER	148-154 153	dep	10	SENT_224	[p14l1784t528r1828b552],[p14l1271t528r1385b551],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_225	[p14l12t674r561b742],
2	*	CD	NUMBER	*	num	3	SENT_225	[p14l12t674r561b742],
3	]	CD	NUMBER	]	dep	1	SENT_225	[p14l12t674r561b742],
4	/	:	O	/	punct	1	SENT_225	[p14l12t674r561b742],
5	*	CD	NUMBER	*	num	6	SENT_225	[p14l12t674r561b742],
6	3	CD	NUMBER	3	npadvmod	7	SENT_225	[p14l12t674r561b742],
7	than	IN	O	than	advmod	8	SENT_225	[p14l608t674r773b741],
8	in	IN	O	in	dep	14	SENT_225	[p14l818t674r890b740],
9	subjects	NNS	O	subject	pobj	8	SENT_225	[p14l939t674r1243b761],
10	with	IN	O	with	_	0	SENT_225	[p14l1291t674r1460b741],
11	a	DT	O	a	det	12	SENT_225	[p14l1506t695r1546b741],
12	CYP2C9	NN	O	cyp2c9	prep_with	9	SENT_225	[p14l1594t674r2139b742],
13	*	CD	NUMBER	*	num	12	SENT_225	[p14l1594t674r2139b742],
14	I	PRP	O	I	dep	1	SENT_225	[p14l1594t674r2139b742],
15	/	:	O	/	punct	14	SENT_225	[p14l1594t674r2139b742],
16	*	CD	NUMBER	*	num	17	SENT_225	[p14l1594t674r2139b742],
17	1	CD	NUMBER	1	dep	14	SENT_225	[p14l1594t674r2139b742],
18	(	CD	NUMBER	(	num	19	SENT_225	[p14l10t789r185b876],
19	Fig	NN	O	fig	dep	17	SENT_225	[p14l10t789r185b876],
20	.	.	O	.	_	0	SENT_225	[p14l10t789r185b876],

1	1	CD	NUMBER	1	_	0	SENT_226	[p14l222t789r310b872],
2	)	NN	O	)	dep	1	SENT_226	[p14l222t789r310b872],
3	.	.	O	.	_	0	SENT_226	[p14l222t789r310b872],

1	Notably	RB	O	notably	advmod	23	SENT_227	[p14l338t789r662b876],
2	,	,	O	,	_	0	SENT_227	[p14l338t789r662b876],
3	a	DT	O	a	det	18	SENT_227	[p14l691t810r731b856],
4	female	JJ	O	female	amod	18	SENT_227	[p14l753t789r1014b856],
5	subject	JJ	O	subject	amod	18	SENT_227	[p14l1041t789r1311b876],
6	with	IN	O	with	_	0	SENT_227	[p14l1334t789r1503b856],
7	a	DT	O	a	det	9	SENT_227	[p14l1528t810r1568b856],
8	CYP2C9	NN	O	cyp2c9	nn	9	SENT_227	[p14l1594t789r1927b856],
9	*	NN	O	*	prep_with	5	SENT_227	[p14l1939t789r2144b856],
10	1	CD	NUMBER	1	tmod	5	SENT_227	[p14l1939t789r2144b856],
11	/	:	O	/	punct	13	SENT_227	[p14l1939t789r2144b856],
12	*	CD	NUMBER	*	number	13	SENT_227	[p14l1939t789r2144b856],
13	3	CD	NUMBER	3	dep	18	SENT_227	[p14l1939t789r2144b856],
14	(	NN	O	(	nn	15	SENT_227	[p14l10t906r202b989],
15	case	NN	O	case	dep	13	SENT_227	[p14l10t906r202b989],
16	#	#	MONEY	#	dep	17	SENT_227	[p14l253t906r377b989],
17	1	CD	MONEY	1	dep	13	SENT_227	[p14l253t906r377b989],
18	)	NN	O	)	nsubj	23	SENT_227	[p14l253t906r377b989],
19	who	WP	O	who	nsubj	22	SENT_227	[p14l431t905r593b973],
20	was	VBD	O	be	cop	22	SENT_227	[p14l643t927r788b973],
21	not	RB	O	not	neg	22	SENT_227	[p14l840t916r962b973],
22	obese	JJ	O	obese	rcmod	18	SENT_227	[p14l1013t905r1228b973],
23	showed	VBD	O	show	_	0	SENT_227	[p14l1284t905r1571b973],
24	a	DT	O	a	det	26	SENT_227	[p14l1622t927r1662b973],
25	remarkable	JJ	O	remarkable	amod	26	SENT_227	[p14l1710t905r2144b973],
26	improvement	NN	O	improvement	nsubj	32	SENT_227	[p14l7t1020r521b1107],
27	in	IN	O	in	_	0	SENT_227	[p14l570t1020r644b1086],
28	her	PRP$	O	she	poss	31	SENT_227	[p14l693t1020r817b1087],
29	blood	NN	O	blood	nn	31	SENT_227	[p14l864t1020r1084b1087],
30	glucose	NN	O	glucose	nn	31	SENT_227	[p14l1135t1020r1426b1107],
31	levels	NNS	O	level	prep_in	26	SENT_227	[p14l1478t1020r1697b1087],
32	(	VBP	O	(	ccomp	23	SENT_227	[p14l1752t1020r1992b1103],
33	Table	NNP	O	Table	nsubj	35	SENT_227	[p14l1752t1020r1992b1103],
34	1	CD	NUMBER	1	num	35	SENT_227	[p14l2053t1021r2140b1103],
35	)	CD	NUMBER	)	xcomp	32	SENT_227	[p14l2053t1021r2140b1103],
36	.	.	O	.	_	0	SENT_227	[p14l2053t1021r2140b1103],

1	Moreover	RB	O	moreover	advmod	20	SENT_228	[p14l7t1136r401b1214],
2	,	,	O	,	_	0	SENT_228	[p14l7t1136r401b1214],
3	an	DT	O	a	det	6	SENT_228	[p14l437t1156r524b1202],
4	obese	JJ	O	obese	dep	5	SENT_228	[p14l555t1135r770b1202],
5	male	NN	O	male	amod	6	SENT_228	[p14l802t1135r987b1202],
6	subject	NN	O	subject	nsubj	20	SENT_228	[p14l1021t1135r1291b1222],
7	with	IN	O	with	_	0	SENT_228	[p14l1321t1135r1490b1202],
8	a	DT	O	a	det	10	SENT_228	[p14l1522t1156r1561b1202],
9	CYP2C9	NN	O	cyp2c9	nn	10	SENT_228	[p14l1594t1135r1927b1202],
10	*	NN	O	*	prep_with	6	SENT_228	[p14l1939t1135r2144b1202],
11	1	CD	NUMBER	1	dep	10	SENT_228	[p14l1939t1135r2144b1202],
12	/	:	O	/	punct	19	SENT_228	[p14l1939t1135r2144b1202],
13	*	CD	NUMBER	*	number	14	SENT_228	[p14l1939t1135r2144b1202],
14	3	CD	NUMBER	3	num	16	SENT_228	[p14l1939t1135r2144b1202],
15	(	NN	O	(	nn	16	SENT_228	[p14l10t1251r203b1333],
16	case	NN	O	case	dep	19	SENT_228	[p14l10t1251r203b1333],
17	#	#	MONEY	#	number	18	SENT_228	[p14l252t1251r376b1333],
18	2	CD	MONEY	2	amod	16	SENT_228	[p14l252t1251r376b1333],
19	)	NN	O	)	dep	10	SENT_228	[p14l252t1251r376b1333],
20	showed	VBD	O	show	_	0	SENT_228	[p14l432t1250r718b1318],
21	good	JJ	O	good	amod	23	SENT_228	[p14l768t1250r959b1337],
22	glycemic	JJ	O	glycemic	amod	23	SENT_228	[p14l1008t1250r1358b1337],
23	control	NN	O	control	dobj	20	SENT_228	[p14l1410t1250r1680b1317],
24	during	IN	O	during	_	0	SENT_228	[p14l1732t1250r1979b1337],
25	the	DT	O	the	det	27	SENT_228	[p14l2030t1250r2145b1317],
26	early	JJ	O	early	amod	27	SENT_228	[p14l8t1365r198b1452],
27	phase	NN	O	phase	prep_during	20	SENT_228	[p14l221t1365r439b1452],
28	of	IN	O	of	_	0	SENT_228	[p14l465t1365r548b1432],
29	treatment	NN	O	treatment	nn	31	SENT_228	[p14l565t1375r931b1432],
30	(	CD	NUMBER	(	num	31	SENT_228	[p14l956t1365r1131b1452],
31	Fig	NN	O	fig	prep_of	27	SENT_228	[p14l956t1365r1131b1452],
32	.	.	O	.	_	0	SENT_228	[p14l956t1365r1131b1452],

1	2	CD	NUMBER	2	num	2	SENT_229	[p14l1161t1366r1257b1448],
2	)	CD	NUMBER	)	nsubj	5	SENT_229	[p14l1161t1366r1257b1448],
3	,	,	O	,	_	0	SENT_229	[p14l1161t1366r1257b1448],
4	but	CC	O	but	advmod	5	SENT_229	[p14l1284t1365r1407b1432],
5	experienced	VBD	O	experience	_	0	SENT_229	[p14l1429t1365r1894b1452],
6	a	DT	O	a	det	7	SENT_229	[p14l1919t1387r1959b1432],
7	gain	NN	O	gain	dobj	5	SENT_229	[p14l1983t1365r2146b1452],
8	in	IN	O	in	_	0	SENT_229	[p14l7t1480r80b1546],
9	body	NN	O	body	nn	10	SENT_229	[p14l119t1480r310b1567],
10	weight	NN	O	weight	prep_in	5	SENT_229	[p14l352t1480r613b1567],
11	when	WRB	O	when	advmod	12	SENT_229	[p14l653t1480r859b1547],
12	treated	VBN	O	treat	advcl	5	SENT_229	[p14l899t1480r1162b1547],
13	with	IN	O	with	_	0	SENT_229	[p14l1203t1480r1371b1547],
14	glimepiride	NN	O	glimepiride	prep_with	12	SENT_229	[p14l1413t1480r1856b1567],
15	over	IN	O	over	_	0	SENT_229	[p14l1899t1501r2066b1547],
16	a	DT	O	a	det	18	SENT_229	[p14l2107t1501r2147b1547],
17	long	JJ	O	long	amod	18	SENT_229	[p14l7t1595r175b1682],
18	period	NN	O	period	prep_over	14	SENT_229	[p14l238t1595r502b1682],
19	.	.	O	.	_	0	SENT_229	[p14l238t1595r502b1682],

1	Because	IN	O	because	mark	7	SENT_230	[p14l570t1597r889b1662],
2	the	DT	O	the	det	5	SENT_230	[p14l953t1595r1067b1662],
3	body	NN	O	body	nn	5	SENT_230	[p14l1129t1595r1320b1682],
4	weight	NN	O	weight	nn	5	SENT_230	[p14l1384t1595r1645b1682],
5	gain	NN	O	gain	nsubj	7	SENT_230	[p14l1708t1595r1871b1682],
6	could	MD	O	could	aux	7	SENT_230	[p14l1934t1595r2146b1662],
7	associate	VB	O	associate	advcl	13	SENT_230	[p14l9t1710r354b1777],
8	with	IN	O	with	_	0	SENT_230	[p14l426t1710r595b1777],
9	the	DT	O	the	det	10	SENT_230	[p14l667t1710r782b1777],
10	hyperinsulinemia	NN	O	hyperinsulinemia	prep_with	7	SENT_230	[p14l855t1710r1547b1797],
11	,	,	O	,	_	0	SENT_230	[p14l855t1710r1547b1797],
12	there	EX	O	there	expl	13	SENT_230	[p14l1623t1710r1814b1777],
13	was	VBD	O	be	_	0	SENT_230	[p14l1886t1731r2030b1777],
14	a	DT	O	a	det	15	SENT_230	[p14l2107t1731r2146b1777],
15	possibility	NN	O	possibility	nsubj	13	SENT_230	[p14l6t1825r407b1912],
16	that	IN	O	that	complm	24	SENT_230	[p14l466t1825r610b1892],
17	the	DT	O	the	det	22	SENT_230	[p14l667t1825r782b1892],
18	long	JJ	O	long	amod	22	SENT_230	[p14l841t1825r1221b1912],
19	—	NN	O	—	nn	22	SENT_230	[p14l841t1825r1221b1912],
20	term	NN	O	term	nn	22	SENT_230	[p14l841t1825r1221b1912],
21	glimepiride	NN	O	glimepiride	nn	22	SENT_230	[p14l1279t1825r1722b1912],
22	treatment	NN	O	treatment	nsubj	24	SENT_230	[p14l1781t1835r2147b1892],
23	might	MD	O	might	aux	24	SENT_230	[p14l7t1940r232b2027],
24	induce	VB	O	induce	ccomp	13	SENT_230	[p14l254t1940r510b2007],
25	his	PRP$	O	he	poss	26	SENT_230	[p14l534t1940r643b2007],
26	hyperinsulinemia	NN	O	hyperinsulinemia	dobj	24	SENT_230	[p14l668t1940r1359b2027],
27	.	.	O	.	_	0	SENT_230	[p14l668t1940r1359b2027],

1	Case	NNP	O	Case	nsubj	4	SENT_231	[p14l1389t1941r1572b2008],
2	#	#	MONEY	#	number	3	SENT_231	[p14l1596t1941r1683b2006],
3	1	CD	MONEY	1	amod	1	SENT_231	[p14l1596t1941r1683b2006],
4	showed	VBD	O	show	_	0	SENT_231	[p14l1718t1940r2007b2008],
5	the	DT	O	the	det	8	SENT_231	[p14l2030t1940r2145b2007],
6	low	JJ	O	low	amod	8	SENT_231	[p14l7t2055r147b2122],
7	insulin	NN	O	insulin	nn	8	SENT_231	[p14l170t2055r431b2122],
8	levels	NNS	O	level	dobj	4	SENT_231	[p14l454t2055r673b2122],
9	in	IN	O	in	_	0	SENT_231	[p14l697t2055r770b2121],
10	Table	NNP	O	Table	prep_in	4	SENT_231	[p14l793t2055r1003b2122],
11	1	CD	NUMBER	1	num	10	SENT_231	[p14l1036t2055r1064b2121],
12	probably	RB	O	probably	advmod	4	SENT_231	[p14l1094t2055r1436b2142],
13	due	JJ	O	due	_	0	SENT_231	[p14l1460t2055r1596b2122],
14	to	TO	O	to	_	0	SENT_231	[p14l1619t2065r1691b2122],
15	the	DT	O	the	det	17	SENT_231	[p14l1715t2055r1830b2122],
16	glucose	NN	O	glucose	nn	17	SENT_231	[p14l1854t2055r2144b2142],
17	toxicity	NN	O	toxicity	prep_due_to	4	SENT_231	[p14l7t2169r300b2256],
18	because	IN	O	because	mark	21	SENT_231	[p14l374t2169r678b2236],
19	her	PRP$	O	she	poss	20	SENT_231	[p14l753t2169r876b2236],
20	HbA1C	NN	O	hba1c	nsubj	21	SENT_231	[p14l949t2169r1200b2252],
21	showed	VBD	O	show	advcl	4	SENT_231	[p14l1279t2170r1566b2237],
22	high	JJ	O	high	acomp	21	SENT_231	[p14l1639t2170r1809b2257],
23	in	IN	O	in	_	0	SENT_231	[p14l1883t2170r1956b2236],
24	the	DT	O	the	det	25	SENT_231	[p14l2030t2170r2145b2236],
25	experiment	NN	O	experiment	prep_in	21	SENT_231	[p14l8t2285r442b2372],
26	of	IN	O	of	_	0	SENT_231	[p14l482t2285r565b2352],
27	Table	NNP	O	Table	prep_of	25	SENT_231	[p14l600t2285r810b2352],
28	1	CD	NUMBER	1	num	27	SENT_231	[p14l861t2286r917b2352],
29	.	.	O	.	_	0	SENT_231	[p14l861t2286r917b2352],

1	Niemi	NNP	PERSON	Niemi	nsubj	4	SENT_232	[p14l962t2285r1202b2352],
2	et	FW	O	et	nn	3	SENT_232	[p14l1244t2295r1312b2352],
3	al.	FW	O	al.	dep	1	SENT_232	[p14l1354t2285r1439b2352],
4	reported	VBD	O	report	_	0	SENT_232	[p14l1483t2285r1806b2372],
5	that	IN	O	that	complm	27	SENT_232	[p14l1846t2285r1990b2352],
6	the	DT	O	the	det	7	SENT_232	[p14l2030t2285r2145b2352],
7	CYP2C9	NN	O	cyp2c9	nsubj	27	SENT_232	[p14l12t2400r561b2467],
8	*	CD	NUMBER	*	num	9	SENT_232	[p14l12t2400r561b2467],
9	]	CD	NUMBER	]	dep	7	SENT_232	[p14l12t2400r561b2467],
10	/	:	O	/	punct	9	SENT_232	[p14l12t2400r561b2467],
11	*	CD	NUMBER	*	number	12	SENT_232	[p14l12t2400r561b2467],
12	3	CD	NUMBER	3	num	13	SENT_232	[p14l12t2400r561b2467],
13	genotype	NN	O	genotype	nsubj	14	SENT_232	[p14l606t2410r956b2487],
14	had	VBD	O	have	dep	9	SENT_232	[p14l998t2400r1137b2467],
15	no	DT	O	no	det	17	SENT_232	[p14l1178t2421r1270b2467],
16	signiﬁcant	JJ	O	signiﬁcant	amod	17	SENT_232	[p14l1317t2400r1715b2487],
17	effects	NNS	O	effect	dobj	14	SENT_232	[p14l1757t2400r2008b2467],
18	on	IN	O	on	_	0	SENT_232	[p14l2053t2421r2146b2467],
19	blood	NN	O	blood	nn	21	SENT_232	[p14l6t2515r226b2582],
20	glucose	NN	O	glucose	nn	21	SENT_232	[p14l296t2515r586b2602],
21	response	NN	O	response	prep_on	17	SENT_232	[p14l656t2536r991b2602],
22	to	TO	O	to	_	0	SENT_232	[p14l1062t2525r1134b2582],
23	glimepiride	NN	O	glimepiride	prep_to	14	SENT_232	[p14l1206t2515r1649b2602],
24	in	IN	O	in	_	0	SENT_232	[p14l1720t2515r1793b2581],
25	healthy	JJ	O	healthy	amod	26	SENT_232	[p14l1861t2515r2144b2602],
26	volunteers	NNS	O	volunteer	prep_in	23	SENT_232	[p14l7t2630r406b2697],
27	[	VBP	O	[	ccomp	4	SENT_232	[p14l496t2630r666b2711],
28	12	CD	NUMBER	12	num	29	SENT_232	[p14l496t2630r666b2711],
29	]	CD	NUMBER	]	dobj	27	SENT_232	[p14l496t2630r666b2711],
30	.	.	O	.	_	0	SENT_232	[p14l496t2630r666b2711],

1	In	IN	O	in	_	0	SENT_233	[p14l752t2631r830b2696],
2	their	PRP$	O	they	poss	3	SENT_233	[p14l911t2630r1088b2697],
3	study	NN	O	study	prep_in	7	SENT_233	[p14l1171t2630r1389b2717],
4	,	,	O	,	_	0	SENT_233	[p14l1171t2630r1389b2717],
5	glimepiride	NN	O	glimepiride	nsubjpass	7	SENT_233	[p14l1475t2630r1918b2717],
6	was	VBD	O	be	auxpass	7	SENT_233	[p14l1999t2651r2144b2697],
7	administered	VBN	O	administer	_	0	SENT_233	[p14l9t2745r506b2812],
8	only	RB	O	only	advmod	9	SENT_233	[p14l590t2745r758b2832],
9	once	RB	DATE	once	advmod	7	SENT_233	[p14l842t2767r1045b2825],
10	;	:	O	;	_	0	SENT_233	[p14l842t2767r1045b2825],
11	therefore	RB	O	therefore	advmod	30	SENT_233	[p14l1132t2745r1500b2825],
12	,	,	O	,	_	0	SENT_233	[p14l1132t2745r1500b2825],
13	the	DT	O	the	det	16	SENT_233	[p14l1587t2745r1702b2812],
14	clinically	RB	O	clinically	advmod	15	SENT_233	[p14l1787t2745r2145b2832],
15	signiﬁcant	JJ	O	signiﬁcant	amod	16	SENT_233	[p14l11t2860r409b2947],
16	disadvantages	NNS	O	disadvantage	nsubj	30	SENT_233	[p14l462t2860r997b2947],
17	of	IN	O	of	_	0	SENT_233	[p14l1055t2860r1138b2927],
18	a	DT	O	a	det	20	SENT_233	[p14l1186t2882r1226b2927],
19	CYPZC9	NN	O	cypzc9	nn	20	SENT_233	[p14l1283t2861r1614b2928],
20	genotype	NN	O	genotype	prep_of	16	SENT_233	[p14l1668t2870r2019b2947],
21	in	IN	O	in	_	0	SENT_233	[p14l2073t2860r2146b2926],
22	patients	NNS	O	patient	prep_in	20	SENT_233	[p14l6t2975r304b3062],
23	receiving	VBG	O	receive	partmod	22	SENT_233	[p14l327t2975r683b3062],
24	long	JJ	O	long	amod	28	SENT_233	[p14l706t2975r1087b3062],
25	—	NN	O	—	nn	28	SENT_233	[p14l706t2975r1087b3062],
26	term	NN	O	term	nn	28	SENT_233	[p14l706t2975r1087b3062],
27	glimepiride	NN	O	glimepiride	nn	28	SENT_233	[p14l1108t2975r1551b3062],
28	treatment	NN	O	treatment	dobj	23	SENT_233	[p14l1574t2985r1940b3042],
29	were	VBD	O	be	cop	30	SENT_233	[p14l1961t2996r2144b3042],
30	unknown	JJ	O	unknown	parataxis	7	SENT_233	[p14l7t3090r362b3157],
31	until	IN	O	until	_	0	SENT_233	[p14l410t3090r586b3156],
32	the	DT	O	the	det	34	SENT_233	[p14l634t3090r750b3156],
33	present	JJ	DATE	present	amod	34	SENT_233	[p14l798t3100r1077b3177],
34	study	NN	O	study	prep_until	30	SENT_233	[p14l1128t3090r1345b3177],
35	.	.	O	.	_	0	SENT_233	[p14l1128t3090r1345b3177],

1	The	DT	O	the	det	3	SENT_234	[p14l1399t3090r1546b3156],
2	present	JJ	DATE	present	amod	3	SENT_234	[p14l1594t3100r1873b3177],
3	study	NN	O	study	nsubj	7	SENT_234	[p14l1924t3090r2142b3177],
4	,	,	O	,	_	0	SENT_234	[p14l1924t3090r2142b3177],
5	however	RB	O	however	advmod	3	SENT_234	[p14l6t3205r350b3285],
6	,	,	O	,	_	0	SENT_234	[p14l6t3205r350b3285],
7	suggested	VBD	O	suggest	dep	16	SENT_234	[p14l402t3205r778b3292],
8	that	IN	O	that	dep	10	SENT_234	[p14l822t3205r966b3272],
9	a	DT	O	a	det	10	SENT_234	[p14l1011t3227r1051b3272],
10	CYP2C9	NN	O	cyp2c9	dep	11	SENT_234	[p14l1099t3206r1556b3273],
11	*	NN	O	*	dep	15	SENT_234	[p14l1099t3206r1556b3273],
12	1	CD	NUMBER	1	num	11	SENT_234	[p14l1099t3206r1556b3273],
13	/	:	O	/	punct	15	SENT_234	[p14l1099t3206r1556b3273],
14	*	CD	NUMBER	*	num	15	SENT_234	[p14l1567t3206r1649b3272],
15	3	CD	NUMBER	3	dep	7	SENT_234	[p14l1567t3206r1649b3272],
16	showed	VBD	O	show	_	0	SENT_234	[p14l1699t3205r1986b3273],
17	the	DT	O	the	det	23	SENT_234	[p14l2030t3205r2145b3272],
18	strong	JJ	O	strong	amod	23	SENT_234	[p14l10t3330r244b3407],
19	blood	NN	O	blood	nn	23	SENT_234	[p14l278t3320r498b3387],
20	glucose	NN	O	glucose	nn	23	SENT_234	[p14l532t3320r1198b3407],
21	—	CD	NUMBER	—	num	23	SENT_234	[p14l532t3320r1198b3407],
22	lowering	NN	O	lowering	nn	23	SENT_234	[p14l532t3320r1198b3407],
23	effect	NN	O	effect	dobj	16	SENT_234	[p14l1233t3320r1450b3387],
24	of	IN	O	of	_	0	SENT_234	[p14l1484t3320r1567b3387],
25	glimepiride	NN	O	glimepiride	prep_of	23	SENT_234	[p14l1595t3320r2038b3407],
26	in	IN	O	in	_	0	SENT_234	[p14l2073t3320r2146b3386],
27	the	DT	O	the	det	28	SENT_234	[p14l7t3435r122b3502],
28	type	NN	O	type	prep_in	16	SENT_234	[p14l148t3445r312b3522],
29	2	CD	NUMBER	2	num	31	SENT_234	[p14l338t3435r382b3501],
30	diabetic	JJ	O	diabetic	amod	31	SENT_234	[p14l408t3435r710b3502],
31	patients	NNS	O	patient	nsubj	16	SENT_234	[p14l737t3435r1034b3522],
32	and	CC	O	and	_	0	SENT_234	[p14l1064t3435r1199b3502],
33	the	DT	O	the	det	35	SENT_234	[p14l1223t3435r1339b3502],
34	weight	NN	O	weight	nn	35	SENT_234	[p14l1363t3435r1624b3522],
35	gain	NN	O	gain	nsubj	16	SENT_234	[p14l1650t3435r1813b3522],
36	over	IN	O	over	_	0	SENT_234	[p14l1839t3456r2007b3502],
37	the	DT	O	the	det	40	SENT_234	[p14l2030t3435r2145b3502],
38	long	JJ	O	long	amod	40	SENT_234	[p14l7t3551r388b3638],
39	—	NN	O	—	nn	40	SENT_234	[p14l7t3551r388b3638],
40	term	NN	O	term	prep_over	35	SENT_234	[p14l7t3551r388b3638],
41	in	IN	O	in	_	0	SENT_234	[p14l422t3551r495b3617],
42	some	DT	O	some	det	43	SENT_234	[p14l533t3572r730b3618],
43	cases	NNS	O	case	prep_in	40	SENT_234	[p14l767t3572r987b3618],
44	.	.	O	.	_	0	SENT_234	[p14l767t3572r987b3618],

1	To	TO	O	to	aux	2	SENT_235	[p14l123t3668r221b3733],
2	understand	VB	O	understand	purpcl	20	SENT_235	[p14l243t3666r675b3733],
3	the	DT	O	the	det	5	SENT_235	[p14l696t3666r813b3733],
4	different	JJ	O	different	amod	5	SENT_235	[p14l836t3666r1174b3733],
5	responses	NNS	O	response	dobj	2	SENT_235	[p14l1193t3688r1572b3753],
6	to	TO	O	to	_	0	SENT_235	[p14l1596t3677r1669b3733],
7	glimepiride	NN	O	glimepiride	nn	8	SENT_235	[p14l1693t3666r2145b3753],
8	treatment	NN	O	treatment	prep_to	2	SENT_235	[p15l7t31r380b88],
9	in	IN	O	in	_	0	SENT_235	[p15l398t21r472b87],
10	patients	NNS	O	patient	prep_in	8	SENT_235	[p15l489t21r795b108],
11	with	IN	O	with	_	0	SENT_235	[p15l817t21r989b89],
12	different	JJ	O	different	amod	15	SENT_235	[p15l1009t21r1346b88],
13	C	NN	O	c	nn	15	SENT_235	[p15l1368t23r1429b89],
14	YP2	NN	O	yp2	nn	15	SENT_235	[p15l1435t22r1586b87],
15	C	NN	O	c	prep_with	10	SENT_235	[p15l1598t23r1658b89],
16	9	CD	NUMBER	9	num	17	SENT_235	[p15l1659t22r1705b89],
17	genotypes	NNS	O	genotype	dep	15	SENT_235	[p15l1724t31r2142b108],
18	,	,	O	,	_	0	SENT_235	[p15l1724t31r2142b108],
19	we	PRP	O	we	nsubj	20	SENT_235	[p15l8t157r118b203],
20	measured	VBD	O	measure	_	0	SENT_235	[p15l141t136r517b203],
21	the	DT	O	the	det	23	SENT_235	[p15l539t136r656b203],
22	pharmacokinetic	JJ	O	pharmacokinetic	amod	23	SENT_235	[p15l677t136r1335b223],
23	parameters	NNS	O	parameter	dep	28	SENT_235	[p15l1358t146r1790b223],
24	in	IN	O	in	_	0	SENT_235	[p15l1814t136r1888b202],
25	type	NN	O	type	prep_in	23	SENT_235	[p15l1910t146r2076b223],
26	2	CD	NUMBER	2	dep	28	SENT_235	[p15l2101t136r2144b202],
27	diabetic	JJ	O	diabetic	amod	28	SENT_235	[p15l8t251r317b317],
28	patients	NNS	O	patient	dep	41	SENT_235	[p15l340t251r645b338],
29	with	IN	O	with	prep	28	SENT_235	[p15l670t251r843b318],
30	C	NN	O	c	nn	32	SENT_235	[p15l870t252r931b318],
31	YPZC9	NN	O	ypzc9	nn	32	SENT_235	[p15l936t251r1207b318],
32	*	NN	O	*	dep	29	SENT_235	[p15l1220t251r1297b317],
33	1	CD	NUMBER	1	dep	32	SENT_235	[p15l1220t251r1297b317],
34	/	:	O	/	punct	32	SENT_235	[p15l1306t251r1334b318],
35	*	CD	NUMBER	*	num	36	SENT_235	[p15l1347t251r1424b317],
36	1	CD	NUMBER	1	dep	32	SENT_235	[p15l1347t251r1424b317],
37	or	CC	O	or	_	0	SENT_235	[p15l1455t272r1534b317],
38	C	NN	O	c	nn	40	SENT_235	[p15l1560t252r1620b318],
39	YP2	NN	O	yp2	nn	40	SENT_235	[p15l1626t251r1778b317],
40	C9	NN	O	c9	dep	32	SENT_235	[p15l1789t251r1896b318],
41	*	NN	O	*	dep	45	SENT_235	[p15l1910t251r1987b317],
42	1	CD	NUMBER	1	num	41	SENT_235	[p15l1910t251r1987b317],
43	/	:	O	/	punct	45	SENT_235	[p15l1995t251r2024b318],
44	*	CD	NUMBER	*	num	45	SENT_235	[p15l2037t251r2141b317],
45	3	CD	NUMBER	3	dep	20	SENT_235	[p15l2037t251r2141b317],
46	.	.	O	.	_	0	SENT_235	[p15l2037t251r2141b317],

1	Data	NNS	O	datum	nsubj	9	SENT_236	[p15l7t368r191b433],
2	from	IN	O	from	_	0	SENT_236	[p15l259t366r449b433],
3	the	DT	O	the	det	6	SENT_236	[p15l516t366r633b433],
4	clinical	JJ	O	clinical	amod	6	SENT_236	[p15l703t366r993b433],
5	pharmacokinetic	JJ	O	pharmacokinetic	amod	6	SENT_236	[p15l1060t366r1717b453],
6	study	NN	O	study	prep_from	1	SENT_236	[p15l1790t366r1997b453],
7	of	IN	O	of	_	0	SENT_236	[p15l2067t366r2152b433],
8	glimepiride	NN	O	glimepiride	prep_of	6	SENT_236	[p15l8t481r461b568],
9	demonstrated	VBD	O	demonstrate	dep	23	SENT_236	[p15l523t481r1052b548],
10	that	IN	O	that	dep	12	SENT_236	[p15l1112t481r1259b548],
11	the	DT	O	the	det	12	SENT_236	[p15l1317t481r1435b548],
12	subjects	NNS	O	subject	dep	18	SENT_236	[p15l1500t481r1810b568],
13	with	IN	O	with	_	0	SENT_236	[p15l1873t481r2045b548],
14	a	DT	O	a	det	17	SENT_236	[p15l2106t502r2146b548],
15	C	NN	O	c	nn	17	SENT_236	[p15l12t597r72b664],
16	YP2	NN	O	yp2	nn	17	SENT_236	[p15l78t596r230b662],
17	C9	NN	O	c9	prep_with	12	SENT_236	[p15l242t596r349b664],
18	*	NN	O	*	dep	22	SENT_236	[p15l362t597r439b662],
19	1	CD	NUMBER	1	num	18	SENT_236	[p15l362t597r439b662],
20	/	:	O	/	punct	22	SENT_236	[p15l447t596r476b663],
21	*	CD	NUMBER	*	num	22	SENT_236	[p15l489t597r571b663],
22	3	CD	NUMBER	3	dep	9	SENT_236	[p15l489t597r571b663],
23	had	VBD	O	have	_	0	SENT_236	[p15l595t596r735b663],
24	a	DT	O	a	det	27	SENT_236	[p15l758t617r797b663],
25	markedly	RB	O	markedly	advmod	26	SENT_236	[p15l818t596r1188b683],
26	higher	JJR	O	higher	amod	27	SENT_236	[p15l1210t596r1462b683],
27	AUC	NN	O	auc	dobj	23	SENT_236	[p15l1482t596r1678b663],
28	and	CC	O	and	_	0	SENT_236	[p15l1704t596r1842b663],
29	a	DT	O	a	det	31	SENT_236	[p15l1866t617r1905b663],
30	lower	JJR	O	lower	amod	31	SENT_236	[p15l1926t596r2148b663],
31	CL	NN	O	cl	dobj	23	SENT_236	[p15l8t711r129b778],
32	than	IN	O	than	_	0	SENT_236	[p15l150t711r318b778],
33	subjects	NNS	O	subject	prep_than	31	SENT_236	[p15l342t711r652b798],
34	with	IN	O	with	_	0	SENT_236	[p15l676t711r849b778],
35	a	DT	O	a	det	37	SENT_236	[p15l871t732r911b778],
36	CYP2C9	NN	O	cyp2c9	nn	37	SENT_236	[p15l936t711r1273b778],
37	*	NN	O	*	prep_with	23	SENT_236	[p15l1286t711r1363b777],
38	1	CD	NUMBER	1	nsubj	23	SENT_236	[p15l1286t711r1363b777],
39	/	:	O	/	punct	41	SENT_236	[p15l1372t711r1400b778],
40	*	CD	NUMBER	*	number	41	SENT_236	[p15l1413t711r1490b777],
41	1	CD	NUMBER	1	dep	38	SENT_236	[p15l1413t711r1490b777],
42	(	CD	NUMBER	(	num	43	SENT_236	[p15l1521t711r1766b794],
43	Table	NNP	O	Table	dep	41	SENT_236	[p15l1521t711r1766b794],
44	2	CD	NUMBER	2	num	43	SENT_236	[p15l1790t711r1887b794],
45	)	CD	NUMBER	)	dep	41	SENT_236	[p15l1790t711r1887b794],
46	.	.	O	.	_	0	SENT_236	[p15l1790t711r1887b794],

1	These	DT	O	these	det	2	SENT_237	[p15l1913t711r2145b778],
2	data	NNS	O	datum	nsubj	4	SENT_237	[p15l8t826r171b893],
3	are	VBP	O	be	cop	4	SENT_237	[p15l209t848r325b893],
4	consistent	JJ	O	consistent	_	0	SENT_237	[p15l364t826r758b893],
5	with	IN	O	with	_	0	SENT_237	[p15l796t826r968b894],
6	previously	RB	DATE	previously	advmod	7	SENT_237	[p15l1004t826r1416b913],
7	reported	VBN	O	report	amod	9	SENT_237	[p15l1453t826r1782b913],
8	pharmacokinetic	JJ	O	pharmacokinetic	amod	9	SENT_237	[p15l1818t826r2143b913, p15l8t941r366b1008],
9	data	NNS	O	datum	prep_with	4	SENT_237	[p15l422t941r584b1008],
10	showing	VBG	O	show	partmod	9	SENT_237	[p15l638t941r962b1028],
11	that	IN	O	that	complm	16	SENT_237	[p15l1015t941r1162b1008],
12	CYP2C9	NN	O	cyp2c9	nsubj	16	SENT_237	[p15l1217t942r1554b1009],
13	genetic	JJ	O	genetic	amod	14	SENT_237	[p15l1606t941r1886b1028],
14	polymorphisms	NNS	O	polymorphism	npadvmod	15	SENT_237	[p15l1939t941r2143b1028, p15l7t1056r440b1143],
15	markedly	RB	O	markedly	advmod	16	SENT_237	[p15l467t1056r837b1143],
16	affected	VBD	O	affect	ccomp	10	SENT_237	[p15l864t1056r1179b1123],
17	the	DT	O	the	det	18	SENT_237	[p15l1203t1056r1320b1123],
18	pharmacokinetics	NNS	O	pharmacokinetic	nsubj	24	SENT_237	[p15l1345t1056r2040b1143],
19	of	IN	O	of	_	0	SENT_237	[p15l2068t1056r2153b1123],
20	glimepiride	NN	O	glimepiride	prep_of	18	SENT_237	[p15l8t1170r462b1258],
21	in	IN	O	in	_	0	SENT_237	[p15l509t1171r584b1237],
22	healthy	JJ	O	healthy	amod	23	SENT_237	[p15l630t1171r919b1258],
23	volunteers	NNS	O	volunteer	prep_in	20	SENT_237	[p15l968t1171r1374b1238],
24	[	VBP	O	[	ccomp	16	SENT_237	[p15l1430t1171r1605b1251],
25	12	CD	NUMBER	12	num	26	SENT_237	[p15l1430t1171r1605b1251],
26	]	CD	NUMBER	]	dobj	24	SENT_237	[p15l1430t1171r1605b1251],
27	.	.	O	.	_	0	SENT_237	[p15l1430t1171r1605b1251],

1	The	DT	O	the	det	4	SENT_238	[p15l1657t1171r1807b1237],
2	clinical	JJ	O	clinical	amod	4	SENT_238	[p15l1855t1171r2146b1237],
3	pharmacokinetic	JJ	O	pharmacokinetic	amod	4	SENT_238	[p15l6t1286r664b1373],
4	data	NNS	O	datum	nsubjpass	7	SENT_238	[p15l736t1286r898b1353],
5	was	VBD	O	be	auxpass	7	SENT_238	[p15l966t1308r1113b1353],
6	also	RB	O	also	advmod	7	SENT_238	[p15l1186t1286r1339b1353],
7	supported	VBN	O	support	_	0	SENT_238	[p15l1412t1286r1796b1373],
8	by	IN	O	by	_	0	SENT_238	[p15l1862t1286r1958b1373],
9	the	DT	O	the	det	10	SENT_238	[p15l2028t1286r2145b1353],
10	enzyme	NN	O	enzyme	agent	7	SENT_238	[p15l8t1422r310b1488],
11	kinetic	JJ	O	kinetic	amod	12	SENT_238	[p15l376t1401r643b1468],
12	data	NNS	O	datum	tmod	7	SENT_238	[p15l712t1401r895b1480],
13	,	,	O	,	_	0	SENT_238	[p15l712t1401r895b1480],
14	which	WDT	O	which	nsubj	15	SENT_238	[p15l964t1401r1202b1468],
15	showed	VBD	O	show	rcmod	12	SENT_238	[p15l1271t1401r1564b1468],
16	a	DT	O	a	det	18	SENT_238	[p15l1631t1422r1671b1468],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_238	[p15l1739t1401r2147b1488],
18	reduction	NN	O	reduction	dobj	15	SENT_238	[p15l6t1516r379b1583],
19	in	IN	O	in	_	0	SENT_238	[p15l403t1516r477b1582],
20	the	DT	O	the	det	22	SENT_238	[p15l502t1516r619b1583],
21	intrinsic	JJ	O	intrinsic	amod	22	SENT_238	[p15l645t1516r967b1583],
22	clearance	NN	O	clearance	prep_in	18	SENT_238	[p15l995t1516r1366b1583],
23	of	IN	O	of	_	0	SENT_238	[p15l1393t1516r1477b1583],
24	glimepiride	NN	O	glimepiride	prep_of	22	SENT_238	[p15l1497t1516r1949b1603],
25	with	IN	O	with	_	0	SENT_238	[p15l1974t1516r2146b1583],
26	CYP2C9	NN	O	cyp2c9	prep_with	15	SENT_238	[p15l8t1631r452b1699],
27	*	CD	NUMBER	*	number	28	SENT_238	[p15l8t1631r452b1699],
28	3	CD	NUMBER	3	num	29	SENT_238	[p15l8t1631r452b1699],
29	enzyme	NN	O	enzyme	tmod	15	SENT_238	[p15l566t1652r890b1718],
30	,	,	O	,	_	0	SENT_238	[p15l566t1652r890b1718],
31	compared	VBN	O	compare	_	0	SENT_238	[p15l1004t1631r1391b1718],
32	with	IN	O	with	prepc_compared_with	29	SENT_238	[p15l1499t1631r1671b1698],
33	that	DT	O	that	pobj	29	SENT_238	[p15l1779t1631r1927b1698],
34	for	IN	O	for	_	0	SENT_238	[p15l2034t1631r2147b1698],
35	CYP2C9	NN	O	cyp2c9	prep_for	33	SENT_238	[p15l8t1747r448b1815],
36	*	CD	NUMBER	*	num	37	SENT_238	[p15l8t1747r448b1815],
37	l	NN	O	l	tmod	33	SENT_238	[p15l8t1747r448b1815],
38	enzyme	NN	O	enzyme	nn	40	SENT_238	[p15l494t1768r796b1833],
39	(	CD	NUMBER	(	num	40	SENT_238	[p15l837t1746r1082b1830],
40	Table	NNP	O	Table	dep	29	SENT_238	[p15l837t1746r1082b1830],
41	3	CD	NUMBER	3	num	42	SENT_238	[p15l1122t1747r1219b1829],
42	)	NN	O	)	dep	12	SENT_238	[p15l1122t1747r1219b1829],
43	.	.	O	.	_	0	SENT_238	[p15l1122t1747r1219b1829],

1	Therefore	RB	O	therefore	advmod	4	SENT_239	[p15l1261t1746r1670b1826],
2	,	,	O	,	_	0	SENT_239	[p15l1261t1746r1670b1826],
3	we	PRP	O	we	nsubj	4	SENT_239	[p15l1710t1768r1821b1814],
4	considered	VBD	O	consider	_	0	SENT_239	[p15l1859t1746r2144b1813, p15l8t1861r175b1928],
5	that	IN	O	that	advmod	4	SENT_239	[p15l256t1861r403b1928],
6	elimination	NN	O	elimination	dobj	4	SENT_239	[p15l485t1861r935b1928],
7	of	IN	O	of	_	0	SENT_239	[p15l1017t1861r1102b1928],
8	plasma	NN	O	plasma	nn	9	SENT_239	[p15l1175t1861r1454b1948],
9	glimepiride	NN	O	glimepiride	prep_of	6	SENT_239	[p15l1536t1861r1989b1948],
10	in	IN	O	in	_	0	SENT_239	[p15l2071t1861r2146b1927],
11	CYP2C9	NN	O	cyp2c9	nn	12	SENT_239	[p15l12t1976r571b2043],
12	*	NN	O	*	prep_in	9	SENT_239	[p15l12t1976r571b2043],
13	1	CD	NUMBER	1	num	12	SENT_239	[p15l12t1976r571b2043],
14	/	:	O	/	punct	17	SENT_239	[p15l12t1976r571b2043],
15	*	CD	NUMBER	*	number	16	SENT_239	[p15l12t1976r571b2043],
16	3	CD	NUMBER	3	num	17	SENT_239	[p15l12t1976r571b2043],
17	subjects	NNS	O	subject	dep	6	SENT_239	[p15l627t1976r938b2063],
18	may	MD	O	may	aux	20	SENT_239	[p15l991t1997r1156b2063],
19	be	VB	O	be	cop	20	SENT_239	[p15l1206t1976r1297b2043],
20	slower	JJR	O	slower	rcmod	17	SENT_239	[p15l1351t1976r1608b2043],
21	than	IN	O	than	_	0	SENT_239	[p15l1657t1976r1824b2043],
22	that	DT	O	that	prep_than	17	SENT_239	[p15l1875t1976r2022b2043],
23	in	IN	O	in	_	0	SENT_239	[p15l2072t1976r2146b2042],
24	C	NN	O	c	nn	27	SENT_239	[p15l12t2092r72b2158],
25	YP2	NN	O	yp2	nn	27	SENT_239	[p15l78t2091r230b2157],
26	C9	NN	O	c9	nn	27	SENT_239	[p15l242t2091r349b2158],
27	*	NN	O	*	prep_in	22	SENT_239	[p15l362t2091r439b2157],
28	1	CD	NUMBER	1	dep	27	SENT_239	[p15l362t2091r439b2157],
29	/	:	O	/	punct	17	SENT_239	[p15l447t2091r476b2158],
30	*	CD	NUMBER	*	number	31	SENT_239	[p15l489t2091r565b2157],
31	1	CD	NUMBER	1	num	32	SENT_239	[p15l489t2091r565b2157],
32	subjects	NNS	O	subject	dep	6	SENT_239	[p15l596t2091r931b2178],
33	,	,	O	,	_	0	SENT_239	[p15l596t2091r931b2178],
34	and	CC	O	and	_	0	SENT_239	[p15l956t2091r1094b2157],
35	that	DT	O	that	det	37	SENT_239	[p15l1113t2091r1260b2157],
36	high	JJ	O	high	amod	37	SENT_239	[p15l1278t2091r1453b2178],
37	concentrations	NNS	O	concentration	nsubj	41	SENT_239	[p15l1473t2091r2045b2157],
38	of	IN	O	of	_	0	SENT_239	[p15l2068t2091r2153b2157],
39	glimepiride	NN	O	glimepiride	prep_of	37	SENT_239	[p15l8t2206r462b2293],
40	may	MD	O	may	aux	41	SENT_239	[p15l503t2228r669b2293],
41	cause	VB	O	cause	conj_and	4	SENT_239	[p15l711t2228r926b2273],
42	the	DT	O	the	det	45	SENT_239	[p15l968t2206r1085b2273],
43	stronger	JJR	O	stronger	amod	45	SENT_239	[p15l1129t2216r1450b2293],
44	pharmacological	JJ	O	pharmacological	amod	45	SENT_239	[p15l1487t2206r2146b2293],
45	effect	NN	O	effect	dobj	41	SENT_239	[p15l8t2321r249b2388],
46	.	.	O	.	_	0	SENT_239	[p15l8t2321r249b2388],

1	In	IN	O	in	_	0	SENT_240	[p15l123t2438r201b2502],
2	conclusion	NN	O	conclusion	prep_in	11	SENT_240	[p15l240t2436r677b2515],
3	,	,	O	,	_	0	SENT_240	[p15l240t2436r677b2515],
4	the	DT	O	the	det	5	SENT_240	[p15l719t2436r834b2503],
5	subjects	NNS	O	subject	nsubj	11	SENT_240	[p15l876t2436r1181b2523],
6	with	IN	O	with	_	0	SENT_240	[p15l1222t2436r1391b2503],
7	CYP2C9	NN	O	cyp2c9	prep_with	11	SENT_240	[p15l1434t2436r1859b2504],
8	*	CD	NUMBER	*	number	9	SENT_240	[p15l1434t2436r1859b2504],
9	3	CD	NUMBER	3	num	10	SENT_240	[p15l1434t2436r1859b2504],
10	alleles	NNS	O	allele	nsubj	11	SENT_240	[p15l1902t2436r2143b2503],
11	exhibited	VBD	O	exhibit	_	0	SENT_240	[p15l8t2551r366b2618],
12	a	DT	O	a	det	13	SENT_240	[p15l435t2572r474b2618],
13	decrease	NN	O	decrease	dobj	11	SENT_240	[p15l542t2551r871b2618],
14	in	IN	O	in	_	0	SENT_240	[p15l940t2551r1013b2617],
15	the	DT	O	the	det	17	SENT_240	[p15l1081t2551r1196b2618],
16	metabolic	JJ	O	metabolic	amod	17	SENT_240	[p15l1265t2551r1643b2618],
17	activity	NN	O	activity	prep_in	11	SENT_240	[p15l1715t2551r1999b2638],
18	of	IN	O	of	_	0	SENT_240	[p15l2069t2551r2152b2618],
19	glimepiride	NN	O	glimepiride	nn	20	SENT_240	[p15l8t2666r451b2753],
20	hydroxylation	NN	O	hydroxylation	prep_of	17	SENT_240	[p15l495t2666r1038b2753],
21	and	CC	O	and	_	0	SENT_240	[p15l1083t2666r1219b2733],
22	a	DT	O	a	det	24	SENT_240	[p15l1264t2688r1304b2733],
23	marked	JJ	O	marked	amod	24	SENT_240	[p15l1347t2666r1635b2733],
24	elevation	NN	O	elevation	conj_and	20	SENT_240	[p15l1680t2666r2029b2734],
25	in	IN	O	in	_	0	SENT_240	[p15l2073t2666r2146b2733],
26	the	DT	O	the	det	28	SENT_240	[p15l7t2781r122b2848],
27	plasma	NN	O	plasma	nn	28	SENT_240	[p15l174t2781r449b2868],
28	concentrations	NNS	O	concentration	prep_in	11	SENT_240	[p15l501t2781r1060b2848],
29	of	IN	O	of	_	0	SENT_240	[p15l1116t2781r1199b2848],
30	glimepiride	NN	O	glimepiride	prep_of	28	SENT_240	[p15l1245t2781r1710b2868],
31	,	,	O	,	_	0	SENT_240	[p15l1245t2781r1710b2868],
32	compared	VBN	O	compare	_	0	SENT_240	[p15l1767t2781r2146b2868],
33	with	IN	O	with	prepc_compared_with	11	SENT_240	[p15l7t2896r176b2963],
34	subjects	NNS	O	subject	pobj	11	SENT_240	[p15l247t2896r551b2983],
35	with	IN	O	with	prep	11	SENT_240	[p15l622t2896r791b2963],
36	a	DT	O	a	det	38	SENT_240	[p15l860t2917r900b2963],
37	CYP2C9	NN	O	cyp2c9	nn	38	SENT_240	[p15l971t2896r1428b2964],
38	*	NN	O	*	dep	35	SENT_240	[p15l971t2896r1428b2964],
39	1	CD	NUMBER	1	dep	38	SENT_240	[p15l971t2896r1428b2964],
40	/	:	O	/	punct	38	SENT_240	[p15l971t2896r1428b2964],
41	*	CD	NUMBER	*	dep	38	SENT_240	[p15l1439t2897r1515b2962],
42	1	CD	NUMBER	1	dep	41	SENT_240	[p15l1439t2897r1515b2962],
43	.	.	O	.	_	0	SENT_240	[p15l1530t2952r1542b2963],

1	The	DT	O	the	det	4	SENT_241	[p15l1614t2896r1762b2963],
2	elevated	JJ	O	elevated	amod	4	SENT_241	[p15l1831t2896r2149b2963],
3	glimepiride	NN	O	glimepiride	nn	4	SENT_241	[p15l8t3011r452b3098],
4	concentrations	NNS	O	concentration	nsubj	16	SENT_241	[p15l569t3011r1129b3078],
5	in	IN	O	in	prep	4	SENT_241	[p15l1247t3011r1320b3077],
6	subject	JJ	O	subject	dep	10	SENT_241	[p15l1438t3011r1708b3098],
7	with	IN	O	with	_	0	SENT_241	[p15l1823t3011r1992b3078],
8	a	DT	O	a	det	9	SENT_241	[p15l2110t3032r2149b3078],
9	CYP2C9	NN	O	cyp2c9	prep_with	6	SENT_241	[p15l12t3127r468b3194],
10	*	NN	O	*	dep	14	SENT_241	[p15l12t3127r468b3194],
11	1	CD	NUMBER	1	num	10	SENT_241	[p15l12t3127r468b3194],
12	/	:	O	/	punct	14	SENT_241	[p15l12t3127r468b3194],
13	*	CD	NUMBER	*	num	14	SENT_241	[p15l480t3127r561b3193],
14	3	CD	DATE	3	dep	5	SENT_241	[p15l480t3127r561b3193],
15	may	MD	DATE	may	aux	16	SENT_241	[p15l649t3148r813b3213],
16	increase	VB	O	increase	_	0	SENT_241	[p15l899t3126r1214b3193],
17	the	DT	O	the	det	19	SENT_241	[p15l1301t3126r1416b3193],
18	pharmacological	JJ	O	pharmacological	amod	19	SENT_241	[p15l1501t3126r2147b3213],
19	effects	NNS	O	effect	dobj	16	SENT_241	[p15l7t3241r280b3308],
20	.	.	O	.	_	0	SENT_241	[p15l7t3241r280b3308],

1	The	DT	O	the	det	2	SENT_242	[p15l344t3241r493b3308],
2	duration	NN	O	duration	nsubj	16	SENT_242	[p15l554t3241r874b3308],
3	of	IN	O	of	_	0	SENT_242	[p15l934t3241r1017b3308],
4	diabetes	NN	O	diabetes	prep_of	2	SENT_242	[p15l1072t3241r1384b3308],
5	and	CC	O	and	_	0	SENT_242	[p15l1449t3241r1585b3308],
6	a	DT	O	a	det	7	SENT_242	[p15l1646t3263r1686b3308],
7	history	NN	O	history	nsubj	16	SENT_242	[p15l1743t3241r2010b3328],
8	of	IN	O	of	_	0	SENT_242	[p15l2071t3241r2154b3308],
9	previous	JJ	O	previous	amod	10	SENT_242	[p15l6t3356r333b3443],
10	treatment	NN	O	treatment	prep_of	7	SENT_242	[p15l380t3366r746b3423],
11	with	IN	O	with	_	0	SENT_242	[p15l790t3356r959b3423],
12	oral	JJ	O	oral	amod	14	SENT_242	[p15l1005t3356r1151b3423],
13	antidiabetic	JJ	O	antidiabetic	amod	14	SENT_242	[p15l1199t3356r1647b3423],
14	agents	NNS	O	agent	prep_with	10	SENT_242	[p15l1695t3366r1937b3443],
15	may	MD	O	may	aux	16	SENT_242	[p15l1984t3377r2147b3443],
16	affect	VB	O	affect	_	0	SENT_242	[p15l8t3471r225b3538],
17	the	DT	O	the	det	18	SENT_242	[p15l285t3471r400b3538],
18	response	NN	O	response	dobj	16	SENT_242	[p15l461t3493r797b3558],
19	to	TO	O	to	_	0	SENT_242	[p15l859t3481r931b3538],
20	glimepiride	NN	O	glimepiride	prep_to	16	SENT_242	[p15l994t3471r1438b3558],
21	[	CD	NUMBER	[	num	20	SENT_242	[p15l1507t3472r1678b3552],
22	29	CD	NUMBER	29	num	23	SENT_242	[p15l1507t3472r1678b3552],
23	]	NN	O	]	dep	20	SENT_242	[p15l1507t3472r1678b3552],
24	.	.	O	.	_	0	SENT_242	[p15l1507t3472r1678b3552],

1	Therefore	RB	O	therefore	advmod	30	SENT_243	[p15l1743t3471r2144b3551],
2	,	,	O	,	_	0	SENT_243	[p15l1743t3471r2144b3551],
3	information	NN	O	information	nsubj	30	SENT_243	[p15l6t3586r462b3653],
4	regarding	VBG	O	regard	_	0	SENT_243	[p15l489t3586r857b3673],
5	a	DT	O	a	det	6	SENT_243	[p15l888t3608r928b3653],
6	patient	NN	O	patient	poss	10	SENT_243	[p15l952t3586r1278b3673],
7	’s	POS	O	’s	_	0	SENT_243	[p15l952t3586r1278b3673],
8	C	NN	O	c	nn	10	SENT_243	[p15l1313t3588r1373b3654],
9	YP2C9	NN	O	yp2c9	nn	10	SENT_243	[p15l1378t3587r1644b3654],
10	genotype	NN	O	genotype	prep_regarding	3	SENT_243	[p15l1672t3596r2044b3673],
11	,	,	O	,	_	0	SENT_243	[p15l1672t3596r2044b3673],
12	in	IN	O	in	_	0	SENT_243	[p15l2076t3586r2149b3652],
13	addition	NN	O	addition	_	0	SENT_243	[p15l8t3701r322b3768],
14	to	TO	O	to	_	0	SENT_243	[p15l356t3711r428b3768],
15	clinical	JJ	O	clinical	amod	16	SENT_243	[p15l465t3701r747b3768],
16	information	NN	O	information	conj_in	10	SENT_243	[p15l783t3701r1239b3768],
17	regarding	VBG	O	regard	_	0	SENT_243	[p15l1272t3701r1641b3788],
18	the	DT	O	the	det	19	SENT_243	[p15l1677t3701r1792b3768],
19	duration	NN	O	duration	prep_regarding	16	SENT_243	[p15l1828t3701r2148b3768],
20	of	IN	O	of	_	0	SENT_243	[p16l8t21r91b88],
21	diabetes	NN	O	diabetes	prep_of	19	SENT_243	[p16l115t21r427b88],
22	and	CC	O	and	_	0	SENT_243	[p16l461t21r597b88],
23	previous	JJ	O	previous	amod	24	SENT_243	[p16l625t21r953b108],
24	treatments	NNS	O	treatment	prep_regarding	16	SENT_243	[p16l985t31r1385b88],
25	using	VBG	O	use	partmod	24	SENT_243	[p16l1416t21r1623b108],
26	SUs	NNS	O	sus	dobj	25	SENT_243	[p16l1656t21r1831b100],
27	,	,	O	,	_	0	SENT_243	[p16l1656t21r1831b100],
28	may	MD	O	may	aux	30	SENT_243	[p16l1865t42r2028b108],
29	be	VB	O	be	cop	30	SENT_243	[p16l2058t21r2147b88],
30	useful	JJ	O	useful	_	0	SENT_243	[p16l6t136r239b203],
31	for	IN	O	for	_	0	SENT_243	[p16l286t136r397b203],
32	reducing	VBG	O	reduce	prepc_for	30	SENT_243	[p16l440t136r777b223],
33	the	DT	O	the	det	34	SENT_243	[p16l823t136r938b203],
34	risk	NN	O	risk	dobj	32	SENT_243	[p16l983t136r1128b203],
35	of	IN	O	of	_	0	SENT_243	[p16l1173t136r1256b203],
36	adverse	JJ	O	adverse	amod	37	SENT_243	[p16l1296t136r1586b203],
37	events	NNS	O	event	prep_of	34	SENT_243	[p16l1633t146r1873b203],
38	at	IN	O	at	_	0	SENT_243	[p16l1921t146r1988b203],
39	the	DT	O	the	det	40	SENT_243	[p16l2032t136r2147b203],
40	initiation	NN	O	initiation	prep_at	32	SENT_243	[p16l6t251r356b318],
41	of	IN	O	of	_	0	SENT_243	[p16l392t251r475b318],
42	glimepiride	NN	O	glimepiride	nn	43	SENT_243	[p16l505t251r949b338],
43	treatment	NN	O	treatment	prep_of	40	SENT_243	[p16l984t261r1369b318],
44	.	.	O	.	_	0	SENT_243	[p16l984t261r1369b318],

1	Acknowledgements	NNS	O	acknowledgement	_	0	SENT_244	[p16l6t513r803b600],

1	The	DT	O	the	det	2	SENT_245	[p16l122t745r270b812],
2	authors	NNS	O	author	nsubj	3	SENT_245	[p16l296t745r575b812],
3	wish	VBP	O	wish	_	0	SENT_245	[p16l601t745r780b812],
4	to	TO	O	to	aux	5	SENT_245	[p16l804t755r875b812],
5	thank	VB	O	thank	xcomp	3	SENT_245	[p16l900t745r1115b812],
6	Shuhei	NNP	PERSON	Shuhei	nn	11	SENT_245	[p16l1139t745r1401b813],
7	Iida	NNP	PERSON	Iida	nn	11	SENT_245	[p16l1426t745r1594b825],
8	,	,	O	,	_	0	SENT_245	[p16l1426t745r1594b825],
9	PhD	NNP	O	PhD	appos	11	SENT_245	[p16l1621t745r1811b825],
10	,	,	O	,	_	0	SENT_245	[p16l1621t745r1811b825],
11	MD	NNP	O	MD	dobj	5	SENT_245	[p16l1837t747r2011b825],
12	,	,	O	,	_	0	SENT_245	[p16l1837t747r2011b825],
13	for	IN	O	for	_	0	SENT_245	[p16l2039t745r2150b812],
14	his	PRP$	O	he	poss	15	SENT_245	[p16l6t860r114b927],
15	encouragement	NN	O	encouragement	prep_for	11	SENT_245	[p16l164t870r755b947],
16	and	CC	O	and	_	0	SENT_245	[p16l803t860r939b927],
17	Takashi	NNP	PERSON	Takashi	nn	24	SENT_245	[p16l985t860r1282b927],
18	Yoshitani	NNP	PERSON	Yoshitani	nn	24	SENT_245	[p16l1330t860r1713b939],
19	,	,	O	,	_	0	SENT_245	[p16l1330t860r1713b939],
20	PhD	NNP	O	PhD	appos	24	SENT_245	[p16l1764t860r1954b939],
21	,	,	O	,	_	0	SENT_245	[p16l1764t860r1954b939],
22	Ms.	NNP	O	Ms.	appos	24	SENT_245	[p16l2003t862r2143b927],
23	Mariko	NNP	PERSON	Mariko	nn	24	SENT_245	[p16l6t975r287b1042],
24	Tanaka	NNP	PERSON	Tanaka	prep_for	11	SENT_245	[p16l351t975r648b1055],
25	,	,	O	,	_	0	SENT_245	[p16l351t975r648b1055],
26	and	CC	O	and	_	0	SENT_245	[p16l716t975r852b1042],
27	Mr.	NNP	O	Mr.	nn	29	SENT_245	[p16l913t977r1043b1042],
28	Hiroshi	NNP	PERSON	Hiroshi	nn	29	SENT_245	[p16l1110t975r1397b1042],
29	Yasuda	NNP	PERSON	Yasuda	dobj	5	SENT_245	[p16l1460t975r1739b1042],
30	for	IN	O	for	_	0	SENT_245	[p16l1800t975r1912b1042],
31	their	PRP$	O	they	poss	32	SENT_245	[p16l1973t975r2150b1042],
32	assistance	NN	O	assistance	prep_for	29	SENT_245	[p16l8t1090r411b1157],
33	.	.	O	.	_	0	SENT_245	[p16l8t1090r411b1157],

1	The	DT	O	the	det	2	SENT_246	[p16l472t1090r620b1157],
2	authors	NNS	O	author	nsubj	4	SENT_246	[p16l679t1090r957b1157],
3	also	RB	O	also	advmod	4	SENT_246	[p16l1018t1090r1168b1157],
4	wish	VBP	O	wish	_	0	SENT_246	[p16l1224t1090r1403b1157],
5	to	TO	O	to	aux	6	SENT_246	[p16l1459t1100r1531b1157],
6	thank	VB	O	thank	xcomp	4	SENT_246	[p16l1588t1090r1803b1157],
7	Aventis	NNP	ORGANIZATION	Aventis	nn	8	SENT_246	[p16l1857t1090r2147b1157],
8	Pharma	NNP	ORGANIZATION	Pharma	dobj	6	SENT_246	[p16l6t1205r301b1271],
9	for	IN	O	for	_	0	SENT_246	[p16l378t1204r490b1271],
10	providing	VBG	O	provide	prepc_for	8	SENT_246	[p16l565t1205r939b1292],
11	the	DT	O	the	det	12	SENT_246	[p16l1018t1205r1133b1271],
12	glimepiride	NN	O	glimepiride	dobj	10	SENT_246	[p16l1212t1205r1656b1292],
13	for	IN	O	for	_	0	SENT_246	[p16l1736t1205r1848b1271],
14	liquid	JJ	O	liquid	amod	15	SENT_246	[p16l1924t1205r2149b1292],
15	chromatography	NN	O	chromatography	prep_for	10	SENT_246	[p16l7t1320r880b1407],
16	—	CD	NUMBER	—	num	19	SENT_246	[p16l7t1320r880b1407],
17	mass	NN	O	mass	nn	19	SENT_246	[p16l7t1320r880b1407],
18	spectrometry	NN	O	spectrometry	nn	19	SENT_246	[p16l971t1330r1471b1407],
19	analysis	NN	O	analysis	dep	15	SENT_246	[p16l1560t1320r1888b1407],
20	.	.	O	.	_	0	SENT_246	[p16l1560t1320r1888b1407],

1	This	DT	O	this	det	2	SENT_247	[p16l1978t1320r2146b1387],
2	study	NN	O	study	nsubjpass	5	SENT_247	[p16l10t1435r212b1522],
3	was	VBD	O	be	auxpass	5	SENT_247	[p16l239t1456r383b1502],
4	partly	RB	O	partly	advmod	5	SENT_247	[p16l410t1435r634b1522],
5	supported	VBN	O	support	_	0	SENT_247	[p16l663t1435r1040b1522],
6	by	IN	O	by	_	0	SENT_247	[p16l1063t1435r1157b1522],
7	the	DT	O	the	det	11	SENT_247	[p16l1183t1435r1298b1502],
8	Japan	NNP	ORGANIZATION	Japan	nn	11	SENT_247	[p16l1324t1436r1542b1522],
9	Health	NNP	ORGANIZATION	Health	nn	11	SENT_247	[p16l1567t1435r1824b1502],
10	Science	NNP	ORGANIZATION	Science	nn	11	SENT_247	[p16l1851t1435r2147b1502],
11	Foundation	NNP	ORGANIZATION	Foundation	agent	5	SENT_247	[p16l6t1550r444b1617],
12	(	CD	NUMBER	(	num	11	SENT_247	[p16l482t1551r583b1633],
13	to	TO	O	to	_	0	SENT_247	[p16l482t1551r583b1633],
14	MT	NNP	O	MT	nn	15	SENT_247	[p16l619t1550r813b1633],
15	)	NNP	O	)	prep_to	5	SENT_247	[p16l619t1550r813b1633],
16	.	.	O	.	_	0	SENT_247	[p16l619t1550r813b1633],

1	References	NNS	O	reference	_	0	SENT_248	[p16l7t1808r454b1877],

1	[	NN	O	[	nn	5	SENT_249	[p16l50t2035r127b2100],
2	1	CD	NUMBER	1	num	5	SENT_249	[p16l50t2035r127b2100],
3	]	CD	NUMBER	]	num	5	SENT_249	[p16l50t2035r127b2100],
4	L.C.	NNP	PERSON	L.C.	nn	5	SENT_249	[p16l173t2035r305b2089],
5	Groop	NNP	PERSON	Groop	_	0	SENT_249	[p16l346t2035r556b2105],
6	,	,	O	,	_	0	SENT_249	[p16l346t2035r556b2105],
7	Sulfonylureas	NNP	MISC	Sulfonylureas	appos	5	SENT_249	[p16l597t2035r1020b2105],
8	in	IN	O	in	_	0	SENT_249	[p16l1057t2035r1115b2088],
9	NIDDM	NNP	ORGANIZATION	NIDDM	prep_in	7	SENT_249	[p16l1151t2036r1426b2098],
10	,	,	O	,	_	0	SENT_249	[p16l1151t2036r1426b2098],
11	Diabetes	NNP	O	Diabetes	nn	12	SENT_249	[p16l1465t2035r1732b2089],
12	Care	NNP	O	Care	appos	5	SENT_249	[p16l1770t2035r1912b2089],
13	15	CD	NUMBER	15	number	14	SENT_249	[p16l1957t2035r2021b2089],
14	(	CD	NUMBER	(	dep	5	SENT_249	[p16l2063t2035r2147b2102],
15	6	CD	NUMBER	6	num	16	SENT_249	[p16l2063t2035r2147b2102],
16	)	NN	O	)	dep	14	SENT_249	[p16l2063t2035r2147b2102],

1	[	NN	O	[	nn	5	SENT_250	[p16l50t2225r127b2290],
2	2	CD	NUMBER	2	num	5	SENT_250	[p16l50t2225r127b2290],
3	]	CD	NUMBER	]	num	5	SENT_250	[p16l50t2225r127b2290],
4	United	NNP	LOCATION	United	nn	5	SENT_250	[p16l173t2224r383b2279],
5	Kingdom	NNP	LOCATION	Kingdom	_	0	SENT_250	[p16l430t2224r720b2294],
6	Prospective	JJ	O	prospective	amod	8	SENT_250	[p16l767t2224r1122b2294],
7	Diabetes	NNP	O	Diabetes	nn	8	SENT_250	[p16l1170t2224r1437b2278],
8	Study	NNP	O	Study	dep	5	SENT_250	[p16l1488t2224r1663b2294],
9	24	CD	NUMBER	24	dep	5	SENT_250	[p16l1713t2224r1803b2278],
10	:	:	O	:	_	0	SENT_250	[p16l1713t2224r1803b2278],
11	a	DT	O	a	det	21	SENT_250	[p16l1857t2241r1890b2278],
12	6-year	JJ	DURATION	6-year	amod	21	SENT_250	[p16l1937t2224r2146b2294],
13	,	,	O	,	_	0	SENT_250	[p16l1937t2224r2146b2294],
14	randomized	VBN	O	randomize	dep	21	SENT_250	[p16l172t2322r553b2385],
15	,	,	O	,	_	0	SENT_250	[p16l172t2322r553b2385],
16	controlled	VBN	O	control	dep	14	SENT_250	[p16l596t2322r909b2376],
17	trial	NN	O	trial	dobj	16	SENT_250	[p16l947t2322r1070b2376],
18	comparing	VBG	O	compare	xcomp	14	SENT_250	[p16l1111t2322r1439b2392],
19	sulfonylurea	NN	O	sulfonylurea	dobj	18	SENT_250	[p16l1481t2322r1879b2392],
20	,	,	O	,	_	0	SENT_250	[p16l1481t2322r1879b2392],
21	insulin	NN	O	insulin	dep	5	SENT_250	[p16l1921t2322r2146b2385],
22	,	,	O	,	_	0	SENT_250	[p16l1921t2322r2146b2385],
23	and	CC	O	and	_	0	SENT_250	[p16l175t2416r284b2470],
24	metformin	NN	O	metformin	nn	25	SENT_250	[p16l314t2416r639b2470],
25	therapy	NN	O	therapy	conj_and	21	SENT_250	[p16l670t2416r900b2486],
26	in	IN	O	in	_	0	SENT_250	[p16l932t2416r990b2470],
27	patients	NNS	O	patient	prep_in	25	SENT_250	[p16l1021t2416r1259b2486],
28	with	IN	O	with	_	0	SENT_250	[p16l1293t2416r1428b2470],
29	newly	RB	O	newly	advmod	30	SENT_250	[p16l1458t2416r1643b2486],
30	diagnosed	VBN	O	diagnose	amod	31	SENT_250	[p16l1676t2416r1988b2486],
31	type	NN	O	type	prep_with	27	SENT_250	[p16l2018t2424r2148b2486],
32	2	CD	NUMBER	2	num	33	SENT_250	[p16l175t2513r209b2566],
33	diabetes	NN	O	diabetes	dep	25	SENT_250	[p16l233t2512r482b2566],
34	that	WDT	O	that	nsubjpass	38	SENT_250	[p16l505t2512r621b2566],
35	could	MD	O	could	aux	38	SENT_250	[p16l643t2512r813b2566],
36	not	RB	O	not	neg	38	SENT_250	[p16l834t2520r932b2566],
37	be	VB	O	be	auxpass	38	SENT_250	[p16l952t2512r1023b2566],
38	controlled	VBN	O	control	rcmod	33	SENT_250	[p16l1047t2512r1358b2566],
39	with	IN	O	with	_	0	SENT_250	[p16l1380t2512r1516b2566],
40	diet	NN	O	diet	nn	41	SENT_250	[p16l1538t2512r1653b2566],
41	therapy	NN	O	therapy	prep_with	38	SENT_250	[p16l1673t2512r1914b2582],
42	.	.	O	.	_	0	SENT_250	[p16l1673t2512r1914b2582],

1	United	NNP	ORGANIZATION	United	nn	2	SENT_251	[p16l1941t2512r2150b2567],
2	Kingdom	NNP	ORGANIZATION	Kingdom	_	0	SENT_251	[p16l175t2608r464b2678],
3	Prospective	JJ	ORGANIZATION	prospective	amod	6	SENT_251	[p16l479t2608r834b2678],
4	Diabetes	NNP	ORGANIZATION	Diabetes	nn	6	SENT_251	[p16l851t2608r1119b2662],
5	Study	NNP	ORGANIZATION	Study	nn	6	SENT_251	[p16l1138t2608r1314b2678],
6	Group	NNP	ORGANIZATION	Group	dep	2	SENT_251	[p16l1331t2609r1541b2678],
7	,	,	O	,	_	0	SENT_251	[p16l1331t2609r1541b2678],
8	Ann	NNP	PERSON	Ann	appos	6	SENT_251	[p16l1574t2609r1720b2662],
9	.	.	O	.	_	0	SENT_251	[p16l1574t2609r1720b2662],

1	Int	NN	O	int	_	0	SENT_252	[p16l1741t2609r1840b2662],
2	.	.	O	.	_	0	SENT_252	[p16l1741t2609r1840b2662],

1	Med	NNP	O	Med	_	0	SENT_253	[p16l1860t2608r2016b2662],
2	.	.	O	.	_	0	SENT_253	[p16l1860t2608r2016b2662],

1	128	CD	NUMBER	128	number	2	SENT_254	[p16l2042t2609r2146b2663],
2	(	CD	NUMBER	(	_	0	SENT_254	[p16l176t2704r259b2770],
3	3	CD	NUMBER	3	num	4	SENT_254	[p16l176t2704r259b2770],
4	)	NN	O	)	dep	2	SENT_254	[p16l176t2704r259b2770],
5	(	CD	NUMBER	(	num	6	SENT_254	[p16l291t2704r490b2770],
6	1998	CD	DATE	1998	dep	2	SENT_254	[p16l291t2704r490b2770],
7	)	CD	NUMBER	)	num	8	SENT_254	[p16l291t2704r490b2770],
8	165-175	CD	NUMBER	165-175	dep	6	SENT_254	[p16l527t2704r803b2758],
9	.	.	O	.	_	0	SENT_254	[p16l527t2704r803b2758],

1	[	NN	O	[	nn	4	SENT_255	[p16l50t2800r127b2865],
2	3	CD	NUMBER	3	num	4	SENT_255	[p16l50t2800r127b2865],
3	]	NN	O	]	nn	4	SENT_255	[p16l50t2800r127b2865],
4	A.	NN	PERSON	a.	_	0	SENT_255	[p16l173t2800r242b2853],
5	Holstein	NNP	PERSON	Holstein	dep	4	SENT_255	[p16l284t2799r560b2863],
6	,	,	O	,	_	0	SENT_255	[p16l284t2799r560b2863],
7	E.H.	NNP	ORGANIZATION	E.H.	nn	8	SENT_255	[p16l601t2800r737b2853],
8	Egberts	NNP	ORGANIZATION	Egberts	appos	5	SENT_255	[p16l779t2799r1030b2869],
9	,	,	O	,	_	0	SENT_255	[p16l779t2799r1030b2869],
10	Risk	NN	O	risk	appos	5	SENT_255	[p16l1071t2799r1211b2853],
11	of	IN	O	of	_	0	SENT_255	[p16l1249t2799r1315b2853],
12	hypoglycaemia	NN	O	hypoglycaemia	prep_of	10	SENT_255	[p16l1348t2799r1820b2869],
13	with	IN	O	with	_	0	SENT_255	[p16l1857t2799r1992b2853],
14	oral	JJ	O	oral	amod	16	SENT_255	[p16l2031t2799r2148b2853],
15	antidiabetic	JJ	O	antidiabetic	amod	16	SENT_255	[p16l175t2895r531b2949],
16	agents	NNS	O	agent	prep_with	12	SENT_255	[p16l563t2903r756b2965],
17	in	IN	O	in	_	0	SENT_255	[p16l786t2895r844b2949],
18	patients	NNS	O	patient	prep_in	16	SENT_255	[p16l871t2895r1110b2965],
19	with	IN	O	with	_	0	SENT_255	[p16l1140t2895r1276b2949],
20	type	NN	O	type	nn	22	SENT_255	[p16l1303t2903r1435b2965],
21	2	CD	NUMBER	2	num	22	SENT_255	[p16l1465t2896r1499b2949],
22	diabetes	NN	O	diabetes	prep_with	18	SENT_255	[p16l1529t2895r1797b2959],
23	,	,	O	,	_	0	SENT_255	[p16l1529t2895r1797b2959],
24	Exp	NN	O	exp	appos	5	SENT_255	[p16l1828t2896r1966b2965],
25	.	.	O	.	_	0	SENT_255	[p16l1828t2896r1966b2965],

1	Clin	NNP	O	Clin	_	0	SENT_256	[p16l1999t2895r2145b2950],
2	.	.	O	.	_	0	SENT_256	[p16l1999t2895r2145b2950],

1	Endocrinol	NN	O	endocrinol	_	0	SENT_257	[p16l173t2991r530b3044],
2	.	.	O	.	_	0	SENT_257	[p16l173t2991r530b3044],

1	Diabetes	NNP	O	Diabetes	_	0	SENT_258	[p16l562t2991r829b3044],
2	111	CD	NUMBER	111	num	3	SENT_258	[p16l865t2991r965b3044],
3	(	NN	O	(	dep	1	SENT_258	[p16l1002t2992r1085b3057],
4	7	CD	NUMBER	7	num	5	SENT_258	[p16l1002t2992r1085b3057],
5	)	NN	O	)	dep	3	SENT_258	[p16l1002t2992r1085b3057],
6	(	CD	NUMBER	(	num	7	SENT_258	[p16l1117t2991r1316b3057],
7	2003	CD	DATE	2003	dep	1	SENT_258	[p16l1117t2991r1316b3057],
8	)	CD	NUMBER	)	num	9	SENT_258	[p16l1117t2991r1316b3057],
9	405-414	CD	NUMBER	405-414	dep	7	SENT_258	[p16l1346t2991r1629b3045],
10	.	.	O	.	_	0	SENT_258	[p16l1346t2991r1629b3045],

1	[	NN	O	[	nn	5	SENT_259	[p16l50t3086r127b3152],
2	4	CD	NUMBER	4	num	5	SENT_259	[p16l50t3086r127b3152],
3	]	CD	NUMBER	]	num	5	SENT_259	[p16l50t3086r127b3152],
4	J.	NNP	PERSON	J.	nn	5	SENT_259	[p16l173t3087r217b3140],
5	Schneider	NNP	PERSON	Schneider	_	0	SENT_259	[p16l247t3086r565b3150],
6	,	,	O	,	_	0	SENT_259	[p16l247t3086r565b3150],
7	An	DT	O	a	det	8	SENT_259	[p16l591t3086r684b3140],
8	overview	NN	O	overview	dep	5	SENT_259	[p16l709t3086r989b3140],
9	of	IN	O	of	_	0	SENT_259	[p16l1015t3086r1081b3140],
10	the	DT	O	the	det	11	SENT_259	[p16l1100t3086r1192b3140],
11	safety	NN	O	safety	prep_of	8	SENT_259	[p16l1219t3086r1398b3156],
12	and	CC	O	and	_	0	SENT_259	[p16l1424t3086r1533b3140],
13	tolerance	NN	O	tolerance	prep_of	8	SENT_259	[p16l1556t3086r1839b3140],
14	of	IN	O	of	_	0	SENT_259	[p16l1864t3086r1930b3140],
15	glimepiride	NN	O	glimepiride	prep_of	11	SENT_259	[p16l1949t3086r2147b3156, p16l172t3182r369b3252],
16	,	,	O	,	_	0	SENT_259	[p16l1949t3086r2147b3156, p16l172t3182r369b3252],

1	Horm	NNP	O	Horm	_	0	SENT_260	[p16l399t3183r592b3236],
2	.	.	O	.	_	0	SENT_260	[p16l399t3183r592b3236],

1	Metab	NNP	PERSON	Metab	_	0	SENT_261	[p16l623t3182r832b3236],
2	.	.	O	.	_	0	SENT_261	[p16l623t3182r832b3236],

1	Res	NNP	O	Res	_	0	SENT_262	[p16l864t3183r993b3236],
2	.	.	O	.	_	0	SENT_262	[p16l864t3183r993b3236],

1	28	CD	NUMBER	28	number	2	SENT_263	[p16l1025t3183r1097b3237],
2	(	CD	NUMBER	(	_	0	SENT_263	[p16l1130t3183r1213b3249],
3	9	CD	NUMBER	9	num	4	SENT_263	[p16l1130t3183r1213b3249],
4	)	NN	O	)	dep	2	SENT_263	[p16l1130t3183r1213b3249],
5	(	CD	NUMBER	(	num	6	SENT_263	[p16l1245t3182r1444b3249],
6	1996	CD	DATE	1996	dep	2	SENT_263	[p16l1245t3182r1444b3249],
7	)	CD	NUMBER	)	num	8	SENT_263	[p16l1245t3182r1444b3249],
8	413-418	CD	NUMBER	413-418	dep	6	SENT_263	[p16l1473t3182r1758b3237],
9	.	.	O	.	_	0	SENT_263	[p16l1473t3182r1758b3237],

1	[	NN	O	[	nn	5	SENT_264	[p16l50t3278r127b3344],
2	5	CD	NUMBER	5	num	5	SENT_264	[p16l50t3278r127b3344],
3	]	CD	NUMBER	]	num	5	SENT_264	[p16l50t3278r127b3344],
4	M.	NNP	NUMBER	M.	nn	5	SENT_264	[p16l173t3280r255b3333],
5	Massi-Benedetti	NNP	PERSON	Massi-Benedetti	_	0	SENT_264	[p16l285t3278r807b3342],
6	,	,	O	,	_	0	SENT_264	[p16l285t3278r807b3342],
7	Glimepiride	NNP	O	Glimepiride	appos	5	SENT_264	[p16l838t3278r1208b3348],
8	in	IN	O	in	_	0	SENT_264	[p16l1235t3278r1293b3332],
9	type	NN	O	type	nn	12	SENT_264	[p16l1320t3287r1451b3348],
10	2	CD	NUMBER	2	num	12	SENT_264	[p16l1480t3279r1514b3332],
11	diabetes	NN	O	diabetes	nn	12	SENT_264	[p16l1542t3278r1792b3333],
12	mellitus	NN	O	mellitus	prep_in	7	SENT_264	[p16l1820t3278r2084b3333],
13	:	:	O	:	_	0	SENT_264	[p16l1820t3278r2084b3333],
14	a	DT	O	a	det	15	SENT_264	[p16l2118t3295r2150b3333],
15	review	NN	O	review	dep	5	SENT_264	[p16l172t3374r378b3428],
16	of	IN	O	of	_	0	SENT_264	[p16l406t3374r472b3428],
17	the	DT	O	the	det	20	SENT_264	[p16l492t3374r585b3428],
18	worldwide	JJ	O	worldwide	amod	20	SENT_264	[p16l611t3374r938b3428],
19	therapeutic	JJ	O	therapeutic	amod	20	SENT_264	[p16l964t3374r1306b3444],
20	experience	NN	O	experience	prep_of	15	SENT_264	[p16l1334t3374r1683b3444],
21	,	,	O	,	_	0	SENT_264	[p16l1334t3374r1683b3444],
22	Clin	NN	PERSON	clin	appos	20	SENT_264	[p16l1712t3374r1858b3428],
23	.	.	O	.	_	0	SENT_264	[p16l1712t3374r1858b3428],

1	Ther	NNP	O	Ther	_	0	SENT_265	[p16l1888t3374r2044b3428],
2	.	.	O	.	_	0	SENT_265	[p16l1888t3374r2044b3428],

1	25	CD	NUMBER	25	number	2	SENT_266	[p16l2075t3374r2146b3428],
2	(	CD	NUMBER	(	_	0	SENT_266	[p16l176t3471r259b3536],
3	3	CD	NUMBER	3	num	4	SENT_266	[p16l176t3471r259b3536],
4	)	NN	O	)	dep	2	SENT_266	[p16l176t3471r259b3536],
5	(	CD	NUMBER	(	num	6	SENT_266	[p16l291t3471r490b3536],
6	2003	CD	DATE	2003	dep	2	SENT_266	[p16l291t3471r490b3536],
7	)	CD	NUMBER	)	num	8	SENT_266	[p16l291t3471r490b3536],
8	799-816	CD	NUMBER	799-816	dep	6	SENT_266	[p16l521t3470r803b3525],
9	.	.	O	.	_	0	SENT_266	[p16l521t3470r803b3525],

1	[	NN	O	[	nn	5	SENT_267	[p16l50t3565r127b3631],
2	6	CD	NUMBER	6	num	5	SENT_267	[p16l50t3565r127b3631],
3	]	CD	NUMBER	]	num	5	SENT_267	[p16l50t3565r127b3631],
4	R.	NNP	PERSON	R.	nn	5	SENT_267	[p16l173t3567r238b3620],
5	Weitgasser	NNP	PERSON	Weitgasser	_	0	SENT_267	[p16l264t3565r615b3635],
6	,	,	O	,	_	0	SENT_267	[p16l264t3565r615b3635],
7	M.	NNP	PERSON	M.	nn	8	SENT_267	[p16l640t3567r722b3620],
8	Lechleitner	NNP	PERSON	Lechleitner	appos	5	SENT_267	[p16l748t3565r1114b3629],
9	,	,	O	,	_	0	SENT_267	[p16l748t3565r1114b3629],
10	A.	NNP	PERSON	A.	nn	11	SENT_267	[p16l1140t3566r1208b3620],
11	Luger	NNP	PERSON	Luger	appos	5	SENT_267	[p16l1235t3567r1432b3635],
12	,	,	O	,	_	0	SENT_267	[p16l1235t3567r1432b3635],
13	A.	NNP	PERSON	A.	nn	14	SENT_267	[p16l1457t3566r1526b3620],
14	Klingler	NNP	PERSON	Klingler	appos	5	SENT_267	[p16l1554t3565r1823b3635],
15	,	,	O	,	_	0	SENT_267	[p16l1554t3565r1823b3635],
16	Effects	NNS	O	effect	appos	5	SENT_267	[p16l1848t3565r2062b3620],
17	of	IN	O	of	_	0	SENT_267	[p16l2087t3565r2154b3620],
18	glimepiride	NN	O	glimepiride	prep_of	16	SENT_267	[p16l174t3662r528b3733],
19	on	IN	O	on	_	0	SENT_267	[p16l547t3679r622b3717],
20	HbA1C	NN	O	hba1c	nn	23	SENT_267	[p16l639t3663r839b3729],
21	and	CC	O	and	_	0	SENT_267	[p16l859t3663r968b3717],
22	body	NN	O	body	nn	23	SENT_267	[p16l984t3662r1137b3733],
23	weight	NN	O	weight	prep_on	18	SENT_267	[p16l1155t3662r1364b3733],
24	in	IN	O	in	_	0	SENT_267	[p16l1380t3663r1438b3716],
25	type	NN	O	type	nn	27	SENT_267	[p16l1456t3671r1586b3733],
26	2	CD	NUMBER	2	num	27	SENT_267	[p16l1606t3663r1641b3716],
27	diabetes	NN	O	diabetes	prep_in	5	SENT_267	[p16l1659t3662r1927b3717],
28	:	:	O	:	_	0	SENT_267	[p16l1659t3662r1927b3717],
29	results	NNS	O	result	dep	5	SENT_267	[p16l1949t3662r2148b3717],
30	of	IN	O	of	_	0	SENT_267	[p17l174t19r241b73],
31	a	DT	O	a	det	34	SENT_267	[p17l263t36r295b73],
32	1.5-year	JJ	DURATION	1.5-year	amod	34	SENT_267	[p17l326t19r574b89],
33	follow-up	JJ	O	follow-up	amod	34	SENT_267	[p17l598t19r899b89],
34	study	NN	O	study	prep_of	29	SENT_267	[p17l927t19r1101b89],
35	,	,	O	,	_	0	SENT_267	[p17l927t19r1101b89],
36	Diabetes	NNP	O	Diabetes	nn	37	SENT_267	[p17l1130t19r1397b73],
37	Res	NNP	O	Res	appos	34	SENT_267	[p17l1423t20r1553b73],
38	.	.	O	.	_	0	SENT_267	[p17l1423t20r1553b73],

1	Clin	NNP	O	Clin	_	0	SENT_268	[p17l1583t19r1729b74],
2	.	.	O	.	_	0	SENT_268	[p17l1583t19r1729b74],

1	Pract	NNP	O	Pract	_	0	SENT_269	[p17l1758t20r1931b73],
2	.	.	O	.	_	0	SENT_269	[p17l1758t20r1931b73],

1	61	CD	NUMBER	61	num	2	SENT_270	[p17l1961t19r2028b74],
2	(	NN	O	(	_	0	SENT_270	[p17l2063t20r2147b86],
3	1	CD	NUMBER	1	number	4	SENT_270	[p17l2063t20r2147b86],
4	)	CD	NUMBER	)	dep	2	SENT_270	[p17l2063t20r2147b86],
5	(	CD	NUMBER	(	num	6	SENT_270	[p17l176t116r375b181],
6	2003	CD	DATE	2003	dep	4	SENT_270	[p17l176t116r375b181],
7	)	CD	NUMBER	)	num	8	SENT_270	[p17l176t116r375b181],
8	13-19	CD	DATE	13-19	dep	4	SENT_270	[p17l412t116r611b170],
9	.	.	O	.	_	0	SENT_270	[p17l412t116r611b170],

1	[	NN	O	[	nn	5	SENT_271	[p17l50t212r127b276],
2	7	CD	NUMBER	7	num	5	SENT_271	[p17l50t212r127b276],
3	]	CD	NUMBER	]	num	5	SENT_271	[p17l50t212r127b276],
4	R.K.	NNP	PERSON	R.K.	nn	5	SENT_271	[p17l173t212r313b265],
5	Campbell	NNP	PERSON	Campbell	_	0	SENT_271	[p17l344t210r660b280],
6	,	,	O	,	_	0	SENT_271	[p17l344t210r660b280],
7	Glimepiride	NNP	O	Glimepiride	appos	5	SENT_271	[p17l691t210r1078b280],
8	:	:	O	:	_	0	SENT_271	[p17l691t210r1078b280],
9	role	NN	O	role	dep	5	SENT_271	[p17l1110t210r1229b265],
10	of	IN	O	of	_	0	SENT_271	[p17l1258t210r1325b265],
11	a	DT	O	a	det	13	SENT_271	[p17l1349t227r1380b265],
12	new	JJ	O	new	amod	13	SENT_271	[p17l1407t227r1531b265],
13	sulfonylurea	NN	O	sulfonylurea	prep_of	9	SENT_271	[p17l1562t210r1944b280],
14	in	IN	O	in	_	0	SENT_271	[p17l1970t210r2029b264],
15	the	DT	O	the	det	16	SENT_271	[p17l2056t210r2148b265],
16	treatment	NN	O	treatment	prep_in	13	SENT_271	[p17l173t314r466b360],
17	of	IN	O	of	_	0	SENT_271	[p17l498t306r565b360],
18	type	NN	O	type	nn	21	SENT_271	[p17l593t314r724b376],
19	2	CD	NUMBER	2	num	21	SENT_271	[p17l760t307r794b360],
20	diabetes	NN	O	diabetes	nn	21	SENT_271	[p17l830t306r1079b360],
21	mellitus	NN	O	mellitus	prep_of	16	SENT_271	[p17l1114t306r1378b370],
22	,	,	O	,	_	0	SENT_271	[p17l1114t306r1378b370],
23	Ann	NNP	PERSON	Ann	appos	21	SENT_271	[p17l1414t307r1560b360],
24	.	.	O	.	_	0	SENT_271	[p17l1414t307r1560b360],

1	Pharmacother	NNP	O	Pharmacother	_	0	SENT_272	[p17l1598t306r2036b360],
2	.	.	O	.	_	0	SENT_272	[p17l1598t306r2036b360],

1	32	CD	NUMBER	32	number	2	SENT_273	[p17l2076t307r2148b361],
2	(	CD	NUMBER	(	_	0	SENT_273	[p17l176t403r298b468],
3	10	CD	NUMBER	10	num	4	SENT_273	[p17l176t403r298b468],
4	)	NN	O	)	dep	2	SENT_273	[p17l176t403r298b468],
5	(	CD	NUMBER	(	num	6	SENT_273	[p17l329t403r529b468],
6	1998	CD	DATE	1998	dep	2	SENT_273	[p17l329t403r529b468],
7	)	CD	NUMBER	)	num	8	SENT_273	[p17l329t403r529b468],
8	1044-1052	CD	DATE	1044-1052	dep	6	SENT_273	[p17l566t402r918b456],
9	.	.	O	.	_	0	SENT_273	[p17l566t402r918b456],

1	[	NN	O	[	nn	5	SENT_274	[p17l50t498r127b562],
2	8	CD	NUMBER	8	num	5	SENT_274	[p17l50t498r127b562],
3	]	CD	NUMBER	]	num	5	SENT_274	[p17l50t498r127b562],
4	J.	NNP	PERSON	J.	nn	5	SENT_274	[p17l173t499r217b552],
5	Rosenstock	NNP	PERSON	Rosenstock	_	0	SENT_274	[p17l252t497r623b561],
6	,	,	O	,	_	0	SENT_274	[p17l252t497r623b561],
7	E.	NNP	PERSON	E.	nn	8	SENT_274	[p17l656t499r717b551],
8	Samols	NNP	PERSON	Samols	appos	5	SENT_274	[p17l755t497r995b561],
9	,	,	O	,	_	0	SENT_274	[p17l755t497r995b561],
10	D.B.	NNP	PERSON	D.B.	nn	11	SENT_274	[p17l1029t499r1169b551],
11	Muchmore	NNP	PERSON	Muchmore	appos	5	SENT_274	[p17l1204t497r1558b561],
12	,	,	O	,	_	0	SENT_274	[p17l1204t497r1558b561],
13	J.	NNP	PERSON	J.	nn	14	SENT_274	[p17l1592t499r1635b552],
14	Schneider	NNP	PERSON	Schneider	appos	5	SENT_274	[p17l1673t497r1992b561],
15	,	,	O	,	_	0	SENT_274	[p17l1673t497r1992b561],
16	Glimepiride	NNP	O	Glimepiride	appos	14	SENT_274	[p17l2028t497r2147b552, p17l173t594r463b664],
17	,	,	O	,	_	0	SENT_274	[p17l2028t497r2147b552, p17l173t594r463b664],
18	a	DT	O	a	det	23	SENT_274	[p17l501t610r533b648],
19	new	JJ	O	new	amod	23	SENT_274	[p17l565t610r689b648],
20	once	RB	DATE	once	advmod	22	SENT_274	[p17l724t593r1048b664],
21	—	RB	O	—	advmod	22	SENT_274	[p17l724t593r1048b664],
22	daily	JJ	SET	daily	amod	23	SENT_274	[p17l724t593r1048b664],
23	sulfonylurea	NN	O	sulfonylurea	appos	5	SENT_274	[p17l1084t593r1480b664],
24	.	.	O	.	_	0	SENT_274	[p17l1084t593r1480b664],

1	A	DT	O	a	det	4	SENT_275	[p17l1517t594r1571b647],
2	double-blind	JJ	O	double-blind	amod	4	SENT_275	[p17l1605t593r1998b648],
3	placebo	NN	O	placebo	nn	4	SENT_275	[p17l2029t594r2147b664, p17l174t688r658b742],
4	—	NN	O	—	nsubj	5	SENT_275	[p17l2029t594r2147b664, p17l174t688r658b742],
5	controlled	JJ	O	controlled	_	0	SENT_275	[p17l2029t594r2147b664, p17l174t688r658b742],
6	study	NN	O	study	dobj	5	SENT_275	[p17l692t688r855b758],
7	of	IN	O	of	_	0	SENT_275	[p17l889t688r956b742],
8	NIDDM	NN	ORGANIZATION	niddm	nn	9	SENT_275	[p17l983t689r1242b742],
9	patients	NNS	O	patient	prep_of	6	SENT_275	[p17l1273t688r1529b758],
10	.	.	O	.	_	0	SENT_275	[p17l1273t688r1529b758],

1	Glimepiride	NNP	O	Glimepiride	_	0	SENT_276	[p17l1567t688r1938b758],
2	Study	NNP	O	Study	nn	3	SENT_276	[p17l1973t688r2148b758],
3	Group	NNP	O	Group	dep	1	SENT_276	[p17l175t785r385b854],
4	,	,	O	,	_	0	SENT_276	[p17l175t785r385b854],
5	Diabetes	NNP	ORGANIZATION	Diabetes	nn	6	SENT_276	[p17l414t784r682b839],
6	Care	NNP	ORGANIZATION	Care	appos	3	SENT_276	[p17l712t785r855b839],
7	19	CD	NUMBER	19	number	8	SENT_276	[p17l890t785r957b839],
8	(	CD	NUMBER	(	dep	1	SENT_276	[p17l988t785r1110b851],
9	11	CD	NUMBER	11	num	10	SENT_276	[p17l988t785r1110b851],
10	)	NN	O	)	dep	8	SENT_276	[p17l988t785r1110b851],
11	(	CD	NUMBER	(	num	12	SENT_276	[p17l1142t784r1341b851],
12	1996	CD	DATE	1996	dep	1	SENT_276	[p17l1142t784r1341b851],
13	)	CD	NUMBER	)	num	14	SENT_276	[p17l1142t784r1341b851],
14	1194-1199	CD	DATE	1194-1199	dep	12	SENT_276	[p17l1379t785r1732b839],
15	.	.	O	.	_	0	SENT_276	[p17l1379t785r1732b839],

1	[	NN	O	[	nn	3	SENT_277	[p17l50t882r127b947],
2	9	CD	NUMBER	9	num	3	SENT_277	[p17l50t882r127b947],
3	]	NN	O	]	_	0	SENT_277	[p17l50t882r127b947],
4	G.	NNP	PERSON	G.	nn	5	SENT_277	[p17l175t882r242b936],
5	Muller	NNP	PERSON	Muller	dep	3	SENT_277	[p17l274t882r497b945],
6	,	,	O	,	_	0	SENT_277	[p17l274t882r497b945],
7	D.	NNP	PERSON	D.	nn	8	SENT_277	[p17l528t883r597b936],
8	Hartz	NNP	PERSON	Hartz	appos	5	SENT_277	[p17l629t883r815b945],
9	,	,	O	,	_	0	SENT_277	[p17l629t883r815b945],
10	J.	NNP	PERSON	J.	nn	11	SENT_277	[p17l846t883r889b936],
11	Punter	NNP	PERSON	Punter	appos	5	SENT_277	[p17l923t883r1136b945],
12	,	,	O	,	_	0	SENT_277	[p17l923t883r1136b945],
13	R.	NNP	PERSON	R.	nn	14	SENT_277	[p17l1167t883r1232b936],
14	Okonomopulos	NNP	PERSON	Okonomopulos	appos	5	SENT_277	[p17l1266t882r1754b952],
15	,	,	O	,	_	0	SENT_277	[p17l1266t882r1754b952],
16	W.	NNP	PERSON	W.	nn	17	SENT_277	[p17l1785t883r1866b936],
17	Kramer	NNP	PERSON	Kramer	appos	5	SENT_277	[p17l1899t883r2146b945],
18	,	,	O	,	_	0	SENT_277	[p17l1899t883r2146b945],
19	Differential	JJ	O	differential	amod	20	SENT_277	[p17l173t978r530b1032],
20	interaction	NN	O	interaction	appos	5	SENT_277	[p17l562t978r893b1032],
21	of	IN	O	of	_	0	SENT_277	[p17l925t978r991b1032],
22	glimepiride	NN	O	glimepiride	prep_of	20	SENT_277	[p17l1018t978r1373b1048],
23	and	CC	O	and	_	0	SENT_277	[p17l1406t978r1515b1032],
24	glibenclamide	NN	O	glibenclamide	prep_of	20	SENT_277	[p17l1547t978r1982b1048],
25	with	IN	O	with	_	0	SENT_277	[p17l2014t978r2149b1032],
26	the	DT	O	the	det	29	SENT_277	[p17l173t1072r266b1127],
27	beta-cell	NN	O	beta-cell	nn	29	SENT_277	[p17l301t1072r567b1127],
28	sulfonylurea	NN	O	sulfonylurea	nn	29	SENT_277	[p17l606t1072r988b1142],
29	receptor	NN	O	receptor	prep_with	5	SENT_277	[p17l1023t1080r1286b1142],
30	.	.	O	.	_	0	SENT_277	[p17l1023t1080r1286b1142],

1	1	LS	NUMBER	1	_	0	SENT_278	[p17l1326t1074r1365b1127],
2	.	.	O	.	_	0	SENT_278	[p17l1326t1074r1365b1127],

1	Binding	NN	O	binding	nn	2	SENT_279	[p17l1405t1072r1652b1142],
2	characteristics	NNS	O	characteristic	_	0	SENT_279	[p17l1689t1072r2146b1136],
3	,	,	O	,	_	0	SENT_279	[p17l1689t1072r2146b1136],
4	Biochim	NNP	LOCATION	Biochim	appos	2	SENT_279	[p17l173t1169r453b1224],
5	.	.	O	.	_	0	SENT_279	[p17l173t1169r453b1224],

1	Biophys	NNS	O	biophy	_	0	SENT_280	[p17l484t1169r755b1240],
2	.	.	O	.	_	0	SENT_280	[p17l484t1169r755b1240],

1	Acta	NNP	O	Acta	nn	3	SENT_281	[p17l787t1170r932b1224],
2	1191	CD	DATE	1191	num	3	SENT_281	[p17l966t1170r1104b1224],
3	(	NN	O	(	_	0	SENT_281	[p17l1140t1170r1224b1236],
4	2	CD	NUMBER	2	number	5	SENT_281	[p17l1140t1170r1224b1236],
5	)	CD	NUMBER	)	dep	3	SENT_281	[p17l1140t1170r1224b1236],
6	(	CD	NUMBER	(	num	7	SENT_281	[p17l1257t1170r1456b1236],
7	1994	CD	DATE	1994	dep	5	SENT_281	[p17l1257t1170r1456b1236],
8	)	CD	NUMBER	)	num	9	SENT_281	[p17l1257t1170r1456b1236],
9	267-277	CD	NUMBER	267-277	dep	5	SENT_281	[p17l1486t1169r1769b1224],
10	.	.	O	.	_	0	SENT_281	[p17l1486t1169r1769b1224],

1	154	CD	NUMBER	154	num	3	SENT_282	[p17l333t1315r379b1339],
2	K.	NNP	PERSON	K.	nn	3	SENT_282	[p17l774t1316r801b1339],
3	Suzuki	NNP	PERSON	Suzuki	_	0	SENT_282	[p17l816t1315r902b1341],
4	et	FW	O	et	nn	5	SENT_282	[p17l914t1320r938b1339],
5	al.	FW	O	al.	dep	3	SENT_282	[p17l949t1315r979b1339],
6	/	:	O	/	punct	3	SENT_282	[p17l986t1316r1001b1339],
7	Diabetes	NNP	ORGANIZATION	Diabetes	dep	3	SENT_282	[p17l1003t1315r1121b1339],
8	Research	NNP	ORGANIZATION	Research	dep	7	SENT_282	[p17l1131t1315r1254b1339],
9	and	CC	ORGANIZATION	and	_	0	SENT_282	[p17l1265t1315r1316b1339],
10	Clinical	JJ	ORGANIZATION	clinical	amod	11	SENT_282	[p17l1328t1315r1433b1339],
11	Practice	NN	ORGANIZATION	practice	dep	3	SENT_282	[p17l1444t1316r1556b1339],
12	72	CD	NUMBER	72	number	13	SENT_282	[p17l1570t1315r1599b1339],
13	(	CD	NUMBER	(	num	14	SENT_282	[p17l1613t1315r1699b1344],
14	2006	CD	DATE	2006	dep	11	SENT_282	[p17l1613t1315r1699b1344],
15	)	CD	NUMBER	)	num	16	SENT_282	[p17l1613t1315r1699b1344],
16	148-154	CD	NUMBER	148-154	dep	11	SENT_282	[p17l1713t1315r1827b1339],

1	[	NN	O	[	nn	5	SENT_283	[p17l6t1456r123b1521],
2	10	CD	NUMBER	10	num	5	SENT_283	[p17l6t1456r123b1521],
3	]	CD	NUMBER	]	num	5	SENT_283	[p17l6t1456r123b1521],
4	M.U.	NNP	PERSON	M.U.	nn	5	SENT_283	[p17l168t1457r325b1510],
5	Kabadi	NNP	PERSON	Kabadi	_	0	SENT_283	[p17l363t1456r600b1520],
6	,	,	O	,	_	0	SENT_283	[p17l363t1456r600b1520],
7	U.M.	NNP	LOCATION	U.M.	nn	8	SENT_283	[p17l635t1457r791b1510],
8	Kabadi	NNP	LOCATION	Kabadi	appos	5	SENT_283	[p17l829t1456r1066b1520],
9	,	,	O	,	_	0	SENT_283	[p17l829t1456r1066b1520],
10	Effects	NNS	O	effect	appos	5	SENT_283	[p17l1100t1456r1315b1510],
11	of	IN	O	of	_	0	SENT_283	[p17l1350t1456r1417b1510],
12	glimepiride	NN	O	glimepiride	prep_of	10	SENT_283	[p17l1445t1456r1801b1526],
13	on	IN	O	on	_	0	SENT_283	[p17l1834t1473r1908b1510],
14	insulin	NN	O	insulin	nn	15	SENT_283	[p17l1940t1456r2149b1510],
15	secretion	NN	O	secretion	prep_on	12	SENT_283	[p17l170t1552r447b1606],
16	and	CC	O	and	_	0	SENT_283	[p17l467t1552r576b1606],
17	sensitivity	NN	O	sensitivity	prep_on	12	SENT_283	[p17l597t1552r909b1622],
18	in	IN	O	in	_	0	SENT_283	[p17l929t1552r987b1606],
19	patients	NNS	O	patient	prep_in	12	SENT_283	[p17l1005t1552r1244b1622],
20	with	IN	O	with	prep	19	SENT_283	[p17l1265t1552r1400b1606],
21	recently	RB	DATE	recently	pobj	20	SENT_283	[p17l1419t1552r1667b1622],
22	diagnosed	VBN	O	diagnose	partmod	10	SENT_283	[p17l1687t1552r2000b1622],
23	type	NN	O	type	nn	26	SENT_283	[p17l2017t1560r2148b1622],
24	2	CD	NUMBER	2	num	26	SENT_283	[p17l169t1650r204b1703],
25	diabetes	NN	O	diabetes	nn	26	SENT_283	[p17l233t1649r484b1703],
26	mellitus	NN	O	mellitus	dobj	22	SENT_283	[p17l513t1649r778b1714],
27	,	,	O	,	_	0	SENT_283	[p17l513t1649r778b1714],
28	Clin	NN	PERSON	clin	appos	26	SENT_283	[p17l809t1649r955b1704],
29	.	.	O	.	_	0	SENT_283	[p17l809t1649r955b1704],

1	Ther	NNP	O	Ther	_	0	SENT_284	[p17l987t1649r1143b1703],
2	.	.	O	.	_	0	SENT_284	[p17l987t1649r1143b1703],

1	26	CD	NUMBER	26	num	2	SENT_285	[p17l1175t1649r1249b1704],
2	(	NN	O	(	_	0	SENT_285	[p17l1280t1650r1363b1716],
3	1	CD	NUMBER	1	number	4	SENT_285	[p17l1280t1650r1363b1716],
4	)	CD	NUMBER	)	dep	2	SENT_285	[p17l1280t1650r1363b1716],
5	(	CD	NUMBER	(	num	6	SENT_285	[p17l1397t1649r1596b1716],
6	2004	CD	DATE	2004	dep	4	SENT_285	[p17l1397t1649r1596b1716],
7	)	CD	NUMBER	)	num	8	SENT_285	[p17l1397t1649r1596b1716],
8	63-69	CD	NUMBER	63-69	dep	4	SENT_285	[p17l1627t1649r1832b1704],
9	.	.	O	.	_	0	SENT_285	[p17l1627t1649r1832b1704],

1	[	NN	O	[	nn	5	SENT_286	[p17l6t1745r123b1810],
2	11	CD	NUMBER	11	num	5	SENT_286	[p17l6t1745r123b1810],
3	]	CD	NUMBER	]	num	5	SENT_286	[p17l6t1745r123b1810],
4	M.	NNP	NUMBER	M.	nn	5	SENT_286	[p17l168t1746r250b1799],
5	Badian	NNP	PERSON	Badian	_	0	SENT_286	[p17l283t1745r518b1809],
6	,	,	O	,	_	0	SENT_286	[p17l283t1745r518b1809],
7	A.	NNP	PERSON	A.	nn	8	SENT_286	[p17l550t1745r619b1799],
8	Korn	NNP	PERSON	Korn	appos	5	SENT_286	[p17l653t1746r823b1809],
9	,	,	O	,	_	0	SENT_286	[p17l653t1746r823b1809],
10	K.H.	NNP	PERSON	K.H.	nn	11	SENT_286	[p17l855t1746r998b1799],
11	Lehr	NNP	PERSON	Lehr	appos	5	SENT_286	[p17l1031t1745r1189b1809],
12	,	,	O	,	_	0	SENT_286	[p17l1031t1745r1189b1809],
13	V.	NNP	PERSON	V.	nn	14	SENT_286	[p17l1222t1746r1281b1799],
14	Malerczyk	NNP	PERSON	Malerczyk	appos	5	SENT_286	[p17l1314t1745r1661b1815],
15	,	,	O	,	_	0	SENT_286	[p17l1314t1745r1661b1815],
16	W.	NNP	PERSON	W.	nn	17	SENT_286	[p17l1692t1746r1773b1799],
17	Waldhausl	NNP	PERSON	Waldhausl	appos	5	SENT_286	[p17l1805t1745r2147b1809],
18	,	,	O	,	_	0	SENT_286	[p17l1805t1745r2147b1809],
19	Absolute	JJ	O	absolute	amod	20	SENT_286	[p17l168t1841r445b1895],
20	bioavailability	NN	O	bioavailability	appos	5	SENT_286	[p17l494t1841r939b1911],
21	of	IN	O	of	_	0	SENT_286	[p17l989t1841r1056b1895],
22	glimepiride	NN	O	glimepiride	nn	25	SENT_286	[p17l1101t1841r1456b1911],
23	(	CD	NUMBER	(	num	25	SENT_286	[p17l1508t1841r1790b1911],
24	Amaryl	NN	O	amaryl	nn	25	SENT_286	[p17l1508t1841r1790b1911],
25	)	NN	O	)	prep_of	20	SENT_286	[p17l1508t1841r1790b1911],
26	after	IN	O	after	_	0	SENT_286	[p17l1842t1841r1983b1895],
27	oral	JJ	O	oral	amod	28	SENT_286	[p17l2031t1841r2149b1895],
28	administration	NN	O	administration	prep_after	20	SENT_286	[p17l169t1937r631b2001],
29	,	,	O	,	_	0	SENT_286	[p17l169t1937r631b2001],
30	Drug	NN	PERSON	drug	appos	5	SENT_286	[p17l677t1938r833b2007],
31	Metabol	NNP	PERSON	Metabol	dep	30	SENT_286	[p17l877t1937r1149b1991],
32	.	.	O	.	_	0	SENT_286	[p17l877t1937r1149b1991],

1	Drug	NN	O	drug	_	0	SENT_287	[p17l1197t1938r1353b2007],
2	Interact	NNP	O	Interact	dep	1	SENT_287	[p17l1397t1938r1647b1991],
3	.	.	O	.	_	0	SENT_287	[p17l1397t1938r1647b1991],

1	11	CD	NUMBER	11	number	2	SENT_288	[p17l1702t1938r1763b1991],
2	(	CD	NUMBER	(	_	0	SENT_288	[p17l1816t1937r1900b2004],
3	4	CD	NUMBER	4	num	4	SENT_288	[p17l1816t1937r1900b2004],
4	)	NN	O	)	dep	2	SENT_288	[p17l1816t1937r1900b2004],
5	(	CD	NUMBER	(	num	6	SENT_288	[p17l1947t1937r2147b2004],
6	1994	CD	DATE	1994	dep	2	SENT_288	[p17l1947t1937r2147b2004],
7	)	CD	NUMBER	)	num	8	SENT_288	[p17l1947t1937r2147b2004],
8	331-339	CD	NUMBER	331-339	dep	6	SENT_288	[p17l170t2034r453b2088],
9	.	.	O	.	_	0	SENT_288	[p17l170t2034r453b2088],

1	[	NN	O	[	nn	5	SENT_289	[p17l6t2129r123b2194],
2	12	CD	NUMBER	12	num	5	SENT_289	[p17l6t2129r123b2194],
3	]	CD	NUMBER	]	num	5	SENT_289	[p17l6t2129r123b2194],
4	M.	NNP	NUMBER	M.	nn	5	SENT_289	[p17l168t2130r250b2183],
5	Niemi	NNP	PERSON	Niemi	_	0	SENT_289	[p17l275t2129r485b2193],
6	,	,	O	,	_	0	SENT_289	[p17l275t2129r485b2193],
7	I.	NNP	PERSON	I.	nn	8	SENT_289	[p17l510t2130r549b2183],
8	Cascorbi	NNP	PERSON	Cascorbi	appos	5	SENT_289	[p17l576t2129r866b2193],
9	,	,	O	,	_	0	SENT_289	[p17l576t2129r866b2193],
10	R.	NNP	PERSON	R.	nn	11	SENT_289	[p17l890t2130r955b2183],
11	Timm	NNP	PERSON	Timm	appos	5	SENT_289	[p17l981t2129r1184b2193],
12	,	,	O	,	_	0	SENT_289	[p17l981t2129r1184b2193],
13	H.K.	NNP	PERSON	H.K.	nn	14	SENT_289	[p17l1209t2130r1353b2183],
14	Kroemer	NNP	PERSON	Kroemer	appos	5	SENT_289	[p17l1380t2130r1666b2193],
15	,	,	O	,	_	0	SENT_289	[p17l1380t2130r1666b2193],
16	P.J.	NNP	PERSON	P.J.	nn	17	SENT_289	[p17l1691t2130r1788b2183],
17	Neuvonen	NNP	PERSON	Neuvonen	appos	5	SENT_289	[p17l1814t2130r2147b2192],
18	,	,	O	,	_	0	SENT_289	[p17l1814t2130r2147b2192],
19	K.T.	NNP	PERSON	K.T.	nn	20	SENT_289	[p17l169t2225r298b2278],
20	Kivisto	NNP	PERSON	Kivisto	conj_and	8	SENT_289	[p17l341t2224r580b2288],
21	,	,	O	,	_	0	SENT_289	[p17l341t2224r580b2288],
22	Glyburide	NNP	MISC	Glyburide	conj_and	8	SENT_289	[p17l621t2224r931b2294],
23	and	CC	O	and	_	0	SENT_289	[p17l970t2224r1079b2278],
24	glimepiride	NN	O	glimepiride	nn	25	SENT_289	[p17l1116t2224r1472b2294],
25	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	8	SENT_289	[p17l1507t2224r2053b2294],
26	in	IN	O	in	_	0	SENT_289	[p17l2091t2224r2149b2278],
27	subjects	NNS	O	subject	prep_in	25	SENT_289	[p17l170t2320r415b2390],
28	with	IN	O	with	_	0	SENT_289	[p17l455t2320r591b2375],
29	different	JJ	O	different	amod	31	SENT_289	[p17l630t2320r895b2375],
30	CYP2C9	NN	O	cyp2c9	nn	31	SENT_289	[p17l936t2321r1202b2375],
31	genotypes	NNS	O	genotype	prep_with	27	SENT_289	[p17l1240t2328r1569b2390],
32	,	,	O	,	_	0	SENT_289	[p17l1240t2328r1569b2390],
33	Clin	NNP	PERSON	Clin	appos	5	SENT_289	[p17l1611t2320r1757b2375],
34	.	.	O	.	_	0	SENT_289	[p17l1611t2320r1757b2375],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_290	[p17l1800t2320r2146b2375],
2	.	.	O	.	_	0	SENT_290	[p17l1800t2320r2146b2375],

1	Ther	NNP	O	Ther	_	0	SENT_291	[p17l168t2417r324b2472],
2	.	.	O	.	_	0	SENT_291	[p17l168t2417r324b2472],

1	72	CD	NUMBER	72	number	2	SENT_292	[p17l356t2418r431b2472],
2	(	CD	NUMBER	(	_	0	SENT_292	[p17l461t2418r545b2484],
3	3	CD	NUMBER	3	num	4	SENT_292	[p17l461t2418r545b2484],
4	)	NN	O	)	dep	2	SENT_292	[p17l461t2418r545b2484],
5	(	CD	NUMBER	(	num	6	SENT_292	[p17l577t2418r777b2484],
6	2002	CD	DATE	2002	dep	2	SENT_292	[p17l577t2418r777b2484],
7	)	CD	NUMBER	)	num	8	SENT_292	[p17l577t2418r777b2484],
8	326-332	CD	NUMBER	326-332	dep	6	SENT_292	[p17l809t2417r1090b2472],
9	.	.	O	.	_	0	SENT_292	[p17l809t2417r1090b2472],

1	[	RB	O	[	dep	5	SENT_293	[p17l6t2514r123b2579],
2	13	CD	NUMBER	13	num	5	SENT_293	[p17l6t2514r123b2579],
3	]	CD	NUMBER	]	num	5	SENT_293	[p17l6t2514r123b2579],
4	H.	NNP	PERSON	H.	nn	5	SENT_293	[p17l168t2514r237b2567],
5	Yamazaki	NNP	PERSON	Yamazaki	_	0	SENT_293	[p17l267t2513r589b2577],
6	,	,	O	,	_	0	SENT_293	[p17l267t2513r589b2577],
7	S.	NNP	PERSON	S.	nn	8	SENT_293	[p17l621t2514r675b2568],
8	Tabata	NNP	PERSON	Tabata	appos	5	SENT_293	[p17l705t2513r925b2577],
9	,	,	O	,	_	0	SENT_293	[p17l705t2513r925b2577],
10	Sex	NN	O	sex	nn	11	SENT_293	[p17l956t2513r1068b2568],
11	difference	NN	O	difference	appos	5	SENT_293	[p17l1094t2513r1404b2567],
12	in	IN	O	in	_	0	SENT_293	[p17l1431t2513r1489b2567],
13	pharmacokinetics	NNS	O	pharmacokinetic	prep_in	11	SENT_293	[p17l1514t2513r2059b2583],
14	of	IN	O	of	_	0	SENT_293	[p17l2088t2513r2154b2567],
15	the	DT	O	the	det	17	SENT_293	[p17l168t2609r261b2664],
16	novel	JJ	O	novel	amod	17	SENT_293	[p17l289t2609r458b2664],
17	sulfonylurea	NN	O	sulfonylurea	prep_of	13	SENT_293	[p17l488t2609r872b2679],
18	antidiabetic	JJ	O	antidiabetic	amod	19	SENT_293	[p17l900t2609r1258b2664],
19	glimepiride	NN	O	glimepiride	dep	29	SENT_293	[p17l1288t2609r1643b2679],
20	in	IN	O	in	_	0	SENT_293	[p17l1671t2609r1730b2663],
21	rats	NNS	O	rat	prep_in	19	SENT_293	[p17l1756t2617r1883b2673],
22	,	,	O	,	_	0	SENT_293	[p17l1756t2617r1883b2673],
23	Arzneimittelforschung	NNP	ORGANIZATION	Arzneimittelforschung	appos	21	SENT_293	[p17l1914t2609r2147b2664, p17l168t2705r656b2775],
24	43	CD	NUMBER	43	num	23	SENT_293	[p17l685t2706r756b2760],
25	(	CD	NUMBER	(	number	26	SENT_293	[p17l791t2706r913b2772],
26	12	CD	NUMBER	12	dep	23	SENT_293	[p17l791t2706r913b2772],
27	)	NN	O	)	dep	29	SENT_293	[p17l791t2706r913b2772],
28	(	CD	NUMBER	(	num	27	SENT_293	[p17l945t2706r1145b2772],
29	1993	CD	DATE	1993	dep	13	SENT_293	[p17l945t2706r1145b2772],
30	)	CD	NUMBER	)	num	31	SENT_293	[p17l945t2706r1145b2772],
31	1317-1321	CD	DATE	1317-1321	dep	29	SENT_293	[p17l1182t2706r1537b2760],
32	.	.	O	.	_	0	SENT_293	[p17l1182t2706r1537b2760],

1	[	RB	O	[	advmod	5	SENT_294	[p17l6t2801r123b2867],
2	14	CD	NUMBER	14	num	5	SENT_294	[p17l6t2801r123b2867],
3	]	CD	NUMBER	]	num	5	SENT_294	[p17l6t2801r123b2867],
4	B.	NNP	NUMBER	B.	nn	5	SENT_294	[p17l168t2802r233b2855],
5	Rosenkranz	NNP	PERSON	Rosenkranz	_	0	SENT_294	[p17l254t2801r635b2865],
6	,	,	O	,	_	0	SENT_294	[p17l254t2801r635b2865],
7	V.	NNP	PERSON	V.	nn	8	SENT_294	[p17l655t2802r714b2855],
8	Profozic	NNP	PERSON	Profozic	conj_and	5	SENT_294	[p17l736t2801r1013b2865],
9	,	,	O	,	_	0	SENT_294	[p17l736t2801r1013b2865],
10	Z.	NNP	PERSON	Z.	nn	11	SENT_294	[p17l1033t2802r1095b2855],
11	Metelko	NNP	PERSON	Metelko	conj_and	5	SENT_294	[p17l1115t2801r1389b2865],
12	,	,	O	,	_	0	SENT_294	[p17l1115t2801r1389b2865],
13	V.	NNP	PERSON	V.	nn	14	SENT_294	[p17l1409t2802r1468b2855],
14	Mrzljak	NNP	PERSON	Mrzljak	conj_and	5	SENT_294	[p17l1490t2801r1750b2871],
15	,	,	O	,	_	0	SENT_294	[p17l1490t2801r1750b2871],
16	C.	NNP	PERSON	C.	nn	17	SENT_294	[p17l1771t2801r1836b2856],
17	Lange	NNP	PERSON	Lange	conj_and	5	SENT_294	[p17l1856t2802r2066b2871],
18	,	,	O	,	_	0	SENT_294	[p17l1856t2802r2066b2871],
19	V.	NNP	PERSON	V.	nn	20	SENT_294	[p17l2086t2802r2145b2855],
20	Malerczyk	NNP	PERSON	Malerczyk	conj_and	5	SENT_294	[p17l168t2897r515b2967],
21	,	,	O	,	_	0	SENT_294	[p17l168t2897r515b2967],
22	Pharmacokinetics	NNP	O	Pharmacokinetics	conj_and	5	SENT_294	[p17l539t2897r1087b2951],
23	and	CC	O	and	_	0	SENT_294	[p17l1112t2897r1222b2951],
24	safety	NN	O	safety	conj_and	5	SENT_294	[p17l1245t2897r1425b2967],
25	of	IN	O	of	_	0	SENT_294	[p17l1449t2897r1516b2951],
26	glimepiride	NN	O	glimepiride	prep_of	24	SENT_294	[p17l1533t2897r1888b2967],
27	at	IN	O	at	_	0	SENT_294	[p17l1912t2905r1966b2951],
28	clinically	RB	O	clinically	advmod	29	SENT_294	[p17l1988t2897r2147b2951, p17l169t2993r317b3063],
29	effective	JJ	O	effective	amod	30	SENT_294	[p17l342t2993r608b3048],
30	doses	NNS	O	dose	prep_at	26	SENT_294	[p17l632t2993r799b3048],
31	in	IN	O	in	_	0	SENT_294	[p17l824t2993r882b3047],
32	diabetic	JJ	O	diabetic	amod	33	SENT_294	[p17l907t2993r1149b3048],
33	patients	NNS	O	patient	prep_in	30	SENT_294	[p17l1173t2993r1412b3063],
34	with	IN	O	with	_	0	SENT_294	[p17l1438t2993r1573b3048],
35	renal	JJ	O	renal	amod	36	SENT_294	[p17l1596t2993r1749b3048],
36	impairment	NN	O	impairment	prep_with	33	SENT_294	[p17l1774t2993r2146b3063],
37	,	,	O	,	_	0	SENT_294	[p17l1774t2993r2146b3063],
38	Diabetologia	NNP	ORGANIZATION	Diabetologia	appos	5	SENT_294	[p17l168t3090r569b3161],
39	39	CD	NUMBER	39	num	38	SENT_294	[p17l596t3091r669b3145],
40	(	CD	NUMBER	(	number	41	SENT_294	[p17l700t3091r823b3157],
41	12	CD	NUMBER	12	num	42	SENT_294	[p17l700t3091r823b3157],
42	)	NN	O	)	dep	38	SENT_294	[p17l700t3091r823b3157],
43	(	CD	NUMBER	(	num	44	SENT_294	[p17l855t3090r1055b3157],
44	1996	CD	DATE	1996	dep	5	SENT_294	[p17l855t3090r1055b3157],
45	)	CD	NUMBER	)	num	46	SENT_294	[p17l855t3090r1055b3157],
46	1617-1624	CD	DATE	1617-1624	dep	44	SENT_294	[p17l1091t3090r1446b3145],
47	.	.	O	.	_	0	SENT_294	[p17l1091t3090r1446b3145],

1	[	RB	O	[	advmod	3	SENT_295	[p17l6t3185r123b3250],
2	15	CD	NUMBER	15	number	3	SENT_295	[p17l6t3185r123b3250],
3	]	CD	NUMBER	]	_	0	SENT_295	[p17l6t3185r123b3250],
4	H.G.	NNP	PERSON	H.G.	nn	5	SENT_295	[p17l168t3186r312b3239],
5	Xie	NNP	PERSON	Xie	dep	3	SENT_295	[p17l342t3185r469b3249],
6	,	,	O	,	_	0	SENT_295	[p17l342t3185r469b3249],
7	H.C.	NNP	PERSON	H.C.	nn	8	SENT_295	[p17l499t3186r639b3239],
8	Prasad	NNP	PERSON	Prasad	appos	3	SENT_295	[p17l670t3185r891b3249],
9	,	,	O	,	_	0	SENT_295	[p17l670t3185r891b3249],
10	R.B.	NNP	PERSON	R.B.	nn	11	SENT_295	[p17l920t3186r1056b3239],
11	Kim	NNP	PERSON	Kim	appos	8	SENT_295	[p17l1089t3185r1240b3249],
12	,	,	O	,	_	0	SENT_295	[p17l1089t3185r1240b3249],
13	C.M.	NNP	PERSON	C.M.	nn	14	SENT_295	[p17l1270t3185r1422b3239],
14	Stein	NNP	PERSON	Stein	appos	8	SENT_295	[p17l1455t3185r1627b3249],
15	,	,	O	,	_	0	SENT_295	[p17l1455t3185r1627b3249],
16	CYP2C9	NN	O	cyp2c9	nn	18	SENT_295	[p17l1658t3186r1932b3240],
17	allelic	JJ	O	allelic	amod	18	SENT_295	[p17l1962t3185r2148b3239],
18	variants	NNS	O	variant	appos	8	SENT_295	[p17l168t3280r426b3335],
19	:	:	O	:	_	0	SENT_295	[p17l168t3280r426b3335],
20	ethnic	JJ	O	ethnic	amod	21	SENT_295	[p17l469t3280r655b3335],
21	distribution	NN	O	distribution	dep	3	SENT_295	[p17l693t3280r1048b3335],
22	and	CC	O	and	_	0	SENT_295	[p17l1086t3280r1195b3335],
23	functional	JJ	O	functional	amod	24	SENT_295	[p17l1231t3280r1543b3335],
24	signiﬁcance	NN	O	signiﬁcance	conj_and	21	SENT_295	[p17l1582t3280r1965b3350],
25	,	,	O	,	_	0	SENT_295	[p17l1582t3280r1965b3350],
26	Adv	NNP	O	Adv	appos	21	SENT_295	[p17l2003t3280r2145b3335],
27	.	.	O	.	_	0	SENT_295	[p17l2003t3280r2145b3335],

1	Drug	NN	O	drug	_	0	SENT_296	[p17l168t3379r324b3448],
2	Deliv	NNP	O	Deliv	dep	1	SENT_296	[p17l353t3378r532b3432],
3	.	.	O	.	_	0	SENT_296	[p17l353t3378r532b3432],

1	Rev.	NNP	O	Rev.	_	0	SENT_297	[p17l563t3379r695b3432],
2	54	CD	NUMBER	54	number	3	SENT_297	[p17l728t3377r802b3432],
3	(	CD	NUMBER	(	dep	1	SENT_297	[p17l832t3378r955b3445],
4	10	CD	NUMBER	10	num	5	SENT_297	[p17l832t3378r955b3445],
5	)	NN	O	)	dep	3	SENT_297	[p17l832t3378r955b3445],
6	(	CD	NUMBER	(	num	7	SENT_297	[p17l987t3378r1187b3445],
7	2002	CD	DATE	2002	dep	1	SENT_297	[p17l987t3378r1187b3445],
8	)	CD	NUMBER	)	num	9	SENT_297	[p17l987t3378r1187b3445],
9	1257-1270	CD	DATE	1257-1270	dep	7	SENT_297	[p17l1224t3377r1578b3432],
10	.	.	O	.	_	0	SENT_297	[p17l1224t3377r1578b3432],

1	[	RB	O	[	advmod	5	SENT_298	[p17l6t3474r123b3539],
2	16	CD	NUMBER	16	num	5	SENT_298	[p17l6t3474r123b3539],
3	]	CD	NUMBER	]	num	5	SENT_298	[p17l6t3474r123b3539],
4	C.R.	NNP	PERSON	C.R.	nn	5	SENT_298	[p17l169t3474r304b3528],
5	Lee	NNP	PERSON	Lee	_	0	SENT_298	[p17l341t3475r473b3537],
6	,	,	O	,	_	0	SENT_298	[p17l341t3475r473b3537],
7	J	NNP	O	J	appos	5	SENT_298	[p17l508t3475r537b3528],
8	.	.	O	.	_	0	SENT_298	[p17l543t3474r627b3528],

1	A.	NN	PERSON	a.	_	0	SENT_299	[p17l543t3474r627b3528],
2	Goldstein	NNP	PERSON	Goldstein	nn	4	SENT_299	[p17l665t3474r980b3538],
3	,	,	O	,	_	0	SENT_299	[p17l665t3474r980b3538],
4	J	NNP	O	J	dep	1	SENT_299	[p17l1015t3475r1044b3528],
5	.	.	O	.	_	0	SENT_299	[p17l1050t3474r1134b3528],

1	A.	NN	PERSON	a.	nn	2	SENT_300	[p17l1050t3474r1134b3528],
2	Pieper	NNP	PERSON	Pieper	_	0	SENT_300	[p17l1171t3474r1382b3544],
3	,	,	O	,	_	0	SENT_300	[p17l1171t3474r1382b3544],
4	Cytochrome	NNP	O	Cytochrome	nn	7	SENT_300	[p17l1419t3474r1798b3544],
5	P450	NN	O	p450	nn	7	SENT_300	[p17l1832t3474r1989b3528],
6	2C9	NN	O	2c9	nn	7	SENT_300	[p17l2023t3474r2147b3529],
7	polymorphisms	NNS	O	polymorphism	appos	2	SENT_300	[p17l167t3568r663b3638],
8	:	:	O	:	_	0	SENT_300	[p17l167t3568r663b3638],
9	a	DT	O	a	det	11	SENT_300	[p17l710t3585r742b3623],
10	comprehensive	JJ	O	comprehensive	amod	11	SENT_300	[p17l780t3568r1245b3638],
11	review	NN	O	review	dep	7	SENT_300	[p17l1282t3568r1488b3623],
12	of	IN	O	of	_	0	SENT_300	[p17l1529t3568r1595b3623],
13	the	DT	O	the	det	18	SENT_300	[p17l1629t3568r1722b3623],
14	in	FW	O	in	nn	15	SENT_300	[p17l1761t3568r1819b3622],
15	vitro	FW	O	vitro	dep	18	SENT_300	[p17l1856t3568r2000b3623],
16	and	CC	O	and	_	0	SENT_300	[p17l2041t3568r2151b3623],
17	human	JJ	O	human	conj_and	15	SENT_300	[p17l167t3666r377b3720],
18	data	NNS	O	datum	prep_of	11	SENT_300	[p17l406t3666r549b3729],
19	,	,	O	,	_	0	SENT_300	[p17l406t3666r549b3729],
20	Pharmacogenetics	NNS	O	pharmacogenetic	appos	2	SENT_300	[p17l580t3666r1141b3736],
21	12	CD	NUMBER	12	num	20	SENT_300	[p17l1177t3666r1244b3719],
22	(	CD	NUMBER	(	number	23	SENT_300	[p17l1275t3666r1359b3732],
23	3	CD	NUMBER	3	num	24	SENT_300	[p17l1275t3666r1359b3732],
24	)	NN	O	)	dep	20	SENT_300	[p17l1275t3666r1359b3732],
25	(	CD	NUMBER	(	num	26	SENT_300	[p17l1391t3666r1591b3732],
26	2002	CD	DATE	2002	dep	2	SENT_300	[p17l1391t3666r1591b3732],
27	)	CD	NUMBER	)	num	28	SENT_300	[p17l1391t3666r1591b3732],
28	251-263	CD	NUMBER	251-263	dep	26	SENT_300	[p17l1622t3665r1905b3720],
29	.	.	O	.	_	0	SENT_300	[p17l1622t3665r1905b3720],

1	K.	NNP	PERSON	K.	nn	2	SENT_301	[p18l169t21r237b74],
2	Takanashi	NNP	PERSON	Takanashi	dep	34	SENT_301	[p18l287t19r615b83],
3	,	,	O	,	_	0	SENT_301	[p18l287t19r615b83],
4	H.	NNP	PERSON	H.	nn	5	SENT_301	[p18l663t21r731b74],
5	Tainaka	NNP	PERSON	Tainaka	appos	2	SENT_301	[p18l781t19r1040b83],
6	,	,	O	,	_	0	SENT_301	[p18l781t19r1040b83],
7	K.	NNP	PERSON	K.	nn	8	SENT_301	[p18l1090t21r1158b74],
8	Kobayashi	NNP	PERSON	Kobayashi	appos	2	SENT_301	[p18l1208t19r1550b90],
9	,	,	O	,	_	0	SENT_301	[p18l1208t19r1550b90],
10	T.	NNP	PERSON	T.	nn	11	SENT_301	[p18l1598t21r1653b74],
11	Yasumori	NNP	PERSON	Yasumori	appos	2	SENT_301	[p18l1703t20r2015b83],
12	,	,	O	,	_	0	SENT_301	[p18l1703t20r2015b83],
13	M.	NNP	PERSON	M.	nn	14	SENT_301	[p18l2063t21r2145b74],
14	Hosakawa	NNP	PERSON	Hosakawa	appos	2	SENT_301	[p18l168t115r504b179],
15	,	,	O	,	_	0	SENT_301	[p18l168t115r504b179],
16	K.	NNP	PERSON	K.	nn	17	SENT_301	[p18l549t117r617b169],
17	Chiba	NNP	PERSON	Chiba	appos	2	SENT_301	[p18l662t115r861b179],
18	,	,	O	,	_	0	SENT_301	[p18l662t115r861b179],
19	CYP2C9	NNP	O	CYP2C9	nn	20	SENT_301	[p18l905t116r1180b170],
20	Ile359	NN	O	ile359	appos	2	SENT_301	[p18l1222t115r1417b170],
21	and	CC	O	and	_	0	SENT_301	[p18l1461t115r1570b169],
22	Leu359	NN	O	leu359	nn	23	SENT_301	[p18l1610t115r1844b170],
23	variants	NNS	O	variant	appos	2	SENT_301	[p18l1886t115r2144b170],
24	:	:	O	:	_	0	SENT_301	[p18l1886t115r2144b170],
25	enzyme	NN	O	enzyme	nn	27	SENT_301	[p18l169t228r407b282],
26	kinetic	JJ	O	kinetic	amod	27	SENT_301	[p18l436t212r645b266],
27	study	NN	O	study	dep	20	SENT_301	[p18l678t212r840b282],
28	with	IN	O	with	_	0	SENT_301	[p18l870t212r1006b266],
29	seven	CD	NUMBER	seven	num	30	SENT_301	[p18l1037t228r1207b266],
30	substrates	NNS	O	substrate	prep_with	27	SENT_301	[p18l1238t211r1555b275],
31	,	,	O	,	_	0	SENT_301	[p18l1238t211r1555b275],
32	Pharmacogenetics	NNPS	ORGANIZATION	Pharmacogenetics	appos	2	SENT_301	[p18l1587t212r2147b282],
33	10	CD	NUMBER	10	num	34	SENT_301	[p18l175t307r243b361],
34	(	NN	O	(	_	0	SENT_301	[p18l273t307r357b374],
35	2	CD	NUMBER	2	number	36	SENT_301	[p18l273t307r357b374],
36	)	CD	NUMBER	)	dep	34	SENT_301	[p18l273t307r357b374],
37	(	CD	NUMBER	(	num	38	SENT_301	[p18l390t307r590b374],
38	2000	CD	DATE	2000	dep	36	SENT_301	[p18l390t307r590b374],
39	)	CD	NUMBER	)	num	40	SENT_301	[p18l390t307r590b374],
40	95-104	CD	NUMBER	95-104	dep	36	SENT_301	[p18l620t306r865b362],
41	.	.	O	.	_	0	SENT_301	[p18l620t306r865b362],

1	T.H.	NNP	PERSON	T.H.	nn	2	SENT_302	[p18l168t405r298b458],
2	Sullivan	NNP	PERSON	Sullivan	_	0	SENT_302	[p18l321t404r795b467],
3	.	.	O	.	_	0	SENT_302	[p18l321t404r795b467],

1	—	NN	O	—	_	0	SENT_303	[p18l321t404r795b467],
2	.	.	O	.	_	0	SENT_303	[p18l321t404r795b467],

1	Klose	NNP	PERSON	Klose	dep	35	SENT_304	[p18l321t404r795b467],
2	,	,	O	,	_	0	SENT_304	[p18l321t404r795b467],
3	B.I.	NNP	PERSON	B.I.	nn	4	SENT_304	[p18l815t405r925b458],
4	Ghanayem	NNP	PERSON	Ghanayem	appos	1	SENT_304	[p18l946t404r1296b474],
5	,	,	O	,	_	0	SENT_304	[p18l946t404r1296b474],
6	D.A.	NNP	PERSON	D.A.	nn	7	SENT_304	[p18l1315t404r1459b458],
7	Bell	NNP	PERSON	Bell	appos	1	SENT_304	[p18l1479t404r1623b467],
8	,	,	O	,	_	0	SENT_304	[p18l1479t404r1623b467],
9	Z.Y.	NNP	PERSON	Z.Y.	nn	10	SENT_304	[p18l1643t405r1769b458],
10	Zhang	NNP	PERSON	Zhang	appos	1	SENT_304	[p18l1790t404r2003b474],
11	,	,	O	,	_	0	SENT_304	[p18l1790t404r2003b474],
12	L.S.	NNP	PERSON	L.S.	nn	13	SENT_304	[p18l2022t404r2146b458],
13	Kaminsky	NNP	PERSON	Kaminsky	appos	1	SENT_304	[p18l169t498r495b568],
14	,	,	O	,	_	0	SENT_304	[p18l169t498r495b568],
15	G.M.	NNP	O	G.M.	nn	16	SENT_304	[p18l537t499r692b553],
16	Shenﬁeld	NNP	O	Shenﬁeld	appos	1	SENT_304	[p18l736t498r1041b562],
17	,	,	O	,	_	0	SENT_304	[p18l736t498r1041b562],
18	et	FW	O	et	nn	19	SENT_304	[p18l1082t506r1136b553],
19	al.	FW	O	al.	appos	1	SENT_304	[p18l1174t498r1263b562],
20	,	,	O	,	_	0	SENT_304	[p18l1174t498r1263b562],
21	The	DT	O	the	det	22	SENT_304	[p18l1303t498r1422b553],
22	role	NN	O	role	appos	1	SENT_304	[p18l1459t498r1579b553],
23	of	IN	O	of	_	0	SENT_304	[p18l1617t498r1684b553],
24	the	DT	O	the	det	27	SENT_304	[p18l1716t498r1809b553],
25	CYP2C9Leu359	NN	O	cyp2c9leu359	nn	27	SENT_304	[p18l1848t499r2148b553, p18l168t595r402b651],
26	allelic	JJ	O	allelic	amod	27	SENT_304	[p18l432t595r618b650],
27	variant	NN	O	variant	prep_of	22	SENT_304	[p18l647t596r860b650],
28	in	IN	O	in	_	0	SENT_304	[p18l886t596r945b649],
29	the	DT	O	the	det	31	SENT_304	[p18l972t596r1065b650],
30	tolbutamide	NN	O	tolbutamide	nn	31	SENT_304	[p18l1092t596r1460b650],
31	polymorphism	NN	O	polymorphism	prep_in	27	SENT_304	[p18l1487t596r1954b666],
32	,	,	O	,	_	0	SENT_304	[p18l1487t596r1954b666],
33	Pharmacogenetics	NNS	ORGANIZATION	pharmacogenetic	appos	1	SENT_304	[p18l1984t596r2148b650, p18l168t692r588b762],
34	6	CD	NUMBER	6	num	35	SENT_304	[p18l618t692r652b746],
35	(	NN	O	(	_	0	SENT_304	[p18l684t692r767b759],
36	4	CD	NUMBER	4	number	37	SENT_304	[p18l684t692r767b759],
37	)	CD	NUMBER	)	dep	35	SENT_304	[p18l684t692r767b759],
38	(	CD	NUMBER	(	num	39	SENT_304	[p18l799t692r999b759],
39	1996	CD	DATE	1996	dep	37	SENT_304	[p18l799t692r999b759],
40	)	CD	NUMBER	)	num	41	SENT_304	[p18l799t692r999b759],
41	341-349	CD	NUMBER	341-349	dep	37	SENT_304	[p18l1031t692r1312b747],
42	.	.	O	.	_	0	SENT_304	[p18l1031t692r1312b747],

1	K.	NNP	PERSON	K.	nn	2	SENT_305	[p18l169t787r237b840],
2	Inoue	NNP	PERSON	Inoue	_	0	SENT_305	[p18l265t787r456b850],
3	,	,	O	,	_	0	SENT_305	[p18l265t787r456b850],
4	H.	NNP	PERSON	H.	nn	5	SENT_305	[p18l483t787r551b840],
5	Yamazaki	NNP	PERSON	Yamazaki	appos	2	SENT_305	[p18l580t786r901b850],
6	,	,	O	,	_	0	SENT_305	[p18l580t786r901b850],
7	K.	NNP	PERSON	K.	nn	8	SENT_305	[p18l929t787r997b840],
8	Imiya	NNP	PERSON	Imiya	appos	2	SENT_305	[p18l1025t786r1221b856],
9	,	,	O	,	_	0	SENT_305	[p18l1025t786r1221b856],
10	S.	NNP	PERSON	S.	nn	11	SENT_305	[p18l1249t786r1303b840],
11	Akasaka	NNP	PERSON	Akasaka	appos	2	SENT_305	[p18l1330t786r1612b850],
12	,	,	O	,	_	0	SENT_305	[p18l1330t786r1612b850],
13	F.P.	NNP	PERSON	F.P.	nn	14	SENT_305	[p18l1638t787r1742b840],
14	Guengerich	NNP	PERSON	Guengerich	appos	2	SENT_305	[p18l1771t786r2147b856],
15	,	,	O	,	_	0	SENT_305	[p18l1771t786r2147b856],
16	T.	NNP	PERSON	T.	nn	17	SENT_305	[p18l168t885r223b938],
17	Shimada	NNP	PERSON	Shimada	appos	2	SENT_305	[p18l249t884r532b947],
18	,	,	O	,	_	0	SENT_305	[p18l249t884r532b947],
19	Relationship	NN	O	relationship	appos	2	SENT_305	[p18l553t883r943b954],
20	between	IN	O	between	_	0	SENT_305	[p18l961t883r1219b938],
21	CYP2	NN	O	cyp2	nn	22	SENT_305	[p18l1241t884r1413b938],
22	C9	NN	O	c9	prep_between	19	SENT_305	[p18l1422t884r1507b938],
23	and	CC	O	and	_	0	SENT_305	[p18l1526t884r1635b938],
24	2C19	NN	O	2c19	nn	25	SENT_305	[p18l1653t884r1819b938],
25	genotypes	NNS	O	genotype	prep_between	19	SENT_305	[p18l1838t892r2148b954],
26	and	CC	O	and	_	0	SENT_305	[p18l169t980r279b1034],
27	tolbutamide	NN	O	tolbutamide	nn	29	SENT_305	[p18l311t980r679b1034],
28	methyl	NN	O	methyl	nn	29	SENT_305	[p18l713t980r926b1050],
29	hydroxylation	NN	O	hydroxylation	appos	2	SENT_305	[p18l958t980r1393b1050],
30	and	CC	O	and	_	0	SENT_305	[p18l1426t980r1536b1034],
31	S-mephenytoin	NN	O	s-mephenytoin	conj_and	8	SENT_305	[p18l1568t980r2035b1050],
32	4	CD	NUMBER	4	num	35	SENT_305	[p18l2067t974r2147b1033, p18l167t1074r601b1144],
33	’	NN	O	’	nn	35	SENT_305	[p18l2067t974r2147b1033, p18l167t1074r601b1144],
34	hydroxylation	NN	O	hydroxylation	nn	35	SENT_305	[p18l2067t974r2147b1033, p18l167t1074r601b1144],
35	activities	NNS	O	activity	dep	2	SENT_305	[p18l643t1074r917b1128],
36	in	IN	O	in	_	0	SENT_305	[p18l959t1074r1018b1128],
37	livers	NNS	O	liver	prep_in	35	SENT_305	[p18l1058t1074r1224b1128],
38	of	IN	O	of	_	0	SENT_305	[p18l1266t1074r1333b1128],
39	Japanese	JJ	MISC	japanese	amod	42	SENT_305	[p18l1368t1075r1642b1144],
40	and	CC	O	and	_	0	SENT_305	[p18l1684t1074r1793b1128],
41	Caucasian	JJ	MISC	caucasian	conj_and	39	SENT_305	[p18l1833t1074r2149b1128],
42	populations	NNS	O	population	prep_of	37	SENT_305	[p18l167t1170r545b1240],
43	,	,	O	,	_	0	SENT_305	[p18l167t1170r545b1240],
44	Pharmacogenetics	NNS	O	pharmacogenetic	appos	2	SENT_305	[p18l575t1170r1136b1240],
45	7	CD	NUMBER	7	num	46	SENT_305	[p18l1165t1171r1199b1224],
46	(	NN	O	(	dep	44	SENT_305	[p18l1231t1170r1315b1237],
47	2	CD	NUMBER	2	number	48	SENT_305	[p18l1231t1170r1315b1237],
48	)	CD	NUMBER	)	dep	2	SENT_305	[p18l1231t1170r1315b1237],
49	(	CD	NUMBER	(	num	50	SENT_305	[p18l1348t1170r1547b1237],
50	1997	CD	DATE	1997	dep	48	SENT_305	[p18l1348t1170r1547b1237],
51	)	CD	NUMBER	)	num	52	SENT_305	[p18l1348t1170r1547b1237],
52	103-113	CD	NUMBER	103-113	dep	48	SENT_305	[p18l1584t1170r1861b1224],
53	.	.	O	.	_	0	SENT_305	[p18l1584t1170r1861b1224],

1	J.	NNP	PERSON	J.	nn	2	SENT_306	[p18l169t1267r212b1320],
2	Kirchheiner	NNP	PERSON	Kirchheiner	_	0	SENT_306	[p18l250t1266r630b1330],
3	,	,	O	,	_	0	SENT_306	[p18l250t1266r630b1330],
4	S.	NNP	PERSON	S.	nn	5	SENT_306	[p18l668t1266r722b1320],
5	Bauer	NNP	PERSON	Bauer	appos	2	SENT_306	[p18l757t1267r954b1330],
6	,	,	O	,	_	0	SENT_306	[p18l757t1267r954b1330],
7	1	CD	NUMBER	1	appos	5	SENT_306	[p18l990t1267r1029b1320],
8	.	.	O	.	_	0	SENT_306	[p18l990t1267r1029b1320],

1	Meineke	NNP	O	Meineke	dep	36	SENT_307	[p18l1065t1266r1351b1330],
2	,	,	O	,	_	0	SENT_307	[p18l1065t1266r1351b1330],
3	W.	NNP	PERSON	W.	nn	4	SENT_307	[p18l1385t1267r1466b1320],
4	Rohde	NNP	PERSON	Rohde	appos	1	SENT_307	[p18l1503t1266r1719b1330],
5	,	,	O	,	_	0	SENT_307	[p18l1503t1266r1719b1330],
6	V.	NNP	PERSON	V.	nn	7	SENT_307	[p18l1753t1267r1813b1320],
7	Prang	NNP	PERSON	Prang	appos	1	SENT_307	[p18l1849t1267r2044b1336],
8	,	,	O	,	_	0	SENT_307	[p18l1849t1267r2044b1336],
9	C.	NNP	PERSON	C.	nn	10	SENT_307	[p18l2079t1266r2144b1320],
10	Meisel	NNP	PERSON	Meisel	appos	1	SENT_307	[p18l169t1362r394b1426],
11	,	,	O	,	_	0	SENT_307	[p18l169t1362r394b1426],
12	et	FW	O	et	nn	13	SENT_307	[p18l416t1370r471b1416],
13	al.	FW	O	al.	appos	1	SENT_307	[p18l490t1362r578b1426],
14	,	,	O	,	_	0	SENT_307	[p18l490t1362r578b1426],
15	Impact	NN	O	impact	appos	1	SENT_307	[p18l600t1363r814b1432],
16	of	IN	O	of	_	0	SENT_307	[p18l833t1362r900b1416],
17	CYP2C9	NN	O	cyp2c9	nn	20	SENT_307	[p18l913t1362r1187b1417],
18	and	CC	O	and	_	0	SENT_307	[p18l1209t1362r1318b1416],
19	CYP2C19	NN	O	cyp2c19	nn	20	SENT_307	[p18l1336t1362r1649b1417],
20	polymorphisms	NNS	O	polymorphism	prep_of	15	SENT_307	[p18l1667t1362r2147b1432],
21	on	IN	O	on	_	0	SENT_307	[p18l170t1475r245b1512],
22	tolbutamide	NN	O	tolbutamide	nn	23	SENT_307	[p18l268t1458r636b1512],
23	kinetics	NNS	O	kinetics	prep_on	20	SENT_307	[p18l659t1458r897b1512],
24	and	CC	O	and	_	0	SENT_307	[p18l924t1458r1034b1512],
25	the	DT	O	the	det	29	SENT_307	[p18l1056t1458r1149b1512],
26	insulin	NN	O	insulin	nn	29	SENT_307	[p18l1173t1458r1382b1512],
27	and	CC	O	and	_	0	SENT_307	[p18l1407t1458r1516b1512],
28	glucose	NN	O	glucose	nn	29	SENT_307	[p18l1540t1458r1773b1528],
29	response	NN	O	response	conj_and	20	SENT_307	[p18l1797t1475r2066b1528],
30	in	IN	O	in	_	0	SENT_307	[p18l2089t1458r2147b1512],
31	healthy	JJ	O	healthy	amod	32	SENT_307	[p18l169t1556r395b1626],
32	volunteers	NNS	O	volunteer	prep_in	29	SENT_307	[p18l424t1556r760b1619],
33	,	,	O	,	_	0	SENT_307	[p18l424t1556r760b1619],
34	Pharmacogenetics	NNS	ORGANIZATION	pharmacogenetic	appos	1	SENT_307	[p18l790t1556r1350b1626],
35	12	CD	NUMBER	12	num	36	SENT_307	[p18l1386t1556r1454b1609],
36	(	NN	O	(	_	0	SENT_307	[p18l1484t1556r1568b1623],
37	2	CD	NUMBER	2	number	38	SENT_307	[p18l1484t1556r1568b1623],
38	)	CD	NUMBER	)	dep	36	SENT_307	[p18l1484t1556r1568b1623],
39	(	CD	NUMBER	(	num	40	SENT_307	[p18l1601t1556r1800b1623],
40	2002	CD	DATE	2002	dep	38	SENT_307	[p18l1601t1556r1800b1623],
41	)	CD	NUMBER	)	num	42	SENT_307	[p18l1601t1556r1800b1623],
42	101-109	CD	NUMBER	101-109	dep	38	SENT_307	[p18l1836t1556r2114b1611],
43	.	.	O	.	_	0	SENT_307	[p18l1836t1556r2114b1611],

1	J.H.	NNP	PERSON	J.H.	nn	2	SENT_308	[p18l169t1651r287b1704],
2	Shon	NNP	PERSON	Shon	_	0	SENT_308	[p18l317t1650r487b1714],
3	,	,	O	,	_	0	SENT_308	[p18l317t1650r487b1714],
4	Y.R.	NNP	PERSON	Y.R.	nn	5	SENT_308	[p18l515t1651r643b1704],
5	Yoon	NNP	PERSON	Yoon	appos	2	SENT_308	[p18l671t1651r849b1714],
6	,	,	O	,	_	0	SENT_308	[p18l671t1651r849b1714],
7	K.A.	NNP	PERSON	K.A.	nn	8	SENT_308	[p18l876t1650r1018b1704],
8	Kim	NNP	PERSON	Kim	appos	2	SENT_308	[p18l1047t1650r1198b1713],
9	,	,	O	,	_	0	SENT_308	[p18l1047t1650r1198b1713],
10	Y.C.	NNP	PERSON	Y.C.	nn	11	SENT_308	[p18l1224t1650r1354b1704],
11	Lim	NNP	PERSON	Lim	appos	2	SENT_308	[p18l1380t1650r1525b1714],
12	,	,	O	,	_	0	SENT_308	[p18l1380t1650r1525b1714],
13	K	NNP	O	K	appos	2	SENT_308	[p18l1553t1651r1670b1704],
14	]	CD	NUMBER	]	num	13	SENT_308	[p18l1553t1651r1670b1704],
15	.	.	O	.	_	0	SENT_308	[p18l1553t1651r1670b1704],

1	Lee	NNP	PERSON	Lee	_	0	SENT_309	[p18l1696t1651r1828b1714],
2	,	,	O	,	_	0	SENT_309	[p18l1696t1651r1828b1714],
3	J	NNP	O	J	appos	1	SENT_309	[p18l1853t1651r1882b1704],
4	.	.	O	.	_	0	SENT_309	[p18l1888t1651r1962b1704],

1	Y.	NNP	O	Y.	nn	2	SENT_310	[p18l1888t1651r1962b1704],
2	Park	NNP	O	Park	_	0	SENT_310	[p18l1990t1650r2146b1713],
3	,	,	O	,	_	0	SENT_310	[p18l1990t1650r2146b1713],
4	et	FW	O	et	nn	5	SENT_310	[p18l170t1753r225b1799],
5	al.	FW	O	al.	conj_and	2	SENT_310	[p18l246t1745r335b1809],
6	,	,	O	,	_	0	SENT_310	[p18l246t1745r335b1809],
7	Effects	NNS	O	effect	conj_and	2	SENT_310	[p18l359t1745r573b1799],
8	of	IN	O	of	_	0	SENT_310	[p18l596t1745r663b1799],
9	CYP2C19	NN	O	cyp2c19	prep_of	7	SENT_310	[p18l682t1746r987b1800],
10	and	CC	O	and	_	0	SENT_310	[p18l1008t1745r1116b1799],
11	CYP2C9	NN	O	cyp2c9	nn	13	SENT_310	[p18l1141t1746r1406b1800],
12	genetic	JJ	O	genetic	amod	13	SENT_310	[p18l1427t1745r1647b1815],
13	polymorphisms	NNS	O	polymorphism	conj_and	2	SENT_310	[p18l1667t1745r2147b1815],
14	on	IN	O	on	_	0	SENT_310	[p18l170t1858r245b1895],
15	the	DT	O	the	det	16	SENT_310	[p18l277t1841r370b1896],
16	disposition	NN	O	disposition	prep_on	13	SENT_310	[p18l403t1841r741b1911],
17	of	IN	O	of	prep	16	SENT_310	[p18l774t1841r840b1896],
18	and	CC	O	and	_	0	SENT_310	[p18l869t1841r979b1896],
19	blood	NN	O	blood	nn	20	SENT_310	[p18l1009t1841r1186b1896],
20	glucose	NN	O	glucose	conj_and	2	SENT_310	[p18l1218t1841r1451b1911],
21	lowering	VBG	O	lower	partmod	2	SENT_310	[p18l1484t1841r1755b1911],
22	response	NN	O	response	dobj	21	SENT_310	[p18l1787t1858r2055b1911],
23	to	TO	O	to	_	0	SENT_310	[p18l2089t1850r2146b1896],
24	tolbutamide	NN	O	tolbutamide	prep_to	21	SENT_310	[p18l169t1937r537b1991],
25	in	IN	O	in	dep	21	SENT_310	[p18l568t1937r626b1991],
26	humans	NNS	O	human	pobj	25	SENT_310	[p18l656t1937r911b2001],
27	,	,	O	,	_	0	SENT_310	[p18l656t1937r911b2001],
28	Pharmacogenetics	NNS	O	pharmacogenetic	dep	32	SENT_310	[p18l945t1937r1504b2007],
29	12	CD	NUMBER	12	dep	28	SENT_310	[p18l1544t1937r1611b1991],
30	(	NN	O	(	dep	32	SENT_310	[p18l1645t1937r1728b2004],
31	2	CD	NUMBER	2	num	30	SENT_310	[p18l1645t1937r1728b2004],
32	)	CD	NUMBER	)	dep	36	SENT_310	[p18l1645t1937r1728b2004],
33	(	CD	NUMBER	(	num	34	SENT_310	[p18l1764t1937r1963b2004],
34	2002	CD	DATE	2002	dep	32	SENT_310	[p18l1764t1937r1963b2004],
35	)	CD	NUMBER	)	num	36	SENT_310	[p18l1764t1937r1963b2004],
36	111119	CD	NUMBER	111119	dep	21	SENT_310	[p18l2002t1937r2149b1991, p18l177t2034r298b2088],
37	.	.	O	.	_	0	SENT_310	[p18l2002t1937r2149b1991, p18l177t2034r298b2088],

1	J	NN	O	j	_	0	SENT_311	[p18l169t2131r197b2184],
2	.	.	O	.	_	0	SENT_311	[p18l203t2174r212b2184],

1	Miners	NNS	O	miner	_	0	SENT_312	[p18l265t2129r499b2193],
2	,	,	O	,	_	0	SENT_312	[p18l265t2129r499b2193],
3	CYP2C9	NN	O	cyp2c9	nn	4	SENT_312	[p18l552t2130r826b2184],
4	polymorphism	NN	O	polymorphism	appos	1	SENT_312	[p18l875t2129r1341b2199],
5	:	:	O	:	_	0	SENT_312	[p18l875t2129r1341b2199],
6	impact	NN	O	impact	dep	4	SENT_312	[p18l1396t2129r1607b2199],
7	on	IN	O	on	_	0	SENT_312	[p18l1656t2146r1731b2184],
8	tolbutamide	NN	O	tolbutamide	nn	9	SENT_312	[p18l1779t2129r2147b2184],
9	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	6	SENT_312	[p18l168t2225r712b2295],
10	and	CC	O	and	_	0	SENT_312	[p18l778t2225r887b2280],
11	response	NN	O	response	prep_on	6	SENT_312	[p18l947t2242r1233b2295],
12	,	,	O	,	_	0	SENT_312	[p18l947t2242r1233b2295],
13	Pharmacogenetics	NNP	ORGANIZATION	Pharmacogenetics	nn	15	SENT_312	[p18l1298t2225r1858b2295],
14	12	CD	NUMBER	12	num	15	SENT_312	[p18l1929t2226r1996b2279],
15	(	NN	O	(	appos	1	SENT_312	[p18l2062t2226r2145b2292],
16	2	CD	NUMBER	2	number	17	SENT_312	[p18l2062t2226r2145b2292],
17	)	CD	NUMBER	)	dep	15	SENT_312	[p18l2062t2226r2145b2292],
18	(	CD	NUMBER	(	num	19	SENT_312	[p18l171t2322r371b2387],
19	2002	CD	DATE	2002	dep	1	SENT_312	[p18l171t2322r371b2387],
20	)	CD	NUMBER	)	num	21	SENT_312	[p18l171t2322r371b2387],
21	91-92	CD	NUMBER	91-92	dep	19	SENT_312	[p18l402t2322r608b2376],
22	.	.	O	.	_	0	SENT_312	[p18l402t2322r608b2376],

1	C.R.	NNP	PERSON	C.R.	nn	2	SENT_313	[p18l170t2417r305b2471],
2	Lee	NNP	PERSON	Lee	_	0	SENT_313	[p18l351t2417r483b2480],
3	,	,	O	,	_	0	SENT_313	[p18l351t2417r483b2480],
4	J.A.	NNP	PERSON	J.A.	nn	5	SENT_313	[p18l527t2417r646b2471],
5	Pieper	NNP	PERSON	Pieper	appos	2	SENT_313	[p18l692t2416r901b2486],
6	,	,	O	,	_	0	SENT_313	[p18l692t2416r901b2486],
7	A.L.	NNP	PERSON	A.L.	nn	8	SENT_313	[p18l947t2417r1083b2470],
8	Hinderliter	NNP	PERSON	Hinderliter	appos	2	SENT_313	[p18l1129t2416r1480b2480],
9	,	,	O	,	_	0	SENT_313	[p18l1129t2416r1480b2480],
10	J.A.	NNP	PERSON	J.A.	nn	11	SENT_313	[p18l1525t2417r1644b2471],
11	Blaisdell	NNP	PERSON	Blaisdell	appos	2	SENT_313	[p18l1690t2416r1981b2480],
12	,	,	O	,	_	0	SENT_313	[p18l1690t2416r1981b2480],
13	J.A.	NNP	PERSON	J.A.	nn	14	SENT_313	[p18l2025t2417r2143b2471],
14	Goldstein	NNP	PERSON	Goldstein	appos	2	SENT_313	[p18l170t2512r485b2576],
15	,	,	O	,	_	0	SENT_313	[p18l170t2512r485b2576],
16	Evaluation	NN	O	evaluation	appos	2	SENT_313	[p18l508t2512r840b2567],
17	of	IN	O	of	_	0	SENT_313	[p18l861t2512r928b2566],
18	cytochrome	NN	O	cytochrome	nn	20	SENT_313	[p18l944t2512r1306b2582],
19	P450	NN	O	p450	nn	20	SENT_313	[p18l1326t2512r1482b2567],
20	2C9	NN	O	2c9	prep_of	16	SENT_313	[p18l1504t2513r1628b2567],
21	metabolic	JJ	O	metabolic	amod	22	SENT_313	[p18l1650t2512r1953b2567],
22	activity	NN	O	activity	dep	2	SENT_313	[p18l1976t2512r2145b2567, p18l169t2608r249b2678],
23	with	IN	O	with	_	0	SENT_313	[p18l273t2608r409b2663],
24	tolbutamide	NN	O	tolbutamide	prep_with	22	SENT_313	[p18l432t2608r799b2662],
25	in	IN	O	in	_	0	SENT_313	[p18l823t2608r881b2662],
26	CYP2C91	NN	O	cyp2c91	nn	27	SENT_313	[p18l905t2609r1213b2663],
27	heterozygotes	NNS	O	heterozygote	prep_in	24	SENT_313	[p18l1242t2608r1687b2678],
28	,	,	O	,	_	0	SENT_313	[p18l1242t2608r1687b2678],
29	Clin	NNP	LOCATION	Clin	appos	2	SENT_313	[p18l1714t2608r1860b2663],
30	.	.	O	.	_	0	SENT_313	[p18l1714t2608r1860b2663],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_314	[p18l1887t2608r2146b2662, p18l170t2704r277b2758],
2	.	.	O	.	_	0	SENT_314	[p18l1887t2608r2146b2662, p18l170t2704r277b2758],

1	Ther	NNP	O	Ther	_	0	SENT_315	[p18l309t2704r465b2758],
2	.	.	O	.	_	0	SENT_315	[p18l309t2704r465b2758],

1	72	CD	NUMBER	72	number	2	SENT_316	[p18l497t2705r571b2758],
2	(	CD	NUMBER	(	_	0	SENT_316	[p18l602t2704r685b2770],
3	5	CD	NUMBER	5	num	4	SENT_316	[p18l602t2704r685b2770],
4	)	NN	O	)	dep	2	SENT_316	[p18l602t2704r685b2770],
5	(	CD	NUMBER	(	num	6	SENT_316	[p18l718t2705r917b2770],
6	2002	CD	DATE	2002	dep	2	SENT_316	[p18l718t2705r917b2770],
7	)	CD	NUMBER	)	num	8	SENT_316	[p18l718t2705r917b2770],
8	562-571	CD	NUMBER	562-571	dep	6	SENT_316	[p18l948t2704r1230b2758],
9	.	.	O	.	_	0	SENT_316	[p18l948t2704r1230b2758],

1	I.I.	NNP	PERSON	I.I.	nn	2	SENT_317	[p18l169t2801r253b2854],
2	Salem	NNP	PERSON	Salem	_	0	SENT_317	[p18l283t2799r489b2863],
3	,	,	O	,	_	0	SENT_317	[p18l283t2799r489b2863],
4	J	NNP	O	J	appos	2	SENT_317	[p18l514t2801r542b2854],
5	.	.	O	.	_	0	SENT_317	[p18l548t2844r557b2854],

1	Idrees	NNP	PERSON	Idrees	_	0	SENT_318	[p18l585t2799r788b2863],
2	,	,	O	,	_	0	SENT_318	[p18l585t2799r788b2863],
3	J	NNP	O	J	appos	1	SENT_318	[p18l813t2801r841b2854],
4	.1	CD	NUMBER	.1	num	3	SENT_318	[p18l848t2801r902b2854],
5	.	.	O	.	_	0	SENT_318	[p18l848t2801r902b2854],

1	Al	NNP	PERSON	Al	nn	2	SENT_319	[p18l929t2799r1003b2853],
2	Tamimi	NNP	PERSON	Tamimi	_	0	SENT_319	[p18l1026t2799r1282b2863],
3	,	,	O	,	_	0	SENT_319	[p18l1026t2799r1282b2863],
4	Determination	NN	O	determination	appos	2	SENT_319	[p18l1307t2799r1753b2854],
5	of	IN	O	of	_	0	SENT_319	[p18l1777t2799r1844b2854],
6	glimepiride	NN	O	glimepiride	prep_of	4	SENT_319	[p18l1863t2799r2145b2869, p18l169t2897r261b2951],
7	in	IN	O	in	_	0	SENT_319	[p18l299t2897r358b2950],
8	human	JJ	O	human	amod	9	SENT_319	[p18l395t2897r605b2951],
9	plasma	NN	O	plasma	prep_in	6	SENT_319	[p18l641t2896r860b2967],
10	by	IN	O	by	_	0	SENT_319	[p18l895t2897r971b2967],
11	liquid	JJ	O	liquid	amod	16	SENT_319	[p18l1009t2896r1189b2967],
12	chromatography-electrospray	JJ	O	chromatography-electrospray	amod	16	SENT_319	[p18l1226t2897r2147b2967],
13	ionization	NN	O	ionization	nn	16	SENT_319	[p18l169t2991r478b3045],
14	tandem	JJ	O	tandem	amod	16	SENT_319	[p18l507t2991r734b3045],
15	mass	NN	O	mass	nn	16	SENT_319	[p18l762t3008r913b3045],
16	spectrometry	NN	O	spectrometry	prep_by	9	SENT_319	[p18l946t2999r1357b3061],
17	,	,	O	,	_	0	SENT_319	[p18l946t2999r1357b3061],
18	J	NN	O	j	appos	2	SENT_319	[p18l1389t2992r1417b3046],
19	.	.	O	.	_	0	SENT_319	[p18l1423t3036r1433b3045],

1	Chromatogr	NNP	O	Chromatogr	_	0	SENT_320	[p18l1467t2991r1849b3061],
2	.	.	O	.	_	0	SENT_320	[p18l1467t2991r1849b3061],

1	B.	NNP	O	B.	nn	2	SENT_321	[p18l1882t2992r1947b3045],
2	Anal	NNP	O	Anal	_	0	SENT_321	[p18l1980t2991r2144b3045],
3	.	.	O	.	_	0	SENT_321	[p18l1980t2991r2144b3045],

1	Technol	NNP	O	Technol	_	0	SENT_322	[p18l169t3087r432b3141],
2	.	.	O	.	_	0	SENT_322	[p18l169t3087r432b3141],

1	Biomed	NNP	O	Biomed	_	0	SENT_323	[p18l464t3087r723b3141],
2	.	.	O	.	_	0	SENT_323	[p18l464t3087r723b3141],

1	Life	NNP	O	Life	nn	2	SENT_324	[p18l754t3087r881b3141],
2	Sci	NNP	O	Sci	_	0	SENT_324	[p18l911t3087r1021b3141],
3	.	.	O	.	_	0	SENT_324	[p18l911t3087r1021b3141],

1	799	CD	NUMBER	799	num	2	SENT_325	[p18l1053t3088r1165b3142],
2	(	NN	O	(	_	0	SENT_325	[p18l1197t3088r1280b3153],
3	1	CD	NUMBER	1	number	4	SENT_325	[p18l1197t3088r1280b3153],
4	)	CD	NUMBER	)	dep	2	SENT_325	[p18l1197t3088r1280b3153],
5	(	CD	NUMBER	(	num	6	SENT_325	[p18l1313t3088r1512b3153],
6	2004	CD	DATE	2004	dep	4	SENT_325	[p18l1313t3088r1512b3153],
7	)	CD	NUMBER	)	num	8	SENT_325	[p18l1313t3088r1512b3153],
8	103-109	CD	NUMBER	103-109	dep	4	SENT_325	[p18l1549t3088r1825b3142],
9	.	.	O	.	_	0	SENT_325	[p18l1549t3088r1825b3142],

1	H.	NNP	PERSON	H.	nn	2	SENT_326	[p18l169t3184r238b3236],
2	Takahashi	NNP	PERSON	Takahashi	_	0	SENT_326	[p18l277t3182r605b3246],
3	,	,	O	,	_	0	SENT_326	[p18l277t3182r605b3246],
4	G.R.	NNP	PERSON	G.R.	nn	5	SENT_326	[p18l645t3183r783b3237],
5	Wilkinson	NNP	PERSON	Wilkinson	appos	2	SENT_326	[p18l822t3182r1158b3246],
6	,	,	O	,	_	0	SENT_326	[p18l822t3182r1158b3246],
7	Y.	NNP	PERSON	Y.	nn	8	SENT_326	[p18l1196t3184r1255b3236],
8	Caraco	NNP	PERSON	Caraco	appos	2	SENT_326	[p18l1296t3183r1529b3246],
9	,	,	O	,	_	0	SENT_326	[p18l1296t3183r1529b3246],
10	M.	NNP	PERSON	M.	nn	11	SENT_326	[p18l1567t3184r1649b3236],
11	Muszkat	NNP	PERSON	Muszkat	appos	2	SENT_326	[p18l1688t3182r1970b3246],
12	,	,	O	,	_	0	SENT_326	[p18l1688t3182r1970b3246],
13	R.B.	NNP	PERSON	R.B.	nn	14	SENT_326	[p18l2008t3184r2144b3236],
14	Kim	NNP	PERSON	Kim	appos	2	SENT_326	[p18l171t3278r322b3342],
15	,	,	O	,	_	0	SENT_326	[p18l171t3278r322b3342],
16	T.	NNP	PERSON	T.	nn	17	SENT_326	[p18l357t3280r413b3333],
17	Kashima	NNP	PERSON	Kashima	appos	2	SENT_326	[p18l452t3279r740b3342],
18	,	,	O	,	_	0	SENT_326	[p18l452t3279r740b3342],
19	et	FW	O	et	nn	20	SENT_326	[p18l777t3287r832b3333],
20	al.	FW	O	al.	appos	2	SENT_326	[p18l865t3279r954b3342],
21	,	,	O	,	_	0	SENT_326	[p18l865t3279r954b3342],
22	Population	NNP	O	Population	nn	23	SENT_326	[p18l990t3279r1325b3349],
23	differences	NNS	O	difference	appos	2	SENT_326	[p18l1358t3278r1696b3333],
24	in	IN	O	in	_	0	SENT_326	[p18l1731t3279r1790b3332],
25	S	NN	O	s	nn	28	SENT_326	[p18l1823t3278r2148b3333],
26	—	CD	NUMBER	—	num	28	SENT_326	[p18l1823t3278r2148b3333],
27	warfarin	NN	O	warfarin	nn	28	SENT_326	[p18l1823t3278r2148b3333],
28	metabolism	NN	O	metabolism	prep_in	23	SENT_326	[p18l169t3373r530b3428],
29	between	IN	O	between	_	0	SENT_326	[p18l548t3373r805b3428],
30	CYP2	NN	O	cyp2	nn	31	SENT_326	[p18l828t3374r1000b3428],
31	C9	NN	O	c9	prep_between	2	SENT_326	[p18l1009t3374r1094b3428],
32	genotype-matched	JJ	O	genotype-matched	amod	2	SENT_326	[p18l1113t3373r1683b3443],
33	Caucasian	JJ	MISC	caucasian	amod	36	SENT_326	[p18l1702t3373r2018b3428],
34	and	CC	O	and	_	0	SENT_326	[p18l2040t3373r2149b3428],
35	Japanese	JJ	MISC	japanese	amod	36	SENT_326	[p18l169t3472r442b3541],
36	patients	NNS	O	patient	tmod	32	SENT_326	[p18l458t3471r714b3541],
37	,	,	O	,	_	0	SENT_326	[p18l458t3471r714b3541],
38	Clin	NNP	PERSON	Clin	appos	36	SENT_326	[p18l735t3471r881b3525],
39	.	.	O	.	_	0	SENT_326	[p18l735t3471r881b3525],

1	Pharmacol	NNP	O	Pharmacol	_	0	SENT_327	[p18l901t3471r1247b3525],
2	.	.	O	.	_	0	SENT_327	[p18l901t3471r1247b3525],

1	T	NN	O	t	_	0	SENT_328	[p18l1266t3472r1312b3524],
2	her	PRP$	O	she	dep	1	SENT_328	[p18l1314t3471r1422b3525],
3	.	.	O	.	_	0	SENT_328	[p18l1314t3471r1422b3525],

1	73	CD	NUMBER	73	number	2	SENT_329	[p18l1443t3471r1514b3525],
2	(	CD	NUMBER	(	_	0	SENT_329	[p18l1537t3471r1621b3537],
3	3	CD	NUMBER	3	num	4	SENT_329	[p18l1537t3471r1621b3537],
4	)	NN	O	)	dep	2	SENT_329	[p18l1537t3471r1621b3537],
5	(	CD	NUMBER	(	num	6	SENT_329	[p18l1642t3471r1841b3537],
6	2003	CD	DATE	2003	dep	2	SENT_329	[p18l1642t3471r1841b3537],
7	)	CD	NUMBER	)	num	8	SENT_329	[p18l1642t3471r1841b3537],
8	253-263	CD	NUMBER	253-263	dep	6	SENT_329	[p18l1861t3470r2144b3525],
9	.	.	O	.	_	0	SENT_329	[p18l1861t3470r2144b3525],

1	M.	NNP	PERSON	M.	nn	2	SENT_330	[p18l169t3568r251b3621],
2	Hiratsuka	NNP	PERSON	Hiratsuka	_	0	SENT_330	[p18l287t3566r602b3630],
3	,	,	O	,	_	0	SENT_330	[p18l287t3566r602b3630],
4	Y.	NNP	PERSON	Y.	nn	5	SENT_330	[p18l636t3568r696b3621],
5	Agatsuma	NNP	PERSON	Agatsuma	appos	2	SENT_330	[p18l731t3567r1058b3637],
6	,	,	O	,	_	0	SENT_330	[p18l731t3567r1058b3637],
7	M.	NNP	PERSON	M.	nn	8	SENT_330	[p18l1093t3568r1175b3621],
8	Mizugaki	NNP	PERSON	Mizugaki	appos	2	SENT_330	[p18l1210t3567r1522b3637],
9	,	,	O	,	_	0	SENT_330	[p18l1210t3567r1522b3637],
10	Rapid	NNP	O	Rapid	nn	11	SENT_330	[p18l1556t3567r1740b3637],
11	detection	NN	O	detection	appos	2	SENT_330	[p18l1772t3567r2054b3621],
12	of	IN	O	of	_	0	SENT_330	[p18l2086t3566r2153b3621],
13	CYP2C9	NN	O	cyp2c9	prep_of	11	SENT_330	[p18l170t3662r519b3716],
14	*	CD	NUMBER	*	number	15	SENT_330	[p18l170t3662r519b3716],
15	3	CD	NUMBER	3	num	16	SENT_330	[p18l170t3662r519b3716],
16	alleles	NNS	O	allele	dep	11	SENT_330	[p18l566t3661r760b3716],
17	by	IN	O	by	dep	2	SENT_330	[p18l803t3661r879b3731],
18	real-time	JJ	O	real-time	amod	20	SENT_330	[p18l921t3661r1200b3716],
19	ﬂuorescence	NN	O	ﬂuorescence	nn	20	SENT_330	[p18l1243t3661r1627b3716],
20	PCR	NN	O	pcr	pobj	17	SENT_330	[p18l1669t3662r1814b3716],
21	based	VBN	O	base	partmod	20	SENT_330	[p18l1855t3661r2031b3716],
22	on	IN	O	on	prep	21	SENT_330	[p18l2073t3678r2147b3716],

1	SYBR	NNP	O	SYBR	nn	2	SENT_331	[p19l171t21r370b75],
2	Green	NNP	O	Green	_	0	SENT_331	[p19l397t21r600b85],
3	,	,	O	,	_	0	SENT_331	[p19l397t21r600b85],
4	M01	NN	O	m01	appos	2	SENT_331	[p19l629t21r772b75],
5	.	.	O	.	_	0	SENT_331	[p19l629t21r772b75],

1	Genet	NNP	PERSON	Genet	_	0	SENT_332	[p19l805t21r1002b75],
2	.	.	O	.	_	0	SENT_332	[p19l805t21r1002b75],

1	Metab	NNP	PERSON	Metab	_	0	SENT_333	[p19l1033t21r1242b75],
2	.	.	O	.	_	0	SENT_333	[p19l1033t21r1242b75],

1	68	CD	NUMBER	68	number	2	SENT_334	[p19l1275t20r1346b75],
2	(	CD	NUMBER	(	_	0	SENT_334	[p19l1379t21r1462b88],
3	3	CD	NUMBER	3	num	4	SENT_334	[p19l1379t21r1462b88],
4	)	NN	O	)	dep	2	SENT_334	[p19l1379t21r1462b88],
5	(	CD	NUMBER	(	num	6	SENT_334	[p19l1496t21r1695b88],
6	1999	CD	DATE	1999	dep	2	SENT_334	[p19l1496t21r1695b88],
7	)	CD	NUMBER	)	num	8	SENT_334	[p19l1496t21r1695b88],
8	357-362	CD	NUMBER	357-362	dep	6	SENT_334	[p19l1726t20r2008b75],
9	.	.	O	.	_	0	SENT_334	[p19l1726t20r2008b75],

1	[	NN	O	[	nn	5	SENT_335	[p19l7t118r124b183],
2	27	CD	NUMBER	27	num	5	SENT_335	[p19l7t118r124b183],
3	]	CD	NUMBER	]	num	5	SENT_335	[p19l7t118r124b183],
4	M.	NNP	NUMBER	M.	nn	5	SENT_335	[p19l169t119r251b172],
5	Kimura	NNP	PERSON	Kimura	_	0	SENT_335	[p19l286t118r535b181],
6	,	,	O	,	_	0	SENT_335	[p19l286t118r535b181],
7	I.	NNP	PERSON	I.	nn	8	SENT_335	[p19l568t119r607b172],
8	Ieiri	NNP	PERSON	Ieiri	conj_and	5	SENT_335	[p19l641t118r784b181],
9	,	,	O	,	_	0	SENT_335	[p19l641t118r784b181],
10	K.	NNP	PERSON	K.	nn	11	SENT_335	[p19l818t119r885b172],
11	Mamiya	NNP	PERSON	Mamiya	conj_and	5	SENT_335	[p19l918t118r1191b188],
12	,	,	O	,	_	0	SENT_335	[p19l918t118r1191b188],
13	A.	NNP	O	A.	nn	14	SENT_335	[p19l1223t118r1292b172],
14	Urae	NNP	O	Urae	conj_and	5	SENT_335	[p19l1326t119r1490b181],
15	,	,	O	,	_	0	SENT_335	[p19l1326t119r1490b181],
16	S.	NNP	PERSON	S.	nn	17	SENT_335	[p19l1525t118r1579b172],
17	Higuchi	NNP	PERSON	Higuchi	conj_and	5	SENT_335	[p19l1612t117r1876b188],
18	,	,	O	,	_	0	SENT_335	[p19l1612t117r1876b188],
19	Genetic	NNP	O	Genetic	nn	20	SENT_335	[p19l1909t117r2146b172],
20	polymorphism	NN	O	polymorphism	conj_and	5	SENT_335	[p19l169t214r620b284],
21	of	IN	O	of	_	0	SENT_335	[p19l636t214r703b268],
22	cytochrome	NN	O	cytochrome	nn	23	SENT_335	[p19l716t214r1078b284],
23	P450s	NNS	O	p450	prep_of	20	SENT_335	[p19l1095t213r1298b277],
24	,	,	O	,	_	0	SENT_335	[p19l1095t213r1298b277],
25	CYP2C	NN	O	cyp2c	conj_and	5	SENT_335	[p19l1319t214r1554b268],
26	19	CD	NUMBER	19	num	25	SENT_335	[p19l1565t214r1650b277],
27	,	,	O	,	_	0	SENT_335	[p19l1565t214r1650b277],
28	and	CC	O	and	_	0	SENT_335	[p19l1671t214r1779b268],
29	CYP2C9	NN	O	cyp2c9	conj_and	5	SENT_335	[p19l1796t214r2070b269],
30	in	IN	O	in	_	0	SENT_335	[p19l2089t214r2147b267],
31	a	DT	O	a	det	33	SENT_335	[p19l171t325r203b363],
32	Japanese	JJ	MISC	japanese	amod	33	SENT_335	[p19l218t310r491b378],
33	population	NN	O	population	prep_in	29	SENT_335	[p19l507t308r853b378],
34	,	,	O	,	_	0	SENT_335	[p19l507t308r853b378],
35	Ther	NNP	O	Ther	conj_and	5	SENT_335	[p19l873t308r1028b363],
36	.	.	O	.	_	0	SENT_335	[p19l873t308r1028b363],

1	Drug	NN	O	drug	_	0	SENT_336	[p19l1048t310r1204b378],
2	Monit	NN	O	monit	dep	1	SENT_336	[p19l1221t308r1424b363],
3	.	.	O	.	_	0	SENT_336	[p19l1221t308r1424b363],

1	20	CD	NUMBER	20	number	2	SENT_337	[p19l1445t309r1519b363],
2	(	CD	NUMBER	(	_	0	SENT_337	[p19l1538t309r1621b375],
3	3	CD	NUMBER	3	num	4	SENT_337	[p19l1538t309r1621b375],
4	)	NN	O	)	dep	2	SENT_337	[p19l1538t309r1621b375],
5	(	CD	NUMBER	(	num	6	SENT_337	[p19l1642t309r1842b375],
6	1998	CD	DATE	1998	dep	2	SENT_337	[p19l1642t309r1842b375],
7	)	CD	NUMBER	)	num	8	SENT_337	[p19l1642t309r1842b375],
8	243-247	CD	NUMBER	243-247	dep	6	SENT_337	[p19l1861t309r2144b363],
9	.	.	O	.	_	0	SENT_337	[p19l1861t309r2144b363],

1	[	NN	O	[	nn	5	SENT_338	[p19l7t406r124b471],
2	28	CD	NUMBER	28	num	5	SENT_338	[p19l7t406r124b471],
3	]	CD	NUMBER	]	num	5	SENT_338	[p19l7t406r124b471],
4	H.	NNP	PERSON	H.	nn	5	SENT_338	[p19l169t407r238b460],
5	Takahashi	NNP	PERSON	Takahashi	_	0	SENT_338	[p19l269t406r597b469],
6	,	,	O	,	_	0	SENT_338	[p19l269t406r597b469],
7	H.	NNP	PERSON	H.	nn	8	SENT_338	[p19l627t407r695b460],
8	Echizen	NNP	PERSON	Echizen	appos	5	SENT_338	[p19l726t406r991b469],
9	,	,	O	,	_	0	SENT_338	[p19l726t406r991b469],
10	Pharrnacogenetics	NNP	O	Pharrnacogenetics	appos	5	SENT_338	[p19l1020t406r1580b476],
11	of	IN	O	of	_	0	SENT_338	[p19l1610t405r1677b460],
12	warfarin	NN	O	warfarin	nn	13	SENT_338	[p19l1699t405r1959b460],
13	elimination	NN	O	elimination	prep_of	10	SENT_338	[p19l1986t405r2145b460, p19l169t502r383b556],
14	and	CC	O	and	_	0	SENT_338	[p19l404t502r513b556],
15	its	PRP$	O	its	poss	17	SENT_338	[p19l532t502r602b556],
16	clinical	JJ	O	clinical	amod	17	SENT_338	[p19l624t502r851b556],
17	implications	NNS	O	implication	conj_and	13	SENT_338	[p19l871t502r1269b572],
18	,	,	O	,	_	0	SENT_338	[p19l871t502r1269b572],
19	Clin	NNP	PERSON	Clin	appos	5	SENT_338	[p19l1292t502r1439b556],
20	.	.	O	.	_	0	SENT_338	[p19l1292t502r1439b556],

1	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_339	[p19l1462t502r1940b556],
2	.	.	O	.	_	0	SENT_339	[p19l1462t502r1940b556],

1	40	CD	NUMBER	40	number	2	SENT_340	[p19l1964t502r2039b556],
2	(	CD	NUMBER	(	_	0	SENT_340	[p19l2062t502r2145b569],
3	8	CD	NUMBER	8	num	4	SENT_340	[p19l2062t502r2145b569],
4	)	NN	O	)	dep	2	SENT_340	[p19l2062t502r2145b569],
5	(	CD	NUMBER	(	num	6	SENT_340	[p19l171t596r371b662],
6	2001	CD	DATE	2001	dep	2	SENT_340	[p19l171t596r371b662],
7	)	CD	NUMBER	)	num	8	SENT_340	[p19l171t596r371b662],
8	587-603	CD	NUMBER	587-603	dep	6	SENT_340	[p19l402t596r684b650],
9	.	.	O	.	_	0	SENT_340	[p19l402t596r684b650],

1	[	NN	O	[	nn	5	SENT_341	[p19l7t693r124b758],
2	29	CD	NUMBER	29	num	5	SENT_341	[p19l7t693r124b758],
3	]	CD	NUMBER	]	num	5	SENT_341	[p19l7t693r124b758],
4	G.	NNP	PERSON	G.	nn	5	SENT_341	[p19l170t693r238b747],
5	Charpentier	NNP	PERSON	Charpentier	_	0	SENT_341	[p19l274t692r650b763],
6	,	,	O	,	_	0	SENT_341	[p19l274t692r650b763],
7	L.	NNP	PERSON	L.	nn	8	SENT_341	[p19l684t694r745b747],
8	Vaur	NNP	PERSON	Vaur	appos	5	SENT_341	[p19l779t694r938b756],
9	,	,	O	,	_	0	SENT_341	[p19l779t694r938b756],
10	S.	NNP	PERSON	S.	nn	11	SENT_341	[p19l974t693r1028b747],
11	Halimi	NNP	PERSON	Halimi	appos	8	SENT_341	[p19l1063t692r1293b756],
12	,	,	O	,	_	0	SENT_341	[p19l1063t692r1293b756],
13	F.	NNP	PERSON	F.	nn	14	SENT_341	[p19l1326t694r1376b747],
14	Fleury	NNP	PERSON	Fleury	appos	8	SENT_341	[p19l1411t693r1622b763],
15	,	,	O	,	_	0	SENT_341	[p19l1411t693r1622b763],
16	E.	NNP	PERSON	E.	nn	17	SENT_341	[p19l1655t694r1716b747],
17	Derobert	NNP	PERSON	Derobert	appos	8	SENT_341	[p19l1751t693r2041b756],
18	,	,	O	,	_	0	SENT_341	[p19l1751t693r2041b756],
19	A.	NNP	PERSON	A.	nn	20	SENT_341	[p19l2075t693r2144b747],
20	Grimaldi	NNP	PERSON	Grimaldi	appos	8	SENT_341	[p19l170t789r464b852],
21	,	,	O	,	_	0	SENT_341	[p19l170t789r464b852],
22	et	FW	O	et	nn	23	SENT_341	[p19l487t797r542b843],
23	a1.	FW	O	a1.	appos	8	SENT_341	[p19l562t789r650b852],
24	,	,	O	,	_	0	SENT_341	[p19l562t789r650b852],
25	Predictors	NNS	O	predictor	appos	8	SENT_341	[p19l674t789r983b843],
26	of	IN	O	of	_	0	SENT_341	[p19l1006t789r1073b843],
27	response	NN	O	response	prep_of	25	SENT_341	[p19l1087t806r1355b859],
28	to	TO	O	to	_	0	SENT_341	[p19l1376t797r1433b843],
29	glimepiride	NN	O	glimepiride	prep_to	27	SENT_341	[p19l1455t789r1809b859],
30	in	IN	O	in	_	0	SENT_341	[p19l1830t789r1888b842],
31	patients	NNS	O	patient	prep_in	29	SENT_341	[p19l1907t789r2146b859],
32	with	IN	O	with	_	0	SENT_341	[p19l170t885r305b939],
33	type	NN	O	type	nn	36	SENT_341	[p19l324t893r455b955],
34	2	CD	NUMBER	2	num	36	SENT_341	[p19l475t885r510b938],
35	diabetes	NN	O	diabetes	nn	36	SENT_341	[p19l530t885r781b939],
36	mellitus	NN	O	mellitus	prep_with	31	SENT_341	[p19l800t885r1065b948],
37	,	,	O	,	_	0	SENT_341	[p19l800t885r1065b948],
38	Diabetes	NNP	O	Diabetes	nn	39	SENT_341	[p19l1087t885r1354b939],
39	Metab	NNP	O	Metab	appos	8	SENT_341	[p19l1374t885r1582b939],
40	.	.	O	.	_	0	SENT_341	[p19l1374t885r1582b939],

1	27	CD	NUMBER	27	num	2	SENT_342	[p19l1607t885r1679b939],
2	(	CD	NUMBER	(	_	0	SENT_342	[p19l1702t885r1759b952],
3	5	CD	NUMBER	5	num	4	SENT_342	[p19l1702t885r1759b952],
4	Pt	NN	O	pt	dep	2	SENT_342	[p19l1781t886r1844b939],
5	1	CD	NUMBER	1	number	6	SENT_342	[p19l1870t885r1922b951],
6	)	CD	NUMBER	)	dep	4	SENT_342	[p19l1870t885r1922b951],
7	(	CD	NUMBER	(	num	8	SENT_342	[p19l1946t885r2146b951],
8	2001	CD	DATE	2001	dep	2	SENT_342	[p19l1946t885r2146b951],
9	)	CD	NUMBER	)	num	10	SENT_342	[p19l1946t885r2146b951],
10	563-571	CD	NUMBER	563-571	dep	8	SENT_342	[p19l170t979r453b1033],
11	.	.	O	.	_	0	SENT_342	[p19l170t979r453b1033],

